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ZUSAMMENFASSUNG	  
	  
Alle	   lebenden	   Organismen	   müssen	   ihre	   genetische	   Information,	   welche	   in	   der	   DNA	  
gespeichert	  ist,	  fehlerfrei	  halten	  und	  korrekt	  an	  Tochterzellen	  weitergeben.	  Diese	  Aufgaben	  
werden	   durch	   die	   DNA-­‐Replikation	   und	   -­‐Reparaturmechanismen	   erledigt.	   Falls	   diese	  
Mechanismen	   versagen,	   kann	   die	   Integrität	   des	   Genoms	   beeinträchtigt	   werden	   und	  
Krankheiten	  wie	  zum	  Beispiel	  Krebs	  können	  entstehen.	  
Dem	  DNA2	  Enzym	  werden	  in	  der	  wissenschaftlichen	  Literatur	  überlebenswichtige	  Rollen	  im	  
DNA-­‐Metabolismus	   zugeschrieben.	   In	   menschlichen	   Zellen	   ist	   DNA2	   für	   die	  
Vervollständigung	   der	   DNA-­‐Replikation	   und	   die	   Reparatur	   von	   DNA-­‐Doppelstrangbrüchen	  
mittels	   homologer	   Rekombination	   verantwortlich.	   Des	  Weiteren	   ist	   DNA2	   wichtig	   für	   die	  
Erhaltung	   von	  Telomeren	  und	  der	  mitochondrialer	  DNA.	   In	  Hefezellen	   ist	  DNA2	   zusätzlich	  
für	   die	   Verarbeitung	   von	   Okazaki-­‐Fragmenten	   und	   die	   Aktivierung	   von	   Zellzyklus-­‐
Kontrollpunkten	  von	  Bedeutung.	  
Meine	   Arbeit	   begann	   mit	   der	   Herstellung	   von	   rekombinanten	   Proteinen	   um	   deren	  
Funktionen	   biochemisch	   zu	   untersuchen.	   Ich	   konnte	   das	   menschliche	   DNA2	   Protein	   und	  
seine	   mutierten	   Varianten	   in	   hohen	   Konzentrationen	   und	   in	   aktiver	   Form	   aufreinigen.	  
Später	   habe	   ich	  weitere	   Proteine,	  wie	   zum	  Beispiel	   die	  Helikasen	  WRN	  und	  BLM	  und	  das	  
DNA-­‐Einzelstrang-­‐bindende	  Protein	  RPA	  aufgereinigt.	  
In	   meinen	   Experimenten	   konnte	   ich	   die	   Nuklease-­‐Aktivität	   von	   DNA2	   und	   dessen	  
Regulierung	  durch	  RPA	  bestätigen.	  Frühere	  Studien	  haben	  vorgeschlagen,	  dass	  DNA2	  eine	  
Helikase-­‐Aktivität	  hat,	  die	  jedoch	  umstritten	  war.	  Ich	  konnte	  zeigen,	  dass	  DNA2	  tatsächlich	  
eine	  Helikase-­‐Aktivität	  besitzt.	  DNA2	  interagiert	  mit	  den	  Helikasen	  WRN	  und	  BLM	  während	  
der	   Resektion	   von	  DNA-­‐Enden.	   Ich	   konnte	   demonstrieren,	   dass	   die	   Helikase-­‐Aktivität	   von	  
DNA2	   hilft,	   die	   Resektionmaschinerie	   zu	   beschleunigen.	   Zusätzlich	   zeigten	   unsere	  
Ergebnisse,	   dass	   die	   Motor-­‐Aktivität	   von	   DNA2	   als	   sogenannte	   Translokase	   auf	  
einzelsträngiger	  DNA	  agiert	  und	  die	  Degradation	  davon	  dadurch	  vorantreibt.	  
Ich	  war	  ausserdem	  an	  verschiedenen	  Kollaborationen	  beteiligt:	  Mithilfe	  von	   in	  vitro	  und	   in	  
vivo	  Experimenten	  konnten	  wir	  zeigen,	  dass	  DNA2	  mit	  WRN/BLM	  in	  der	  DNA-­‐Endresektion	  
und	   mit	   WRN	   beim	   Neustart	   von	   DNA-­‐Replikationsgabeln	   verantwortlich	   ist.	   In	   einer	  
weiteren	  Publikation	  haben	  wir	  gezeigt,	  dass	  RPA	  die	  Fähigkeit	  hat	  doppelsträngige	  DNA	  zu	  
öffnen.	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SUMMARY	  
	  
Living	  organisms	  must	  keep	  their	  DNA	  content	  intact	  to	  assure	  the	  integrity	  of	  their	  genomic	  
information.	  DNA	  replication	  and	  DNA	  damage	  repair	  are	  the	  main	  efforts	  to	  accomplish	  this	  
task.	   Hence,	   the	   failure	   of	   these	   mechanisms	   could	   lead	   to	   genomic	   instability	   and	  
subsequently	  development	  of	  diseases	  such	  as	  cancers	  could	  occur.	  
The	  DNA2	  enzyme	  was	   shown	   to	  have	  essential	   roles	   in	  DNA	  metabolism.	   In	  human	  cells	  
DNA2	  was	   implicated	   in	  the	  completion	  of	  DNA	  replication	  and	  the	  repair	  of	  DNA	  double-­‐
strand	  breaks	  via	  the	  homologous	  recombination	  pathway.	  In	  addition,	  DNA2	  was	  shown	  to	  
be	   important	   for	   telomeric	   and	   mitochondrial	   DNA	   maintenance	   as	   well	   as	   Okazaki	  
fragment	  processing	  and	  cell	  cycle	  checkpoint	  activation	  in	  yeast	  cells.	  
My	   PhD	   project	   started	   with	   the	   preparation	   of	   recombinant	   proteins	   that	   allowed	  
biochemical	  investigations	  of	  their	  functions.	  I	  could	  purify	  human	  DNA2	  and	  its	  variants	  in	  
an	   active	   state	   and	   in	   concentrations	   sufficient	   for	   our	   assays.	   Further	   I	   produced	   DNA2	  
partners	  WRN	  and	  BLM	  helicases	  and	  various	  single-­‐stranded	  DNA	  binding	  proteins	  such	  as	  
the	   replication	   protein	   A	   (RPA).	   In	  my	   experiments,	   I	   could	   recapitulate	   DNA2’s	   nuclease	  
activity	   and	   its	   regulation	   by	   RPA.	  While	   in	   the	   absence	   of	   RPA	   DNA2	   degrades	   3’	   or	   5’	  
terminated	  single-­‐stranded	  DNA,	  the	  nuclease	  is	  restricted	  to	  degrade	  5’	  terminated	  DNA	  in	  
the	  presence	  of	  RPA.I	  was	  able	  to	  describe	  the	  helicase	  activity	  of	  human	  DNA2	  nuclease-­‐
deficient	  mutant	  that	  had	  been	  a	  matter	  of	  contradiction	  in	  the	  field.	  We	  observed	  that	  the	  
helicase	  activity	  of	  hDNA2	  is	  cryptic	  and	  it	  is	  masked	  by	  its	  nuclease	  activity.	  Studying	  DNA	  
end	   resection	  processes,	  we	   found	   that	  DNA2	   functionally	   integrates	  with	  BLM	  and	  WRN	  
helicases.	  We	  showed	   that	   the	  helicase	  activity	  of	  DNA2	  acts	  as	  a	  motor	   speeding	  up	   the	  
degradation	  of	  ssDNA	  produced	  by	  its	  helicase	  partners	  WRN	  or	  BLM.	  We	  propose	  that	  the	  
DNA2	  motor	  acts	  as	  a	  translocase	  on	  single-­‐stranded	  DNA	  accelerating	  the	  degradation	  by	  
the	  nuclease	  domain	  of	  hDNA2.	  
I	   also	   participated	   in	   several	   collaborative	   projects	   showing	   that	   DNA2	   cooperates	   with	  
WRN/BLM	  in	  DNA	  end	  resection	  and	  the	  restart	  of	  reversed	  replication	  forks	  with	  WRN	  but	  
not	  BLM	  in	  vitro	  and	  in	  vivo.	  	  Finally,	  we	  showed	  that	  RPA	  possesses	  double-­‐stranded	  DNA	  
melting	  capacity	  and	  characterized	  its	  dynamics	  at	  DNA	  forks.	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1.	  INTRODUCTION	  
	  
Cancer	  is	  a	  general	  term	  for	  a	  broad	  range	  of	  diseases	  that	  can	  affect	  every	  part	  of	  the	  body.	  
During	   the	   development	   of	   cancer,	   cells	   undergo	   a	   transition	   from	   normal	   growth	   to	  
expansion	   in	   an	   uncontrolled	   way	   forming	   new	   tissues	   that	   eventually	   become	   tumours.	  
Some	   cancer	   cells	   acquire	   the	   ability	   to	   grow	  beyond	   their	   natural	   boundaries,	   spread	   all	  
over	  the	  body	  and	  invade	  other	  tissues	  or	  organs,	  leading	  in	  the	  worst	  case	  to	  death	  of	  the	  
whole	  organism.	  Ten	  hallmarks	  of	  cancer	  are	  described	  in	  the	  literature	  so	  far	  (1),	  including	  
deregulating	   cellular	   energetics,	   enabling	   replicative	   immortality	   or	   evading	   growth	  
suppressors.	  Of	  special	  interest	  here	  is	  a	  further	  characteristic	  defined	  as	  genome	  instability	  
and	  mutation.	   The	  DNA	   serves	   as	   the	  main	   carrier	  of	   genomic	   information	   (2).	  When	   the	  
genetic	  information	  is	  changed	  due	  to	  mutations	  or	  larger	  genomic	  rearrangements,	  this	  can	  
lead	   to	   the	   activation	   of	   oncogenes	   or	   to	   the	   loss	   of	   tumour	   suppressors.	   Therefore,	  
maintaining	   genomic	   stability	   is	   a	   fundamental	   task	   during	   the	   entire	   lifespan	   of	   each	  
organism.	  Only	  if	  the	  entire	  information	  stored	  in	  the	  DNA	  is	  constantly	  and	  correctly	  passed	  
from	   one	   cell	   generation	   to	   the	   next	   one	   via	   mitosis	   or	   meiosis	   genomic	   stability	   is	  
guaranteed.	  To	  fulfil	  these	  requirements	  cells	  have	  evolved	  many	  mechanisms	  to	  replicate,	  
repair	   and	   recombine	   their	   DNA	   in	   a	   correct	   way.	   However,	   if	   these	   mechanisms	   fail,	  
genomic	  instability	  could	  become	  a	  consequence	  leading	  to	  pathological	  situations.	  	  
	  
1.1	  DNA	  repair	  mechanisms	  
	  
1.1.1	  General	  overview	  
	  
The	  DNA	   is	   damaged	   through	   the	  whole	   life	   span	   of	   a	   cell.	   Two	  main	   groups	   of	   possible	  
causes	  were	  defined:	  environmental	  influences	  such	  as	  ionizing	  radiation	  (IR),	  UV	  light	  and	  
DNA	  intercalating	  chemicals	  or	  endogenous	  sources	  such	  as	  reactive	  oxygen	  species	  (ROS),	  
replication	   errors	   or	   aberrant	   DNA	   repair	   (3).	   These	   causes	   can	   result	   in	   a	  wide	   range	   of	  
various	  DNA	   lesions,	   including	  DNA	  strand	  breaks	   (due	   to	   ionizing	   radiation	  and	  collapsed	  
replication	   forks),	   dimerization	   of	   thymine	   bases	   (UV),	   oxidation	   of	   bases	   (ROS)	   or	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mismatches	   (incorrect	   replication).	  A	  plethora	  of	  DNA	  repair	  mechanisms	  have	  evolved	   to	  
maintain	  genome	  stability	  (Figure	  1;	  (4)).	  
DNA	   damage	   that	   results	   from	   methylation,	   deamination	   and	   hydroxylation	   of	   bases	   or	  
similar	  lesions	  generated	  by	  reactive	  oxygen	  species	  (ROS)	  and	  do	  not	  alter	  the	  structure	  of	  
the	  DNA	  are	  repaired	  by	  the	  base-­‐excision	  repair	  (BER)	  mechanism.	  In	  the	  BER	  pathway,	  the	  
altered	  bases	  become	  flipped	  out	  of	   the	  DNA	  double	  helix	  and	  are	  subsequently	  removed	  
from	  their	  nucleotide	  backbone	  due	  to	  the	  action	  of	  various	  glycosylases	   (5).	  Additionally,	  
spontaneous	   hydrolysis	   of	   intact	   bases	  may	   also	   result	   in	   an	   abasic	   site	   (6).	   In	   the	   repair	  
pathway	  named	  as	  short-­‐patch	  BER,	  the	  APE1	  endonuclease	  nicks	  the	  strand	  at	  the	  abasic	  
site	  generating	  a	  single-­‐strand	  break	  (7).	  DNA	  polymerase	  β	  (Polβ)	  fills	  the	  single	  nucleotide	  
gap	  and	  removes	  the	  abasic	  nucleotide	  from	  the	  strand	  (8).	  Then	  the	  DNA	  ligase	  1	  re-­‐ligates	  
the	  inserted	  nucleotide	  creating	  an	  intact	  DNA	  strand	  (9).	  In	  long-­‐patch	  BER,	  2-­‐10	  bases	  are	  
replaced	   by	   the	   combined	   action	   of	   Polβ,	   Polδ/ε	   and	   Proliferating-­‐Cell-­‐Nuclear-­‐Antigen	  
(PCNA)	   that	   incorporate	  new	  nucleotides.	   The	   generated	  DNA	   flap	   is	   then	   cleaved	  by	   the	  
FEN1	  nuclease	  and	  the	  DNA	  ligase	  1	  finally	  ligates	  the	  DNA	  strands	  (reviewed	  in	  (10,	  11)).	  
Bulky	  DNA	  lesions	  that	  affect	  the	  structure	  of	  DNA,	   including	  DNA	  adducts	  and	  pyrimidine	  
dimers,	  mainly	  arise	  from	  exogenous	  influences	  such	  as	  oxidative	  damage	  or	  UV	  light	  (12).	  
Nucleotide-­‐excision	  repair	  (NER)	  that	   is	  sub-­‐divided	  into	  global	  genome	  NER	  (GG-­‐NER)	  and	  
transcription-­‐coupled	   repair	   (TCR-­‐NER)	   is	   needed	   to	   repair	   such	   lesions.	   In	   TCR,	   the	   RNA	  
polymerase	   II	   is	   stopped	   by	   a	   DNA	   lesion	   and	   needs	   to	   be	   removed	   giving	   access	   to	   the	  
repair	   pathway	   proteins	   to	   fulfill	   their	   function	   (13).	   GG-­‐NER	   does	   not	   depend	   on	  
transcription	   and	   thus	   only	   differs	   from	   TCR-­‐NER	   the	   initial	   step	   of	   the	   repair	   (14).	  
Components	  of	  multi-­‐subunit	   transcription	   factor	  TFIIH	  unwind	  ~30	  base	  pairs	  around	   the	  
damage	   leading	   to	   the	   formation	   of	   single-­‐stranded	   DNA	   (ssDNA;	   (12)).	   The	   ssDNA	   gets	  
bound	   by	   Replication	   Protein	   A	   (RPA)	   and	   stabilized	   in	   the	   open	   conformation.	   A	   ~24-­‐32	  
nucleotides-­‐long	  gap	   is	  created	  by	  the	  action	  of	  NER-­‐endonucleases	  cleaving	  the	  damaged	  
strand	   up-­‐	   and	   down-­‐stream	   from	   the	   lesion.	   The	   gap	   is	   then	   filled	   and	   ligated	   by	   the	  
regular	   DNA	   replication	   machinery	   creating	   an	   intact	   double-­‐stranded	   DNA	   (dsDNA)	  
molecule	  again	  (reviewed	  in	  (12)).	  
DNA	  polymerase	  errors	   lead	   to	   the	   incorporation	  of	  wrong	  nucleotides	  during	   replication,	  
leading	   to	  mismatches	  or	   short	   insertion-­‐deletion	   loops	   (15).	   Such	   lesions	  are	   repaired	  by	  
the	  mismatch	   repair	   (MMR)	   pathway.	   The	   heterodimer	   hMSH2/hMSH6	   (hMutSα)	   detects	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mismatches	   or	   single-­‐base	   loops	   and	   the	   hMSH2/hMSH3	   (hMutSβ)	   heterodimer	   senses	  
larger	   insertion/deletions	   loops	   (16-­‐18).	  The	  second	  step	   in	  DNA	  mismatch	  repair	   involves	  
the	   recruitment	   of	   additional	   MMR	   factors,	   such	   as	   hMLH1/hPMS2	   (hMutLα)	   and	  
hMLH1/hPMS1	  (hMutLβ)	  and	  the	  nicking	  of	  the	  damaged	  strand	  (18).	  The	  newly	  synthesized	  
strand	   needs	   to	   be	   detected	   during	   this	   process	   to	   determine	   the	   strand	   containing	   the	  
mismatch	   error.	   It	   is	   possible	   that	   this	   identification	   is	   supported	   by	   contact	   with	   the	  
replication	  machinery	  close	  to	  the	  mismatch,	  strand	  discontinuities	  in	  the	  lagging	  strand	  or	  
by	  recently	  misincorporated	  ribonucleotides	  (19).	  Strand	  degradation	  and	  correct	  synthesis	  
of	  the	  lacking	  DNA	  property	  is	  mediated	  by	  many	  proteins	  including	  Polδ/ε,	  RPA,	  PCNA,	  RFC,	  
EXO1	   and	   FEN1	   upon	   the	   recognition	   of	   the	   strand	   containing	   the	   false	   nucleotide(s)	  
(reviewed	  in	  (18,	  20-­‐22)).	  
The	   covalent	   linking	   of	   two	   complementary	  DNA	   strands	   (named	   as	   interstrand	   crosslink,	  
ICL)	  leads	  to	  serious	  issues	  in	  the	  DNA	  metabolism	  since	  both	  replication	  and	  transcription	  
can	  be	  blocked.	  In	  brief,	  the	  linked	  strands	  are	  separated	  and	  the	  damage	  is	  repaired	  by	  the	  
coordinated	  action	  of	  proteins	  of	  the	  Fanconi	  anemia	  (FA)	  pathway	  and	  the	  help	  of	  several	  
additional	  factors	  from	  the	  NER,	  translesion	  synthesis	  (TLS)	  and	  homologous	  recombination	  
(HR)	   pathways	   (reviewed	   in	   (23,	   24)).	   TLS	   polymerases	   have	   the	   ability	   to	   bypass	   such	  
crosslinks	   to	   help	   the	   replication	   fork	   to	   progress	   (25)	   and	   the	   repair	   of	   the	   lesion	   could	  
occur	  subsequently.	  
DNA	   strand	  breaks	   are	   sub-­‐divided	   into	  DNA	   single-­‐strand	  breaks	   and	  DNA	  double-­‐strand	  
breaks	  (DSB).	  DSBs	  occur	  through	  replication	  across	  a	  single-­‐strand	  break	  or	  damage	  caused	  
by	  ionizing	  radiation,	  free	  radicals	  or	  chemicals	  (26).	  In	  the	  case	  of	  a	  DSB	  the	  chromosome	  is	  
separated	   into	   two	  parts	   losing	   the	  covalent	  bonds	   in	   the	  backbone	   in	  both	  DNA	  strands,	  
while	  in	  a	  single-­‐strand	  break	  the	  chromosome	  stays	  as	  an	  entity.	  It	  can	  occur	  that	  the	  DNA	  
ends	  of	  a	  DSB	  are	  chemically	  “clean”,	  for	  example	  after	  a	  restriction	  enzyme	  cleavage,	  and	  
ready	   to	   be	   re-­‐ligated	   immediately.	   However,	   for	   example	   IR	   induces	   DSB	   ends	   that	   are	  
modified	  and	  which	  need	  processing	  of	  the	  molecules	  to	  make	  them	  suitable	  for	  re-­‐ligation	  
(26,	  27).	  Likewise,	  DNA	  breaks	  caused	  by	  aberrant	   topoisomerase	  reactions	   result	   in	  DSBs	  
with	  covalently	  attached	  topoisomerase	  polypeptides	  (28).	  
DSBs	   can	   lead	   to	   point	   mutations	   or	   nucleotide	   insertions	   and	   deletions,	   changing	   the	  
reading	   frameshift,	   but	   also	   to	   chromosomal	   rearrangements	   such	   as	   insertions,	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translocations	  or	  lager	  deletions.	  Nature	  has	  evolved	  various	  pathways	  to	  handle	  the	  repair	  
of	  DSBs.	  
Non-­‐homologous	  end	   joining	   (NHEJ)	   is	  a	  mechanism	  that	   repairs	  broken	  chromosomes	  by	  
ligating	  the	  DNA	  breaks.	  NHEJ	  can	  happen	  during	  the	  whole	  cell	  cycle	  but	  is	  predominant	  in	  
the	  G1	  phase	  and	  is	  considered	  as	  a	  fast	  repair	  mechanism	  compared	  to	  HR	  (29).	  Briefly,	  the	  
NHEJ	  mechanism	  includes	  the	  binding	  of	  the	  Ku70/80	  heterodimer	  to	  the	  two	  ends	  of	  the	  
broken	   chromosome	  most	   likely	   acting	   as	   a	   scaffold	   for	   further	   proteins	   involved	   in	   the	  
NHEJ	  pathway.	  The	  enzyme	  DNA-­‐dependent	  protein	  kinase	  catalytic	   subunit	   (DNA-­‐PKCS)	   is	  
recruited	  to	  DNA	  ends	  via	  the	  Ku70/80-­‐DNA	  complex	  and	  helps	  to	  form	  a	  synaptic	  complex	  
brining	   the	   two	   fragments	   of	   a	   broken	   chromosome	   together.	   The	   DNA	   ends	   are	   then	  
processed	   by	   several	   enzymes	   including	   nucleases	   and	   polymerases	   to	   make	   the	   ends	  
suitable	   for	   re-­‐ligation.	   The	   ligation	   process	   is	   catalyzed	   by	   the	   ligase	   IV/XRCC4	   complex.	  
NHEJ	  is	  considered	  as	  error-­‐prone	  due	  to	  the	  processing	  at	  the	  break	  site	  potentially	  leading	  
to	  mutations	  such	  as	  small	  deletions,	  as	  well	  as	  due	  to	  the	  possible	  ligation	  of	  two	  fragments	  
from	  different	  chromosomes	  leading	  to	  translocations	  (reviewed	  in	  (30,	  31)).	  
In	   the	   S/G2	   phase	   of	   the	   cell	   cycle,	   when	   each	   chromosome	   consists	   of	   two	   sister	  
chromatids,	  homologous	  recombination	  can	  operate	  as	  a	  mechanism	  for	  the	  repair	  of	  DSBs.	  
The	   broken	   chromatid	   is	   processed	   and	   resynthesized	   using	   the	   intact	   chromatid	   as	  
template	  to	  copy	  the	  missing	  information.	  The	  mechanisms	  of	  HR	  are	  explained	  in	  detail	  in	  
the	   next	   section.	   Sister	   chromatid	   is	   preferred	   over	   a	   homologue	   chromosome	   as	   repair	  
template	  during	  HR	  in	  vegetative	  cells	  (32).	  HR	  does	  not	  only	  occur	  to	  repair	  DSBs	  generated	  
upon	  pathological	  DNA	  damage	  events	  but	  also	  during	  meiosis,	  where	  germ	  cells	  use	  DSB	  
formation	  and	  subsequent	  repair	  via	  HR	  with	  preferentially	  the	  homologous	  chromosome	  as	  
a	   template	   to	   increase	   the	   genomic	   diversity	   of	   the	   progeny	   and	   to	   ensure	   proper	  
segregation	  of	  chromosomes	  (33,	  34).	  
Single-­‐strand	   annealing	   (SSA)	   is	   an	   additional	   pathway	   to	   repair	   DSBs	   in	   case	   the	   break	  
occurs	   in	   a	   region	   of	   a	   chromosome	   where	   tandemly	   repeated	   DNA	   sequences	   exist.	  
Similarly,	  as	  in	  HR,	  3’	  overhangs	  are	  produced	  via	  DNA	  end	  resection.	  However,	  the	  resected	  
overhangs	   do	   not	   invade	   another	   chromosome	   but	   can	   anneal	   to	   their	   complementary	  
ssDNA	  sequence.	  Notably,	  the	   interstitial	  DNA	  as	  well	  as	  one	  of	  the	  repeated	  homologous	  
sequences	  are	  lost	  during	  SSA	  (35).	  In	  SSA	  the	  complementary	  sequence	  is	  often	  more	  than	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100	   bp	   in	   size,	   while	   in	   microhomology-­‐mediated	   NHEJ	   (MMEJ	   or	   alternative	   NHEJ)	   the	  
complementary	  DNA	  is	  only	  few	  base	  pairs	  in	  length	  (36).	  
The	   DSB	   repair	   pathway	   choice	   is	   tightly	   regulated	   in	   cells.	   Depending	   on	   the	   cell	   cycle	  
phase,	  cyclin-­‐dependent	  kinases	  (CDKs)	  help	  to	  determine	  which	  mechanism	  is	  used.	  In	  G0	  
and	  G1	  the	  initial	  resection	  of	  a	  DSB	  is	  suppressed	  dependent	  on	  53BP1	  guiding	  the	  repair	  
towards	   canonical	   NHEJ.	   In	   S/G2	   S-­‐phase	   CDKs	   promote	   DNA	   end	   resection	   via	  
phosphorylation	  of	  downstream	  factors	  (such	  as	  Sae2/CtIP)	  leading	  to	  the	  use	  of	  annealing-­‐
dependent	   pathways	   (HR,	   alternative	   NHEJ,	   SSA).	   Furthermore,	   the	   resection/annealing-­‐
dependent	  pathways	  compete	  for	  the	  repair	  of	  DSBs.	   In	  a	  complex	   interplay	  many	  factors	  
regulate	  which	  machinery	  is	  used	  (reviewed	  in	  (37)).	  
	  
Figure	   1:	   Overview	   of	   different	   types	   of	   DNA	   damages,	   their	   sources,	   corresponding	   repair	  
mechanisms	  and	  consequences.	  Multiple	  DNA	  repair	  mechanisms	  cope	  with	  various	  types	  of	  DNA	  
damages	   induced	  by	  different	  DNA	  damaging	   causes.	  DNA	  damage	   can	   lead	   to	   cell-­‐cycle	   arrest	  
providing	   the	   cell	   time	   to	   properly	   repair	   the	   damage.	   Cell	   death	   but	   also	   the	   development	   of	  
diseases	   such	   as	   cancers	   can	   be	   the	   consequences	   if	   the	   repair	   fails.	   Abbreviations:	   cis-­‐Pt,	  
cisplatin;	  MMC,	  mitomycin	  C;	  (6-­‐4)PP,	  6-­‐4	  photoproduct;	  CPD,	  cyclobutane	  pyrimidine	  dimer;	  BER,	  
base-­‐excision	   repair;	   NER,	   nucleotide-­‐excision	   repair;	   HR,	   homologous	   recombination;	   EJ,	   end	  
joining.	  Modified	  from	  (4).	  
	  
replication downstream of the blocking injury. The resulting gap is
filled in by recombinational replication, using the newly synthesized
complementary strand as a template and ignoring the original
lesion-containing one (Fig. 2, follow lower strand). Yeast proteins
implicated in this process, such as the Ubc13/Mms2 complex, are
conserved all the way to mammals. Thus, this largely unexplored 
system undoubtedly exists in humans and may be mportant in 
carcinogenesis. The endpoint of both of these pathways is that dam-
age persists and — when unrepaired — will cause similar problems in
subsequent rounds of replication. This is particularly relevant for
damage that is not efficiently recognized by any mammalian repair
process, such as cyclobutane pyrimidine dimers. 
Double-strand DNA breaks (DSBs) induced by X-rays, chemicals
or during replication of single-strand breaks (SSBs) and presumably
during repair of interstrand crosslinks are particularly relevant for
the recombination machinery. Cells with specialized DNA recombi-
nation activities, such as B- and T-cells, may be very sensitive to DSBs
when they are rearranging their immunoglobin or T-cell-receptor
genes. This explains the frequent involvement of these genetic loci in
oncogenic translocations in leukaemia and lymphomas and the 
preferential induction of these cancers by ionizing irradiation. DSBs
also pose problems during mitosis, as intact chromosomes are a 
prerequisite for proper chromosome segregation during cell 
division. Thus, these lesions frequently induce various sorts of 
chromosomal aberrations, including aneuploidy, deletions (loss of
heterozygosity) and chromosomal translocations — events which
are all intimately associated with carcinogenesis. 
The cell-cycle machinery somehow senses genome injury and
arrests at specific checkpoints in G1, S, G2 and M to allow repair of
lesions before they are converted into permanent mutations
(reviewed in ref. 11). Lesion detection may occur by blocked 
transcription, replication or specialized sensors. When damage is too
significant, a cell may opt for the ultimate mode of rescue by initiating
apoptosis at the expense of a whole cell (see review by Evan and 
Vousden, pages 342–348).
DNA damage repair systems 
In view of the plethora of types of lesions, no single repair process can
cope with all kinds of damage. Instead, evolution has moulded a
tapestry of sophisticated, interwoven DNA repair systems that as a
whole cover most (but not all) of the insults inflicted on a cell’s vital
genetic information. Inherited defects in any of these pathways in
general predisposes to malignancy (Table 1). Because the problem of
DNA damage has existed ab initio, DNA repair systems must have
arisen early in evolution. This explains why all known repair 
pathways are highly conserved (usually across the pro/eukaryotic
evolutionary border). At least four main, partly overlapping damage
repair pathways operate in mammals — nucleotide-excision repair
(NER), base-excision repair (BER), homologous recombination and
end joining12,13. The division of tasks between them can be roughly
defined as follows (see also Fig. 1a). 
NER deals with the wide class of helix-distorting lesions that
interfere with base pairing and generally obstruct transcription and
normal replication. Small chemical alterations of bases are targeted
by BER. These lesions may or may not impede transcription and
replication, although they frequently miscode. BER is therefore par-
ticularly relevant for preventing mutagenesis. Most NER lesions arise
from exogenous sources (except for some oxidative lesions), whereas
BER is mostly, but not exclusively, concerned with damage of
endogenous origin. Lesions for these two repair processes affect only
insight review articles
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Figure 1 DNA damage, repair mechanisms and consequences. a, Common DNA damaging agents (top); examples of DNA lesions induced by these agents (middle); and most
relevant DNA repair mechanism responsible for the removal of the lesions (bottom). b, Acute effects of DNA damage on cell-cycle progression, leading to transient arrest in the G1,
S, G2 and M phases (top), and on DNA metabolism (middle). Long-term consequences of DNA injury (bottom) include permanent changes in the DNA sequence (point mutations
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1.1.2	  Repair	  of	  DNA	  double	  strand	  breaks	  by	  homologous	  recombination	  
	  
Homologous	  recombination	   is	  considered	  as	  a	  mostly	  error-­‐free	  mechanism	  of	  DSB	  repair.	  
DNA	  end	  resection	  is	  required	  as	  a	  start	  point	  for	  every	  HR	  sub-­‐pathway	  (38).	  The	  5’	  to	  3’	  
nucleolytic	  degradation	  of	  the	  broken	  DNA	  ends	  via	  the	  action	  of	  several	  enzymes	  leads	  to	  
the	  production	  of	  a	  3’	  terminated	  overhang	  (reviewed	  in	  (39)).	  This	  resection	  procedure	  is	  
explained	  in	  more	  detail	  below.	  The	  Replication	  Protein	  A	  (RPA),	  known	  for	  its	  high	  affinity	  
to	   ssDNA	   (40),	   covers	   the	   generated	   3’	   terminated	   ssDNA	   overhang.	   Recombination	  
mediators	   such	   as	   Rad52	   and	   Rad51	   paralogues	   (Rad55,	   Rad57)	   in	   yeast	   or	   BRCA2	   and	  
RAD51	  paralogues	  in	  humans	  catalyze	  the	  replacement	  of	  RPA	  with	  RAD51	  or	  DMC1	  (41-­‐43).	  	  
Rad51	  recombinase	  then	  searches	  for	  homologous	  sequences	  in	  other	  DNA	  molecules	  (44).	  
Rad51	  can	  bind	  two	  different	  DNA	  strands	  bringing	  them	  into	  close	  proximity	  (reviewed	  in	  
(45)).	  Upon	  a	  stable	   interaction,	   the	   invasion	  of	   the	  3’	  overhang	   into	   the	  double-­‐stranded	  
sister	   chromatid	   (or	   the	   homologous	   chromosome)	   leads	   to	   a	   displacement	   loop	   (D-­‐loop,	  
(46,	  47)).	  However,	  the	  exact	  mechanism	  and	  the	  timing	  of	  the	  homology	  search	  are	  still	  a	  
matter	  of	  discussion	   (45).	  The	   invading	  3’	   terminated	  strand	  serves	  as	  a	  primer,	  while	   the	  
recipient	  DNA	  strand	  acts	  as	  a	  template	  for	  the	  DNA	  synthesis	  by	  DNA	  polymerases.	  The	  3’	  
overhang	   is	   extended	   until	   it	   can	   be	   ligated	   to	   the	   5’	   end	   of	   the	   other	   end	   of	   the	   DSB	  
without	   losing	  any	  genomic	   information	   (35).	   In	  a	  process	   termed	  as	   second-­‐end	  capture,	  
the	   other	   (resected)	   end	   of	   a	   DSB	   can	   either	   anneal	   to	   the	   D-­‐loop	   or	   invade	   the	   intact	  
molecule	  as	  well	  using	  either	  one	  as	  synthesis	   template.	  The	   resulting	  structure	   linking	   to	  
two	  different	  DNA	  molecules	   is	   termed	  as	  a	  double	  Holliday	   junction	   (dHJ,	   (48)).	  Rad52	   is	  
considered	  as	  a	  key	  protein	   in	  the	  second-­‐end	  capture	  process	   in	  yeast.	  Rad52	  can	  anneal	  
ssDNA	   bound	   by	   RPA	   to	   the	   other	   end	   of	   the	   DSB	   forming	   a	   double	   Holliday	   junction.	  
RAD52,	  the	  human	  homolog	  of	  yeast	  Rad52,	  shows	  strand	  annealing	  capability	  in	  the	  human	  
system	  as	  well	  but	  most	  likely	  there	  are	  other	  proteins	  for	  example	  BRCA2	  having	  redundant	  
functions	  (49,	  50).	  
Various	  mechanisms	  have	  been	  described	   to	   resolve	  dHJs	   in	  order	   to	   finish	  HR	   leading	   to	  
two	  intact	  and	  separate	  DNA	  molecules.	  In	  a	  process	  called	  resolution,	  the	  cleavage	  of	  a	  dHJ	  
via	  human	  MUS81-­‐EME1,	  SLX1-­‐SLX4	  or	  GEN1	  endonucleases	   results	   in	  either	   crossover	  or	  
non-­‐crossover	   products	   depending	   on	   the	   symmetry	   of	   the	   cleavage	   (51).	   A	   dissolution	  
pathway	  exists	   in	  addition	  to	   the	  resolution	  pathway.	  The	  BLM	  (Bloom	  syndrome	  protein)	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helicase	   in	   concert	   with	   TopoIIIα	   topoisomerase	   and	   RMI1/2	   can	   dissolve	   dHJ	   leading	   to	  
non-­‐crossover	  products	  (51).	  However,	  the	  classical	  HR	  sub-­‐pathway	  involving	  the	  formation	  
and	  resolution/dissolution	  of	  dHJ	  is	  neither	  considered	  as	  the	  only	  nor	  as	  the	  most	  common	  
HR	  pathway.	  
During	  Synthesis-­‐dependent	  strand	  annealing	  (SDSA)	  the	  invading	  strand	  is	  elongated	  after	  
D-­‐loop	   formation	   but	   then	   released	   from	   the	   intact	   DNA	   molecule	   without	   subsequent	  
second-­‐end	   capture.	   Complementary	   sequences	   in	   the	   newly	   synthesized	   strand	   help	   to	  
anneal	  to	  the	  other	  chromosome	  part	  and	  to	  re-­‐ligate	  the	  two	  fragments.	  SDSA	  leads	  to	  a	  
non-­‐crossover	  product	  (Figure	  2;	  (35,	  41)).	  
In	   a	   third	   HR	   sub-­‐pathway	   termed	   as	   break-­‐induced	   replication	   (BIR),	   the	   3’	   terminated	  
ssDNA	  from	  a	  broken	  fragment	  end	  invades	  an	  intact	  template	  chromosome	  and	  copies	  the	  
whole	   missing	   sequence	   to	   restore	   a	   complete	   chromosome.	   Repairing	   DSB	   via	   BIR	   can	  
result	  in	  a	  phenomenon	  called	  loss	  of	  heterozygosity	  (LOH)	  if	  the	  homologous	  chromosome	  
is	   used	   as	   template	   since	   both	   resulting	   chromosomes	   show	   then	   the	   same	   genetic	  
information	  in	  the	  whole	  newly	  synthesized	  part	  (compared	  to	  only	  partial	  overlaps	  due	  to	  
SDSA	  or	  dHJ	  pathways;	  Figure	  2;	  (35,	  41)).	  
	  
	  
Figure	   2:	   Scheme	   of	   DSB	   repair	   pathways.	   DNA	   double	   strand	   breaks	   are	   repaired	   using	  
Non-­‐Homologous	   End	   Joining	   (NHEJ),	   Single-­‐Strand	   Annealing	   (SSA)	   and	   Homologous	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Recombination	   (HR).	   NHEJ	   is	   sub-­‐divided	   into	   canonical	   and	   alternative	   (also	   known	   as	  
microhomology-­‐mediated	  end	  joining,	  MMEJ,	  not	  indicated	  here).	  HR	  consist	  of	  the	  double	  
Holliday	   Junction	   (dHJ),	   Synthesis	   Dependent	   Strand	   Annealing	   (SDSA)	   and	   Break-­‐Induced	  
Replication	   (BIR,	   leading	   to	   loss	   of	   heterozygosity	   (LOH)).	   Yeast	   proteins	   are	   indicated	   in	  
blue,	  human	  proteins	  in	  brown.	  Modified	  from	  (35).	  
	  
1.1.3	  Regulation	  of	  HR	  initiation	  
	  
Cells	  have	   to	  determine	  which	   repair	  pathway	   to	  use	  upon	  a	  DSB	  has	  occurred.	  DNA	  end	  
resection	   is	   an	   initial	   and	   essential	   process	   for	   DSB	   repair	   by	   homologous	   recombination	  
(38).	  
In	  eukaryotic	  cells,	  it	  seems	  that	  the	  phosphorylation	  of	  Sae2	  in	  yeast	  or	  CtIP	  in	  humans	  by	  
cyclin-­‐dependent	  kinases	  (CDKs)	   is	  a	  common	  mechanism	  to	  commit	  DSB	  repair	  to	  HR.	  Six	  
different	  CDKs	  driving	  cell-­‐cycle	  progression	  were	  described	  in	  mammals	  compared	  to	  one	  
in	  the	  yeast	  system.	  These	  six	  different	  CDKs	  vary	  in	  their	  importance	  from	  tissue	  to	  tissue	  
and	  cell	  cycle	  phase	  (35).	  In	  yeast	  Sae2	  is	  phosphorylated	  by	  Cdc28	  at	  serine	  267	  mediating	  
DSB	  end	  resection	  (52,	  53).	  Replacing	  Sae2	  S267	  to	  a	  non-­‐phosphorylatable	  alanine	  leads	  to	  
a	  mutant	   phenotype	   showing	  unresected	  DSBs	   similar	   like	   in	   sae2Δ	  mutants	   (52).	  On	   the	  
other	  hand,	  changing	  S267	  to	  the	  phosphomimetic	  aspartic	  acid	  gives	  rise	  to	  cells	  that	  show	  
extensive	  DSB	   resection	   (52).	  CtIP,	   the	  human	  homolog	  of	   Sae2,	   fulfills	   similar	   function	   in	  
the	  initiation	  of	  DSB	  end	  resection	  (54).	  CtIP	  threonine	  847	  phosphorylation	  is	  essential	  for	  
DNA	   end	   resection.	   Replacing	   T847	   by	   alanine	   abolishes	   resection	   while	   introducing	   the	  
phosphomimetic	   mutation	   results	   in	   DSB	   resection	   even	   upon	   CDK	   inhibition	   (55).	   Both	  
Mre11	   and	   Xrs2	   show	   residues	   that	   are	   potential	   CDK	   targets.	   However,	   mutating	   these	  
residues	  does	  not	  change	  the	  resection	  phenotype	  in	  mutant	  cells	  (53).	  	  
While	  phosphorylation	  of	  Sae2/CtIP	  initiates	  DSB	  end	  resection	  and	  will	  be	  covered	  in	  more	  
detail	   later,	  phosphorylation	  of	  Exo1	  by	  Rad53	  reduces	  its	  nuclease	  activity	  (56).	   In	  human	  
cells	  EXO1	  phosphorylation	  by	  ATR	   (ataxia	   telangiectasia	  and	  Rad3-­‐related	  protein)	  kinase	  
targets	  the	  enzyme	  for	  degradation	  (57).	  
	   	  
	   	   INTRODUCTION	  
	   15	  
1.2	  Biochemistry	  and	  functions	  of	  DNA2	  
	  
1.2.1	  Overview	  of	  human	  and	  yeast	  DNA2	  
	  
Saccharomyces	  cerevisiae	  Dna2	  (DNA	  replication	  ATP-­‐dependent	  helicase/nuclease,	  yDna2)	  
is	  described	  as	  a	  protein	  with	  a	  wide	  variety	  of	  functions	  in	  the	  eukaryotic	  DNA	  metabolism.	  
Previously,	   it	  was	   shown	   that	   yDna2	   participates	   in	  Okazaki	   fragment	   processing	   (58-­‐60),	  
telomere	   maintenance	   (61),	   aging	   (62),	   long-­‐patch	   base	   excision	   repair	   (63)	   and	   the	  
processing	  of	  intermediates	  at	  stalled	  replication	  forks	  (64,	  65).	  
The	  yDna2	  polypeptide	  consists	  of	  a	  RecB	  family	  nuclease	  domain	  (Figure	  3),	  whose	  function	  
can	  be	  suppressed	  by	  a	  substitution	  of	  the	  glutamic	  acid	  at	  position	  675	  to	  alanine	  (E675A,	  
(66)).	  yDna2	  shows	  single-­‐strand	  DNA	  specific	  nuclease	  activity	  with	  both	  5'-­‐3'	  as	  well	  as	  3'-­‐
5'	   polarity,	   whereas	   in	   the	   presence	   of	   yeast	   RPA	   (yRPA)	   5'	   tailed	   DNA	   substrates	   were	  
preferred	   (67,	   68).	   Beside	   its	   more	   prominent	   nuclease	   activity,	   yDna2	   contains	   a	  
superfamily	  I	  helicase	  domain	  located	  in	  the	  C-­‐terminal	  region	  of	  the	  protein	  showing	  5'-­‐3'	  
helicase	  activity	   (69,	  70).	  The	  helicase	  function	   is	  dependent	  on	  the	  hydrolysis	  of	  ATP	  (71)	  
and	  mutating	  the	  amino	  acid	  residue	  1080	  from	  lysine	  to	  glutamic	  acid	  (K1080E)	  abrogates	  
the	  ATPase	  and	  the	  helicase	  activity	  (71).	  In	  contrast	  to	  its	  nuclease	  activity,	  yDna2	  helicase	  
activity	  was	  believed	  to	  be	  weak	  and	  to	  play	  only	  a	  minor	  role	   in	   its	   function	  (59,	  69,	  72).	  
However,	   more	   recently	   it	   was	   shown	   that	   yDna2	   exhibits	   a	   strong	   helicase	   activity	  
comparable	   to	   the	   most	   efficient	   helicases	   in	   eukaryotes	   (70).	   The	   helicase	   function	   of	  
yDna2	   is	   regulated	   by	   the	   protein's	   nuclease	   function	   (70).	   Nuclease-­‐deficient	   yDna2	  
preferentially	   binds	   to	   ssDNA	   structures	   and	   its	   helicase	   activity	   is	   the	   highest	  when	   a	   5'	  
overhang	  is	  present	  (70).	  However,	  the	  nuclease	  of	  the	  wild	  type	  enzyme	  degrades	  these	  5'	  
overhangs	   and	   therefore	   lowers	   the	  binding	   to	   the	   substrates	   that	   is	   prerequisite	   for	   the	  
helicase	  function	  (70).	  Thus,	  the	  helicase	  activity	  of	  yDna2	  is	  cryptic	  and	  becomes	  apparent	  
upon	   inactivation	  of	   the	  nuclease	   (70).	  Yeast	   cells	  expressing	   the	  helicase-­‐deficient	  yDna2	  
protein	   are	   only	   viable	   under	   certain	   growth	   conditions,	   but	   highly	   sensitive	   to	   DNA	  
damaging	  agents,	  while	  the	  nuclease	  function	  of	  yDna2	  is	  essential	  (71,	  73).	  Dna2	  seems	  to	  
be	   largely	   conserved	   from	   yeast	   to	   human,	   although	   significant	   differences	   exist	   and	   the	  
function	  of	   the	  human	  DNA2	  (hDNA2)	   in	  DNA	  metabolism	   is	  not	  completely	  clear.	  Human	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DNA2	   consists	   of	   1060	   amino	   acids	   and	   contains	   a	   nuclease-­‐	   and	   a	   helicase-­‐domain	   like	  
yDna2,	   while	   the	   N-­‐terminal	   region	   is	   missing	   (Figure	   3;	   (74)).	   Human	   cells	   depleted	   of	  
hDNA2	  show	  genomic	  instability	  (75)	  and	  a	  high	  expression	  of	  hDNA2	  negatively	  correlated	  
with	   the	   disease	   outcome	   in	   human	   cancers	   (76).	   Heterozygous	   DNA2+/−	   mice	   showed	  
higher	  cancer	  susceptibility	  than	  wild	  type	  mice	  and	  the	  complete	  knockout	  of	  DNA2	  leads	  
to	  embryonic	  lethality	  (77).	  
Yeast	  and	  human	  DNA2	  contain	  an	  iron-­‐sulfur	  cluster	  consisting	  of	  an	  iron	  ion	  coordinated	  
by	   four	   cysteine	   residues	   located	   in	   the	   nuclease	   domain.	   The	   putative	   role	   of	   the	   iron-­‐
sulfur	   could	  be	   the	   stabilization	  of	   the	  protein’s	   structure	   (78,	   79).	  Mutating	   the	   cysteine	  
residues	  in	  the	  yeast	  protein	  led	  to	  decreased	  nuclease	  and	  ATPase	  activity	  (78).	  Due	  to	  the	  
iron-­‐sulfur	  cluster	  the	  protein	  is	  very	  prone	  to	  oxidation	  and	  likely	  unstable.	  yDna2	  showed	  
highly	   specific	   ssDNA	   nuclease	   activity	   and	   helicase	   function	   upon	   minimizing	   oxidation	  
during	  the	  protein	  purification	  and	  reducing	  the	  duration	  of	  the	  procedure	  (67,	  70)	  	  
	  
Figure	   3:	   Schematic	   overview	   of	   the	   yeast	   enzyme	   yDna2	   and	   the	   human	   homologue	  
hDNA2	   (courtesy	   of	   P.	   Cejka).	   Both	   enzymes	   contain	   a	   nuclease-­‐	   and	   helicase-­‐domain	  
whereas	   the	  N-­‐terminal	   regulatory	  domain	   is	   lacking	   in	  hDNA2.	  Mutations	   inactivating	   the	  
respective	  biochemical	  activity	  are	  indicated.	  
	  
1.2.2	  DNA2	  in	  Okazaki	  fragment	  processing	  
	  
Before	  each	  cell	  division,	  cells	  must	  double	  their	  complete	  genetic	  information	  to	  pass	  it	  on	  
to	  the	  next	  generation.	  The	  copying	  of	  the	  DNA	  occurs	  during	  the	  S-­‐phase	  of	  the	  cell	  cycle.	  
The	   replication	   machinery	   uses	   both	   strands	   of	   a	   double-­‐stranded	   DNA	   molecule	   as	  
templates	  (reviewed	  in	  (80)).	  However,	  eukaryotic	  DNA	  polymerases	  can	  only	  synthesize	  the	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new	  DNA	  strand	   in	  5’-­‐3’	  direction	   (81).	  Since	   the	  opening	  of	   the	  dsDNA	  and	  the	  synthesis	  
occurs	  almost	  at	  the	  same	  time,	  only	  one	  strand	  can	  be	  synthesized	  in	  a	  continuous	  manner	  
(leading	  strand),	  while	  the	  other	  one	  (lagging	  strand)	  is	  synthesized	  discontinuously	  starting	  
at	  many	  origins	   forming	   the	  Okazaki	   fragments	   (82).	   The	   replication	  machinery	  opens	   the	  
dsDNA	   molecule	   and	   Pol	   α	   (DNA	   polymerase	   alpha	   catalytic	   subunit)-­‐primase	   complex	  
synthesizes	  RNA-­‐DNA	  primers	  needed	  for	   the	  replicative	  polymerases	  to	  start	   (83).	  Such	  a	  
primer	   usually	   consists	   of	   ~10	   RNA	   followed	   by	   ~20	   DNA	   subunits	   (84).	   Pol	   δ	   (DNA	  
polymerase	   delta)	   continues	   replicating	   the	  DNA	   (85)	   until	   after	   ~150	   (in	   eukaryotes)	   the	  
replication	  machinery	   hits	   a	   downstream	   primer	   of	   the	   lagging	   strand.	  While	   Escherichia	  
coli’s	   DNA	   polymerase	   I	   has	   5'	   to	   3'	   exonuclease	   activity	   and	   can	   remove	   a	   primer	   (86),	  
eukaryotic	  polymerases	  do	  not	  exhibit	  this	  5'	  to	  3'	  exonuclease	  activity	  (86).	  In	  addition,	  Pol	  
α	   is	   lacking	  a	  proofreading	  activity,	  making	   the	  DNA	  part	  of	   every	  primer	  prone	   to	  errors	  
(87).	  Therefore,	  it	  is	  essential	  to	  remove	  not	  only	  the	  RNA	  portion,	  but	  also	  the	  DNA	  part	  of	  
a	  primer	  in	  order	  to	  reduce	  the	  risk	  of	  mutagenesis	  (88,	  89).	  The	  current	  model	  for	  Okazaki	  
fragment	  processing	  suggests	  that	  Pol	  δ	  converts	  the	  RNA-­‐DNA	  primer	  into	  a	  5’	  flap	  during	  
the	  synthesis	  of	  the	  DNA	  strand	  in	  a	  process	  termed	  strand	  displacement	  synthesis	  (58,	  90,	  
91).	  This	  is	  stimulated	  by	  the	  helicase	  Pif1,	  which	  leads	  to	  longer	  5'	  flaps	  (92,	  93).	  These	  flap	  
structures	  need	  to	  be	  removed	  to	  allow	  ligation	  of	  Okazaki	  fragments	  forming	  a	  continuous	  
linear	  duplex	  DNA	  molecule	  again	  (94,	  95).	  
Short	  flaps	  generated	  during	  lagging	  strand	  replication	  are	  degraded	  by	  FEN1	  (Rad27/Fen1	  
in	   yeast),	   a	   5'	   to	   3'	   flap	   endonuclease	   (96).	   RPA	   covers	   the	   single-­‐stranded	   5’	   flap	   if	   it	  
becomes	  longer	  than	  20-­‐25	  nts	  due	  to	  RNA-­‐DNA	  primer	  displacement	  by	  Polδ.	  RPA	  inhibits	  
Fen1	  cleavage	  but	  stimulates	  yDna2	  cleavage	  of	   the	   flap	   (58).	  yDna2	  cleaves	   the	   long	   flap	  
generating	  a	  shorter	  one,	  that	  does	  not	  bind	  RPA	  and	  subsequently	  can	  be	  cleaved	  by	  Fen1.	  
RPA	   plays	   an	   important	   regulatory	   role	   in	   the	   two-­‐step	   processing	   of	   long	   flaps	   (58).	  
Previously,	  yDna2	  was	  shown	  to	  be	   incapable	  of	   the	   flap	  processing	  on	   its	  own,	  and	  Fen1	  
was	   believed	   to	   function	   downstream	   of	   Dna2	   in	   all	   cases	   (58).	   Short	   flaps	   can	   be	   also	  
degraded	  by	  other	  nucleases	  such	  as	  Exo1,	  which	  becomes	  essential	  when	  Fen1	   is	  absent	  
(97),	  and	  the	  overexpression	  of	  Exo1	  suppresses	  growth	  defects	  observed	  in	  yDna2	  mutants	  
(98).	  The	  DNA	  ligase	  I	  ligates	  the	  nicked	  double-­‐stranded	  DNA	  after	  the	  flap	  is	  removed	  (63,	  
99).	  
	   	   INTRODUCTION	  
	   18	  
yDna2	  is	  an	  essential	  protein	  in	  yeast	  (71,	  100).	  However,	  cells	  lacking	  yDna2	  became	  viable	  
when	  the	  generation	  of	  long	  5’	  flaps	  was	  suppressed	  in	  pif1-­‐m2	  mutants	  (101).	  This	  finding	  
strongly	  indicates	  that	  the	  essential	  function	  of	  yDna2	  is	  the	  removal	  of	  long	  5’	  flaps	  (101),	  
and	   that	   long	   flaps	   that	   necessitate	   Dna2	   functions	   only	   occur	   when	   Pif1	   is	   present.	  
Furthermore,	   growth	   defects	   that	  were	   observed	   in	   cells	   that	  were	   rad27	   (Fen1)	   deleted	  
were	   rescued	   by	   yDna2	   overexpression	   (102),	   showing	   that	   Dna2	   can	   partially	   process	  
Fen1's	  substrates.	   In	  addition,	  overexpression	  of	  Fen1	  helped	  to	  overcome	  the	   lethality	  of	  
dna2	   deleted	   cells	   (102).	   This	   indicated	   that	   yDna2	   and	   Fen1	   might	   work	   in	   separate	  
pathways.	   However,	   in	   vitro	   reconstitution	   assays	   of	   Okazaki	   fragment	   processing	   using	  
recombinant	  yDna2	  suggested	  that	  yDna2	  was	  not	  able	  to	  cleave	  the	  flap	  on	  its	  own	  since	  
the	   enzyme	   left	   a	   ~5-­‐8	   nt	   long	   flap	   that	   would	   require	   the	   cleavage	   by	   an	   additional	  
nuclease	  (58,	  60,	  69).	   In	  contrast	  to	  this,	  new	  findings	  could	  show	  that	  yDna2	  was	  able	  to	  
cleave	  the	  flap	  near	  its	  base	  leading	  to	  a	  product	  that	  could	  be	  ligated	  by	  the	  DNA	  Ligase	  1	  
and	   therefore	   accomplish	   Okazaki	   fragment	   maturation	   on	   its	   own	   without	   the	   need	   of	  
Fen1	  in	  vitro	  (103).	  
hDNA2	   is	   essential	   in	   the	   human	   DNA	   metabolism	   (75).	   However,	   in	   contrast	   to	   yeast,	  
where	   the	   essential	   role	   of	   yDna2	   is	   strongly	   linked	   to	   replication	   and	   Okazaki	   fragment	  
processing,	   the	   function	   in	  human	   cells	   is	   less	   clear.	  Human	  FEN1	   is	   essential	   for	  Okazaki	  
fragment	  maturation,	  while	  the	  depletion	  of	  hDNA2	  did	  not	  result	  in	  a	  detectable	  defect	  in	  
Okazaki	   fragment	   processing	   (75).	   No	   significant	   differences	   in	   the	  DNA	  maturation	  were	  
observed	  comparing	  FEN1	  single	  mutants	  to	  FEN1-­‐hDNA2	  co-­‐depleted	  mutants	  (75).	  These	  
findings	   indicated	   that	   hDNA2	  may	   possess	   distinct	   function	   in	   DNA	   replication	   than	   the	  
processing	  of	  Okazaki	  fragments	  (75).	  Importantly,	  hDNA2-­‐depleted	  cells	  showed	  more	  DNA	  
damage	   than	   FEN1-­‐depleted	   cells,	   while	   the	   depletion	   of	   hDNA2	   did	   not	   change	   the	  
replication	   fork	   rate	   (75).	   Together	   these	   results	   indicate	   that	   hDNA2	   contribute	   to	   DNA	  
integrity	  with	  other	  yet	  unknown	  functions,	  but	  not	  via	  Okazaki	  fragment	  processing	  (75).	  Of	  
note,	   it	   is	   also	  possible	   that	   the	   contribution	  of	   hDNA2	   in	  Okazaki	   fragment	  processing	   is	  
very	   limited	   in	   human	   cells	   and	   escaped	   the	   limit	   of	   detection	   in	   the	   performed	   assays.	  
Ectopic	  expression	  of	  either	  nuclease-­‐	  or	  helicase-­‐deficient	  hDNA2	  in	  hDNA2-­‐depleted	  cells	  
did	   not	   rescue	   the	   mutant	   phenotype	   indicating	   that	   both	   functions	   are	   essential	   for	  
genome	  integrity	  (75).	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1.2.3	  DNA2	  in	  the	  DNA	  double	  strand	  break	  end	  resection	  
	  
The	   resection	  of	   the	  broken	  DNA	  ends	  after	  a	  DSB	   is	   the	   initial	   step	   towards	  homologous	  
recombination	  (38).	  A	  3’	  overhanged	  DNA	  molecule	  is	  generated	  by	  the	  specific	  nucleolytic	  
degradation	   of	   the	   5’	   terminated	   strand	   (39).	   This	   3’	   terminated	   moiety	   will	   invade	   a	  
template	   DNA	   molecule	   after	   successful	   homology	   search	   and	   will	   serve	   to	   prime	   DNA	  
synthesis	  (45).	  At	  least	  three	  nucleases	  including	  MRE11,	  EXO1	  and	  DNA2	  are	  suggested	  to	  
be	  involved	  in	  the	  current	  models	  for	  DNA	  end	  resection	  (39,	  104).	  
Mre11,	  as	  part	  of	  the	  MRX	  (Mre11,	  Rad50,	  Xrs2)	  complex,	  together	  with	  Sae2	  are	  proposed	  
to	  catalyze	  the	  initial	  steps	  in	  DSB	  processing	  in	  the	  yeast	  system	  (39).	  This	  short-­‐range	  end	  
resection	  removes	  about	  50-­‐100	  nucleotides	  at	  a	  DSB	  (104).	  Mre11	  was	  initially	  described	  to	  
possesses	  a	  3’-­‐5’	  exonuclease	  activity	  that	  cannot	  be	  responsible	  for	  the	  5’-­‐3	  cleavage	  that	  is	  
needed	  for	  establishing	  a	  long	  3’	  overhang	  (105).	  Later,	  it	  was	  shown	  that	  Mre11	  exhibits	  an	  
endonuclease	   activity	   that	   can	   nick	   the	   DNA	   strand	   near	   the	   DSB	   from	  where	   then	   DNA	  
degradation	  could	  start	  (106).	  The	  current	  model	  suggests	  that	  MRX	  nicks	  the	  5’	  terminated	  
DNA	   strand	   in	   an	   Sae2-­‐dependent	   manner	   (107).	   The	   incised	   strand	   is	   then	   degraded	  
towards	  the	  DSB	  most	  likely	  using	  the	  3’-­‐5’	  nuclease	  of	  Mre11.	  It	  was	  shown	  that	  the	  nicking	  
activity	  of	   the	   complex	   is	   strictly	  dependent	  on	   the	  ATP	  hydrolysis	   function	  of	  Rad50	  and	  
highly	   stimulated	   by	   phosphorylated	   Sae2	   (107).	   The	   Xrs2	   subunit	   is	   dispensable	   for	   the	  
nicking,	   though	  needed	   for	   the	  nuclear	   localization	  of	   the	  MRX	   complex	   as	  well	   as	   for	   its	  
function	  other	  than	  DNA	  end	  resection,	  namely	  in	  Tel1	  signaling	  and	  NHEJ	  (108).	  The	  human	  
MRN	  (MRE11,	  RAD50,	  NBS1)	  complex	  endonuclease	  activity	  was	  shown	  to	  have	  very	  similar	  
roles	  in	  DNA	  end	  resection	  as	  MRX,	  but	  its	  function	  is	  completely	  dependent	  on	  NBS1	  (the	  
homolog	   of	   yeast	   Xrs2)	   as	   well	   as	   on	   phosphorylated	   CtIP	   (the	   homolog	   of	   yeast	   Sae2,	  
(109)).	  
Two	  separate	  pathways	  are	  responsible	  for	  the	  extended	  DNA	  end	  resection.	  The	  helicase	  
Sgs1	  in	  a	  synergy	  with	  the	  nuclease	  activity	  of	  yDna2	  or	  the	  exonuclease	  Exo1	  catalyze	  the	  
long-­‐range	  5’-­‐3’	   degradation	  of	   broken	  DNA	  ends	   leading	   to	   3’	   overhangs	  of	   hundreds	   to	  
thousands	   of	   nucleotides	   in	   length	   (110,	   111).	   Biochemical	   analysis	   of	   the	   Sgs1-­‐yDna2	  
pathway	  suggested	  that	  the	  DNA	  unwinding	  activity	  of	  Sgs1	  as	  well	  as	  the	  nuclease	  activity	  
of	   yDna2	   were	   essential	   for	   DNA	   resection	   while	   the	   helicase-­‐deficient	   version	   of	   yDna2	  
possessed	  less	  efficient	  degradation	  capacity	  (67).	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Purified	   yDna2	   exhibits	   ssDNA-­‐dependent	   3’-­‐5’	   and	   5’-­‐3’	   nuclease	   activities	   (59).	   Adding	  
yRPA	  to	  the	  reaction	  mixture	  modulates	  the	  polarity	  of	  yDna2	  nuclease	  by	  abolishing	  the	  3’-­‐
5’	   and	   stimulating	   the	   5’-­‐3’	   degradation	   (67,	   68).	   This	   preference	   for	   the	   5’	   terminated	  
ssDNA	   strand	   fits	   very	  well	   to	   the	   in	   vivo	   DNA	   end	   resection	  model	  where	   exclusively	   3’	  
overhanged	  DNA	  ends	  are	  produced	  by	  yDna2.	  Supplementing	  the	  reaction	  with	  E.	  coli	  SSB	  
inhibited	   the	   yDna2	   nuclease	   completely	   indicating	   that	   the	   ability	   of	   yRPA	   to	   regulate	  
yDna2	  is	  specific	  (67).	  
Sgs1	   functions	  as	   a	  helicase	   to	  unwind	  dsDNA	   to	   ssDNA	   that	   then	   serves	  as	   substrate	   for	  
nucleolytic	  degradation	  by	  yDna2.	  Sgs1	  and	  yDna2	  are	   form	  a	   functional	  cognate	  complex	  
since	   neither	   Pif1	   nor	   Srs2	   helicases	   could	   show	   similar	   synergistic	   effects	   in	   dsDNA	  
degradation	   in	  concert	  with	  yDna2	  (67).	  E.	  coli	  RecQ	  helicase	  could	  only	  support	  yDna2	   in	  
DNA	  resection	  at	  1000-­‐fold	  higher	  concentrations	  (67).	  Furthermore,	  it	  was	  shown	  that	  Sgs1	  
physically	   interacts	   with	   yDna2	   and	   that	   the	   Top3-­‐Rmi1	   complex	   increases	   the	   DNA	  
resection	  capability	  of	  the	  Sgs1-­‐yDna2	  complex	  (67).	  The	  stimulatory	  effects	  of	  Top3-­‐Rmi1	  
on	  Sgs1-­‐yDna2	  are	  more	  likely	  due	  to	  the	  stimulation	  of	  the	  Sgs1	  helicase	  than	  via	  increasing	  
the	  nuclease	  of	  yDna2.	  In	  addition,	  the	  MRX	  complex	  helps	  to	  recruit	  Sgs1	  to	  DNA	  ends	  and	  
therefore	   enhances	   the	   degradation	   capacity	   of	   the	   Sgs1-­‐yDna2	   complex	   (67).	   Figure	   4	  
summarizes	  the	  DNA	  end	  resection	  in	  the	  yeast	  system.	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Figure	   4:	   Schematic	   overview	   of	   the	   DNA	   end	  
resection	  in	  budding	  yeast.	  The	  MRX	  complex	  is	  
rapidly	   recruited	   to	   blocked	  DNA	  ends	   followed	  
by	   Sae2.	   MRX	   incises	   the	   5’	   terminated	   DNA	  
strand	   nucleolytically	   stimulated	   by	  
phosphorylated	  Sae2.	  The	  MRX	  complex	  helps	  to	  
recruit	   Sgs1-­‐Dna2	   and	   Exo1.	   In	   a	   bidirectional	  
resection	   process	   MRX	   might	   degrade	   towards	  
the	  DNA	  end	  using	   its	   3’-­‐5’	   exonuclease	  activity	  
while	  Sgs1-­‐Dna2	  and	  Exo1	  perform	  processive	  5’-­‐
3	   resection	   leading	   to	   a	   long	   3’	   overhang.	  
Modified	  from	  (39).	  
	  
Human	  DNA2	  possesses	  single-­‐stranded	  DNA-­‐dependent	  5'-­‐3'	  and	  3'-­‐5'	  nuclease	  activities,	  
similar	  to	  its	  yeast	  homologue	  (112,	  113).	  The	  addition	  of	  human	  RPA	  to	  the	  reaction	  buffer	  
abolishes	   the	  degradation	  of	   3'	   tailed	  DNA	  and	  enhances	   the	  degradation	  of	   5'	   tail	   (113).	  
The	   helicase	   activity	   of	   recombinant	   hDNA2	  was	   either	   described	   as	   weak	   (112)	   or	   non-­‐
existent	   (114).	  hDNA2	  together	  with	  BLM	  helicase,	  a	  human	  homolog	  of	  yeast	  Sgs1,	  could	  
degrade	   dsDNA	   substrates	   (113,	   115,	   116).	   The	   resection	   was	   dependent	   on	   the	   hDNA2	  
nuclease	  and	  BLM	  helicase,	  but	  not	  on	  the	  helicase	  of	  DNA2	  (113,	  116).	  Initially	  when	  BLM	  
was	   exchanged	  with	   another	   human	   helicase	   dsDNA	   degradation	   could	   not	   be	   observed,	  
while	  yeast	  Sgs1	  could	  adopt	  BLM's	  function	  as	  leading	  helicase	  in	  the	  interplay	  with	  hDNA2	  
to	  degrade	  dsDNA	  (113).	  Physical	   interaction	  between	  hDNA2	  and	  BLM	  was	  detected	  and	  
this	  interaction	  was	  not	  dependent	  on	  DNA	  (113).	  The	  MRN	  complex	  was	  shown	  to	  recruit	  
BLM	  to	  dsDNA	  stimulating	  its	  DNA	  unwinding	  and	  boosting	  the	  degradation	  of	  dsDNA	  by	  the	  
hDNA2-­‐BLM	   complex	   (113).	   It	   is	   well	   established	   that	   BLM	   interacts	   with	   the	   Topo	   IIIa-­‐
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RMI1-­‐RMI2	   complex	   (TRR	   complex)	   in	   the	   dissolution	   of	   dHJ	   (117).	   Furthermore,	   it	   was	  
reported	  that	  the	  TRR	  complex	  enhances	  the	  ability	  of	  BLM-­‐hDNA2	  to	  resect	  dsDNA	  (115).	  
Later	   it	   was	   shown	   that	  WRN	   (Werner	   syndrome	   ATP-­‐dependent	   helicase)	   together	  with	  
hDNA2	   can	   degrade	   dsDNA	   (116).	   These	   results	   coming	   from	   biochemical	   assays	   using	  
recombinant	   proteins	   could	   be	   supplemented	   with	   in	   vivo	   data	   using	   single-­‐strand	   DNA	  
annealing	   reporter	  assays	  and	  RPA	   foci	   formations	  as	   readouts	   for	  efficacy	  of	   resection	   in	  
vivo	  (116).	  Not	  only	  BLM	  helicase	  but	  also	  WRN	  helicase	  seem	  to	  interact	  with	  hDNA2	  in	  the	  
resection	   of	   DSBs	   (116).	   Beside	   the	   functional	   interplay	   of	   hDNA2	   and	   WRN,	   a	   direct	  
physical	   interaction	  was	   demonstrated	   (116).	   The	   helicase	   function	   of	   BLM/WRN	  and	   the	  
nuclease	  but	  not	  the	  helicase	  activity	  of	  hDNA2	  were	  essential	  for	  resection	  (113,	  115,	  116).	  
Together,	  these	  data	  suggest	  that	  hDNA2	  can	  either	  associate	  with	  BLM	  or	  WRN	  helicase	  to	  
resect	  dsDNA,	  but	  detailed	  biochemical	  investigations	  of	  the	  mechanisms	  were	  lacking.	  
Recent	   work	   on	   the	   architecture	   of	   full-­‐length	   mouse	   DNA2	   showed	   that	   the	   nuclease	  
domain	  is	  located	  in	  a	  tunnel-­‐like	  structure	  through	  which	  the	  DNA	  substrate	  has	  to	  thread	  
(Figure	  5;	  (118)).	  The	  narrow	  structure	  of	  the	  tunnel	  could	  explain	  why	  the	  DNA2	  nuclease	  
activity	   is	   ssDNA-­‐dependent	   since	   the	   tunnel	   is	   too	  narrow	   for	  dsDNA	   to	   reach	   the	  active	  
site	   (59,	  118).	   In	  vitro	   yDna2	  cleaves	  ssDNA	  with	  5’-­‐3’	  and	  3’-­‐5’	  polarity,	  while	  addition	  of	  
yRPA	  to	  the	  reaction	  abolishes	  the	  3’-­‐5’	  polarity	  (67,	  68).	  Mouse	  DNA2	  was	  able	  to	  remove	  
RPA	  from	  ssDNA	  only	  from	  the	  5’	  but	  not	  3’	  end	  leading	  to	  “uncovered”	  ssDNA	  explaining	  
how	   RPA	   could	   confer	   the	   DNA2	   nuclease	   polarity	   (118).	   Furthermore,	   the	   nucleases	  
domain	   is	   located	   ahead	   of	   the	   helicase	   domain	   (118),	   which	   may	   degrade	   the	   DNA	  
substrate	   before	   it	   can	   reach	   the	   helicase	   domain.	   This	   would	   explain	   why	   the	   strong	  
helicase	  activity	  of	  yDna2	  was	  only	  observed	  using	  a	  nuclease-­‐deficient	  yDna2	  variant,	  and	  
why	  the	  nuclease	  of	  Dna2	  apparently	  masks	  its	  helicase	  activity	  (70).	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Figure	  5:	  Schematic	  domain	  structure	  of	  mouse	  DNA2.	  The	  nuclease	  domain	  (nuc)	  forms	  a	  narrow	  
tunnel	  that	  only	  ssDNA	  (depicted	  in	  red)	  can	  reach	  and	  is	  located	  ahead	  of	  the	  helicase	  domain	  (1A,	  
2A).	  Modified	  from	  (118).	  
	  
1.2.4	  Replication	  fork	  reversal	  
	  
The	  reversal	  of	  a	   typical	   replication	   fork	   (three-­‐way	   junction)	   to	  a	   reversed	   fork	   (four-­‐way	  
junction)	  was	  initially	  believed	  to	  be	  a	  pathological	  event	  in	  eukaryotes	  (Figure	  6).	  However,	  
more	   recent	   studies	   identified	   fork	   reversal	   as	   a	   global	   response	   to	   replication	   stress	  
protecting	   from	   fork	   collapse	   (reviewed	   in	   (119)).	   This	   fork	   reversal	   was	   observed	   upon	  
treatment	  of	   cells	  with	   the	  DNA	   topoisomerase	   I	   inhibitor	   camptothecin	   (CPT,	   (120)),	   but	  
also	   after	   treatments	   with	   a	   wide	   variety	   of	   chemicals	   such	   as	   etoposide,	   mitomycin	   C,	  
methyl	  methanosulfate	   (MMS)	  or	  hydroxyurea	   (HU,	   (121)).	  The	  fork	  reversal	   is	  dependent	  
on	  RAD51	  (121)	  and	  other	  factors,	  such	  as	  FBH1,	  SMARCAL1	  or	  ZRANB3,	  are	  believed	  to	  be	  
important	   in	   the	   fork	   reversal	   (122-­‐125).	   It	   was	   shown	   that	   the	   human	   RECQ1	   helicase	  
catalyzes	   the	   restart	   of	   reversed	   replication	   fork	   using	   its	   ATPase-­‐dependent	   branch	  
migration	   activity	   in	   a	   PARP1-­‐regulated	   manner	   (126).	   Data	   from	   Schizosaccharomyces	  
pombe	   show	   that	   DNA2	   can	   prevent	   stalled	   replication	   forks	   from	   reversing	   upon	   HU	  
treatment	  (64).	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Figure	   6:	   Schematic	   overview	   of	   replication	   fork	   reversal.	   In	   a	   first	   step,	   the	   newly	   synthesized	  
strands	  (light	  blue)	  are	  separated	  from	  the	  parental	  strands	  (dark	  blue).	  Then	  the	  parental	  strands	  as	  
well	  as	  the	  nascent	  strands	  reanneal.	  Modified	  from	  (119).	  
	  
1.2.5	  DNA2	  in	  the	  telomere	  maintenance	  
	  
The	  linear	  nature	  of	  eukaryotic	  chromosomes	  causes	  challenges	  at	  its	  ends,	  the	  telomeres.	  
Replication	  at	  telomeres	  faces	  several	  difficulties,	  for	  example	  repetitive	  TTAGGG	  sequences	  
forming	   so	   called	   G-­‐quadruplex	   (G4)	   structures	   that	   are	   difficult	   to	   replicate	   or	   the	  
replication	  of	  the	  lagging	  strand	  at	  telomeres,	  where	  the	  “last”	  Okazaki	  fragment	  cannot	  be	  
synthesized	  (127,	  128).	  This	  effect	  could	   lead	  to	  telomere	  shortening.	  To	  avoid	  the	   loss	  of	  
genetic	  information,	  the	  telomeres	  are	  elongated	  by	  a	  telomerase	  (129).	  The	  telomeres	  can	  
then	   function	   as	   template	   for	   the	   priming	   of	   new	   Okazaki	   fragments.	   DNA2	   localizes	   to	  
telomeres	   as	   shown	   by	   immunofluorescence	   experiments	   (61,	   77).	   G4	   structures	   are	  
expected	  to	  block	  replication	  fork	  progression	  and	  stall	  replication	  and	  therefore	  need	  to	  be	  
removed	  to	  allow	  proper	  replication	  of	  telomeres.	  Various	  helicases	  including	  RTEL1,	  BLM,	  
WRN	   and	   RECQL4	   are	   expected	   to	   reduce	   the	   formation	   of	   such	   structures	   (130,	   131).	  
hDNA2	   was	   shown	   to	   act	   in	   a	   nuclease-­‐dependent	   way	   to	   resolve	   G4	   structures	   and	  
therefore	   allow	   efficient	   telomeric	   DNA	   replication	   (77).	   Shelterin	   complex	   consisting	   of	  
several	  proteins,	  e.g.	  TRF1/TRF2,	  functions	  in	  suppressing	  ATM/ATR-­‐mediated	  DNA	  damage	  
response	  and	  therefore	  protects	  telomere	  ends	  from	  DNA	  repair	  activities	  (132).	  hDNA2	  was	  
shown	   to	   interact	  with	   TRF1/TRF2,	   suggesting	   a	   role	   for	  hDNA2	   in	   telomere	  maintenance	  
(77).	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1.2.6	  Human	  DNA2	  in	  the	  mitochondrial	  DNA	  metabolism	  
	  
hDNA2	  localizes	  to	  the	  nucleus	  (133)	  and	  to	  the	  mitochondria	  (63,	  133),	  where	  it	   interacts	  
with	  Pol	   γ	   (DNA	  polymerase	   subunit	   gamma	   (63)).	   Pol	   γ	   is	  part	  of	   the	  mitochondrial	  DNA	  
replication	  and	  the	  base	  excision	  repair	  (BER)	  machinery	  (134).	  It	  was	  proposed	  that	  hDNA2	  
helicase	   supports	   the	   mitochondrial	   replication	   by	   unwinding	   the	   DNA	   and	   providing	   a	  
template	  for	  Pol	  γ	  (63).	  BER	  is	  considered	  to	  play	  an	  important	  role	  in	  the	  repair	  of	  oxidative	  
DNA	   damage,	   since	   plenty	   of	   a	   cell’s	   oxidative	  metabolism	   happens	   in	   the	  mitochondria	  
(10).	  hDNA2	  together	  with	  FEN1	  was	  needed	  for	  the	  efficient	  removing	  of	  RNA	  primer	  flaps	  
created	   during	   mitochondrial	   replication	   (63).	   Cells	   that	   were	   depleted	   of	   hDNA2	   upon	  
siRNA	  treatment	  showed	  higher	  oxidative	  damage	  burden	  in	  the	  mitochondria	  compared	  to	  
control	  cells	  and	  the	  recovery	  rate	  of	  mitochondrial	  DNA	  was	  reduced	  in	  hDNA2	  knockdown	  
cells	   (63).	   Such	   effects	   were	   not	   observed	   testing	   the	   behavior	   of	   nuclear	   DNA	   after	  
oxidative	   treatment.	   From	   these	   results,	   it	   is	   proposed	   that	  hDNA2	   functions	   in	   the	   long-­‐
patch	   BER	   dealing	  with	   oxidative	   damage	   in	   the	  mitochondria	   (63).	  Most	   likely	   hDNA2	   is	  
involved	   together	  with	  Pol	  γ	  and	  FEN1	   in	   the	   replication	  and	   repair	  of	  mitochondrial	  DNA	  
(63,	  135).	  
	  
1.2.7	  DNA2	  in	  the	  checkpoint	  activation	  
	  
The	  transition	  from	  the	  one	  cell	  cycle	  phase	  to	  the	  subsequent	  one	  is	  strictly	  regulated	  by	  
several	  checkpoints	  (136).	  Yeast	  Tel1	  (human	  ATM)	  responding	  to	  dsDNA	  breaks	  and	  yeast	  
Mec1	   (human	   ATR)	   sensing	   ssDNA	   coated	   by	   RPA	   are	   the	   main	   kinases	   to	   activate	  
checkpoints	  upon	  DNA	  damage	  (137).	  
The	  function	  of	  the	  S-­‐phase	  checkpoint	  is	  to	  avoid	  that	  a	  cell	  progresses	  to	  the	  G2/M	  phase	  
before	  proper	  DNA	  replication	  and	  repair	  is	  completed	  (138).	  Mec1	  has	  a	  major	  role	  in	  the	  
S-­‐phase	  checkpoint	  while	  Tel1	  contribution	  is	  minor.	  Depending	  on	  the	  cell	  cycle	  phase,	  the	  
9-­‐1-­‐1	  complex,	  Dpb11	  and	  yDna2	  were	  shown	  to	  activate	  Mec1	  in	  yeast	  cells	  (reviewed	  in	  
(139)).	  yDna2	  was	  reported	  to	  stimulate	  Mec1	  upon	  hydroxyurea	  (HU)	  treatment	  that	  leads	  
to	  the	  stalling	  of	  replication	  forks	  and	  accumulation	  off	  ssDNA	  (140).	  This	  function	  of	  yDna2	  
seems	  more	   likely	   to	  be	  structural	   than	  enzymatic	  since	   it	  did	  not	  require	  the	  nuclease	  or	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helicase	   activity	   of	   yDna2.	   However,	   the	   N-­‐terminal	   domain	   (NTD),	   lacking	   in	   the	   human	  
protein,	   was	   essential	   for	   this	   function.	   Further,	   mutations	   in	   the	   NTD	   abolished	   the	  
checkpoint	  activation	  (140).	  
Dna2	  is	  phosphorylated	  at	  serine	  220	  by	  Cds1Chk1	  in	  Schizosaccharomyces	  pombe	  becoming	  
an	   S-­‐phase	   checkpoint	   target	   itself.	   Upon	   phosphorylation	  Dna2	  was	   active	   in	   preventing	  
the	  reversal	  of	  stalled	  replication	  forks.	  The	  nuclease	  but	  not	  helicase	  activity	  was	  required	  
to	  prevent	  the	  generation	  of	  “chicken	  foot”	  structures,	  while	  the	  exact	  mechanisms	  of	  these	  
processes	  are	  still	  a	  matter	  of	  debate	  (64).	  
	  
1.3.1	  WRN	  and	  BLM	  
	  
Human	  cells	  possess	  five	  RecQ	  like	  helicases,	  namely	  RECQ1,	  BLM,	  WRN,	  RECQ4	  and	  RECQ5	  
all	   of	  which	   playing	   important	   roles	   in	   the	   genome	  maintenance	   (141-­‐143).	  Mutations	   in	  
WRN	   can	   cause	   a	   disease	   named	   Werner	   syndrome	   (WS).	   WS	   patients	   usually	   grow	   up	  
normally	  until	  puberty	  and	   then	   show	  premature	  aging	  and	   susceptibility	   to	   rare	   types	  of	  
cancer	   (144-­‐147).	   Mutations	   in	   BLM	   can	   cause	   Bloom	   syndrome	   (BS).	   BS	   patients	   suffer	  
from	   pre-­‐	   and	   post-­‐natal	   growth	   retardation	   leading	   to	   dwarfism	   and	   show	   early	  
development	  of	  cancer	  (148).	  
	  
Human	   RECQ	   helicases	   belong	   to	   the	   SF2	   helicase	   superfamily	   per	   the	   classification	   of	  
helicases	   (149,	   150).	   Although	   the	   different	   RecQ	   helicases	   vary	   in	   size	   and	   domain	  
structure,	   most	   of	   them	   share	   the	   highly	   conserved	   domains	   (151):	   the	   core	   helicase	  
domain,	  the	  RecQ	  C-­‐terminal	  domain	  and	  the	  helicase	  and	  RNase	  D-­‐like	  C-­‐terminal	  (HRDC)	  
domain	  (143).	  The	  HRDC	  is	  found	  in	  E.	  coli	  RecQ	  and	  yeast	  Sgs1	  as	  well	  as	  in	  human	  BLM	  and	  
WRN	  but	  not	  in	  the	  other	  human	  RecQ	  helicases	  (Figure	  7;	  (143,	  152,	  153))	  pointing	  towards	  
a	  specialized	  role.	  The	  HRDC	  domain	  is	  important	  to	  localize	  WRN	  and	  BLM	  to	  damaged	  DNA	  
(154-­‐156).	   Both	   BLM	   and	  WRN	   are	   3’-­‐5’	   helicases	   (144,	   157).	   WRN	   is	   linked	   to	   BER,	   for	  
example	  due	  to	   its	  stimulation	  of	  NEIL1	  glycosylase	  (158)	  or	   inhibition	  of	  APE1	  glycosylase	  
(159).	  Further,	  WRN	  can	  stimulate	  Polβ	  (160)	  and	  WRN’s	  exonuclease	  activity	  could	  act	  as	  
proofreading	   mechanism	   that	   is	   intrinsically	   missing	   in	   Polβ	   (161).	   WRN	   interacts	   with	  
components	   of	   the	   NHEJ	   machinery	   such	   as	   Ku70/80	   (162,	   163)	   or	   DNA-­‐PKCS	   (164).	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Moreover,	  WS	   cells	   are	   sensitive	   to	   IR-­‐induced	   DSBs	   (164).	   However,	   the	   contribution	   of	  
WRN	  to	  NHEJ	  is	  not	  well	  understood.	  In	  the	  past,	  BLM	  was	  suggested	  as	  the	  main	  helicase	  
important	  for	  HR	  via	  its	  role	  in	  DNA	  end	  resection.	  BLM	  was	  shown	  to	  enhance	  the	  affinity	  
of	  EXO1	  to	  DNA	  ends	  (113)	  and	  to	  interact	  with	  hDNA2	  stimulating	  DNA	  end	  resection	  (113)	  
in	  contrast	   to	  WRN,	  where	  such	  behaviour	  was	  not	  observed.	  However,	  more	  recent	  data	  
contradict	  with	   these	   findings	  and	  suggest	  a	   role	   for	  WRN	   in	  DNA	  end	  resection	   (65,	  116,	  
165),	  which	  will	  be	   further	  extended	   in	  my	  thesis.	  Physical	   interactions	  between	  BLM	  and	  
WRN	  with	  hDNA2	  were	  reported	  in	  addition	  to	  functional	  interactions	  (113,	  116).	  WRN	  and	  
BLM	  show	  pro-­‐recombinational	  properties	  due	  to	  their	   function	   in	  DNA	  end	  resection.	  On	  
the	  other	  hand,	  however,	  BLM	  was	   linked	  with	  anti-­‐recombinational	  activity	  by	  disrupting	  
RAD51	  nucleoprotein	   filaments	   (166,	  167),	  while	  such	  effects	  were	  not	  observed	  for	  WRN	  
(168).	  In	  the	  later	  steps	  of	  HR,	  Both	  WRN	  and	  BLM	  were	  shown	  to	  interact	  with	  HJ/double	  
HJ	  and	  could	  branch	  migrate	  or	  even	  dissolve	  them	  (BLM	  with	  TopoIIIa/RMI1/RMI2,	   (117,	  
169-­‐171)).	   In	   addition	   to	   their	   contribution	   to	   DNA	   repair	   human	   RECQ	   helicases	   are	  
proposed	  to	  have	  roles	  in	  DNA	  replication.	  Replication	  appears	  to	  be	  slower	  in	  cells	  from	  WS	  
and	  BS	  patients,	  since	  these	  cells	  show	  a	  longer	  S-­‐phase	  (172,	  173)	  and	  DNA	  fiber	  analysis	  of	  
such	   cells	   support	   the	   notion	   that	   defects	   in	   WRN	   or	   BLM	   reduces	   the	   replication	   fork	  
progression	   rate	   (174,	   175).	   WRN	   and	   BLM	   were	   suggested	   to	   help	   restart	   regressed	  
replication	   forks	   via	   branch	  migration	   activity	   (176-­‐178).	   Furthermore,	   BLM	  and	  WRN	  are	  
suggested	  to	  participate	  in	  Okazaki	  fragment	  maturation	  due	  to	  their	  interaction	  with	  FEN1	  
(179-­‐182),	  but	  a	  detailed	  model	  is	  lacking.	  
Finally,	  it	  was	  shown	  that	  RECQ1	  could	  help	  to	  restart	  regressed	  replication	  forks	  (126)	  that	  
were	  reversed	  upon	  CPT-­‐induced	  Topoisomerase	  I	  inhibition	  (120).	  This	  function	  of	  RECQ1	  is	  
regulated	   by	   PARP1	   preventing	   premature	   fork	   restart	   (126).	   Since	   CPT	   and	   other	  
topoisomerase	   inhibitors	   are	   used	   as	   cancer	   treatment,	   interfering	   with	   DNA	   replication	  
restart	  mechanism	  could	  lead	  to	  a	  beneficial	  effect	  for	  the	  patients.	  Interestingly,	  synthetic	  
lethality	  was	  observed	  using	  topoisomerase	  inhibitors	  in	  WRN-­‐depleted	  cells	  (183-­‐185).	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Figure	  7:	  Schematic	  overview	  of	  the	  domain	  structure	  of	  RecQ	  helicases	  from	  E.	  coli,	  S.	  cerevisiae	  
and	  H.	  sapiens.	  The	  RecQ	  helicases	  differ	   in	  size	  and	  structure	  but	  partially	  share	  several	  domains	  
such	  as	  the	  helicase	  domain	  and	  the	  RQC	  domain.	  The	  HRDC	  domain	  is	  found	  in	  E.	  coli	  RecQ,	  yeast	  
Sgs1	  and	  human	  WRN	  and	  BLM.	  Modified	  from	  (143)	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2.	  RESULTS	  
	  
2.1	  Summary	  of	  results	  
	  
My	   work	   started	   with	   optimizing	   the	   expression	   and	   purification	   of	   the	   human	   DNA2	  
enzyme.	   I	  could	  purify	  highly	  active	  and	  pure	  wild	  type,	  nuclease-­‐,	  helicase-­‐	  and	  nuclease-­‐
helicase-­‐deficient	   variants	   of	   hDNA2	   by	   applying	   biochemical	   strategies	   that	   helped	   to	  
improve	  the	  purification.	  These	  strategies	  included	  codon-­‐optimization	  of	  the	  hDNA2	  gene	  
(for	  the	  expression	  in	  Sf9	  cells),	  working	  under	  reducing	  conditions	  to	  prevent	  oxidation	  of	  
hDNA2’s	   iron-­‐sulfur	   cluster,	   as	   well	   as	   shortening	   the	   purification	   procedure.	   Further,	   I	  
purified	  WRN	  and	  BLM	  helicases	  plus	  their	  enzymatically-­‐inactive	  forms	  and	  several	  single-­‐
strand	   DNA	   binding	   proteins	   (RPA,	   human	   mitochondrial	   SSB,	   SOSS	   complex).	   Together,	  
these	  recombinant	  proteins	  gave	  a	  solid	  base	  for	  studying	  the	  contribution	  of	  hDNA2	  in	  DNA	  
metabolism.	  
I	  could	  recapitulate	  that	  hDNA2	  possesses	  a	  nuclease	  activity	  that	  is	  regulated	  by	  SSBs.	  My	  
work	  showed	  that	  hDNA2	  is	  a	  strong	  and	  processive	  helicase,	  although	  this	  helicase	  activity	  
is	  masked	  by	  its	  nuclease	  activity.	  I	  showed	  that	  hDNA2	  synergies	  with	  WRN/BLM	  to	  resect	  
dsDNA,	   and	   observed	   that	   DNA2	   stimulates	   BLM/WRN	   activities	   and	   vice	   versa.	   This	  
indicated	   that	   hDNA2-­‐BLM	   and	   hDNA2-­‐WRN	   form	   a	   functional	   integrated	   complex	   (see	  
2.2.1	  (186)).	  
We	   proposed	   that	   the	   hDNA2	   motor	   activity	   however	   functions	   more	   likely	   as	   a	   ssDNA	  
translocase	   than	   as	   a	   DNA	   unwinding	   enzyme.	   The	   translocase	   activity	   accelerates	   the	  
degradation	   of	   ssDNA	   by	   wild	   type	   hDNA2,	   which	   results	   from	   dsDNA	   unwinding	   by	  
BLM/WRN.	  Thus,	  DNA2	  does	  not	  rely	  on	  diffusion	  to	  degrade	  ssDNA,	  but	  it	  is	  using	  its	  motor	  
activity	  to	  facilitate	  ssDNA	  resection.	  Such	  ssDNA	  degradation	  capacity	  was	  enhanced	  by	  the	  
presence	  of	  WRN/BLM	  in	  the	  reactions	  (see	  2.2.2,	  (187)).	  These	  data	  fit	  very	  well	  to	  the	   in	  
vivo	   evidence	   from	   our	   collaborators	   showing	   that	   DNA2	   cooperate	   with	   WRN	   or	   BLM	  
helicase	  in	  the	  long-­‐range	  DNA	  end	  resection	  in	  human	  cell	  lines	  (see	  2.3.3,	  (116)).	  Together,	  
our	  data	   support	   a	  model	   for	  DNA	  end	   resection	   in	  which	  WRN	  and	  BLM	  can	  act	   as	   lead	  
helicases	   opening	   dsDNA	   leading	   to	   ssDNA	   that	   is	   covered	   by	   RPA.	   RPA	   confers	   the	  
degradation	  of	  the	  5’	  terminated	  ssDNA	  strand	  by	  hDNA2,	  which	  is	  exploiting	  the	  interplay	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of	  motor	  and	  nuclease	  activities	  to	  efficiently	  degrade	  5'-­‐terminated	  DNA.	  This	  establishes	  a	  
3’	  overhanged	  DNA	  molecule	  that	  is	  needed	  for	  HR.	  
Additionally,	  in	  a	  collaborative	  project	  we	  showed	  that	  DNA2	  and	  WRN	  function	  together	  in	  
the	   restart	   of	   stalled	   replication	   forks	   upon	   replication	   stress-­‐induced	   reversal	   (see	   2.3.2,	  
(65)).Also,	  we	  helped	  define	  the	  dsDNA	  melting	  activity	  of	  human	  RPA	  in	  biochemical	  assay	  
setups	  and	  followed	  up	  the	  behaviour	  and	  dynamics	  of	  RPA	  at	  DNA	  forks	  (see	  2.3.1,	  (188)).	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2.2	  Primary	  results	  
	  
2.2.1	  Human	  DNA2	  possesses	  a	  cryptic	  DNA	  unwinding	  activity	  that	  functionally	  integrates	  
with	  BLM	  or	  WRN	  helicases	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Human DNA2 possesses a cryptic DNA
unwinding activity that functionally
integrates with BLM or WRN helicases
Cosimo Pinto1, Kristina Kasaciunaite2, Ralf Seidel2, Petr Cejka1*
1Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland;
2Institute of Experimental Physics I, University of Leipzig, Leipzig, Germany
Abstract Human DNA2 (hDNA2) contains both a helicase and a nuclease domain within the
same polypeptide. The nuclease of hDNA2 is involved in a variety of DNA metabolic processes.
Little is known about the role of the hDNA2 helicase. Using bulk and single-molecule approaches,
we show that hDNA2 is a processive helicase capable of unwinding kilobases of dsDNA in length.
The nuclease activity prevents the engagement of the helicase by competing for the same
substrate, hence prominent DNA unwinding by hDNA2 alone can only be observed using the
nuclease-deficient variant. We show that the helicase of hDNA2 functionally integrates with BLM or
WRN helicases to promote dsDNA degradation by forming a heterodimeric molecular machine.
This collectively suggests that the hDNA2 motor promotes the enzyme’s capacity to degrade
dsDNA in conjunction with BLM or WRN and thus promote the repair of broken DNA.
DOI: 10.7554/eLife.18574.001
Introduction
DNA replication, repair and recombination require the function of multiple DNA helicases and nucle-
ases (Tsutakawa et al., 2014; Wu and Hickson, 2006). The DNA replication ATP-dependent heli-
case/nuclease 2 (DNA2) is an enzyme that contains both helicase and nuclease domains within the
same polypeptide (Bae et al., 1998), and has important functions in a variety of DNA metabolic pro-
cesses. Dna2 was first described in Saccharomyces cerevisiae where it is required for DNA replica-
tion under unperturbed conditions (Budd and Campbell, 1995; Kuo et al., 1983). Specifically,
during Okazaki fragment processing, yeast Dna2 (yDna2) cleaves long 5’-flaps that are coated by the
Replication Protein A (RPA) and are therefore refractory to cleavage by Rad27 (FEN1)
(Bae et al., 2001; Levikova and Cejka, 2015). Moreover, yDna2 is one of the nucleases that resect
5’-terminated strands of DNA double-strand breaks (DSBs) (Cejka et al., 2010; Niu et al., 2010;
Zhu et al., 2008). This process leads to the formation of 3’-tailed DNA, which becomes a substrate
for the strand exchange protein Rad51 to initiate homology search and accurate DSB repair by the
recombination machinery (Cejka, 2015; Heyer et al., 2010; Symington, 2014). Yeast Dna2 also
functions upon replication stress to degrades structures such as reversed replication forks (Hu et al.,
2012; Thangavel et al., 2015) and has a structural role in DNA damage signaling, where it is a com-
ponent in one out of three signaling branches that activate the Mec1 kinase in response to ssDNA in
S-phase (Kumar and Burgers, 2013). Additionally, yDna2 was described to be required for the
proper function of telomeres (Choe et al., 2002). In contrast to Okazaki fragment processing and
DNA end resection, the involvement of yDna2 in these latter DNA metabolic processes is poorly
understood. The yeast Dna2 protein contains a large unstructured N-terminal domain, which medi-
ates a physical interaction with yRPA (Bae et al., 2003), is required for Dna2’s checkpoint function
(Kumar and Burgers, 2013) and its capacity to melt secondary structures within 5’ DNA flaps
(Lee et al., 2013). The N-terminal domain is followed by a RecB-like nuclease domain
Pinto et al. eLife 2016;5:e18574. DOI: 10.7554/eLife.18574 1 of 24
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(Budd et al., 2000) and a Superfamily I helicase domain in the C-terminal part of the polypeptide
(Budd and Campbell, 1995). With the exception of checkpoint signaling, all Dna2 functions are
exclusively dependent on its nuclease activity (Sturzenegger et al., 2014; Thangavel et al., 2015;
Wanrooij and Burgers, 2015; Zhu et al., 2008). Dna2 homologs are present in all eukaryotic organ-
isms including human cells (Budd and Campbell, 1995; Eki et al., 1996; Gould et al., 1998). Both
helicase and nuclease domains are well conserved in evolution, but the unstructured N-terminal
domain is only present in lower eukaryotes (Bae et al., 1998; Kang et al., 2010; Wanrooij and Bur-
gers, 2015).
Human DNA2 (hDNA2) also functions in DNA end resection (Gravel et al., 2008;
Nimonkar et al., 2011; Sturzenegger et al., 2014) and in the processing of non-canonical DNA rep-
lication structures, such as reversed replication forks upon replication stress (Duxin et al., 2012;
Thangavel et al., 2015). In contrast to yeast, however, hDNA2 appears to be dispensable for the
processing of most Okazaki fragments (Duxin et al., 2012). Specific inactivation of the nuclease, as
well as the depletion or knockout of the protein/gene, result in lethal phenotypes in all organisms
tested to date (Budd et al., 2000; Duxin et al., 2012; Kang et al., 2000; Lin et al., 2013). In yeast,
this has been ascribed to yDna2’s role in Okazaki fragment processing (Kang et al., 2010). Human
DNA2-depleted cells arrest at late S/G2 phase of the cell cycle (Duxin et al., 2012). The nature of
DNA intermediates that require the processing by hDNA2 is still rather elusive. It is conceivable that
the lethality of hDNA2-depleted cells results from the failure to process reversed replication forks or
other aberrant structures that arise during replication stress even in the absence of treatment with
genotoxic drugs (Duxin et al., 2012; Thangavel et al., 2015). The role of hDNA2 in DSB end resec-
tion in contrast does not appear to be essential for viability as it functions redundantly with another
nuclease, Exonuclease 1 (EXO1) (Gravel et al., 2008; Nimonkar et al., 2011; Tomimatsu et al.,
2012). EXO1 is not involved in the processing of reversed replication forks, pointing towards an
essential function of hDNA2 in the response to intermediates arising during DNA replication
(Thangavel et al., 2015).
The nuclease of hDNA2 is specific for ssDNA (Kim et al., 2006; Masuda-Sasa et al., 2006) and
therefore requires an associated helicase activity to resect/degrade dsDNA. This was shown to be
either BLM or WRN during DSB end resection (Gravel et al., 2008; Nimonkar et al., 2011;
Sturzenegger et al., 2014), or primarily WRN to degrade non-canonical DNA structures arising dur-
ing DNA replication (Thangavel et al., 2015). Interestingly, the inherent helicase of hDNA2 was not
required for these processes (Sturzenegger et al., 2014; Thangavel et al., 2015), and the function
of the hDNA2 motor activity remains unclear. The helicase function is not essential for viability in
yeast (Bae et al., 2002), where it was proposed to unwind secondary structures forming on long
flaps at the 5’ ends of Okazaki fragments (Lee et al., 2013). Yeast dna2 cells lacking the helicase
activity are dramatically sensitive to alkylating agents such as methyl methanesulfonate (MMS)
(Budd and Campbell, 1995), suggesting that the yDna2 helicase might also play a role in the
response to replication stress. In contrast to yeast, both helicase and nuclease functions are essential
for viability in human cells (Duxin et al., 2012). Similarly to hDNA2 nuclease-deficient cells, hDNA2
helicase-deficient cells also exhibit a terminal S/G2 cell cycle arrest, most likely due to the inability to
resolve structures arising in S-phase (Duxin et al., 2012). Furthermore, hDNA2 nuclease-deficient
cells displayed cell cycle defects that were even more severe than upon depletion of hDNA2; inter-
estingly, this phenotype was dependent on the integrity of the Walker A motif within the helicase
domain (Duxin et al., 2012). This suggested that the hDNA2 helicase performs essential functions
during DNA replication, yet it becomes toxic in the absence of the nuclease (Duxin et al., 2012),
although mechanistic insights into the interplay between both activities have been lacking. There-
fore, it remains to be determined how the hDNA2 helicase contributes to the overall function of the
polypeptide.
The clear requirement for the helicase of hDNA2 for the viability of human cells (Duxin et al.,
2012) stands in contrast to the inconclusive reports regarding the capacity of the human recombi-
nant hDNA2 polypeptide to unwind dsDNA. One work concluded that hDNA2 lacks a helicase activ-
ity (Kim et al., 2006), whereas another study could detect DNA unwinding, albeit very weak and
distributive (Masuda-Sasa et al., 2006). It has been also proposed that the helicase domain may be
more responsible for DNA binding rather than as a motor activity per se (Zhou et al., 2015). Here
we present that hDNA2 possesses a processive helicase activity capable of unwinding dsDNA of sev-
eral kilobases in length. Paradoxically, the helicase is cryptic and becomes detectable only upon
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inactivation of the nuclease. This explains the more pronounced phenotypes of the hDNA2 nuclease-
deficient cells as opposed to double nuclease- and helicase-deficient cells or depletions of the poly-
peptide (Duxin et al., 2012). Finally, we show that the helicase of hDNA2 contributes to dsDNA
degradation in complex with Bloom syndrome protein (BLM) or Werner syndrome protein (WRN)
helicases, and may play a supporting role in the resection of DSBs or other aberrant structures aris-
ing during DNA replication. The motor activities within hDNA2 and BLM/WRN function in a synergis-
tic manner, and the stimulatory effect observed with the hDNA2-WRN and hDNA2-BLM pairs is
highly specific. This shows that the hDNA2-BLM and hDNA2-WRN complexes are functionally more
integrated molecular machines than previously thought.
Results
Expression and purification of human DNA2
Human DNA2 was prepared using a construct, which contained an N-terminal 6x-histidine and a
C-terminal FLAG affinity tags (Figure 1A). The sequence of hDNA2 was codon-optimized
(Supplementary file 1A) for the expression in Spodoptera frugiperda 9 (Sf9) cells, which improved
the yield ~2–3 fold (data not shown). Considering that hDNA2 contains an iron-sulfur cluster
(Pokharel and Campbell, 2012; Yeeles et al., 2009), all buffers were degassed and contained
reducing agents throughout the preparation procedure to prevent oxidation of the cluster, as
described previously for S. cerevisiae Dna2 (Levikova et al., 2013). Wild type hDNA2, nuclease-defi-
cient D277A, helicase-deficient K654R as well as nuclease- and helicase-deficient D277A K654R var-
iants were purified in the same manner to near homogeneity (Figure 1B and Figure 1—figure
supplement 1A–C). The yield of the recombinant proteins was ~330–390 mg from 3 liters of Sf9 cell
culture except for the variant containing the K654R mutation, which yielded only ~27 mg.
hDNA2 preferentially degrades 5’-tailed DNA in the presence of RPA
Human DNA2 is known to possess ssDNA-specific nuclease activity (Kim et al., 2006; Masuda-
Sasa et al., 2006). Considering that hDNA2 performs multiple functions during DNA metabolism,
we set out to analyze the preference of its nuclease activity using various oligonucleotide-based
DNA structures. Without the human Replication Protein A (hRPA), hDNA2 most efficiently degraded
ssDNA, while 5’-overhanged, 3’-overhanged and Y-structured DNA were degraded ~7–20-fold less
efficiently, based on the hDNA2 concentration required for the degradation of 50% DNA substrate
(Figure 1C and Figure 1—figure supplement 1D). In contrast, dsDNA was largely refractory to
cleavage (Figure 1C and Figure 1—figure supplement 1D), in agreement with the observations
that hDNA2 needs a helicase partner in DNA end resection to initiate homologous recombination
(Cejka et al., 2010; Gravel et al., 2008; Nimonkar et al., 2011; Sturzenegger et al., 2014;
Zhu et al., 2008). As reported previously (Masuda-Sasa et al., 2006), the helicase-deficient hDNA2
(K654R) variant displayed a nuclease activity indistinguishable from that of the wild type enzyme on
a 5’-tailed DNA substrate (Figure 1—figure supplement 1D–F). Using a 3’-end labeled ssDNA, we
observed that hRPA directs the nuclease of hDNA2 towards the 5’ terminus; while at the same time
inhibits the 3’-5’ nuclease activity (Figure 1D). This is in agreement with previous observations in var-
ious organisms (Cejka et al., 2010; Nimonkar et al., 2011; Zhou et al., 2015) and explains how
hRPA enforces the correct polarity of DNA degradation during DNA end resection. Interestingly, in
the presence of hRPA, hDNA2 most efficiently cleaved Y-structured and 5’-tailed DNA substrates,
which were degraded ~5–10-fold more efficiently than ssDNA (Figure 1E and Figure 1—figure sup-
plement 1G). In summary, the nuclease activities of yeast Dna2 and human DNA2 are very similar
qualitatively, but human DNA2 appears somewhat less active (~2-fold in degradation of 5’-tailed
DNA) than its yeast homologue (Levikova et al., 2013).
The nuclease-deficient hDNA2 D277A was subsequently used to determine DNA binding prefer-
ence. hDNA2 D277A strongly bound ssDNA, with KD ~2 nM for ssDNA of 50 nucleotides in length
(Figure 1F,G). Similar binding affinity was observed for Y-structured DNA, while the apparent DNA
binding to 5’ and 3’-tailed structures was reduced ~8–12-fold, respectively, compared to ssDNA. In
contrast, dsDNA was bound very poorly (Figure 1G and Figure 1—figure supplement 2A–D). Fur-
ther experiments revealed that the DNA binding affinity was determined by the length of ssDNA
rather than the specific structure (Figure 1H,I and Figure 1—figure supplement 2A–F).
Pinto et al. eLife 2016;5:e18574. DOI: 10.7554/eLife.18574 3 of 24
Research article Biochemistry Genes and Chromosomes
	   	   RESULTS	  
	   35	  
Figure 1. Human DNA2 preferentially binds and degrades 5’ terminated ssDNA. (A) A schematic representation of
the recombinant hDNA2 protein used in this study. The polypeptide contains an N-terminal 6xHis- and a
C-terminal FLAG affinity tag. The positions of the mutations inactivating the nuclease (D277A) activity or the
helicase (K654R) activity are indicated. (B) A 10% polyacrylamide gel stained with Coomassie blue showing
fractions from a representative purification of hDNA2 D277A. (C) Quantitation of hDNA2 nuclease activity on
various DNA substrates in the absence of hRPA from experiments such as shown in Figure 1—figure supplement
1D. Averages shown, n = 2; error bars, SEM. (D) Human DNA2 (0.2 nM) was incubated with ssDNA 32P-labeled at
Figure 1 continued on next page
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Interestingly, the hDNA2-bound DNA species either entered the polyacrylamide gels during electro-
phoresis, or remained stuck in the wells, indicative of a multiprotein-DNA complex and most likely a
non-specific aggregate. Remarkably, the distinct DNA-protein species that entered the polyacryl-
amide gel were only observed with substrates containing a free 5’ end such as Y-structured, 5’ tailed
or ssDNA substrates (Figure 1F and Figure 1—figure supplement 2A,B,F), suggesting that hDNA2
exhibits a preference for this structure even in the absence of hRPA. This likely reflects its role in 5’
DNA end degradation in various metabolic processes (Kang et al., 2010; Nimonkar et al., 2011;
Sturzenegger et al., 2014; Zheng et al., 2008).
hDNA2 shows DNA structure-dependent ATPase activity
Previous reports concluded that hDNA2 hydrolyses ATP, as expected from a protein containing an
SFI helicase domain (Budd and Campbell, 1995). We next determined the ATP hydrolysis rate of
nuclease-deficient hDNA2 D277A in the presence of various DNA structures. The ATPase activity
was strongly enhanced in the presence the DNA cofactors. The greatest stimulation, ~13-fold, was
observed with 5’-tailed DNA (Figure 2A), in agreement with the 5’-3’ polarity of the hDNA2 helicase
(Balakrishnan et al., 2010a; Balakrishnan et al., 2010b; Masuda-Sasa et al., 2006). The apparent
turnover rate (kcat) of the ATP hydrolysis in the presence of 5’-tailed substrates of different lengths
was 6.9 ± 1.1 s!1 and 6.2 ± 0.9 s!1. In contrast, dsDNA stimulated the hDNA2 ATPase to the lowest
extent, ~four-fold, compared to reactions without DNA. Next we performed the ATPase assays in
the presence of various amounts of poly(dT) DNA, which is a ssDNA devoid of any secondary struc-
ture. As expected, the ATP hydrolysis rate increased with poly(dT) concentration. The measured
reaction rate values were fitted into a Michaelis-Menten curve with Vmax = 3.1 ± 0.3 mM"min
!1 and
KM = 115 ± 45 nM (in nucleotides, Figure 2B), which corresponds to kcat = 4.3 ± 0.4 s
!1. The nucle-
ase-deficient DNA2 D277A variant was used for the above assays, as the nuclease of wild type
DNA2 interferes with its capacity to hydrolyze ATP by degrading DNA that serves as a co-factor of
the ATPase activity. As demonstrated in Figure 2C, the rate of ATP hydrolysis by the nuclease-defi-
cient D277A variant incubated with 5’-tailed substrate was constant over time. In contrast the rate of
ATP consumption decreased quickly in case of wild type DNA2 (Figure 2C). We believe that the
nuclease activity of hDNA2 rapidly degrades the 5’ ssDNA overhang, producing a substrate that is
less efficient as a cofactor for the ATPase activity. Very similar behavior was previously observed
with yeast Dna2 (Levikova et al., 2013). Collectively, these experiments establish that the ATPase
activity of hDNA2 qualitatively resembles that of the yeast Dna2 homologue in terms of DNA sub-
strate preference and interplay with the nuclease activity, but it is ~10-fold less active in quantitative
terms (Levikova et al., 2013).
Figure 1 continued
its 3’ end and various concentrations of hRPA. The panel shows a representative denaturing 20% polyacrylamide
gel. The blue triangle indicates a truncation of the substrate. (E) Quantitation of hDNA2 nuclease activity on
various DNA substrates in the presence of hRPA (15 nM) from experiments such as shown in Figure 1—figure
supplement 1G. Averages shown, n = 2; error bars, SEM. (F) A representative 6% polyacrylamide gel showing the
binding of hDNA2 D277A to ssDNA of 50 nt in length. The blue triangle indicates the position of the wells. (G)
Quantitation of DNA binding from experiments such as shown in Figure 1F and Figure 1—figure supplement
2A–D. Averages shown, n = 2–3; error bars, SEM. (H) DNA binding and its dependence on the length of ssDNA.
Quantitation is based on experiments such as shown in Figure 1F and Figure 1—figure supplement 2E. Long
ssDNA was more efficiently bound by hDNA2. Averages shown, n = 2–3, error bars, SEM. (I) DNA binding and its
dependence on the length of 5’ single-stranded DNA overhang. Quantitation is based on experiments such as
shown in Figure 1—figure supplement 2B,F. Averages shown, n = 3; error bars, SEM.
DOI: 10.7554/eLife.18574.002
The following figure supplements are available for figure 1:
Figure supplement 1. Human RPA guides the hDNA2 nuclease to 5’ terminated ssDNA.
DOI: 10.7554/eLife.18574.003
Figure supplement 2. hDNA2 binds ssDNA.
DOI: 10.7554/eLife.18574.004
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The helicase of hDNA2 is capable to unwind plasmid-length dsDNA
substrates
The capacity to unwind DNA by human DNA2 has been controversial. Previously, hDNA2’s helicase
activity was either described as undetectable (Kim et al., 2006) or very weak (Balakrishnan et al.,
2010a; Masuda-Sasa et al., 2006), capable to unwind only short duplexes. In our earlier studies, we
could show that S. cerevisiae Dna2 possesses a vigorous and processive helicase activity that is
masked by its nuclease activity (Levikova et al., 2013). To this point, we set out to test whether our
preparation of hDNA2 is capable to unwind dsDNA. The nuclease-deficient hDNA2 D277A
variant was used in these experiments, as the nuclease activity of wild type hDNA2 may mask its heli-
case activity similarly as for the yeast enzyme (Levikova et al., 2013). We incubated various concen-
trations of the hDNA2 D277A variant with bacteriophage lDNA that had been digested with HindIII,
resulting in dsDNA fragments of various lengths. Figure 3A and B demonstrate that hDNA2 D277A
efficiently unwound dsDNA fragments of up to 2.3 kbp in length, whereas unwinding of !9.4 kbp-
long fragments was barely detectable within the 30 min incubation time. Unwinding of these long
DNA molecules was however evident in kinetic experiments upon longer incubation times
(Figure 3C and Figure 3—figure supplement 1A). This unexpected dsDNA unwinding capacity of
hDNA2 D277A was fully dependent on hRPA and ATP (Figure 3A). The nuclease-deficient hDNA2
D277A variant also similarly unwound a 2.7 kbp-long plasmid-based dsDNA substrate in a concen-
tration-dependent manner (Figure 3D,E). In contrast, the nuclease- and helicase-deficient DNA2
D277A K654R mutant did not unwind DNA, as expected, showing that the unwinding capacity is
inherent to the helicase activity of hDNA2 (Figure 3—figure supplement 1B). The above assays
require the use of a high hRPA concentration to fully saturate DNA (~200–350 nM range), which can
lead to dsDNA melting in the vicinity of the ends (Georgaki and Hu¨bscher, 1993;
Kemmerich et al., 2016). This might provide hDNA2 with ssDNA overhangs that are required for
the unwinding activity. To define substrate preference for the hDNA2 D277A helicase, we next used
a variety of oligonucleotide-based DNA structures. The hRPA concentration (7.5 nM) used in these
assays did not result in a significant dsDNA melting. We found that the Y-structure was unwound
most efficiently (Figure 3F,G), followed by the 5’ overhang (Figure 3G and Figure 3—figure
Figure 2. hDNA2 D277A shows DNA structure-dependent ATPase activity. (A) Apparent ATP turnover number kcat with various DNA cofactors,
including short 5’ overhang* (19 nt/31 bp), long 5’ overhang** (30 nt/31 bp), Y-structure (19 nt/ 31 bp), 3’ overhang (19 nt/ 31 bp), ssDNA (50 nt), dsDNA
(31 bp). The reactions contained 12 nM hDNA2 D277A. Averages shown, n = 2–8; error bars, SEM. (B) Rate of ATP hydrolysis and its dependence on
the DNA substrate concentration. The reactions contained 12 nM hDNA2 D277A and the indicated concentrations of poly(dT) DNA. Averages shown, n
= 2; error bars, SEM. (C) Wild type hDNA2 or the D277A variant (both 12 nM) was incubated with 5’ overhang DNA substrate and the rate of ATP
hydrolysis was determined over time. The ATP hydrolysis rate was constant at ~4–5 mM"min#1 for hDNA2 D277A and decreased over time for wild type
hDNA2. Averages shown, n = 3; error bars, SEM.
DOI: 10.7554/eLife.18574.005
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Figure 3. hDNA2 D277A unwinds kilobase-lengths of dsDNA. (A) Representative 1% agarose gel showing the
helicase activity of hDNA2 D277A on lDNA/HindIII substrate with 346 nM hRPA. DNA unwinding leads to
products that co-migrate with heat-denatured substrate (Lane 8). Lane 5, helicase activity of nuclease-deficient
yeast Dna2 E675A at 30˚C; Lane 6, no ATP; Lane 7, no RPA; Lane 8, heat-denatured DNA substrate; Lane 9, wild
Figure 3 continued on next page
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supplement 1C). In contrast, no DNA unwinding was observed with 3’ overhang and dsDNA
(Figure 3G and Figure 3—figure supplement 1D,E), in agreement with the 5’-3’ polarity of DNA
unwinding by hDNA2 and its homologues (Bae et al., 1998).
Importantly, no dsDNA unwinding was observed with wild type hDNA2 (Figure 3A, lane 9). The
hDNA2 nuclease is efficient in ssDNA degradation at sub-nanomolar concentrations (Figure 1E),
and thus likely degrades the 5’ ssDNA overhangs that are required for the initiation of DNA unwind-
ing. By degrading 5’-tailed DNA the nuclease of hDNA2 masks the helicase capacity of the wild type
polypeptide, similarly as in yeast (Levikova et al., 2013). This is in agreement with a recent structural
study, which determined that the nuclease of DNA2 is situated ahead of the helicase domain, and
therefore has the capacity to degrade 5’-terminated ssDNA tails to prevent DNA loading of the heli-
case domain (Zhou et al., 2015). Our observation that the inactivation of the hDNA2 nuclease
unleashes the hDNA2 helicase likely provides explanation for the pronounced toxicity of a nuclease-
deficient hDNA2 construct in vivo, which was dependent on the integrity of the Walker A motif
within hDNA2 (Duxin et al., 2012). In summary, we show that nuclease-deficient hDNA2 possesses
the capacity to unwind dsDNA of kilobases in length in a reaction dependent on hRPA and ATP.
Wild type hDNA2 is devoid of any apparent dsDNA unwinding activity, which likely infers the exis-
tence of mechanisms that allow the manifestation of the motor activity in the context of the wild
type polypeptide under specific conditions.
DNA unwinding by hDNA2 D277A is slow but highly processive
DNA unwinding experiment with lDNA (Figure 3A–C and Figure 3—figure supplement 1A)
showed that hDNA2 D277A can unwind long stretches of dsDNA. We next performed a kinetic
experiment with a 2.7 kbp-long DNA substrate, and compared the DNA unwinding of the nuclease-
deficient human DNA2 D277A and the yeast Dna2 E675A. As DNA2 cannot unwind DNA from inter-
nal sites and can only initiate from a free DNA end (Balakrishnan et al., 2010a; Zhou et al., 2015),
we used a 20-fold excess of each helicase over the substrate to saturate the DNA ends. We detected
ssDNA after only one minute of the reaction with the yeast enzyme, whereas it took eight minutes to
detect a similar amount of unwound DNA for the human DNA2 variant (Figure 3—figure supple-
ment 1F,G). To better define the unwinding rate and processivity of the hDNA2 D277A helicase, we
applied a single molecule unwinding assay based on magnetic tweezers. We used a 5’ tailed dsDNA
substrate of 6.1 kbp in length, which was tethered at one end to the surface of a fluidic cell and at
the other end to a magnetic bead. An externally applied magnetic field gradient allowed thus to
hold the DNA in a stretched configuration. DNA unwinding (Levikova et al., 2013) was monitored
by a change of the position of the magnetic bead as a result of different lengths of double- and sin-
gle-stranded DNA (Figure 4A). We observed that hDNA2 unwound the dsDNA substrate slowly but
consecutively over time (Figure 4B). Most of the DNA molecules underwent significant dsDNA
unwinding of several kilobases in length, with some molecules showing unwinding of the full-length
Figure 3 continued
type hDNA2. (B) Unwinding of selected lDNA/HindIII fragments by various concentrations of hDNA2 D277A upon
30 min reaction time. Quantitation of experiments such as shown in Figure 3A. Averages shown, n = 2–4; error
bars, SEM. (C) Unwinding of selected lDNA/HindIII fragments by hDNA2 D277A (20 nM) and its dependence on
reaction time. Quantitation of experiments such as shown in Figure 3—figure supplement 1A. Averages shown,
n = 2–4; error bars, SEM. (D) Representative 1% agarose gel showing the helicase activity of hDNA2 D277A on a
2.7 kbp-long substrate. Reactions contained 215 nM RPA. Heat, heat-denatured DNA substrate. (E) Quantitation of
experiments such as shown in Figure 3D. Averages shown, n = 4–9; error bars, SEM. (F) Representative 10%
polyacrylamide gel showing the helicase activity of hDNA2 D277A on an oligonucleotide-based Y-structure (45 nt/
48 bp). Reactions contained 7.5 nM RPA. Heat, heat-denatured DNA substrate. (G) Quantitation of experiments
such as shown in Figure 3F and Figure 3—figure supplement 1C–E. Beside Y-structure (45 nt/48 bp), DNA
substrates with 5’ or 3’ overhangs (both 45 nt/ 48 bp) and blunt-ended dsDNA (50 bp) were tested. Reactions
contained 7.5 nM RPA. Averages shown, n = 2–4; error bars, SEM. Heat, heat-denatured DNA substrate.
DOI: 10.7554/eLife.18574.006
The following figure supplement is available for figure 3:
Figure supplement 1. hDNA2 D277A unwinds plasmid- and oligonucleotide-based DNA substrates.
DOI: 10.7554/eLife.18574.007
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6.1 kbp substrate. To quantify the unwinding rate, unwinding trajectories (n = 30) were split into suc-
cessive segments that each had approximately a constant unwinding velocity. Unwinding rates were
determined from the slope of a linear fit to each segment (Figure 4C). The unwinding rates were
broadly distributed between 0 to 40 bp/s. Such a broad distribution is in agreement with measure-
ments for yDna2 (Levikova et al., 2013). The distribution had a pronounced maximum at around 10
bp!s"1 and the mean unwinding rate was 12.8 ± 0.8 bp!s"1, which is ~3-fold slower than that of the
yeast homologue (Levikova et al., 2013). Long-range processive dsDNA unwinding was dependent
Figure 4. Single molecule experiments reveal highly processive DNA unwinding by hDNA2 D277A. (A) A sketch of
the magnetic tweezers assay. (B) Representative DNA unwinding events (n = 7, colored) catalyzed by hDNA2
D277A at 22 ± 3 pN force. Experiments were conducted at 37˚C in a reaction buffer supplemented with 25 nM
hDNA2 D277A and 25 nM hRPA. DNA lengthening was observed only after the addition of hDNA2 D277A. (C)
Histogram of the observed unwinding rates. Unwinding trajectories were divided into segments with
approximately constant rate. The unwinding rates of the individual segments were determined from a linear fit of
the data. (D) DNA unwinding experiment at 21 pN force, initiated by adding hRPA (25 nM) at 100 s and hDNA2
D277A (25 nM) at 220 s. The buffer containing hDNA2 D277A was washed away subsequently as indicated by the
gray bars.
DOI: 10.7554/eLife.18574.008
The following figure supplement is available for figure 4:
Figure supplement 1. Single molecule experiments reveal that DNA unwinding by hDNA2 D277A is dependent
on ATP and hRPA.
DOI: 10.7554/eLife.18574.009
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on ATP and hRPA (Figure 4—figure supplement 1A–D), in agreement with the experiments shown
above. To confirm that the observed dsDNA unwinding events resulted from the activity of a single
hDNA2 D277A molecule, we performed an unwinding experiment similar that that in Figure 4B, but
flushed in ATP and hRPA containing buffer at regular intervals (Figure 4D) such that any free hDNA2
D277A was removed. DNA unwinding continued despite successive washing steps, indicating that
the originally acting unwinding complex remained bound and active during the course of the obser-
vation period. This demonstrated that the DNA2 D277A helicase is highly processive (Figure 4D).
The recently-published structure of DNA2 shows that ssDNA must feed through a narrow tunnel to
reach the helicase domain (Zhou et al., 2015), which likely prevents dissociation of DNA2 from its
substrate and corroborates the high processivity observed in our assays. In agreement with this no
direction reversals during unwinding (i.e. rezipping) that could originate from strand–switches were
observed (Dessinges et al., 2004; Klaue et al., 2013).
Regulation of hDNA2 nuclease and helicase activities by single-stranded
DNA binding proteins
The hRPA protein is a critical cofactor of the hDNA2 nuclease (Figure 1) as well as the helicase activ-
ities (Figure 3) (Nimonkar et al., 2011; Zhou et al., 2015). We next set out to define the interplay
of hDNA2 with other cognate ssDNA binding proteins. Initially, hDNA2 was described as a mito-
chondrial protein (Zheng et al., 2008) before its function in nuclear DNA metabolism was deter-
mined (Duxin et al., 2009; Gravel et al., 2008). Mitochondria are devoid of hRPA; instead, they
contain the mitochondrial single-stranded DNA binding protein (mtSSB), a homotetramer similar to
the SSB protein of Escherichia coli (Curth et al., 1994). Furthermore, the sensor of single-stranded
DNA (SOSS) complex was described in the nucleus of human cells (Huang et al., 2009; Li et al.,
2009). SOSS likely regulates various aspects of DNA metabolism including DNA recombination and
DNA end resection by the MRE11-RAD50-NBS1 (MRN) complex and EXO1 (Richard et al., 2011;
Yang et al., 2013). We purified both mtSSB and SOSS and ascertained that both complexes bind
ssDNA with a high affinity (Figure 5—figure supplement 1A–D). Next we investigated whether
dsDNA unwinding by hDNA2 D277A can be promoted by mtSSB or the SOSS complex similarly as
by hRPA. Neither mtSSB (Figure 5A–C and Figure 5—figure supplement 1E) nor SOSS (Figure 5C
and Figure 5—figure supplement 1E) were able to substitute hRPA to promote dsDNA unwinding.
The hDNA2-hRPA functional interaction was largely species-specific, as yRPA from S. cerevisiae pro-
moted DNA unwinding to a much lesser extent than the cognate hRPA (Figure 5A–C and Figure 5—
figure supplement 1E). Therefore, hRPA is a unique and an essential co-factor of the hDNA2 heli-
case, which is required for the unwinding of all DNA duplex substrate lengths tested.
In contrast to dsDNA unwinding, hRPA could be replaced by yRPA in ssDNA degradation, which
similarly directed the nuclease activity of hDNA2 towards the 5’ end of ssDNA (Figure 1D,
Figure 5D and Figure 5—figure supplement 1F). Similar, albeit much weaker effect was observed
in the presence of the SOSS complex (Figure 5—figure supplement 1F, lane 28), possibly due to a
lower affinity of SOSS towards ssDNA compared to the RPA proteins. Considering the postulated
function of the hDNA2 nuclease in mitochondrial DNA metabolism, the mtSSB unexpectedly dramat-
ically inhibited all nuclease activities of hDNA2 (Figure 5D and Figure 5—figure supplement 1F).
Therefore it remains to be elucidated how the hDNA2 nuclease/helicase functions in mitochondria.
The helicase of hDNA2 promotes DNA end resection in conjunction
with WRN or BLM helicases
It has been established that hDNA2 functions in conjunction with a helicase partner in DNA end
resection. Initially, it has been described that the cognate partner is BLM (Gravel et al., 2008;
Nimonkar et al., 2011). Later, it was demonstrated that also WRN could function in a redundant
manner instead of BLM, or even be the sole helicase partner of hDNA2 during resection of reversed
replication forks (Sturzenegger et al., 2014; Thangavel et al., 2015). Having demonstrated that
hDNA2 possesses a helicase activity, we wondered whether either BLM or WRN could stimulate
hDNA2 or vice versa, i.e., whether the enzyme complex may form an integrated unit. To this point,
we expressed wild type WRN and BLM helicases as well as their variants in Sf9 insect cells and puri-
fied all polypeptides to near homogeneity (Figure 6—figure supplement 1A–D). We next moni-
tored the resection of a 2.7 kbp-long dsDNA substrate. We selected wild type WRN and BLM
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concentrations that led to a partial unwinding of the substrate (Figure 6A lane 2, Figure 6B, lane 2).
Titrating wild type or helicase-deficient (K654R) hDNA2 into these reactions led to the degradation
of the unwound ssDNA, as expected. At the same time, the overall degradation of the dsDNA sub-
strate increased as well (Figure 6A–C). Under the same conditions, hDNA2 did not degrade dsDNA
without the helicase partner (Figure 6A, lane 11). This indicates a synergistic relationship between
the two enzyme pairs, i.e. that dsDNA unwinding/degradation by the enzyme pair is up to six-fold
higher than the sum of activities of the polypeptides acting individually (Figure 6C). Furthermore,
wild type hDNA2 was more efficient in DNA degradation than its helicase-deficient variant, in partic-
ular together with the WRN helicase (Figure 6A,C). As shown above, both wild type and helicase-
deficient hDNA2 variants had indistinguishable nuclease activity on 5’-labeled oligonucleotide based
substrate (Figure 1—figure supplement 1E,F). We could observe a similar stimulatory effect when
using a fixed concentration of hDNA2 and titrating either WRN or BLM helicases into the reactions
(Figure 6D,E,J).
To this point, the experiments demonstrated that DNA degradation by hDNA2 was stimulated by
a DNA helicase added in trans. To determine whether the stimulatory effect by WRN or BLM is spe-
cific for these two helicases, we tested if other human RecQ helicase family members could substi-
tute WRN or BLM in the DNA end resection assays. We did not observe any enhancement of DNA
degradation by hDNA2 upon adding either RecQ1 or RecQ5 helicases (Figure 6—figure
Figure 5. hDNA2 nuclease and helicase activities are regulated by ssDNA-binding proteins. (A) Representative 1%
agarose gels showing the helicase activity of hDNA2 D277A supplemented with indicated ssDNA-binding proteins
on a 32P-labeled 2.7 kbp-long dsDNA substrate. (B) Quantitation of experiments such as shown in Figure 5A.
Averages shown, n = 3–9; error bars, SEM. (C) Quantitation of unwinding experiments with Y-structured
oligonucleotide-based DNA such as shown in Figure 5—figure supplement 1E. Averages shown, n = 2; error
bars, SEM. (D) Quantitation of ssDNA degradation from experiments such as shown in Figure 1D and Figure 5—
figure supplement 1F. Averages shown, n = 2; error bars, SEM.
DOI: 10.7554/eLife.18574.010
The following figure supplement is available for figure 5:
Figure supplement 1. hDNA2 nuclease and helicase activities are regulated by ssDNA-binding proteins.
DOI: 10.7554/eLife.18574.011
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Figure 6. hDNA2 synergizes with WRN and BLM in the degradation of dsDNA. Representative 1% agarose gels showing dsDNA degradation by wild
type or helicase-deficient hDNA2 K654R variant with (A) WRN or (B) BLM. The reactions were supplemented with 50 mM NaCl and 215 nM hRPA. (C)
Quantitation of experiments such as shown in Figure 6A,B. Averages shown, n = 4–6; error bars, SEM. Representative 1% agarose gels showing dsDNA
processing by hDNA2 and (D) WRN, (E) BLM or (F) yeast Sgs1. The reactions were supplemented with 50 mM NaCl and 215 nM hRPA. Representative
Figure 6 continued on next page
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supplement 1E). However, RecQ1 and RecQ5 did not show detectable unwinding of the 2.7 kbp-
long dsDNA on their own. Therefore, we next used Sgs1, which shows a vigorous DNA helicase
activity and functions in conjunction with yDna2 in resection (Cejka et al., 2010). Importantly, adding
hDNA2 to reactions together with Sgs1 resulted in the degradation of unwound ssDNA, but in con-
trast to the reactions with BLM or WRN, no additional double-stranded substrate was degraded.
Moreover, hDNA2 even appeared to inhibit dsDNA unwinding by Sgs1 (Figure 6F). The specific
stimulatory effect was also observed in kinetic experiments with BLM and WRN, while no stimulation
was observed with hDNA2 and Sgs1 (Figure 6G–J). The stimulation of DNA degradation by hDNA2
was particularly pronounced together with WRN, where a gradual degradation of the substrate was
observed (Figure 6G). As our substrate is labeled on the 3’ end, the observed degradation pattern
is indicative of a 5’-3’ polarity of DNA degradation by hDNA2, and appears unrelated to the 3’-5’
exonuclease of WRN on recessed 3’ ends (Figure 6G). Together, these experiments show that the
hDNA2-BLM and hDNA2-WRN functionally integrate and that the helicase of hDNA2 may have a
stimulatory role in DNA end resection.
The WRN or BLM helicases functionally integrate with the helicase of
hDNA2
Our previous work revealed that nuclease-deficient yDna2 E675A exhibits a very vigorous DNA heli-
case activity similar to the helicase of Sgs1, one of the most active helicases in eukaryotes
(Cejka and Kowalczykowski, 2010; Levikova et al., 2013). Interestingly, we found here that under
elevated ionic strength conditions, the yDna2 E675A variant was even more active than Sgs1
(Figure 7A). In contrast DNA unwinding by hDNA2 D277A was highly sensitive to NaCl, to a much
greater extent than dsDNA unwinding by BLM or WRN (Figure 7B). Having established that hDNA2
with WRN or BLM synergize in DNA resection (Figure 6), we decided to determine the specific inter-
play of the helicases in more detail. At first, we tested whether helicase-deficient BLM K695A or heli-
case-deficient WRN K577M can stimulate DNA unwinding by nuclease-deficient hDNA2 D277A. At
low salt concentrations (25 mM), the helicase activity of hDNA2 D277A is already strongly reduced
(Figure 7B). Supplementing the reaction with WRN K577M or BLM K695A stimulated the hDNA2
D277A helicase activity ~7 or ~4-fold, respectively (Figure 7C,D). Therefore, both BLM and WRN
have structural roles to promote dsDNA unwinding by the nuclease-deficient hDNA2 D277A. This
stimulatory effect was specific for WRN and BLM helicases, as none of the other helicase-deficient
enzymes tested stimulated DNA unwinding to a comparable extent (Figure 7—figure supplement
1A–C). At 50 mM NaCl, the unwinding by the nuclease-deficient hDNA2 D277A alone was
completely inhibited (Figure 7B,E–H). Under the same conditions, we could observe that adding the
hDNA2 D277A variant to dsDNA unwinding reactions containing wild type WRN resulted in an
increase in DNA unwinding (~2.4-fold), which was more that upon the addition of the nuclease- and
helicase-deficient hDNA2 D277A K654R variant (~1.5-fold stimulation, Figure 7E,F). Therefore, the
hDNA2 helicase functionally integrates with WRN even under experimental conditions when no
inherent helicase activity was detected. In contrast, we observed that hDNA2 has only a structural
role to promote dsDNA unwinding by wild type BLM, as both hDNA2 D277A and DNA2 D277A
K654R variants stimulated DNA unwinding by BLM to the same extent (Figure 7G,H), as noted by
Sung and colleagues previously (Daley et al., 2014). Taken together, these data strongly suggest
that the helicases of hDNA2 and WRN or BLM, respectively, function in an integrated manner, where
one polypeptide stimulates the motor activity of its partner, in a mode reminiscent to that observed
in prokaryotic resection machineries (Dillingham and Kowalczykowski, 2008). This is in agreement
Figure 6 continued
1% agarose gels showing the kinetics of dsDNA processing by hDNA2 and (G) WRN (H) BLM and (I) yeast Sgs1. The reactions were supplemented with
50 mM NaCl and 215 nM hRPA. (J) Quantitation of experiments such as shown in Figure 6D,E,G–I. Averages shown, n = 3; error bars, SEM.
DOI: 10.7554/eLife.18574.012
The following figure supplement is available for figure 6:
Figure supplement 1. Purification of WRN and BLM proteins.
DOI: 10.7554/eLife.18574.013
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Figure 7. The helicase activity of hDNA2 functionally integrates with BLM or WRN helicases. (A) Quantitation of
2.7 kbp-long dsDNA unwinding by yDna2 E675A or Sgs1 with 400 nM of yeast RPA. Reactions were supplemented
with 100 mM sodium acetate and 5 mM magnesium acetate and incubated at 30˚C. Averages shown, n = 2–3;
error bars, SEM (B) Quantitation of DNA unwinding by yDna2 E675A (1 nM), BLM (10 nM), WRN (30 nM), hDNA2
D277A (30 nM) and its dependence on NaCl concentration. Reactions were supplemented with indicated NaCl
concentrations and 2 mM magnesium acetate and incubated at 37˚C. Averages shown, n = 2–3; error bars, SEM.
(C) Representative 1% agarose gel showing DNA unwinding by hDNA2 D277A (20 nM) and its stimulation by
helicase-deficient WRN K577M (20 nM) and BLM K695A (20 nM) variants. The reactions were supplemented with
Figure 7 continued on next page
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with physical interactions between hDNA2 and BLM or WRN, respectively (Nimonkar et al., 2011;
Sturzenegger et al., 2014).
Discussion
The involvement of DNA2 in cellular metabolism is absolutely dependent on its nuclease activity in
all organisms tested to date (Kang et al., 2010; Wanrooij and Burgers, 2015). The only exception
appears to be S. cerevisiae Dna2’s function in S-phase checkpoint signaling, where yeast Dna2 has a
structural and not an enzymatic role (Kumar and Burgers, 2013). In all other cases, DNA2 mutants
lacking the nuclease activity are as deficient as knockdowns and/or deletion mutants (Budd et al.,
2000; Duxin et al., 2012; Kang et al., 2000, 2010; Lin et al., 2013; Wanrooij and Burgers, 2015).
Indeed, DNA2 nuclease-deficiency brings about cellular lethality in yeast as well as human cells
(Budd et al., 2000; Duxin et al., 2012; Lee et al., 2000). Much less is known about the function of
the DNA2 helicase, despite both nuclease and helicase domains are equally conserved in evolution
(Bae et al., 1998). Helicase-deficient yeast mutants are viable under most growth conditions
(Budd et al., 1995; Formosa and Nittis, 1999), while in contrast the helicase appears to be essential
in human cells (Duxin et al., 2012). Here we present that human DNA2 possesses a marked DNA
unwinding activity (Figure 3), which can separate DNA duplexes of several kilobases in length in a
reaction that is dependent on the presence of the single-strand DNA binding protein hRPA. Single
molecule experiments using magnetic tweezers revealed that dsDNA unwinding by hDNA2 is highly
processive (Figure 4). Together, this indicates that the motor activity of the polypeptide is con-
served in evolution. Similarly to yeast (Levikova et al., 2013), the unwinding capacity of hDNA2 is
cryptic as it is masked by the nuclease within the same polypeptide. Therefore, the dsDNA unwind-
ing can only be observed with the nuclease-deficient hDNA2 D277A variant. We showed that the
nuclease of hDNA2 degrades 5’-tailed DNA at subnanomolar concentrations. The hDNA2 D277A
helicase requires 5’-terminated ssDNA strands for loading onto the DNA substrate; hence, we
believe that the nuclease of wild type hDNA2 cleaves these 5’ overhangs, which prevents loading of
hDNA2 onto the substrate and the engagement of its motor activity. This observation is in agree-
ment with the recently published structure of mouse DNA2, which demonstrated that the nuclease
active site is located along the entrance of a narrow tunnel. In order for the 5’ terminated DNA to
reach the helicase domain, the DNA molecule must thread half way through the tunnel (Zhou et al.,
2015). Thus, the position of the nuclease domain ahead of the helicase clearly explains the functional
interplay we observed in our experiments. Interestingly, in knockdown-rescue experiments, the
expression of the nuclease-deficient hDNA2 variant was much more detrimental than the expression
of the double nuclease- and helicase-deficient polypeptide (Duxin et al., 2012). Duxin et al. pro-
posed that the nuclease-deficient hDNA2 variant is likely toxic; our results that revealed that the
inactivation of the nuclease unleashes the helicase of hDNA2, which, when uncontrolled, likely
explains the cellular toxicity of the D277A mutant seen in vivo (Duxin et al., 2012).
The observation that the helicase of hDNA2 is only apparent upon inactivation of the nuclease
raises the question about the physiological relevance of such motor activity, despite this interplay is
Figure 7 continued
25 mM NaCl and contained 215 nM hRPA. (D) Quantitation of experiments such as shown in Figure 7C. Averages
shown, n = 5–7; error bars, SEM. (E) Representative 1% agarose gel showing the interplay of wild type WRN (30
nM) and nuclease-deficient hDNA2 D277A (60 nM) or nuclease- and helicase-deficient hDNA2 D277A K654R (60
nM) mutants. The reactions were supplemented with 50 mM NaCl and 215 nM hRPA. (F) Quantitation of
experiments such as shown in Figure 7E. Averages shown, n = 3–4; error bars, SEM. (G) Representative 1%
agarose gel showing the interplay of wild type BLM (10 nM) and nuclease-deficient hDNA2 D277A (20 nM) or
nuclease- and helicase-deficient hDNA2 D277A K654R (20 nM) mutants. The reactions were supplemented with 50
mM NaCl and 215 nM hRPA. (H) Quantitation of experiments such as shown in Figure 7G. Averages shown, n =
2–4; error bars, SEM.
DOI: 10.7554/eLife.18574.014
The following figure supplement is available for figure 7:
Figure supplement 1. The functional integration of the helicase activity of hDNA2 is specific for WRN and BLM.
DOI: 10.7554/eLife.18574.015
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conserved from yeast to man (Bae et al., 1998; Levikova et al., 2013). Previously, we speculated
that the interplay of the helicase and nuclease activities might be regulated by post-translational
modifications, protein partners and/or specific DNA structures (Levikova et al., 2013). In such a sce-
nario, e.g. a post-translational modification may selectively lower the nuclease activity, which could
allow manifestation of the hDNA2 helicase. This may be also achieved by regulating the redox state
of the hDNA2 iron-sulfur cluster, which is embedded in the nuclease domain, and the function of
which remains unclear (Pokharel and Campbell, 2012; Wu and Brosh, 2012). Likewise, it is possible
that protein partners such as BLM or WRN may functionally integrate with the enzymatic activities of
hDNA2, and modulate the interplay of the helicase-nuclease within the polypeptide. The helicase of
hDNA2 might therefore only engage when hDNA2 functions in complex with the BLM or WRN fac-
tors. Interestingly, the quantitative comparison of yDna2 and hDNA2 unwinding capacities revealed
that the human homologue is approximately 3–10-fold slower than its yeast counterpart. Moreover,
also human BLM or WRN appear to be about an order of magnitude less active than yeast Sgs1, the
partner of yDna2 and the most active RecQ helicase identified to date (Cejka and Kowalczykowski,
2010; Gray et al., 1997; Janscak et al., 2003; Karow et al., 1997). These results may suggest that
the two motor activities of yDna2/hDNA2 and Sgs1/BLM/WRN might have co-evolved to match the
speed of each other’s partner, and that Sgs1-yDna2 and BLM-hDNA2 or WRN-hDNA2 pairs might
operate as functional units. Indeed, we observed here that adding hDNA2 to reactions containing
BLM or WRN, hDNA2 not only degraded the unwound ssDNA, but the concerted activity of the
enzyme pair resulted in an overall stimulation of the dsDNA degradation activity. This effect was
specific for the hDNA2-WRN and hDNA2-BLM enzyme pairs, as no such stimulation was observed
together with Sgs1. These hDNA2-WRN and hDNA2-BLM resection complexes might be the func-
tional analogs of the DNA-end processing machineries in prokaryotes. In most gram-negative bacte-
ria such as E. coli, the RecBCD complex consists of subunits that function autonomously but
integrate into a molecular machine that has helicase-nuclease activities exceeding the sum of its
parts. The RecB subunit contains a 3’-5’ helicase (therefore, opposite to DNA2) followed by a dual
polarity nuclease, which integrates with the 5’-3’ motor of the RecD subunit
(Dillingham et al., 2003; Spies et al., 2007; Taylor and Smith, 2003). In gram-positive bacteria
such as Bacillus subtilis, the AddAB complex has two nucleases but only one helicase
(Rocha et al., 2005; Yeeles and Dillingham, 2007). Similarly to DNA2, the AddB subunit contains
an iron-sulfur cluster (Yeeles et al., 2009), and the structure of the nuclease domain shows a high
level of similarity with mouse DNA2 (Krajewski et al., 2014; Zhou et al., 2015). Furthermore, most
bacteria also contain the RecQ-RecJ complex (Morimatsu and Kowalczykowski, 2014; Persky and
Lovett, 2008), which likewise provides complementary activities that integrate within a complex
capable to resect DNA for the RecF recombination pathway. Having uncovered the cryptic helicase
capacity within hDNA2, we sought to determine whether it might function synergistically together
with the BLM and/or the WRN helicase. The results presented here clearly show that although both
wild type and helicase-deficient hDNA2 variants have the same nuclease activity on 5’-tailed DNA,
the wild type enzyme is clearly more proficient in DNA end resection under limiting enzyme concen-
trations (Figure 6). This indicated that the motor activity within nuclease-proficient hDNA2 contrib-
utes to DNA degradation in reactions containing WRN or BLM helicases. We believe that BLM and
WRN helicases provide the lead motor activity, while the hDNA2 motor has an accessory function,
possibly to enhance the processivity of the complex, to help traverse strand discontinuities or to
degrade unwound ssDNA. Neither WRN nor BLM could inhibit ssDNA degradation by hDNA2 (data
not shown), so we do not believe that WRN/BLM’s function to facilitate the engagement of hDNA2
motor activity results from an inhibition of its nuclease. How specifically the motor of hDNA2 over-
comes the inhibition by the hDNA2 nuclease thus remains to be established. Our results show that
the helicase of hDNA2 may play a non-essential but stimulatory role in conjunction with BLM or
WRN. Previously, the helicase of hDNA2 and its yeast homologue was found dispensable for resec-
tion in vivo (Thangavel et al., 2015; Zhu et al., 2008), which contrasts with the results obtained in
this study. However, the previous experiments were carried out under conditions where the comple-
menting hDNA2 variants, either wild type or helicase-deficient, were expressed ectopically from a
plasmid. This might have masked the stimulatory role of the hDNA2 helicase. Overexpression of wild
type yDna2 leads to cell cycle arrest (Parenteau and Wellinger, 1999), showing that the levels of
DNA2 must be balanced. Further experiments presented here provided evidence that both WRN
and BLM promote dsDNA unwinding by hDNA2 and vice versa, showing that the helicases of
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hDNA2 and WRN/BLM functionally integrate (Figure 7). Taken together, our results suggest that the
helicase of hDNA2 might play a supportive role in DNA end resection of DNA double-strand breaks,
reversed replication forks and/or other structures arising in S phase. The failure and/or delay in the
repair of these structures then result in the pronounced G2 phase cell cycle arrest and checkpoint
signaling that had been observed in the absence of the hDNA2 helicase (Duxin et al., 2012).
Finally, hDNA2 was found to be overexpressed in various human cancers, and the hDNA2 expres-
sion level negatively correlated with disease outcome (Peng et al., 2012; Strauss et al., 2014). This
suggested that hDNA2 might especially promote viability of rapidly-dividing cancer cells with high
levels of replication stress. This identified hDNA2 as a potential target for anti-cancer therapy. We
show that inhibition of the nuclease activity unleashes the hDNA2 helicase, which is likely to contrib-
ute to the cytotoxic effects of the hDNA2 nuclease inhibitors. Duxin et al. observed that human cells
expressing the nuclease-deficient variant were rapidly selected against during the course of the
experiment, unlike in case of the double mutant lacking both nuclease and helicase activities that
was maintained at constant levels (Duxin et al., 2012). Therefore, subsequent inactivation of the
helicase might lead to resistance to the hDNA2 nuclease inhibitors. The assays developed in this
study will be invaluable to assess the specificity and the mechanism of action of the various hDNA2
inhibitors that are currently being developed.
Materials and methods
Preparation of recombinant proteins
The hDNA2 sequence was codon optimized for the expression in Sf9 insect cells
(Supplementary file 1A) and was purchased from GenScript (Piscataway, NJ). The hDNA2 gene was
amplified by PCR using primers 5’-TAGGAAGGATCCATGCATCACCATCACCATCACGGTGGTTC
TGGTATGGAGCAATTGAACGAACTCGAAC-3’ and 5’-GGTCACAAGCTTTTACTTATCGTCGTCA
TCCTTGTAATCTTCACGCTGGAAGTCGCCG-3’ to introduce BamHI and HindIII restriction sites as
well as 6xHis and FLAG tags (Figure 1A). The PCR products were digested with BamHI and HindIII
restriction endonucleases (New England Biolabs, Ipswich, MA) and ligated into a pFastBac1 vector
(Invitrogen, Carlsbad, CA) generating pFB-His-hDNA2-FLAG. The D277A point mutation inactivating
the hDNA2 nuclease was introduced with oligonucleotide pair 5’-GGCCTGAAGGGAAAGATCGCTG
TCACAGTTGGAGTGAAG-3’ and 5’-CTTCACTCCAACTGTGACAGCGATCTTTCCCTTCAGGCC-3’
whereas the K654R point mutation abolishing the hDNA2 helicase was introduced with oligonucleo-
tide pair 5’-GGCATGCCGGGAACTGGCAGGACAACCACTATCTGCACA-3’ and 5’-TGTGCAGATAG
TGGTTGTCCTGCCAGTTCCCGGCATGCC-3’ using the QuikChange XL Site-directed mutagenesis
kit (Agilent, Santa Clara, CA) according to manufacturer’s recommendations. The construct for the
expression of the helicase and nuclease-deficient D277A K654R hDNA2 double mutant was pre-
pared sequentially using the primers described above. All hDNA2 variants were expressed in Sf9
insect cells in SFX Insect serum-free medium (Hyclone, GE Healtcare, UK) using the Bac-to-Bac
expression system (Thermo Fisher Scientific, Waltham, MA), according to manufacturer’s recommen-
dations. Frozen Sf9 pellets from 3 liters culture for each variant were re-suspended in lysis buffer (50
mM Tris-HCl pH 7.5, 2 mM b-mercaptoethanol, 1 mM phenylmethanesulfonylfluoride [PMSF], 1 mM
ethylenediaminetetraacetic acid [EDTA], 10 mM imidazole, protease inhibitor cocktail [P8340,
Sigma-Aldrich, St. Louis, MO] diluted 1:250, 30 mg/ml leupeptin [Merck Millipore, Billerica, MA]) and
incubated at 4˚C for 20 min. Glycerol was added to a final concentration of 15%, NaCl was added to
a final concentration of 305 mM and the solution was incubated at 4˚C for 30 min. The mixture was
centrifuged at 39’000 g at 4˚C for 30 min. The soluble extract was incubated with Ni-NTA agarose
resin (Qiagen, Germany) at 4˚C for 1 hr. Ni-NTA resin was washed with Ni-NTA wash buffer 1 M (50
mM Tris-HCl pH 7.5, 2 mM b-mercaptoethanol, 1 mM PMSF, 1 mM EDTA, 10 mM imidazole, 1:1000
protease inhibitor cocktail, 30 mg/ml leupeptin, 10% glycerol, 1 M NaCl) and subsequently washed
with Ni-NTA wash buffer 150 mM (the same buffer as above, but only with 150 mM NaCl). Proteins
were eluted using Ni-NTA wash buffer 150 mM supplemented with 300 mM imidazole, and subse-
quently diluted with 4 volumes of FLAG wash buffer 150 mM (50 mM Tris-HCl pH 7.5, 0.5 mM b-
mercaptoethanol, 1 mM PMSF, 10% glycerol, 150 mM NaCl) to lower the imidazole and b-mercap-
toethanol concentrations. The mixture was incubated with anti-FLAG M2 Affinity Gel (A2220, Sigma-
Aldrich) at 4˚C for 1 hr. Proteins were eluted using FLAG wash buffer 150 mM supplemented with
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300 mg/ml FLAG peptide (F4799, Sigma-Aldrich), aliquoted, snap-frozen in liquid nitrogen and
stored at !80˚C. Yeast Dna2, Sgs1, human and yeast RPA were purified as described previously
(Cejka and Kowalczykowski, 2010; Henricksen et al., 1994; Kantake et al., 2003; Levikova et al.,
2013). Human RecQ1, RecQ5 and yeast Srs2 and their variants were kind gifts from A. Vindigni
(Saint Louis University, USA), P. Janscak (University of Zurich, Switzerland) and L. Krejci (Masaryk Uni-
versity, Czech Republic).
The BLM gene was amplified by PCR from pZL4 plasmid (Kanagaraj et al., 2006) with primers 5’-
TAGGAAGCTAGCGGATCCATGGCTGCTGTTCCTCAAAA-3’ and 5’-TAGGAACTCGAGCCCGGG
TGAGAATGCATATGAAGGCTT-3’ to introduce XhoI and NheI restriction sites. The WRN gene was
amplified by PCR from plasmid pBlueBacHis-WRN (Gray et al., 1997) with primers 5’-TAGGAAGC
TAGCGGATCCATGAGTGAAAAAAAATTGGAAACAA-3’ and 5’-TAGGAACTCGAGCCCGGGAC
TAAAAAGACCTCCCCTTTT-3’ to introduce XhoI and NheI restriction sites. The PCR products were
cloned into pFB-MBP-Sgs1-his (Cejka et al., 2010) generating pFB-MBP-BLM-his and pFB-MBP-
WRN-his, respectively. Mutations for the helicase-deficient variants were introduced as described
above using oligonucleotide pairs 5’-ACTGGAGGTGGTGCGAGTTTGTGTTACCAGCTC-3’ and 5’-
GAGCTGGTAACACAAACTCGCACCACCTCCAGT-3’ for BLM K695A and 5’-GCAACTGGATA
TGGAATGAGTTTGTGCTTCCAGTATCC-3’ and 5’-GGATACTGGAAGCACAAACTCATTCCATA
TCCAGTTGC-3’ for WRN K577M. All BLM and WRN variants were expressed in Sf9 cells. Frozen Sf9
pellets from 1.2–2 l culture for each variant were resuspended in lysis buffer and soluble extract was
prepared as for hDNA2 (see above). The soluble extract was incubated with amylose resin (New
England Biolabs) at 4˚C for 1 hr. The resin was washed with amylose wash buffer 1 M (50 mM Tris-
HCl pH 7.5, 5 mM b-mercaptoethanol, 1 mM PMSF, 10% glycerol, 1 M NaCl). Proteins were eluted
using amylose elution buffer (50 mM Tris-HCl pH 7.5, 5 mM b-mercaptoethanol, 1 mM PMSF, 10%
glycerol, 300 mM NaCl, 10 mM maltose). The MBP-tagged variants were incubated with PreScission
protease (~25 mg PreScission protease per 100 mg of tagged protein) at 4˚C for 1.5 hr to cleave the
MBP tag. Subsequently, imidazole was added to a final concentration of 10 mM and the solution
was incubated with pre-equilibrated Ni-NTA agarose resin (Qiagen) at 4˚C for 1 hr, in agitation. The
resin was washed with NTA Buffer A1 (50 mM Tris-HCl pH 7.5, 5 mM b-mercaptoethanol, 1 mM
PMSF, 10% glycerol, 1 M NaCl, 58 mM imidazole) and subsequently with NTA Buffer A2 (50 mM
Tris-HCl pH 7.5, 5 mM b-mercaptoethanol, 1 mM PMSF, 10% glycerol, 150 mM NaCl, 58 mM imidaz-
ole). The BLM or WRN variants were eluted with NTA Buffer B (50 mM Tris HCl pH 7.5, 5 mM b-mer-
captoethanol, 1 mM PMSF, 10% glycerol, 100 mM NaCl, 300 mM imidazole). Fractions containing
high protein concentration were pooled and dialyzed against 1 l of dialysis buffer (50 mM Tris-HCl
pH 7.5, 5 mM b-mercaptoethanol, 0.5 mM PMSF, 10% glycerol, 100 mM NaCl) for 1 hr at 4˚C. Pro-
teins were aliquoted, snap-frozen in liquid nitrogen and stored at !80˚C. The typical yield was ~50–
280 mg from 1.2–2 liters culture for each variant.
The plasmid pSF1-hsmtSSB coding for human mitochondrial single-stranded DNA binding protein
(mtSSB) was received from Ute Curth (Hannover Medical School) (Curth et al., 1994). The mtSSB
gene was amplified by PCR using primers 5’-GTGACCGAATCATGGACTCCGAAACAACTACCAG
TTTGG-3’ and 5’-GTGACCGGATCCCTACTCCTTCTCTTTCGTCTGGTCACTC-3’ and cloned into the
pMALT-P expression vector (Taeho Kim, Kowalczykowski laboratory, unpublished) using EcoRI and
BamHI restriction sites. This placed mtSSB behind an MBP tag and a PreScission Protease site creat-
ing pMALT-P-mtSSB. The MBP-mtSSB fusion was expressed in E. coli BL21 cells upon induction with
Isopropyl b-D-1-thiogalactopyranoside (IPTG, 400 mM) for 3 hr at 37˚C. Frozen E. coli pellets from 2 l
E. coli culture were re-suspended in buffer B1 (50 mM Tris-HCl pH 7.5, 1 mM EDTA, protease inhibi-
tor cocktail [1:400], 30 mg/ml leupeptin, 1 mM PMSF, 1 mM dithiothreitol [DTT], 10% glycerol, 100
mM NaCl) and lysed by sonication. Whole cell extract was centrifuged at 39’000g at 4˚C for 30 min.
The supernatant was collected and incubated with pre-equilibrated 3 ml amylose resin (New England
Biolabs) for 1 hr at 4˚C. The resin was washed in buffer B2 (50 mM Tris-HCl pH 7.5, 1 mM DTT, 10%
glycerol, 100 mM NaCl). MBP-mtSSB was eluted using buffer B3 (50 mM Tris-HCl pH 7.5, 1 mM
DTT, 10% glycerol, 100 mM NaCl, 10 mM maltose). The MBP tag was cleaved with PreScission pro-
tease (~15 mg per 100 mg MBP-mtSSB) overnight at 4˚C. The solution was then diluted with 1 volume
of water. The sample was loaded onto a HiTrap Blue column (GE Healthcare). The column was
washed with buffer B2 sequentially supplemented with 50 mM KCl, 800 mM KCl, 0.5 M sodium thio-
cyanate and 1.5 M sodium thiocyanate. The mtSSB protein was eluted using buffer B4 (20 mM Tris-
HCl pH 7.5, 1 mM EDTA, 1 mM DTT, 10% glycerol, 2 M NaCl, 5 M urea). The eluate was dialyzed
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twice against 1 l buffer B5 (50 mM Tris-HCl pH 7.5, 1 mM DTT, 10% glycerol, 50 mM NaCl) for 1.5 hr
each time. The final mtSSB preparation was aliquoted, snap-frozen in liquid nitrogen and stored at
!80˚C.
The three pDONR plasmids (Thermo Fisher Scientific) coding for SOSSA, SOSSB1 and SOSSC,
respectively, were gifts from Jun Huang (Life Sciences Institute, Hangzhou, Zhejiang University)
(Huang et al., 2009). The SOSSA gene was cloned into pDEST20 vector using Gateway recombina-
tion cloning technology (Thermo Fisher Scientific) creating pDEST20-GST-SOSSA. To add a N-termi-
nal 6xhis tag to SOSSB1, the SOSSB1 gene was amplified by PCR using primers 5’-GTGACCGGA
TCCATGCATCACCATCACCATCACATGACGACGGAGACCTTTGTGAAGGATATC-3’ and 5’-G
TGACCCCCGGGCTATCTCTTGCTGCTCCTCCGGGTTT-3’. The PCR product was cloned into a
pFastBac1 vector using BamHI and XmaI restriction sites, creating pFB-hisSOSSB1. The SOSSC gene
was amplified by PCR using primers 5’-GTGACCGGATCCATGGCAGCAAACTCTTCAGGACAAGG
TTTTC-3’ and 5’-GTGACCC’CCGGGTCATTCTGGGTCAAGGCGAGGTAAAACAG-3’. The gene was
cloned into pFastBac1 vector using BamHI and XmaI restriction sites, creating pFB-SOSSC. The het-
erotrimer was expressed as a complex in Sf9 cells for in 2 l of culture. The pellet was re-suspended
in buffer B1 (50 mM Tris-HCl pH 8, 1 mM EDTA, protease inhibitor cocktail [1:400], 30 mg/ml leupep-
tin, 1 mM PMSF, 1 mM DTT) and incubated for 20 min at 4˚C in agitation. Glycerol was added to a
final concentration of 15% and NaCl was added to a final concentration of 305 mM. The solution
was incubated for another 30 min at 4˚C in agitation. The solution was centrifuged for 30 min at
39’000 g at 4˚C. The soluble extract was then incubated with 2 ml pre-equilibrated Glutathione
HiCap matrix (Qiagen) for 1 hr at 4˚C in agitation. The resin was washed 3x batch-wise and subse-
quently on column with wash buffer (50 mM Tris-HCl pH 8, protease inhibitor [1:1000], 1 mM PMSF,
2 mM 2-mercaptoethanol). The proteins were eluted using the wash buffer supplemented with 10
mM glutathione. Imidazole was added to the eluate to a final concentration of 10 mM and incubated
with pre-equilibrated Ni-NTA agarose resin (Qiagen) for 1 hr at 4˚C in agitation. The resin was
washed twice with buffer A2 (50 mM Tris HCl pH 7.5, 2 mM 2-mercaptoethanol, 150 mM NaCl, 10%
glycerol, 1 mM PMSF, 58 mM imidazole) and the proteins were eluted with buffer B (50 mM Tris-HCl
pH 7.5, 2 mM 2-mercaptoethanol, 100 mM NaCl, 10% glycerol, 1 mM PMSF, 300 mM imidazole).
The eluate was dialyzed against 1 l of dialysis buffer (50 mM Tris-HCl pH 7.5, 2 mM 2-mercaptoetha-
nol, 100 mM NaCl, 10% glycerol, 0.5 mM PMSF) for 1.5 hr at 4˚C.
DNA substrates
Oligonucleotides were labeled either at the 5’ terminus with [g-32P]ATP and T4 polynucleotide kinase
(New England Biolabs), or at the 3’ terminus with [a-32P] cordycepin-5-triphosphate and terminal
transferase (New England Biolabs) according to standard protocols. The sequences of all oligonu-
cleotides are listed in Supplementary file 1B. The substrates were prepared by annealing the 32P-
labeled oligonucleotide with a two-fold excess of the unlabeled oligonucleotide in a PNK buffer
(New England Biolabs). The substrates and component oligonucleotides are listed in
Supplementary file 1C.
lDNA/HindIII fragments (Bacteriophage l DNA-HindIII Digest, New England Biolabs) were
labeled at the 3’ ends with [a-32P]dATP and Klenow fragment of DNA polymerase I (New England
Biolabs) in NEBuffer 2. The pUC19 plasmid was digested by HindIII-HF restriction enzyme and puri-
fied by phenol-chloroform extraction and ethanol precipitation. The resulting linear dsDNA was
labeled at the 3’ ends with [a-32P]dATP and Klenow fragment of DNA polymerase I (New England
Biolabs) in NEBuffer 2. Unincorporated radioactive ATP was in all cases removed using Micro Spin
G25 columns (GE Healthcare). The positions of the radioactive labels are indicated in the substrate
schematics with a star symbol.
Electrophoretic mobility shift assays
The reactions (15 ml volume) were performed in a binding buffer (25 mM Tris-acetate pH 7.5, 2 mM
magnesium acetate, 1 mM DTT, 0.1 mg/ml BSA) with the respective DNA substrate (1 nM). The reac-
tions were incubated at 37˚C for 30 min. Loading dye (50% glycerol, bromophenol blue) was added
and the products were separated by polyacrylamide gel electrophoresis (6%, ratio acrylamide-bisa-
crylamide 19:1, BioRad) in Tris-Acetate-EDTA (TAE) buffer. The electrophoresis was carried out in a
gel tank surrounded by ice. The gels were dried on DE81 chromatography paper (Whatman, UK).
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The dried gels were then exposed to Storage Phosphor screens (GE Healthcare) and scanned by
Typhoon 9400 (GE Healthcare). The data was quantified using Image Quant TL software (GE
Healthcare).
Nuclease assays
Nuclease assays (15 ml volume) were performed in a reaction buffer (25 mM Tris-acetate pH 7.5, 2
mM magnesium acetate, 1 mM ATP, 1 mM DTT, 0.1 mg/ml BSA, 1 mM phosphoenolpyruvate (PEP),
0.02 units/ml pyruvate kinase [Sigma]) containing DNA substrates (1 nM) and recombinant proteins
as indicated. Reactions were incubated at 37˚C for 30 min. For analysis on native gels the reactions
were stopped by adding 5 ml 2% stop solution (150 mM EDTA, 2% sodium dodecyl sulfate [SDS],
30% glycerol, bromophenol blue) and 1 ml Proteinase K (14-22 mg/ml, Roche, Switzerland) and incu-
bated at 37˚C for 10 min. The samples were then analyzed by native polyacrylamide gel electropho-
resis (10%, ratio acrylamide-bisacrylamide 19:1, Biorad, Hercules, CA). For analysis on denaturing
gels the reactions were stopped by adding an equal amount of formamide dye (95% [v/v] formam-
ide, 20 mM EDTA, bromophenol blue), samples were heated at 95˚C for 4 min and separated on
20% denaturing polyacrylamide gels (ratio acrylamide:bisacrylamide 19:1, Biorad). After fixing in a
solution containing 40% methanol, 10% acetic acid and 5% glycerol for 30 min the gels were dried
and analyzed as described above.
Helicase and ATPase assays
Helicase assays (15 ml volume) were performed in a reaction buffer (25 mM Tris-acetate pH 7.5, 2
mM magnesium acetate, 1 mM ATP, 1 mM DTT, 0.1 mg/ml BSA, 1 mM PEP, 0.02 units/ml pyruvate
kinase) with the respective DNA substrate (1 nM for oligonucleotide- and pUC19/HindIII-based and
0.15 nM for lDNA/HindIII-based substrates). Recombinant proteins were added as indicated. Reac-
tions were incubated at 37˚C for 30 min and stopped as described above in the nuclease assay sec-
tion. To avoid re-annealing of the oligonucleotide-based substrates, the stop solution was
supplemented with a 20-fold excess of the oligonucleotide with the same sequence as the 32P-
labeled one. The products were analyzed either by polyacrylamide gel electrophoresis (10%) for oli-
gonucleotide-based DNA substrates or 1% agarose gels for plasmid and lDNA-based DNA sub-
strates. The gels were dried on DE81 chromatography paper (Whatman) and analyzed as described
above. The ATPase assays were performed as described previously (Kowalczykowski and Krupp,
1987). The reaction buffer contained 25 mM Tris-acetate pH 7.5, 1 mM magnesium acetate, 1 mM
DTT, 0.1 mg/ml BSA, 1 mM ATP and 1 mM PEP, 0.025 units/ml pyruvate kinase, 0.025 units/ml L-lac-
tic dehydrogenase (Sigma).
Magnetic tweezers assay
The DNA construct was prepared as described before (Levikova et al., 2013). The central part is a
6.1 kbp dsDNA having a ssDNA flap of 40 nt in length placed 1 kbp from its proximal DNA end. A
digoxigenin- and a biotin-modified handle of 600 bp length were attached to the 6.1 kbp fragment
at its flap-proximal and distal ends, respectively. The magnetic tweezers experiments were carried
out as described previously (Klaue and Seidel, 2009; Levikova et al., 2013). In brief, the DNA sub-
strate was bound to 2.8 mm streptavidin-coated magnetic beads (M280, Invitrogen) and were flushed
into the fluidic cell, whose bottom glass slide was covered with digoxigenin. After a brief incubation
to allow the attachment of the digoxigenin-modified DNA end, a pair of magnets above the flow
cell was approached to remove unbound beads and to stretch the bead tethered DNA molecules.
The DNA length was obtained by videomicroscopy of the beads and GPU-accelerated real-time par-
ticle tracking (Huhle et al., 2015). The stretching force was adjusted by changing the distance of the
magnet to the fluidic cell. Forces were calibrated for each bead using fluctuation analysis
(Daldrop et al., 2015). The unwinding assays were performed in a reaction buffer (25 mM Tris-ace-
tate pH 7.5, 5 mM magnesium acetate, 1 mM ATP, 1 mM DTT, 0.1 mg/ml BSA) supplemented with
25 nM hRPA and 25 nM hDNA2 D277A at 37˚C. For temperature control of the setup an objective
heater (Okolab, Pozzuoli, Italy) was employed. With respect to the bulk assays, the magnesium ace-
tate concentration was increased to 5 mM to prevent DNA melting by hRPA (Kemmerich et al.,
2016). The DNA extension resulting from unwinding was converted from mm into bp applying a
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conversion factor that was calculated from the force extension curves for the DNA molecule at the
certain force (Kemmerich et al., 2016).
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Figure 1—figure supplement 1. Human RPA guides the hDNA2 nuclease to 5’ terminated 
ssDNA.  (A–C) Representative 10% polyacrylamide gels stained with Coomassie blue 
showing samples from (A) wild type hDNA2, (B) helicase-deficient hDNA2 K654R, and (C) 
nuclease- and helicase-deficient hDNA2 D277A K654R purifications. A mutation within the 
helicase motif leads to reduced expression levels. (D) Representative 10% polyacrylamide 
gels showing the nuclease activity of wild type hDNA2 on various 32P-labeled 
oligonucleotide-based substrates. Reactions were carried out without hRPA. (E) Nuclease 
activity of the helicase-deficient hDNA2 K654R mutant. Assay as in panel D with 5' 
overhanged DNA substrate. (F) Quantitation of data from experiments as shown in Figure 
1—figure supplement 1D,E. Averages shown, n = 2; error bars, SEM. (G) Reactions as in D 
but with 15 nM hRPA. 
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Figure 1—figure supplement 2. hDNA2 binds ssDNA. (A–F) Representative 6% 
polyacrylamide gels showing the binding of nuclease-deficient hDNA2 D277A to various 
32P-labeled oligonucleotide-based substrates. The blue triangle indicates the position of 
wells. 
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Figure 3—figure supplement 1. hDNA2 D277A unwinds plasmid- and oligonucleotide-based 
DNA substrates. (A) Representative 1% agarose gel showing hDNA2 D277A helicase 
activity on a λDNA/HindIII substrate in a time-course experiment with 346 nM hRPA. Heat, 
heat-denatured DNA substrate. (B) Representative 1% agarose gel showing that nuclease- 
and helicase-deficient hDNA2 D277A K654R (lanes 2–6) and helicase-deficient hDNA2 
K654R (lane 8) do not exhibit helicase activity. Lane 7, DNA unwinding by nuclease-deficient 
DNA2 D277A. Reactions contained 215 nM hRPA. (C–E) Representative 10% 
polyacrylamide gels showing the helicase activity of hDNA2 D277A with (C) 5’ overhang, (D) 
3’ overhang and with (E) dsDNA substrates. Reactions contained 7.5 nM RPA. Heat, heat-
denatured DNA substrate. (F) Representative 1% agarose gels showing DNA unwinding of a 
2.7 kbp-long substrate by either hDNA2 D277A (left part, at 37°C) or yDna2 E675A (right 
part, at 30°C) in a kinetic experiment with 215 nM human RPA or 267 nM yeast RPA 
respectively. (G) Quantitation of experiments such as shown in F. Averages shown, n = 2; 
error bars, SEM. 
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Figure 4—figure supplement 1.Single molecule experiments reveal that DNA unwinding by 
hDNA2 D277A is dependent on ATP and hRPA.Experiments were carried out as in Figure 
4B by adding hDNA2 D277A but omitting (A) both ATP and hRPA, (B) ATP or (C) hRPA 
only. While no activity was observed at all in the absence of ATP (independently of the 
presence of hRPA), some slow length changes were observed in presence of ATP but 
absence of hRPA that indicate a residual unwinding activity of hDNA2 D277A. This activity 
was dependent on the intact helicase domain of hDNA2 since experiments testing the 
nuclease- and helicase-deficient hDNA2 D277A K654R variant did not show such length 
changes as shown in (D). Length shortening may occur due to DNA looping with at least two 
hDNA2 molecules bound at different positions on the substrate. At this point however we 
have no evidence that this is physiologically relevant. 
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Figure 5—figure supplement 1. hDNA2 nuclease and helicase activities are regulated by 
ssDNA-binding proteins.10% SDS-PAGE stained with Coomassie blue showing the 
purification procedures of (A) mtSSB and (B) the SOSS complex. PP, PreScission Protease. 
The ssDNA-binding properties of (C) mtSSB and (D) SOSS were tested in electrophoretic 
mobility shift assay. Increasing concentrations of either complex were incubated with 32P-
labeled ssDNA. Representative 6% polyacrylamide gels are shown. (E) Representative 10% 
polyacrylamide gels showing the helicase activity of hDNA2 D277A on a 32P-labeled Y-
structured DNA substrate supplemented with increasing concentrations of yRPA, mtSSB, 
SOSS and hRPA. 10 nM hRPA was able to melt the Y-structure to a minor degree on its 
own (lane 35). Heat, heat-denatured DNA substrate. Quantitation is shown in Figure 5C. (F) 
Representative 20% polyacrylamide denaturing urea gels showing the nuclease activity of 
hDNA2 (0.2 nM) on a 93 nt-long ssDNA 32P-labeled at its 3’ end. Reactions were 
supplemented with increasing concentrations of yRPA, mtSSB and SOSS. The blue triangle 
indicates a truncation of the substrate. Quantitation is shown in Figure 5D. 
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Figure 6—figure supplement 1. Purification of WRN and BLM proteins. (A) 10% SDS-PAGE 
stained with Coomassie blue showing the purification procedure of wild type WRN. PP, 
PreScission Protease. (B) 10% SDS-PAGE stained with Coomassie showing wild type 
WRN, helicase-deficient WRN K577M, wild type BLM and helicase-deficient BLM K695A 
protein preparations used in this study. (C) Apparent ATP turnover number kcat showing the 
ATPase activity of WRN or BLM incubated with 3' overhang DNA substrate. The reactions 
contained 12 nM of the respective enzyme. WRN K577M and BLM K695A are devoid of 
ATPase activity. Averages shown, n = 2; error bars, SEM. (D) Representative 1% agarose 
gel showing results of unwinding assays with helicase-deficient WRN K577M and BLM 
K695A variants. The reactions were supplemented with 25 mM NaCl and contained 215 nM 
hRPA. Heat, heat-denatured DNA substrate. (E) Representative 1% agarose gel showing 
dsDNA degradation/unwinding reactions containing hDNA2 and RecQ1 or RecQ5 
respectively. The reactions were supplemented with 50 mM NaCl and 215 nM RPA. 
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Figure 7—figure supplement 1. The functional integration of the helicase activity of hDNA2 is 
specific for WRN and BLM. (A) Representative 1% agarose gel showing that the helicase-
deficient mutants of various DNA helicases are not able to unwind a 2.7 kbp-long dsDNA 
substrate. (B) Representative 1% agarose gel showing DNA unwinding by hDNA2 D277A 
and its stimulation by helicase-deficient variants of various DNA helicases. The reactions 
were supplemented with 25 mM NaCl and contained 215 nM hRPA. (C) Quantitation of 
experiments such as shown in Figure 7—figure supplement 1. Averages shown, n = 2–8; 
error bars, SEM. 
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!
Supplementary!file!1C:!Oligonucleotide5based!DNA!substrates!used!in!this!
study.!
DNA!substrate:! 5'!labeled!
oligonucleotide:!
Unlabeled!
oligonucleotide:!ssDNA!(20!nt)! Primer!308! (!ssDNA!(50!nt)! X12(3! (!dsDNA!(31!bp)! X(12(3SC! X12(4SC!dsDNA!(50!bp)! X12(3! X12(4C!5’!overhang!(19!nt!/!31!bp)! X12(3! X12(4SC!5’!overhang!(30!nt!/!31!bp)! #292! X12(4SC!5’!overhang!(45!nt!/!48!bp)! X12(3!HJ1S! X12(3!TOPL!3’!overhang!(19!nt!/!31!bp)! X12(3SC! X12(4NC!3’!overhang!(45!nt!/!48!bp)! X12(3!HJ2Sb! X12(3!HJ3!Y(structure!(19!nt!/31!bp)! X12(3! X12(4NC!
DNA!substrate:! 3'!labeled!
oligonucleotide:! Unlabeled!oligonucleotide:!ssDNA!(93!nt)! X12(3HJ3! 5!Y(structure!(45!nt!/!48!bp)! X12(3HJ3! X12(3TOPL!
Supplementary!file!1C:!Oligonucleotide(based!DNA!substrates!used!in!this!study!and!their!components.!The!following!substrates!were!used!for!the!assays:!ssDNA!(50!nt),!dsDNA!(50!bp),!5'!overhang!(19!nt!/!31!bp),!3'!overhang!(19!nt!/!31!bp),!Y(structure!(19!nt!/31!bp),!unless!indicated!differently!in!the!figure!legends.!
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The motor activity of DNA2 functions
as an ssDNA translocase to promote DNA
end resection
Maryna Levikova,1,3 Cosimo Pinto,1,3 and Petr Cejka1,2
1Institute of Molecular Cancer Research, University of Zurich, 8057 Zurich, Switzerland; 2Institute for Research in Biomedicine,
Università della Svizzera italiana, 6500 Bellinzona, Switzerland
DNA2 nuclease–helicase functions in DNA replication and recombination. This requires the nuclease of DNA2,
while, in contrast, the role of the helicase activity has been unclear. We now show that the motor activity of both
recombinant yeast and human DNA2 promotes efficient degradation of long stretches of ssDNA, particularly in the
presence of the replication protein A. This degradation is further stimulated by a direct interaction with a cognate
RecQ family helicase, which functions with DNA2 in DNA end resection to initiate homologous recombination.
Consequently, helicase-deficient yeast dna2 K1080E cells display reduced resection speed of HO-induced DNA
double-strand breaks. These results support a model of DNA2 and the RecQ family helicase partner forming a
bidirectional motormachine, where the RecQ family helicase is the lead helicase, and themotor of DNA2 functions
as a ssDNA translocase to promote degradation of 5′-terminated DNA.
[Keywords: DNA helicase; DNA nuclease; yDna2; hDNA2; ssDNA translocase; DNA end resection]
Supplemental material is available for this article.
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ssDNA translocases are motor proteins that couple ATP
hydrolysis to translocation on ssDNA with either 3′→ 5′
or 5′→ 3′ polarity (Lohman et al. 2008). Some but not
all ssDNA translocases are DNA helicases capable of
unwindingdsDNA(Lohmanetal. 2008).TheDNAreplica-
tion-dependent helicase/nuclease 2 (yDna2 from Saccha-
romyces cerevisiae, hDNA2 from humans) possesses a
RecB family nuclease domain and a superfamily I helicase
domain (Budd et al. 1995, 2000; Bae et al. 1998). The nucle-
ase of both yeast and human DNA2 is specific for ssDNA
and can degrade both 3′- and 5′-terminated ssDNA strands
(Bae et al. 1998; Masuda-Sasa et al. 2006). The cognate
ssDNA-binding replicationproteinA (RPA) specifically in-
hibits3′→ 5′ DNAdegradationbyDNA2(Cejkaetal.2010;
Niu et al. 2010; Nimonkar et al. 2011), suggesting that
the DNA2 nuclease degrades ssDNA exclusively with a
5′→ 3′ directionality under physiological conditions.
The helicase activity of both yeast and human DNA2 is
paradoxically cryptic, as it unwinds dsDNA only when
the nuclease activity is inactivated (Levikova et al. 2013;
Pinto et al. 2016). The structure of mouse DNA2 revealed
that the nuclease active site is located inside a narrow tun-
nel that accommodates only ssDNA (Zhou et al. 2015).
Importantly, the nuclease tunnel is positioned ahead of
the superfamily I helicase domain. This supported a mod-
el in which the DNA2 nuclease cleaves ssDNA overhangs
that are required for loading of the DNA2 helicase domain
on the DNA substrate (Levikova et al. 2013; Pinto et al.
2016). Overhang cleavage by theDNA2 nuclease thus pre-
vents DNA unwinding by the DNA2 helicase, but the rea-
son why the helicase domain appears to competewith the
nuclease domain for DNA substrate in a physiological
context has remained unclear. Genetic and cell biological
experiments offer few insights into the function of the
DNA2 helicase. These experiments are limited by the
fact that DNA2 and its nuclease activity are required for
viability in yeast cells, while both helicase and nuclease
activities are essential in human cells,making phenotypic
analysis associated with DNA2 defects challenging (For-
mosa and Nittis 1999; Budd et al. 2000; Duxin et al.
2012; Wanrooij and Burgers 2015; Olmezer et al. 2016).
To repair a DNA double-strand break (DSB) by homolo-
gous recombination, the 5′-terminated strand of the DSB
must be first nucleolytically resected to reveal a 3′-termi-
nated ssDNA overhang (Cejka 2015). This serves as a
substrate for the strand exchange protein RAD51 and
primes DNA synthesis in later steps of the recombination
3These authors contributed equally to this work.
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pathway. There are two main pathways capable of resect-
ing long lengths of dsDNA, catalyzed by either the EXO1
or DNA2 nuclease (Gravel et al. 2008; Mimitou and Sy-
mington 2008; Zhu et al. 2008). While EXO1 is able to re-
sect a 5′-terminated DNA strand of a DNA duplex (Tran
et al. 2002; Cannavo et al. 2013), research from several lab-
oratories established that DNA2 functions in complex
with a cognate RecQ family helicase. This includes Sgs1
in S. cerevisiae and the Werner syndrome protein (WRN)
or Bloom syndrome protein (BLM) in human cells (Zhu
et al. 2008; Nimonkar et al. 2011; Sturzenegger et al.
2014). The helicase activity of the respective RecQ family
member and the nuclease of DNA2 are essential in DNA
end resection (Zhu et al. 2008; Nimonkar et al. 2011; Stur-
zenegger et al. 2014). All studies to date failed to explain
the function of the DNA2 helicase. Here we report that
the motor activity of both yeast and human DNA2 pro-
teins greatly stimulates degradation of long ssDNAmole-
cules by acting as a ssDNA translocase with a 5′→ 3′
polarity. Themotor activity withinwild-type DNA2 is in-
capable of unwinding and degrading dsDNA (Levikova
et al. 2013; Pinto et al. 2016) but, in contrast, is required
to efficiently degrade long ssDNA. These results infer a
model in which the cognate RecQ helicase partner is the
lead helicase that provides DNA2 with ssDNA, and
DNA2 is using its motor coupled with nuclease activity
to efficiently degrade the unwound 5′-terminated ssDNA
strand. Yeast cells expressing physiological levels of the
helicase-deficient Dna2 K1080E variant from its natural
locus in genomic DNA display an impaired DNA end re-
section phenotype, suggesting that the helicase activity
ofDNA2 functions to promoteDNAend resection in vivo.
Results
The motor of yeast and human DNA2 promotes
degradation of long ssDNA
Both yeast and human DNA2 possess the capacity to un-
wind dsDNA, yet this is paradoxically revealed only when
the nuclease of DNA2 is inactivated (Levikova et al. 2013;
Pinto et al. 2016). In accord with these observations, we
show here that nuclease-deficient yDna2 E675A efficient-
ly unwound Y-structured DNA, producing ssDNA. In
contrast, the processing of this substrate by wild-type
and helicase-deficient yDna2 K1080E variants was indis-
tinguishable and resulted only in DNA degradation (Fig.
1A–C; Supplemental Fig. S1A). The helicase activity of
yDna2 thus had no apparent effect on the degradation of
the oligonucleotide-based DNA by wild-type yDna2 (Fig.
1A–C; Supplemental Fig. S1A). The nuclease of yDna2
masks its unwinding activity, in agreement with previous
data in both yeast and human systems (Levikova et al.
2013; Pinto et al. 2016). To elucidate the function of the
DNA2 motor, we investigated the helicase-proficient
and helicase-deficient yeast Dna2 variants in the degrada-
tion of long ssDNA. As DNA2 proteins in all eukaryotic
organisms function in conjunction with a DNA helicase,
ssDNA may better mimic the structure on which DNA2
acts in vivo. To this point, we digested λDNA with Hin-
dIII, 32P-labeled the restricted fragments at the 3′ end,
and heat-denatured the dsDNA to prepare ssDNA frag-
ments of∼100 to ∼23,000 nucleotides (nt) in length. Strik-
ingly, wild-type yDna2 was dramatically faster in ssDNA
degradation than the helicase-deficient K1080E variant
(Fig. 1D) despite equivalent levels of nuclease activity in
both preparations when assayed on oligonucleotide-based
DNA (Fig. 1A–C; Supplemental Fig. S1A). We detected no
endonuclease activity of yDna2 under our experimental
conditions when yRPA was present (Supplemental Fig.
S1B), which suggested that the ssDNA degradation occurs
from an open end. The gradual DNA degradation and the
presence of smear below the 3′-labeled substrate bands in
Figure 1D clearly indicate that the ssDNA degradation by
yDna2 occurred with a 5′→ 3′ polarity, as expected for
yDna2 in the presence of yRPA (Cejka et al. 2010; Niu
et al. 2010). The motor activity of yDna2 also promoted
ssDNA degradation when using a yDna2 mutant lacking
the N-terminal regulatory domain (yDna2 ΔN), showing
that the first 405 residues of yDna2 are dispensable for
the motor-assisted ssDNA degradation (Supplemental
Fig. S1C,D). These results could be recapitulated with re-
combinant human DNA2, which lacks the N-terminal
regulatory domain found in yeast (Fig. 1E). In accord with
the slower rate of DNA unwinding by hDNA2 compared
with yDna2 (Levikova et al. 2013; Pinto et al. 2016), the
overall rate of ssDNA degradation was slower by the hu-
manprotein thanby theyeasthomolog. Importantly, how-
ever, thehelicase-deficienthDNA2K654Rwasclearly less
efficient in ssDNA degradation than wild-type hDNA2,
showing that the involvement of the DNA2 motor in ac-
celerating ssDNA degradation is conserved in evolution
(Fig. 1E). In summary, we show that, unlike in the process-
ing of duplexDNA,where the helicase of yeast and human
DNA2 is entirelymasked by its nuclease, themotor activ-
ity of DNA2 promotes degradation of long ssDNA.
To gain further insights into the role of the yDna2 mo-
tor in DNA degradation, we prepared a 2200-nt-long
ssDNA randomly labeled with [α-32P] dATP. We analyzed
the degradation of this substrate by wild-type yDna2 and
the helicase-deficient yDna2 K1080E variant in a kinetic
setup and separated the reaction products on agarose
gels (Fig. 2A). Wild-type yDna2 degraded ssDNA rapidly
and unexpectedly produced DNA degradation products
of two different lengths (indicated by the open and closed
arrows in Fig. 2A). In contrast, DNA degradation by heli-
case-dead yDna2 K1080E was slower and more gradual
and resulted in only the shorter ssDNA degradation prod-
ucts (Fig. 2A). We next analyzed the reaction products on
denaturing gels to determine the length of the ssDNA
products (Fig. 2B). Wild-type yDna2 gave rise to fragments
ranging from ∼5 to ∼100 nt in length (Fig. 2B [lanes 2–4],
C), while helicase-deficient yDna2 K1080E yielded only
products between ∼5 and ∼12 nt in length (Fig. 2B [lanes
6–8], C). Kinetic experiments revealed that wild-type
yDna2 first produced the longer fragments, which were
further degraded at later time points (Fig. 2D,G). In con-
trast, the majority of the products generated by helicase-
deficient yDna2 K1080E were <20 nt at any time point
tested (Fig. 2E,G). In the absence of ATP, the rates of
Levikova et al.
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DNA degradation by wild-type and helicase-deficient
yDna2 variants were indistinguishable, and both enzymes
gave rise to only the short DNA degradation products (Fig.
2F; Supplemental Fig. S2A), confirming the involvement
of the ATP-dependent motor activity in ssDNA degrada-
tion by yDna2. Changing the ATP:Mg2+ ratio influenced
the product size distribution produced by wild-type but
not by helicase-deficient yDna2 K1080E (Fig. 2H;
Supplemental Fig. S2B). Specifically, higher ATP to Mg2+
ratios are known to favor the yDna2 helicase (Bae and
Seo 2000; Budd et al. 2000; Masuda-Sasa et al. 2006;
Fortini et al. 2011), which consequently stimulated
the production of longer ssDNA fragments (Fig. 2H;
Supplemental Fig. S2B). Elevated Mg2+ ions instead pro-
mote the yDna2 nuclease; hence, we observed a reduction
of the long yDna2 translocase-dependent degradation frag-
ments (Supplemental Fig. S2C). The yDna2 ΔN variant
lacking the first 405 amino acids behaved similarly to
the full-length protein and produced the long ssDNA deg-
radation fragments in an ATP-dependent manner
(Supplemental Fig. S2D). As the yDNA2/hDNA2 motor
promotes the degradation of ssDNA but not dsDNA,
these results collectively imply that the motor of DNA2
functions as a ssDNA translocase rather than a helicase
to promote efficient degradation of ssDNA.
RPA is required for the DNA2 motor-dependent
degradation of ssDNA
Cognate RPA is a critical regulator of nuclease and heli-
case activities of DNA2 in both yeast and human cells
(Bae et al. 2001, 2003; Cejka et al. 2010; Niu et al. 2010;
Nimonkar et al. 2011; Levikova et al. 2013). In accord
with previous data, ssDNAdegradation by yDna2without
yRPA was slow (cf. Figs. 3A and 2B). Surprisingly, in the
absence of yRPA, wild-type yDna2 produced only the
short DNA degradation fragments in a manner similar
to the helicase-deficient yDna2 K1080E variant even in
the presence of ATP (Fig. 3A,B). Thus, the motor activity
of yDna2 facilitates ssDNA degradation only when both
yRPA and ATP are present. Likewise, the long DNA deg-
radation products can be observed only with wild-type
yDna2 in the presence of both ATP and yRPA, implying
that the long DNA degradation products result from fast
ssDNA degradation (Figs. 2B, 3B). We failed to detect a
similar variation of DNA degradation fragment lengths
Figure 1. The helicase activity of yeast and human DNA2 promotes ssDNA degradation. (A) Processing of 5′ 32P-labeled Y-structured
DNA substrate by wild-type, helicase-deficient K1080E, and nuclease-deficient E675A yDna2 variants. The reactions contained 22.5
nM yeast RPA. (Heat) Heat-denatured substrate. The panel shows representative native 10% polyacrylamide gels. (B) Quantitation of
the assays shown in A. Averages are shown for n = 2. Error bars indicate range. (C ) Quantitation of experiments that are shown in
Supplemental Figure S1A. Various concentrations of the yDna2 variants were used with the Y-structured DNA substrate. (D) Represen-
tative 1% agarose gel showing degradation kinetics of 3′ 32P-labeled ssDNA fragments (derived from λDNA) of various lengths by wild-
type or helicase-deficient K1080E yDna2 in the presence of 1.08 µMyRPA. The sizes of the corresponding dsDNA fragments are indicated
at the left. (E) Similar experiment as inD, showing the degradation kinetics of ssDNA by 20 nM human wild-type and helicase-deficient
K654R hDNA2 in the presence of 576 nM hRPA.
Motor activity of DNA2 acts as ssDNA translocase
GENES & DEVELOPMENT 3
 Cold Spring Harbor Laboratory Press on March 29, 2017 - Published by genesdev.cshlp.orgDownloaded from 
	   	   RESULTS	  
	   71	  
in reactions with human DNA2 (Supplemental Fig. S3).
However, the motor of hDNA2, similar to that in the
yeast system, accelerated the speed of ssDNA degradation
only in the presence of hRPA (Fig. 3C,D; Supplemental
Fig. S3). The results presented here suggest that DNA2
is using its motor activity to facilitate the degradation of
RPA-coated ssDNA, which results from DNA unwinding
by a cognate RecQ family helicase partner.
WRN or BLM stimulate the ssDNA nuclease activity
of DNA2
Recently, we demonstrated that the helicase activity of
nuclease-deficient hDNA2 was enhanced by physical in-
teractions with BLM or WRN and vice versa: hDNA2
stimulated DNA unwinding by WRN/BLM in the pres-
ence of hRPA (Pinto et al. 2016). This suggested that
hDNA2–BLM and hRPA as well as hDNA2–WRN and
hRPA form functional complexes, with their subunits
stimulating each other. Here we set out to test whether
BLM or WRN could promote the degradation of long
ssDNA by hDNA2 and hRPA. As above, wild-type
hDNA2 was much more efficient in ssDNA degradation
than the helicase-deficient enzyme (Fig. 4A [cf. lanes 3
and 4], B,D). Strikingly, helicase-deficient WRN or BLM
proteins strongly stimulated ssDNA degradation by both
wild-type and helicase-deficient hDNA2 (Fig. 4A–D).
Helicase-deficient WRN or BLM preparations alone did
not show any nuclease activity, confirming that the
ssDNA degradation capacity was inherent to hDNA2
(Fig. 4A, lanes 9,10). Interestingly, wild-type WRN and
BLM proteins promoted the degradative capacity of
hDNA2 to a lesser extent than helicase-deficient polypep-
tides (Supplemental Fig. S4A, cf. lanes 4 and 5 and lanes 6
and 7), possibly due to being active translocases, with a
fraction of molecules moving on the same DNA strand
in the opposite direction from hDNA2 and thus blocking
DNA degradation. The structural role of WRN/BLM in
promoting DNA degradation by hDNA2 was apparent
only on long ssDNA but not when hDNA2 was assayed
with WRN on oligonucleotide-based 5′ overhang DNA
(Supplemental Fig. S4B). As both wild-type and helicase-
deficient hDNA2 variants were stimulated by WRN and
BLM (Fig. 4), the acceleration of DNA degradation is a re-
sult of WRN/BLM stimulating the hDNA2 nuclease
directly and not indirectly through promoting the
hDNA2 motor activity. Together, these results indicate
that BLM andWRNnot only stimulate the hDNA2motor
Figure 2. Cleavage of ssDNAby yDna2 results in two groups of DNAdegradation products. (A) Degradation kinetics of ssDNA randomly
labeled with 32P by wild-type and helicase-dead K1080E yDna2 in the presence of 315 nM yRPA as analyzed by 1% agarose gel electro-
phoresis. The two main groups of DNA degradation products are indicated by the open and closed arrows. (B) Representative 20% poly-
acrylamide denaturing gels showing the degradation of ssDNA randomly labeled with 32P by wild-type and K1080E yDna2. The DNA
substrate was incubated with various concentrations of yDna2 for 10 min in the presence of 315 nM yRPA. (C ) Image analysis of the ex-
periment shown inB showing optical density analysis of gel lanes 1–9. Red arrows indicate the position of∼80-nt-longDNA fragments. (D,
E) Same reactions as in A, but the products were separated on 20% polyacrylamide denaturing gels. (F ) Degradation kinetics of randomly
labeled ssDNA by wild-type yDna2 in the absence of ATP with 315 nM yRPA. (G) Quantitation of experiments shown in D and E. The
relative proportion of DNA degradation products >20 nt in length was determined. Averages are shown for n = 2. Error bars indicate range.
(H) The effect of ATP concentration on the ssDNA degradation product length by 0.5 nMwild-type and helicase-deficient K1080E yDna2
in the presence of 315 nM yRPA in standard Mg2+ concentration (2 mM). Quantitation of experiments that are shown in Supplemental
Figure S2B. Averages are shown for n = 2. Error bars indicate range.
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as established previously (Pinto et al. 2016) but also have a
structural role to promote the ssDNA-specific nuclease
activity of hDNA2. This underpins the integrated nature
of the hDNA2–WRN and hDNA2–BLM complexes.
DNA end resection by Sgs1 and yDna2 is stimulated
by yDna2 helicase in vitro and in vivo
Initial reports suggested that the nuclease but not the heli-
case activity of DNA2 was required for DNA end resec-
tion in yeast and humans (Zhu et al. 2008; Cejka et al.
2010; Nimonkar et al. 2011). These studies suggested
that the DNA2 motor function may be dispensable in re-
section. Using limiting concentrations of recombinant
proteins, we instead later observed that the helicase activ-
ity of hDNA2 promoted DNA end resection in conjunc-
tion with WRN or BLM helicases (Pinto et al. 2016). We
could recapitulate this observation with yeast recombi-
nant proteins: Helicase-deficient yDna2 K1080E was
approximately twofold less efficient in DNA end resec-
tion than wild-type yDna2 in conjunction with Sgs1
(Supplemental Fig. S5A,B). Notably, the stimulatory effect
of the yDna2 helicase was also apparent only at limiting
yDna2 concentrations, suggesting that higher than physi-
ological yDna2 levels might mask the involvement of the
yDna2 helicase in DNA end resection in vivo (Zhu et al.
2008). Therefore, we set out to test for the effect of the
yDna2 helicase in yeast cells where each yDna2 variant
was expressed from its endogenous promoter on chromo-
somal DNA and thus was present at physiological levels.
To this end, we monitored the resection of a single HO
endonuclease-induced DSB by Southern blotting (White
and Haber 1990). DNA end resection renders DNA sin-
gle-stranded, which prevents cleavage by a restriction en-
donuclease and leads to the disappearance of the Southern
blot signal. By using probes complementary to DNA
at various distances from the break, the progression of
DNA end resection can be monitored at various time
points upon DSB induction, as used previously (Fig. 5A;
Zhu et al. 2008). We constructed strains containing either
wild-type DNA2 or helicase-deficient dna2 K1080E in an
exo1Δ rad51Δ pif1-m2 background. The exo1Δ mutation
eliminates long-range resection by the separate Exo1 path-
way, making the relative contribution of the yDna2–Sgs1
pathwaymore apparent. The rad51Δmutation renders the
DSB unrepairable, which allows monitoring of resection
of long DNA lengths over extended periods of time. The
pif1-m2 mutation is a suppressor of yDna2 function in
Okazaki fragment processing (Budd et al. 2006; Zhu
et al. 2008). As the dna2Δ exo1Δ rad51Δ pif1-m2 mutant
is not viable, we used sgs1Δ exo1Δ rad51Δ pif1-m2 cells
as a reference strain for deficient long-range DNA end re-
section. We monitored resection 0, 3, 10, and 28 kb away
from the HO-induced DSB at the indicated time points
(Fig. 5A,B). The dna2 K1080E strain was slower than
DNA2 at every distance measured but faster than the cor-
responding sgs1Δ strain in the exo1Δ rad51Δ pif1-m2
background (Fig. 5B,C). Collectively, these observations
demonstrate that the yDna2motor is required for efficient
DNA end resection in conjunction with Sgs1 in vivo. This
is apparent only when yDna2 is present at physiological
levels, and our data thus also provide an explanation for
why this effect was not detected when the yDna2 variants
were expressed from a plasmid (Zhu et al. 2008).
Finally, we analyzed the length of the DNA degradation
products as a footprint for the yDna2 motor activity in
DNA end resection. To this end, we reconstituted an in
vitro kinetic resection experiment of plasmid-length
dsDNAwith Sgs1, yDna2 (or its helicase-deficient yDna2
K1080E variant), and yRPA as well as Top3–Rmi1 and
Mre11–Rad50–Xrs2 complexes, which stimulate Sgs1–
yDna2 (Cejka et al. 2010; Cejka and Kowalczykowski
2010; Niu et al. 2010). As demonstrated in Supplemental
Figure S5C,D, reactions with wild-type but not helicase-
deficient yDna2 K1080E produced the extended ssDNA
degradation products. This is consistent with the model
that DNA2 motor activity functions in DNA end resec-
tion and further demonstrates that themotor ofDNA2 en-
gages even in the presence of other DNA end resection
factors.
Discussion
Our results collectively demonstrate that the motors of
both yeast and human DNA2 promote the degradation
of long ssDNA. DNA2 is known to function together
with a cognate RecQ family helicase in DNA end
Figure 3. Themotor of human and yeast DNA2 promotes degra-
dation of RPA-coated ssDNA. (A) Degradation of ssDNA by wild-
type and K1080E yDna2 as in Figure 2B but in the absence of
yRPA, analyzed by 20% polyacrylamide denaturing gel electro-
phoresis. (B) Quantitation of DNA degradation product lengths
by 1 nM wild-type and K1080E yDna2 variants from the experi-
ments shown inA and Figure 2B. Averages are shown for n = 3. Er-
ror bars indicate SEM. (C,D) Degradation of randomly labeled
ssDNA by 20 nM wild-type or helicase-deficient K654E hDNA2
variants. Quantitation of experiments that are shown in
Supplemental Figure S3 without (C ) or with (D) 176 nM hRPA.
Averages are shown for n = 4. Error bars indicate SEM.
Motor activity of DNA2 acts as ssDNA translocase
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resection (Zhu et al. 2008). Our results support a model in
which the RecQ family helicase—either Sgs1 or WRN/
BLM—uses its motor activity to translocate in a 3′→ 5′ di-
rection and unwinds duplex DNA. Helicase-deficient
Sgs1/WRN/BLM variants in conjunction with the respec-
tive yDna2 or hDNA2 are completely inactive in DNA
end resection in vitro and in vivo (Zhu et al. 2008; Cejka
et al. 2010;Niu et al. 2010;Nimonkar et al. 2011), support-
ing the notion that the RecQ helicase provides the lead
helicase activity (Fig. 6A). The motor of DNA2 then pow-
ers its translocationontheunwound5′-terminated ssDNA
strand in a 5′→ 3′ direction. As the motor exclusively ac-
celerates the degradation of ssDNA, themost likely expla-
nation is that the DNA2 motor functions as an ssDNA
translocase rather than a helicase to facilitate movement
along the unwound ssDNA behind Sgs1/BLM/WRN (Fig.
6A). DNA2 thus likely uses an active translocation mode
on ssDNA to accelerate its degradation rather than relying
on passive diffusion. RPA promotes DNA unwinding by
Sgs1/BLM/WRN and additionally directs the nuclease ac-
tivity of yDna2/hDNA2 to the 5′-terminated DNA strand
in a species-specific manner (Cejka et al. 2010; Niu et al.
2010; Nimonkar et al. 2011; Pinto et al. 2016). Here we
showthat themotorofDNA2 facilitatesDNAdegradation
in the presence of RPA. This further supports a model in
which RPA is an integral component of the Sgs1–yDna2,
WRN–hDNA2, and BLM–hDNA2 resection machineries
(Fig. 6A).
Previously, we observed that the nucleases of yeast and
human DNA2 cleaved short 5′-terminated ssDNA over-
hangs of DNA duplexes, which prevented loading of
DNA2 onto ssDNAand therefore duplexDNAunwinding
(Levikova et al. 2013; Pinto et al. 2016). Paradoxically, the
nuclease activity of DNA2 thus masks its helicase func-
tion in yeast and humans (Levikova et al. 2013; Pinto
et al. 2016). The mouse DNA2 structure revealed that
theDNA2nuclease forms a narrow tunnel that accommo-
dates only ssDNA (Zhou et al. 2015). Therefore, upon
binding to a DNA end, wild-type DNA2 likely first moves
along ssDNA in a passive diffusion-limited manner.
DNA2 likely pauses once it encounters a junction be-
tween ssDNA and dsDNA, which represents an energy
barrier. This provides time to the DNA2 nuclease active
site within the tunnel to efficiently cleave the ssDNA
overhang before it can reach the helicase domain located
behind the tunnel. This prevents the engagement of the
DNA2 motor activity and thus DNA unwinding of over-
hanging substrates by wild-type DNA2. The nuclease-de-
ficient DNA2 instead does not cleave the ssDNA
overhang within the tunnel. This allows time for the
DNA2 variant to melt into the DNA duplex, possibly ex-
ploiting spontaneous “breathing” at the ssDNA and
dsDNA junction or through a potential inherent dsDNA
destabilization capacity of DNA2. This DNA melting
then allows the nuclease-dead DNA2 variant to thread
further onto the 5′-terminated DNA strand, which can
reach the helicase domain to start the active ATP hydroly-
sis-dependent translocation and processive dsDNA un-
winding observed previously (Levikova et al. 2013; Pinto
et al. 2016).
Figure 4. WRNor BLM enhances the ssDNA degradative capac-
ity of hDNA2. (A). Representative 1% agarose gel showing degra-
dation of 3′ 32P-labeled ssDNA (heat-denatured pUC19/HindIII)
by 30 nM wild-type or helicase-deficient hDNA2 K654R variant
with or without 30 nM helicase-deficient WRN K577M or 30
nM BLM K695A. The reactions were supplemented with 50
mM NaCl and 215 nM hRPA. (B). Representative 1% agarose
gel showing the kinetics of ssDNA degradation (as in A) by 30
nM wild-type or helicase-deficient hDNA2 K654R. (C ). Repre-
sentative 1% agarose gel showing the kinetics of ssDNA degrada-
tion (as in A) by 30 nM wild-type or helicase-deficient hDNA2
K654R together with 30 nM helicase-deficient WRN K577M.
(D). Quantitation of the experiments shown in B and C. The Y-
axis shows the distance of the band midpoint from the position
of intact ssDNA, relative to the distance between dsDNA and
ssDNA. Averages are shown for n = 2. Error bars indicate range.
Levikova et al.
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The results presented here show that the nuclease of
DNA2 instead does not prevent translocation on extended
ssDNA. Translocation along ssDNA represents a lower-
energy barrier than the unwinding of duplex DNA, which
might allow the ssDNA strand to pass uncleaved with a
higher frequency through the nuclease tunnel into the
helicase domain, which would power the ssDNA translo-
cation (Fig. 6B). This model is in accord with previous ob-
servations that DNA2 nuclease must load onto a free
ssDNA end but then cleaves ssDNA endonucleolytically
(Balakrishnan et al. 2010). This also implies that DNA2
may cleave ssDNAwith a certain frequency, whichmight
depend on the rate of ssDNA translocation. To this point,
using yeast Dna2, we observed dramatic variations be-
tween the degradation fragment lengths: A passive mode
of ssDNA translocation resulted inDNAdegradation frag-
ments of ∼5 to ∼10 nt in length, whereas active mode pro-
ducedmuch longer fragments of ∼80 to ∼100 nt in length.
The structure of mouse DNA2 revealed that 7 nt of
ssDNA are bound to the helicase domain followed by a
2-nt-long linker and 6-nt-long fragment bound to the nu-
clease domain; therefore, the distance between the two
active sites is larger than the “short” DNA fragments ob-
served in our experiments. The presence of the “long”
DNA degradation fragments is thus a clear indicator
that the ssDNA passes intact through the nuclease tunnel
of yDna2 to the helicase domain. Similar product frag-
ment length variation was not observed with hDNA2,
and thus it remains to be determined whether this was
due to technical issues or whether the mode of transloca-
tion along ssDNA and its degradation by human DNA2
are different. Nevertheless, the ATP-dependent motor ac-
tivity promoted ssDNA degradation by human DNA2 as
well. It is possible that any “long” ssDNA fragments pro-
duced by hDNA2were rapidly converted into shorter ones
by other hDNA2 molecules present in solution, which
prevented detection. The difference between the yeast
and human enzymes could be explained by distinct
DNA association versus degradation and translocation
rates. Interestingly, ssDNA fragments produced during
DNA end resection have been proposed to regulate check-
point response (Jazayeri et al. 2008; Eapen et al. 2012);
however, any function of the DNA2 motor activity in
this process has yet to be demonstrated.
The Sgs1–yDna2 and WRN/BLM–hDNA2 complexes
have been compared with AddAB, RecBCD, or other bac-
terial DNA end resection machines (Dillingham et al.
2003; Yeeles and Dillingham 2007; Dillingham and
Kowalczykowski 2008; Yeeles et al. 2009; Cejka et al.
2010). Unlike in Escherichia coli’s RecBCD, where both
RecB and RecD are per se DNA helicases capable of
unwinding dsDNA, we propose that the motor of DNA2
is engaged only downstream from the RecQ family heli-
case partner. Despite this difference, Sgs1–yDna2,
WRN/BLM–hDNA2, and RecBCD appear quite similar,
as both complexes likely use a bidirectional DNA translo-
cation mode and form a complex that is more than the
sum of its parts (Dillingham and Kowalczykowski 2008).
This bidirectional mode of DNA translocation is likely
not used by Bacillus subtilis’s AddAB, which contains
only one motor activity within the AddA subunit despite
the nuclease of AddB being similar to the nuclease of
Figure 5. The helicase activity of wild-type yDna2 promotes resection of DSBs in vivo. (A) A scheme of the resection assay. DSB is in-
duced by HO endonuclease. Resection past the indicated EcoRI sites (in black) leads to the disappearance of the signal obtained with site-
specific probes (in red) by Southern blotting. Only those restriction sites that govern the appearance of the respective DNA fragments are
shown. (B) Southern blot analysis of 5′ DNA end resection kinetics of HO-induced DSBs in DNA2, helicase-deficient dna2 K1080E, or
sgs1Δ cells. All strains are exo1Δ rad51Δ pif1-m2. (C ) Quantitation of B. Plots show the fraction of unresected 5′ strand (percentages)
at each distance from the DSB. Averages are shown for n≥ 2. Error bars indicate range.
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DNA2 due to the presence of the iron–sulfur cluster
(Yeeles et al. 2009). However, theDNA2 domain organiza-
tion in which the nuclease of DNA2 precedes its motor is
unique and not found in other prokaryotic resection en-
zymes characterized to date.
ManyDNAhelicases unwind dsDNAas a result of their
ssDNAtranslocaseactivity, althoughnot all ssDNAtrans-
locases are DNA helicases (Lohman et al. 2008). In fact, it
hasbeendemonstratedthatseveral superfamily IDNAhel-
icases, including E. coli UvrD, are ssDNA translocases as
monomers and become capable of processive dsDNA un-
winding only upon dimerization or interaction with a pro-
tein partner (Maluf et al. 2003; Fischer et al. 2004).
Although direct DNA binding between DNA2 and the
respective cognate RecQ family helicase has been demon-
strated (Cejka et al. 2010;Nimonkar et al. 2011; Sturzeneg-
ger et al. 2014), there are no data on oligomerization of
DNA2.DNA2might thus be an unusual example of an en-
zyme in which the motor functions as a ssDNA translo-
case, and the nuclease domain prevents duplex DNA
unwinding.Theresultspresentedhere identifyaconserved
functionfortheDNA2helicasetopromoteDNAendresec-
tion in conjunction with a cognate RecQ family helicase
both invitro and invivo.Themechanismmightbe also rel-
evant for the degradation of reversed replication forks that
formupon replication stress,whichmight explain reduced
viability and/or pronounced sensitivity of helicase-defi-
cientyeastcells toalkylatingagentsandionizing radiation,
treatmentsthatalsoleadtoDSBs (FormosaandNittis1999;
Budd and Campbell 2000; Thangavel et al. 2015).
Materials and methods
Recombinant proteins
Wild-type yDna2 as well yDna2 E675A and yDna2 K1080E vari-
ants were expressed and purified as described previously (Levi-
kova et al. 2013). The construct for the expression of the yDna2
ΔNvariant was prepared by cloning the yDNA2 sequence lacking
the first 1215 residues (corresponding to 405 amino acids) be-
tween the 5′-terminal Flag tag and the 3′-terminal 6His tag into
BamHI and EcoRI sites in a pYes2 vector (Invitrogen). The trun-
cated protein was expressed and purified as the full-length pro-
tein. Wild-type hDNA2, hDNA2 K654E, and hDNA2 K654R
were prepared as described previously (Pinto et al. 2016). No dif-
ference was observed between the hDNA2 K654E and hDNA2
K654R variants in the experiments presented in this report
(data not shown). Wild-type BLM, WRN, BLM K695A, and
WRN K577M were expressed and purified as described (Pinto
et al. 2016). Sgs1, Top3–Rmi1, and Mre11–Rad50–Xrs2 were ex-
pressed and purified as described previously (Cejka and Kowalc-
zykowski 2010; Cejka et al. 2010; Cannavo and Cejka 2014).
The yRPA and hRPA proteins were expressed and purified as de-
scribed (Henricksen et al. 1994; Kantake et al. 2003).
DNA substrates
The oligonucleotides X12-3 and X12-4NCwere used for the prep-
aration of the Y-structured DNA substrate, and oligonucleotides
X12-3 and X12-4SC were used for the preparation of the 5′ tailed
DNA, as described previously (Cejka and Kowalczykowski 2010;
Levikova et al. 2013). Bacteriophage λ dsDNA (New England Biol-
abs) was digested by HindIII (New England Biolabs). The linear-
ized dsDNA fragments were then labeled with [α-32P] dATP and
a Klenow fragment of DNA polymerase I (New England Biolabs)
at the 3′ end. Unincorporated nucleotides were removed using
MicroSpin G25 columns (GE Healthcare). The substrate was de-
natured by heating for 5 min at 95°C prior to each experiment.
The 6.4-kb-long ssDNA (M13mp18)was purchased fromNewEn-
gland Biolabs. The 2686-base-pair-long pUC19 dsDNA was line-
arized with HindIII, purified by phenol-chloroform extraction
and ethanol precipitation, and denatured as described above
where necessary.
The randomly labeled 2200-nt-long substrate was prepared by
amplification of the S. cerevisiae LIG1 gene by PCR from yeast
genomic DNA (yWH436 strain) (see Supplemental Table S2) us-
ing Phusion high-fidelity DNA polymerase (New England
Figure 6. Model for the involvement of yDna2 heli-
case activity in DNA end resection. (A) Sgs1 translo-
cates on the 3′-terminated DNA strand and functions
as the lead helicase. YeastDna2 is using itsmotor activ-
ity to translocate on the unwound 5′-terminated DNA
strand, which is degraded by its nuclease activity. (B,
top) The motor of yDna2 accelerates degradation of
ssDNA, which requires ATP hydrolysis and the pres-
ence of yRPA. This fast mode of DNA degradation re-
sults in long DNA degradation fragments. (Bottom)
Without active translocation, the ssDNA degradation
by yDna2 is slow, resulting in short DNA degradation
fragments.
Levikova et al.
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Biolabs) and the following primers: forward, 5′-ACGCATTAGC
TAGCGGATCCCTGGAAGTTCTGTTCCAGGGGCCCATGC
GCAGATTACTGACCGGTTG-3′; and reverse, 5′-ACGCATT
ACTCGAGATTTTGCATGTGGGATTGGT-3′. In addition to
the standard dNTP concentration in the PCR reaction (200 µM
each), 66 nM [α-32P] dATP was added. The PCR reaction product
was purified using Chroma Spin TE-400 columns (Clontech). The
substrate was denatured by heating for 5 min at 95°C before the
experiment to obtain ssDNA where necessary. The 10- to
100-nt low-molecular-weight marker (Affymetrix) was 32P-la-
beled at the 5′ terminus with [γ-32P] ATP and T4 polynucleotide
kinase (New England Biolabs). An asterisk indicates the position
of the radioactive label where indicated.
Nuclease and helicase assays
Unless indicated otherwise, the experiments were performed in a
15-µL volume in 25 mMTris-acetate (pH 7.5), 2 mMmagnesium
acetate, 1 mM ATP, 1 mM dithiothreitol, 0.1 mg/mL bovine
serum albumin (New England Biolabs), 1 mM phosphoenolpyr-
uvate, 16 U/mL pyruvate kinase (Sigma), and 1 nM (inmolecules)
32P-labeled oligonucleotide-based, pUC19-based, or PCR-based
DNA substrate or 0.15 nM λDNA-based substrate (corresponding
to 2.4 nM 5′-terminated ssDNA ends upon denaturation). For re-
actions with unlabeled substrates, 100 ng of DNA was used.
Where indicated, human and yeast RPAwas included to saturate
all ssDNA. Recombinant proteins were added on ice to the as-
sembled reaction mixtures. The reactions were incubated for
30 min at 30°C for yeast and 37°C for human proteins unless in-
dicated otherwise. Reactions were stopped by adding either 5 µL
of 2% stop solution for native gels as described previously (Cejka
and Kowalczykowski 2010) or 15 µL of formamide dye for dena-
turing gels (Cannavo and Cejka 2014). All gels with radioactive
substrates were dried on DE81 chromatography paper (Whatman)
and exposed to storage phosphor screens (GE Healthcare). The
screens were scanned by a Typhoon 9400 phosphorimager (GE
Healthcare). Where unlabeled DNA substrates were used, DNA
was visualized by staining with ethidium bromide (Sigma) or
GelRed (Biotium) as indicated.
Southern blot
Yeast cell growth, HO-break induction, and DNA isolation were
performed as described previously (Zhu et al. 2008). The 0-h time
point was collected immediately after adding galactose, before
the HO cut occurred. DNA samples were separated on 1% aga-
rose gel, and DNA was transferred onto a nylon membrane (GE
Healthcare) and hybridized with DNA probes radioactively la-
beled by random primed DNA labeling kit (Roche) according to
manufacturer’s instructions. Primers used to prepare the 32P-la-
beled probes were used as described previously (Zhu et al. 2008)
and are listed in Supplemental Table S1. Membranes were ex-
posed to storage phosphor screens (GE Healthcare) that were
scanned by a Typhoon 9400 phosphorimager (GE Healthcare).
Yeast strains used in this study are listed in Supplemental
Table S2. Briefly, the dna2 K1080Emutation was introduced us-
ing the allele replacement strategy (Widlund and Davis 2005) by
transforming the parental yWH436 strain with the pRS306 plas-
mid (Sikorski and Hieter 1989) containing the SacII/BamHI frag-
ment of the point-mutagenized yDNA2 gene that was excised
previously from the pGAL18 Dna2 K1080E plasmid (gift from
J. Campbell). Gene deletions were performed by PCR-based sub-
stitution cassettes, as described previously (Janke et al. 2004;
Hegemann et al. 2006). The EXO1 gene was deleted by using
the PCR cassette amplified from pFA6a plasmid using the follow-
ing primers: forward, 5′-ACCACATTAAAATAAAAGGAGCTCG
AAAAAACTGAAAGGCGTAGAAAGGACAGCTGAAGCTTC
GTACGCTGC-3′; and reverse, 5′-TTTTCATTTGAAAAATATA
CCTCCGATATGAAACGTGCAGTACTTAACTTCATAGGCC
ACTAGTGGATCTG-3′.
The SGS1 gene was deleted by using the PCR cassette ampli-
fied from pUG72 with the following primers: forward, 5′-
ATTATTGTTGTATATATTTAAAAAATCATACACGTACAC
ACAAGGCGGTA-3′; and reverse, 5′-TTGGCGAATGGTGTC
GTAGTTATAAGTAACACTATTTATTTTTCTACTCTGCAT
AGGCCACTAGTGGATCTG-3′. The RAD51 gene was deleted
by using the PCR cassette amplified from pUG6 using the fol-
lowing primers: forward, 5′-AAGAGCAGACGTAGTTATTT
GTTAAAGGCCTACTAATTTGTTATCGTCATCAGCTGAA
GCTTCGTACGCTGC-3′; and reverse, 5′-AGAATTGAAAG
TAAACCTGTGTAAATAAATAGAGACAAGAGACCAAATACC
ATAGGCCACTAGTGGATCTG-3′.
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Figure	S1.		
The	role	of	the	Dna2	motor	ac1vity	 in	DNA	degrada1on	by	Dna2.	(A)	Processing	of	Y-structured	
DNA	 substrate	 by	 wild	 type,	 helicase-deﬁcient	 K1080E	 and	 nuclease-deﬁcient	 E675A	 yDna2	
variants.	 Heat,	 heat-denatured	 substrate.	 The	 panel	 shows	 representa1ve	 na1ve	 10%	
polyacrylamide	gels.	Helicase	ac1vity	of	yDna2	does	not	promote	degrada1on	of	duplex	DNA.	(B)	
A	 representa1ve	 agarose	 gel	 showing	 the	 lack	 of	 endonuclease	 ac1vity	 of	wild	 type	 yDna2	 on	
circular	 6.4	 knt-long	 ssDNA	 substrate	 (1.6	 nM)	 in	 the	 presence	 of	 yRPA	 (770	 nM).	 DNA	 was	
visualized	by	post-staining	with	GelRed.	(C)	Yeast	Dna2	ΔN,	lacking	405	amino	acids	from	the	N-
terminus,	 used	 in	 this	 study.	 Panel	 shows	 a	 representa1ve	 Coomassie	 blue-stained	
polyacrylamide	gel.	(D)	Assay	as	in	Fig.	1D,	but	with	yDna2	ΔN.		
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Figure	S2.	
Inﬂuence	of	ATP	and	magnesium	on	the	Dna2	motor	ac9vity	in	ssDNA	degrada9on.	(A)	
Degrada9on	kine9cs	of	randomly	32P-labeled	ssDNA	by	yDna2	K1080E	in	the	absence	of	ATP.	
Shown	is	a	representa9ve	denaturing	20%	polyacrylamide	gel.	(B)	The	eﬀect	of	ATP	concentra9on	
on	ssDNA	degrada9on	by	wt	and	helicase-deﬁcient	K1080E	yDna2.	(C)	The	eﬀect	of	magnesium	
concentra9on	on	ssDNA	degrada9on	by	wt	and	helicase-deﬁcient	K1080E	yDna2.	(D)	The	eﬀect	of	
ATP	on	ssDNA	degrada9on	by	yDna2	ΔN.	
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Figure	S3.		
Helicase	ac*vity	of	hDNA2	accelerates	its	ssDNA	degrada*on	capacity	in	the	presence	of	hRPA.	
Representa*ve	denaturing	20%	polyacrylamide	gels	showing	the	ssDNA	degrada*on	capacity	of	
wild	type	or	helicase-deﬁcient	hDNA2	K654E	with	(176	nM)	or	without	hRPA.	The	substrate	was	
ssDNA	randomly	labeled	with	32P.		
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(B)	The	eﬀect	of	helicase-deﬁcient	WRN	K577M	on	the	oligonucleo5de	based	5'-tailed	DNA	
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Figure	S5.		
The	motor	ac,vity	of	yDna2	promotes	DNA	end	resec,on.	(A)	DNA	end	resec,on	by	wild	type	
yDna2	or	helicase-deﬁcient	yDna2	K1080E	variant	in	conjunc,on	with	1	nM	Sgs1	on	5'	tailed	2.7	
kbp-long	dsDNA	substrate.	DNA	was	visualized	by	staining	with	ethidium	bromide.	(B)	
Quan,ta,on	of	(A).	Averages	shown,	n=2;	error	bars,	range.	(C)	Analysis	of	DNA	degrada,on	
products	lengths	of	DNA	end	resec,on	assays	with	Sgs1	(0.3	nM),	Top3-Rmi1	(10	nM),	Mre11-
Rad50-Xrs2	(40	nM)	and	either	wt	yDna2	or	yDna2	K1080E	with	randomly	32P-labeled	dsDNA	
substrate.		Reac,on	buﬀer	contained	100	mM	sodium	acetate.	The	reac,on	products	were	
analyzed	by	20%	polyacrylamide	denaturing	electrophoresis,	representa,ve	gels	are	shown.	
Reac,ons	with	wt	yDna2	gave	rise	to	longer	DNA	degrada,on	products.	This	is	a	footprint	of	the	
yDna2	helicase	ac,vity	in	DNA	end	resec,on.(D)	Quan,ta,on	of	(C).	Rela,ve	propor,on	of	DNA	
degrada,on	products	larger	than	20	nt	in	length	was	determined.	Averages	shown,	n=2;	error	
bars,	range.	
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Table	S1.		Primer	sequences	used	to	prepare	DNA	probes	for	hybridization.	
1	 MAT_0kb_1	 5'	CTTGATTGTTTGCTTGAGTCTG		 MAT_0kb_2	 5'	ACTAACAATACTTCAGTTTA	2	 BUD5_3kb_1	 5'	CCAGTTATCGTCCTACGTTC		 BUD5_3kb_2	 5'	GGTAAGCCTTGGAACCTTAG	3	 SNT1_10kb_1	 5'	CTATCGATGGCTCTATAAGAC		 SNT1_10kb_2	 5'	CACGACTTATTGGACTAGTG	4	 FEN2_28kb_1	 5'	CACCAATGCATATATATCCG		 FEN2_28kb_2	 5'	GAATAGTCGACCAGTCTAAC	5	 Ctrl_TRA1_1	 5’-	GTC	CTA	ATA	CGA	CTT	TTC	AAA	TTG	TCC	TTT	ATG	TCC	GTC	A			 Ctrl_TRA1_2	 5’-	ATA	CTT	GTA	AGC	ACT	CTT	CCT	GTA	GTG	AAT	ATC	ACT	TTT	G	
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2.3	  Results	  from	  collaborations	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ABSTRACT
Replication protein A (RPA) is a single-stranded DNA
binding protein, involved in most aspects of eukary-
otic DNA metabolism. Here, we study the behavior
of RPA on a DNA substrate that mimics a replica-
tion fork. Using magnetic tweezers we show that
both yeast and human RPA can open forked DNA
when sufficient external tension is applied. In con-
trast, at low force, RPA becomes rapidly displaced
by the rehybridization of the DNA fork. This process
appears to be governed by the binding or the release
of an RPA microdomain (toehold) of only few base-
pairs length. This gives rise to an extremely rapid ex-
change dynamics of RPA at the fork. Fork rezipping
rates reach up to hundreds of base-pairs per second,
being orders of magnitude faster than RPA dissoci-
ation from ssDNA alone. Additionally, we show that
RPA undergoes diffusive motion on ssDNA, such that
it can be pushed over long distances by a rezipping
fork. Generally the behavior of both human and yeast
RPA homologs is very similar. However, in contrast
to yeast RPA, the dissociation of human RPA from ss-
DNA is greatly reduced at low Mg2+ concentrations,
such that human RPA can melt DNA in absence of
force.
INTRODUCTION
Replication protein A (RPA) is a highly ubiquitous (1),
heterotrimeric (2), protein essential in virtually all aspects
of eukaryotic DNA processing involving single-stranded
DNA (ssDNA) intermediates (3). Due to the strong bind-
ing of RPA to ssDNA (2,4–6). RPA was originally thought
to solely prevent the formation of secondary structures and
confer protection from nucleolytic degradation. However,
strong evidence for direct interactions with specific protein
partners has been reported (7–10), and a new paradigm
emerged. RPA is now thought to act additionally as a scaf-
fold for the recruitment of other DNA processing enzymes
on ssDNA intermediates, in order to channel the process-
ing along specific pathways (11,12). RPA coated ssDNA for
example signals the presence of DNA damage to the check-
pointmachinery through direct binding of ATR-interacting
protein (ATRIP) (8,13,14). From this viewpoint, the bound-
aries between ssDNAanddouble-strandedDNA (dsDNA),
i.e. the interface upon which a multitude of DNA process-
ing factors are acting, are of particular interest. Here, the
binding and release of RPA must be highly dynamic, and
organized in such a way that the DNA can be rapidly made
accessible to subsequent processing machinery.
The importance of ssDNA–dsDNA boundaries is also
highlighted by the fact that despite the low affinity toward
dsDNA (15), RPAbinds appreciably to ssDNAstretches ex-
posed upon dsDNA damage (16,17), is able to disrupt par-
tially dsDNA structures such as triplexes (18), tetraplexes
(19,20) and suppresses formation of secondary structures
such as hairpins (11). Under certain circumstances, the
ATP-independent melting of dsDNA by RPA has also been
shown (21–23), where it was proposed that the observed du-
plex destabilization proceeds by trapping fluctuations of the
helix (23).
Several recent studies have advanced our understanding
of the molecular mechanisms that may control the coordi-
nation of RPA by employing single-molecule analysis tech-
niques: (i) Using single-molecule DNA supercoiling exper-
iments in magnetic tweezers it was shown that RPA can
bind to transiently forming bubbles in the DNA duplex in a
torque-dependent manner (24). (ii) Single-molecule imag-
ing of fluorescent RPA has shown that RPA bound ss-
DNAmay undergo more rapid exchange in presence of free
RPA in solution (25). (iii) Using a combination of single-
molecule fluorescence techniques it was found that under
high salt conditions RPA may diffuse/slide along ssDNA
(26), suggesting the intriguing possibility that in this way
access to the DNA is provided to other enzymes. Recently,
Chen and Wold (12) pointed out that central to all of these
single-molecule studies is the emerging view that RPA bind-
ing is highly dynamic and that microscopic rearrangements
*To whom correspondence should be addressed. Tel: +49 341 97 32501; Fax: +49 341 97 32599; Email: ralf.seidel@physik.uni-leipzig.de
†These authors contributed equally to this work as first authors.
C⃝ The Author(s) 2016. Published by Oxford University Press on behalf of Nucleic Acids Research.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which
permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
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of the RPA DNA binding domains (DBDs) are underlying
the observed dynamics. However, it was also emphasized
that more work is required to fully understand the rich dy-
namics of RPA in complex with various DNA structures.
Here, we investigate in detail the dynamics of RPA at the
boundary of ssDNA and dsDNA such as present at a repli-
cation fork. We utilize magnetic tweezers that allow pre-
cise manipulation and length determination of immobilized
DNA substrates via an attachedmagnetic microsphere (27).
At the single-molecule level they support the study of fast
dynamic processes, and allow dissecting inherent molecular
variation with spatial resolution on the scale of one base-
pair (bp) (27).
We have characterized the force-dependent binding dy-
namics of RPA from human and budding yeast (Saccha-
romyces cerevisiae), henceforth referred to as hRPA and
yRPA (see Materials and Methods for details) on a DNA
fork down to single protein association events. The interplay
between RPA, the forked DNA substrate and force tightly
regulates the balance of RPA binding and the opening and
closing of the fork. Our results indicate that RPA uses a
‘toehold’-like mechanism to trap small transient openings
of the DNA helix with a microdomain, which are then ex-
panded as the full protein wedges in to bind. Similarly, RPA
displacement by the rezipping fork first occurs through an
initial rate-limiting displacement of a toehold. This gives
rise to a very rapid helix rezipping upon which RPA dis-
sociates much faster than on ssDNA. Facilitated by our ob-
servation of both RPA homologs, we can confirm that the
described behavior is a general trait of RPA across different
organisms. Thus, while RPA protects ssDNA rather firmly
and statically, it is extremely dynamic at DNA processing
sites. This is additionally supported by the observation that
a DNA fork can slide/push RPA upon rezipping.
MATERIALS AND METHODS
DNA substrates
ADNA substrate containing a 488 bp long hairpin was pre-
pared as described previously (28). The 5′-end of the hairpin
carried a single biotin modification, while the 3′-end was
linked through a 60 nt ssDNA spacer to a 1 kb dsDNA
spacer, followed by a 600 bp digoxigenin-modified attach-
ment handle.
Preparation of the flapped DNA duplex substrate has
been described previously (29,30). Central part is a 6.1 kb
unmodified dsDNA with a flap located 1 kb from its prox-
imal DNA end. Approximately 600 bp attachment handles
carrying multiple digoxigenins and biotins were attached to
the 6.1 kb fragment at its flap-proximal and distal ends, re-
spectively.
Recombinant proteins
yRPA and hRPA were recombinantly expressed and pu-
rified as described previously (31,32). In brief, yRPA was
expressed in the yeast strain BJ5464 containing three plas-
mids, coding for subunits Rfa1, Rfa2 andRfa3, respectively.
Cells were lysed and yeast RPA was purified by affinity on
a ssDNA cellulose column (USB corporation, Cleveland,
USA) and by ion exchange chromatography using a Hi-
Trap Q column (GE Healthcare, Little Chalfont, UK). Hu-
man RPA was expressed from the p11d-tRPA vector (32)
in BL21 E. coli cells and purified by chromatography using
HiTrap Blue and HiTrap Q columns (GEHealthcare, Little
Chalfont, UK).
Magnetic tweezers experiments
For the single molecule experiments a custom magnetic
tweezers setup was utilized (27,33). Magnetic tweezers
experiments were conducted at room temperature using
flow cells assembled from two coverslips (Menzel, Braun-
schweig, Germany) that were separated by a layer of
Parafilm (Bemis, Oshkosh, USA) into which a sample
chamber was cut out. The bottom coverslip was coated
with polystyrene (Sigma-Aldrich, St. Louis, USA). Three
micrometers carboxyl-modified latex beads (Life Technolo-
gies,Darmstadt,Germany) that served as reference, were at-
tached to the bottom slide of the mounted flow cell by incu-
bation in 1 M NaCl for 1 h. Subsequently, anti-digoxigenin
antibodies (Roche, Penzberg,Germany)were allowed to un-
specifically bind to the coated surface of the flow cell, by
incubation at a concentration of 50 !g/ml for 1 h at room
temperature. Subsequently, the flow cell was passivated by
overnight incubation with 10 mg/ml bovine serum albu-
min (BSA, New England Biolabs, Ipswich, USA). DNA
constructs were bound to streptavidin-coated M280 mag-
netic beads (Life Technologies, Darmstadt, Germany) and
then flushed into the flow cell. After allowing them to
bind for ∼5 min, excess beads were washed out with phos-
phate buffered saline (PBS) solution rendering the sample
chamber ready for experiments. The positions of reference
and DNA-attached beads were tracked in all three dimen-
sions at 300 Hz using videomicroscopy and real-time GPU-
accelerated image analysis (27). Typically 15-20 beads were
evaluated in parallel. Forces were calibrated using a recent
methodology that supports the usage of short molecules
and high forces (34). Experiments were conducted in 50mM
Tris acetate pH 7.5 supplemented with magnesium acetate
in concentrations as described in the results. Data were an-
alyzed in Labview (National Instruments, Austin, USA),
Origin 9.1 (OriginLab, Northampton, USA) and Matlab
(MathWorks, Natick, USA). Length changes measured in
nm for opening of the hairpin ormelting of the nickedDNA
construct were converted into the number of opened bp
(Supplementary Data).
Gel-based DNA melting experiments
As substrate for dsDNA melting experiments by gel elec-
trophoresis, double-stranded Lambda DNA was digested
with HindIII (New England Biolabs, Ipswich, United
States) and 3′-labeled with ["32P]dATP using the Large
Klenow fragment of DNA polymerase I (New England
Biolabs, Ipswich, USA). Unincorporated nucleotides were
removed using MicroSpin G25 columns (GE Healthcare,
Little Chalfont, UK). The resulting labelled DNA frag-
ments had short 3 nt long 5′ ssDNA tails. Experiments were
performed in a 15 !l volume in 25 mM Tris-acetate pH
7.5, 1 mM dithiotreitol, 0.1 mg/ml BSA, 1 mM phospho-
enolpyruvate, 0.02 U/ml pyruvate kinase (Sigma-Aldrich,
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Figure 1. Force controlled association and dissociation of RPA on a DNA
fork substrate. (A) Schematic of the experiment: a 488 bp long DNA hair-
pin substrate (red) is immobilized onto a glass surface and tethered to a
magnetic bead. When sufficient force is applied to the bead, RPA (yellow)
can bind to the ssDNA/dsDNA interface at the fork. As a result, the hair-
pin is opened to accommodate the entire RPA heterotrimer. Further asso-
ciation proceeds by the contiguous binding of RPA to the fork until the
hairpin is fully opened. Upon lowering the magnetic force the DNA helix
refolds reversibly and RPA dissociates from the ssDNA. (B) Example time
trace of force controlled yRPA association and dissociation (in presence of
20 nM yRPA and 3 mMMg2+). At a force of 13.2 pN, sequential binding
of RPA opens the hairpin with a rate of 4.7 bp/s, until it is fully opened
and completely covered with RPA. Lowering the force to 4.5 pN causes
dissociation of RPA evident in rapid refolding of the hairpin with a rate of
107 bp/s.
St. Louis, USA), 0.15 nM DNA substrate and magnesium
acetate and recombinant proteins as indicated. RPA was
present in the reactions at saturating concentrations corre-
sponding to an excess over DNA as indicated, assuming all
DNA was single-stranded and a DNA-binding site size of
25 nt for human RPA and of 20 nt for yeast RPA. A com-
plete 100% DNA saturation thus corresponds to 576 nM
hRPA or 720 nM yRPA. Reactions were incubated at 37◦C
or 30◦C as indicated for 30 min, and then terminated by
adding 5!l stop buffer (150mMEDTA, 2%SDS, 30% glyc-
erol and 0.01% bromophenol blue), and analyzed on 1%
agarose gels in 1X TAE buffer. Gels were dried, exposed
to a storage phosphor screen and analyzed on a Typhoon
phosphor imager (GE Healthcare, Little Chalfont, UK).
RESULTS
RPA association and dissociation at a DNA fork
We measured the association and dissociation of RPA on a
488 bp long DNA hairpin substrate using magnetic tweez-
ers. One end of the hairpin was immobilized via a dsDNA
spacer at the bottom surface of a fluidic cell. The other end
was tethered to a 2.8 !m magnetic bead (Figure 1A). A set
of permanent magnets was mounted on a movable stage
above the fluidic-cell, such that the magnetic force acting
on the bead could be controlled by lowering or raising the
magnets (see Materials and Methods for details).
The DNA hairpin substrate can be opened mechanically
by applying sufficient force to the bead. At forces above a
critical force, which will be referred to as unzipping force, a
series of sudden, well-defined transitions in DNA extension
occurs, amounting to about 475 nm from the fully-closed
to the fully-open state over the course of about 1 s (see Sup-
plementary Figure S1). In contrast, after adding yRPA a
gradual opening of the hairpin at forces well below the un-
zipping force was observed. In this case, the opening process
lasted for much longer time-scales and continued until the
hairpin was extended to the fully-opened state (Figure 1B).
Upon reduction of the applied force, a gradual reversion to
the closed state took place. We interpret these gradual tran-
sitions as the result of RPA binding to the fork of the hair-
pin. The sequential association of more RPA opened the
hairpin and generated RPA-covered ssDNA. Upon lower-
ing the force, RPA is displaced by the rezipping of the DNA
(Figure 1A). The slopes of both association and dissocia-
tion were approximately constant throughout the complete
hairpin opening or closing process, irrespective of length of
dsDNA remaining. This suggests that RPA binding occurs
only at the fork, and in a contiguous manner with respect
to the previously bound RPA. We emphasize that the pro-
cess is fully reversible and the same substrate molecule can
be opened and closed multiple times without systematic al-
teration of the resulting curves.
Force dependence of RPA binding at the fork
Next we investigated the influence of the applied force on
the association and dissociation rates of RPA on the DNA
hairpin substrate. These rates showed a strong dependence
on the applied force. Above 11 pN we observed a gradual
opening of the hairpin and the rate of opening increased
with stronger force (Figure 2A). When the force acting on
such an RPA covered, open hairpin, was reduced below 11
pN, we observed a gradual closing of the hairpin. The ob-
served closing rates were the faster the lower the applied
force (Figure 2B).
Plotting the rates of hairpin opening and closing against
the applied force, it became apparent that both the associ-
ation and dissociation rates varied exponentially with force
as shown in Figure 2C.We devised a model in which the net
rate of RPA binding to the DNA is the difference between
the rates of force-dependent RPA association and RPA dis-
sociation from the fork. Each rate is expressed as an ex-
ponential Arrhenius term as obtained from transition-state
theory in which the applied force F scales with height of the
energetic barrier to the transition state:
vnet = kon exp
(
(cF · F − cunz · Funz)!zon
kBT
)
− koff exp
(
−cF · F ·!zoff
kBT
)
(1)
Pre-exponential factors kon and koff describe the expected
rates for association and dissociation at the unzipping force
Funz or at zero force, respectively. The second pair of fit pa-
rameters (!zon and!zoff ) corresponds to the distance of the
initial state (before association/dissociation of a new RPA)
to the transition state along the relevant reaction coordi-
nate, in this case the number of bp along the DNA hairpin.
For association, !zon thus corresponds to the number of
bp that need to open spontaneously to accommodate a suf-
ficiently long part of an RPA complex, such that the full
complex can subsequently bind. For dissociation !zoff is
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Figure 2. Force dependence of the RPA association/dissociation kinetics at the fork. (A) Example time traces of yRPA (20 nM in presence of 3 mMMg2+)
association on the DNA hairpin at different forces. The DNA hairpin sequentially opened due to successive association events of RPA. With increasing
forces the overall association rate becomes faster, ranging from 2.8 bp/s at 12.4 pN (blue) to 36.6 bp/s at 15.7 pN (red). (B) yRPA (20 nM in presence of 3
mMMg2+) dissociation time traces for varying force. Following a complete coverage of RPA on the DNA hairpin substrate, the force was lowered to the
indicated values causing the hairpin to close and RPA to dissociate. The rate of dissociation is much faster than association and ranges from 107 bp/s at 2.8
pN (blue) to 16.2 bp/s at 6.3 pN (red). (C) Association and dissociation rates as a function of force, obtained by tracking multiple DNA tethered magnetic
beads in parallel for yRPA (red circles, 20 nM in presence of 3 mMMg2+) or by tracking a single bead with hRPA (blue squares, 50 nM in presence of 10
mMMg2+). The data were fit using Equation 1 (red and blue lines for yRPA and hRPA, respectively) with fit parameters listed in Table 1.
the number of bp that need to rezip and displace part of
the RPA complex, to allow full complex dissociation. The
factor c converts the number of bp into a DNA extension
change, i.e. a length. This conversion is a function of force
(see Supplementary Figure S2) and was determined as de-
scribed in the Supplementary Information. The model de-
scribes the force-dependent rates well, as evident from the
fits to the data (Figure 2C). At concentrations of 20 nM
yRPA and 3 mM Mg2+ the fit yields a fast hairpin closure
rate of at zero force of koff = 239 ± 14 bp/s. Furthermore,
values of !zon = 3.3 ± 0.6 bp and !zoff = 1.6 ± 0.1 bp
were obtained, indicating that spontaneous helix opening
or partial RPA displacement amounting to only a few bp is
required to overcome the transition state for RPA associa-
tion or dissociation, respectively. This is analogous to the
toehold mechanism in DNA nanotechnology (35), where
the association of a small protein microdomain (toehold)
is the rate-limiting step for full protein binding and further
helix opening. Conversely, the disengagement of a terminal
microdomain is rate-limiting for helix rezipping.
The fit also provided the hairpin opening rate kon =
180 ± 42 bp/s at the unzipping force of Funz = 18.2 pN.
At the unzipping force the hairpin no longer imposes an
energetic hurdle for RPA association, such that the extrap-
olated rate should approximate the RPA association to free
ssDNA.Hairpin opening rates at a given force increased lin-
early with the RPA concentration (between 5 and 50 nM,
see Supplementary Figure S5), allowing us to calculate stan-
dardized (per nM) rates (see Table 1 for the full set of fit
parameters).
Taken together, the data so far show that in the absence
of force, dissociation dominates such that the closed hair-
pin state is favored. Increasing the forces ultimately tips
the scales and hairpin opening becomes favored. From our
model parameters one can also calculate the force Fequi (see
Table 1), at which hairpin opening and closing rates are at
equilibrium, which is 12.4 pN for 20 nM yRPA in 3 mM
Mg2+.
To test whether hairpin opening/closing driven by the
association/dissociation ofmicrodomains is a general prop-
erty of RPA, we repeated our experiments with hRPA. Sim-
ilarly to yRPA, a force-dependent opening and closing of
the DNA hairpin due to the association and dissociation
of hRPA at the fork was observed (Figure 2C). Our model
(Equation 1) also described the hRPA data well, and a fit to
the data yielded parameters that were comparable to yRPA
(Table 1). Most importantly the transition state distances
again amounted to only few bp also for hRPA, which sug-
gests that both RPA homologs use a toeholdmechanism for
binding/dissociation at a DNA junction.
RPA binding on a DNA duplex substrate
Next, we probed whether the observed RPA binding behav-
ior is unique to the DNA hairpin geometry, where both
ssDNA strands at the junction are subjected to force, or
whether it could also be observed on a DNA duplex with
an internal 63 nt gap and an adjacent 38 nt 5′-flap. For this
substrate only one of the two DNA strands is under force
at the junction, while the other strand, bearing the 5′-flap, is
free from tension. In this geometry RPAmolecules from the
two strands at the junction are allowed to interact with each
other, which may provide a different behavior. The DNA
substrate utilized in this case consisted of a 6.1 kb stretch of
dsDNA where the gap was 1 kb away from the 5′-end, fol-
lowed by a ssDNA flap (see Materials andMethods, Figure
3A). This DNA construct underwent a rapid disruption of
the base-pairing in the dsDNA when the applied force ex-
ceeds 65 pN, as indicated by a marked increase in the DNA
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Figure 3. Association and dissociation of yRPA on a flap bearing DNA duplex substrate (at 20 nM yRPA in presence of 3 mM Mg2+). (A) RPA also
associates reversibly onto a 6.1 kb long DNA duplex with a 38 nt long 5′-end flap subject to force. (B) Example time trace of RPA association and
dissociation. The duplex is seen to open continuously over several thousand bp, caused by the association of RPA. In this geometry, association proceeds
at a rate of 63.8 bp/s, when a magnetic force of 48.7 pN is exerted. Complete opening is avoided, to prevent detachment of the magnetic bead, by lowering
the force. At a force of 26.7 pN force, the helix refolds rapidly with a rate of 70 bp/s as RPA dissociates. (C) Association and dissociation rates are plotted
against the applied force (red circles). Again both the association and dissociation rates vary exponentially with the applied force. A double exponential
(see main text) fits the data well (red line), fit Parameters are given in Table 1.
length. This corresponds to the well established DNA over-
stretching transition (36,37).
In the presence of yRPA, a gradual increase in DNA
length was observed at forces well below the overstretch-
ing transition. This extension corresponds to the opening
of the duplex, which proceeded for several thousand bp
(Figure 3B) in agreement with the association of RPA at
the junction between ssDNA and dsDNA (Figure 3A and
B). As observed for the DNA hairpin geometry, the pro-
cess was fully reversible such that upon force reduction
the DNA extension gradually decreased until full restora-
tion of duplex DNA. Measured hairpin opening and clos-
ing rates also varied exponentially with the applied force
(Figure 3C). We fit these data with Equation 1, account-
ing for the altered DNA stretching geometry by means of
a different conversion factor c (Supplementary Informa-
tion). The fit parameters obtained compare well with those
obtained for the hairpin geometry, !zon = 2.9 ± 0.2 bp
and !zoff = 1.6 ± 0.1 bp, suggesting a geometry indepen-
dent behavior of RPA binding and dissociation. Again mi-
crodomain association/dissociation appeared to govern the
observed opening or closing of the duplex. The closure rate
of koff = 564 ± 11 bp/s suggests extremely rapid exchange.
An elevated force of 43 pN was required to bring both
competing processes to equilibrium, which can be fully ex-
plained by considering the stretching energetics of this ge-
ometry (see Discussion).
Magnesium dependence of RPA binding
The ionic strength and in particular the magnesium level
are of vital importance for DNA-protein interactions due
to both a general screening of charges and also the specific
mediation of important contacts (38,39). Earlier work re-
ported that hRPA is capable of melting dsDNA under con-
ditions of lowmagnesium concentration even in the absence
of force (21–23). Here, we investigated this observation in
more detail for both hRPA and yRPA.
We first probedDNAmelting in bulk solution by gel elec-
trophoresis using LambdaDNA digested with HindIII that
produced dsDNA fragments of various lengths. Melting of
dsDNA by hRPA occured at Mg2+ concentrations below 3
mM (Figure 4B). The extent of melting increased with de-
creasingMg2+ levels (Supplementary Figure S4), increasing
hRPA concentration (Supplementary Figure S3) and de-
Table 1. Fit parameters for yRPA and hRPA association and dissociation kinetics
yRPA hRPA
1 mMMg2+ 3 mMMg2+ 10 mMMg2+ 3 mMMg2+ 5 mMMg2+ 10 mMMg2+
kon
[bp s-1 nM-1] 34.2 ± 16.9 9.0 ± 2.1 18.2 ± 8.9 2.1 ± 0.3 3.2 ± 0.4 6.2 ± 1.1
koff [bp s-1] 233 ± 19 239 ± 14 336 ± 51 37 ± 7 109 ± 28 189 ± 23
!zon[bp] 5.0 ± 1.0 3.3 ± 0.6 2.4 ± 0.7 1.6 ± 0.6 2.1 ± 0.4 2.5 ± 0.5
!zoff [bp] 1.8 ± 0.2 1.6 ± 0.1 1.8 ± 0.2 0.6 ± 0.5 1.1 ± 0.5 0.9 ± 0.2
Funz [pN] 17.8 18.2 19.9 18.2 18.8 19.9
Fequi[pN] 12.4 12.4 11.1 11.8 12.2 14.5
kon and koff are the rates of association and dissociation at the unzipping force Funz or zero force, respectively. !zon and !zoff are the transition state
distances for binding or dissociation of anRPAheterotrimer in bp. The parameters were obtained by fitting the force-dependent association and dissociation
rates of yRPA and hRPA on the 488 bp DNA hairpin, to a model comprised of two Arrhenius terms (see Equation 1).
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Figure 4. DNA melting capacity of human RPA depends on Mg2+ con-
centration. (A) yRPA does not melt dsDNA. Lambda/HindIII DNA (lane
1) was incubated with 2.2 !M yRPA (corresponding to 300% saturation)
with various magnesium acetate concentrations (lanes 2–9, 0–10 mM as
indicated) for 30 min at 30◦C and subsequently analyzed on a 1% agarose
gel. Throughout the range of magnesium concentrations tested, no melt-
ing occurred (cf. heat denatured substrate in lane 10). (B) Experiment as
in panel a but with 2.2 !M hRPA (corresponds to 375% DNA saturation)
incubated for 30 min at 37◦C. In contrast to yRPA, hRPA melts dsDNA
at Mg2+ concentrations below 3 mM (lanes 5–9).
creasing dsDNA fragment length (Figure 4A, Supplemen-
tary Figure S4). Surprisingly and in a remarkable contrast,
no sign of dsDNAmelting was observed with yRPA (Figure
4A, Supplementary Figure S3). We also tested the effect of
monovalent salt on the melting activity, which was retained
in 50 mM KCl and 0–1 mM Mg2+ (Supplementary Figure
S7A) but not longer observed at 100 mM or higher concen-
trations of KCl (Supplementary Figure S7B).
To gain a more detailed insight into this distinct behav-
ior of hRPA versus yRPA, we probed RPA-mediated open-
ing and closing of dsDNA with our single-molecule assay
for varying magnesium concentrations, but in the absence
of monovalent salt to make the effect easier to characterize.
In agreement with the gel electrophoresis experiments, the
force-dependent DNA opening and closing remained con-
stant within margins of error for yRPA in Mg2+ concentra-
tions between 1 and 10 mM (Figure 5A, Table 1). In the
absence of Mg2+, the curve is plainly shifted by 3.5 pN to
lower forces, comparable to the reduction of Funz between
1 and 0 mMMg2+ (see Supplementary Figure S5). The ab-
sence of melting by yRPA is not simply due to the lower
concentration of yRPA (20 nM) as compared to hRPA (50
nM). This is evidenced by the fact that hRPAmelts dsDNA
across a range of concentrations in bulk whereas this does
not occur with yRPA (see Supplementary Figure S3).
For hRPA however, a pronounced effect of the magne-
sium level on the dissociation rates was observed. Hairpin
closure rates at zero force dropped from 189 bp/s at 10 mM
Mg2+ down to 109 bp/s at 5mMMg2+ and 32 bp/s at 3mM
Mg2+. Below 3 mM Mg2+ hairpin closure did not occur at
all, as illustrated by exemplary time trajectories recorded at
2 pN (Figure 5B).
Even in the absence of force the DNA hairpin was al-
ready completely opened after introducing hRPA in buffer
containing<3 mMMg2+. Overall the observed DNAmelt-
ing at low Mg2+ concentration in bulk and single-molecule
experiments is governed by an inhibited RPA dissociation,
since the hairpin opening due to RPA association was much
less affected (Figure 5A, Table 1). Linear extrapolation of
the hairpin closing rates for hRPA as a function of theMg2+
concentration allows to estimate a value of 2.5 mMMg2+ at
which no more dissociation would occur. This is in good
agreement with the onset of melting activity observed in
bulk.
Stepwise fork opening upon RPA binding
Close examination of the progressive dsDNA opening due
to RPA binding revealed that it did not occur uniformly
with constant velocity, but rather in a stepwisemanner (Fig-
ure 3A). To assess whether the observed stepping is intro-
duced by the stepwise association of single RPA molecules,
we carried out additional hairpin opening experiments at
moderate force and low RPA concentration. These condi-
tions favor slow RPA association such that individual steps
became well resolved and discernible (Figure 6A). To eval-
uate the size distribution of these steps we employed a step
finding algorithm (40). Step sizes for hairpin opening follow
a Gaussian distribution (Figure 6B), the mean step sizes for
dsDNA opening were 21.8 ± 5.5 bp for yRPA and 23.8 ±
2.1 bp for hRPA. These values are in agreement with bind-
ing site sizes ofRPAon ssDNAreported in literature (26,41)
in both their magnitudes (∼23 nt for yRPA and ∼26 nt
for hRPA) and relative extent (with hRPA slightly larger).
Thus, the observed steps appear to be single RPA binding
events. Most likely, one RPA is binding to one strand and
binding to the other strand then rapidly follows suit. We
note that under our measurement conditions also a minor
fraction of dsDNA closing steps with similar size as the
opening steps were observed (Figure 6B). These backward
steps stem from the dynamic competition between RPA
binding and dissociation at the DNA fork.
Sliding of hRPA along ssDNA induced by a rezipping fork
As shown above, at low force a rezipping hairpin rapidly
displaces RPA from ssDNA. Recently, it was however re-
ported that RPA is able to undergo diffusive motion along
ssDNA (26). We therefore sought to test whether a rezip-
ping DNA fork is able to push a single RPA heterotrimer
along ssDNA in front of it. If this occurred, ssDNA sec-
ondary structure might impose pressure onto RPA fila-
ments to keep them in a dense state. To test this hypothesis
a hairpin was repetitively opened and closed by alternating
between forces above and below the characteristic unzip-
ping force (22.5 and 15.5 pN, respectively). The lower force
bound allowed rapid hairpin closure in the absence of RPA
in a single abrupt transition, while being sufficiently high
to inhibit RPA dissociation from ssDNA. When adding
small amounts of hRPA (150 pM in buffer containing 1mM
Mg2+) the hairpin closing transitionwas blocked in some in-
stances and instead a slower rezipping with approximately
constant velocity took place (Figure 7A). Such continuous
closing events occurred only about once in 10 force cycles.
Given that the applied lower force bound strongly disfavors
RPA dissociation, we attribute these RPA induced events
to the sliding of a single RPAmolecule in front of the rezip-
ping fork. RPA gets pushed along the ssDNA by the fork
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Figure 5. Magnesium dependence of DNA fork opening due to RPA binding. (A) Hairpin opening and closing rates of 20 nM yRPA (left panel) and
50 nM hRPA (right panel) as a function of force measured for different Mg2+ concentrations. While the behavior of yRPA is rather independent of the
Mg2+ concentration between 1 to 10 mM, the dissociation of hRPA becomes impeded at low Mg2+ levels. Fit parameters are tabulated in Table 1. (B)
Example trajectories for the dissociation of yRPA and hRPA at ∼2 pN for different magnesium concentrations. For hRPA, closure of an opened hairpin
is completely impeded below 3 mMMg2+.
but slows down the rapid rezipping by the friction it expe-
riences during sliding on ssDNA (see Figure 7B). The fact
that the sliding can be interrupted by unzipping the hairpin
and reinitiated by closing the hairpin again (see Figure 7A,
second highlighted portion) substantiates this explanation.
To determine a friction coefficient and thus a diffusion
coefficient for RPA sliding on ssDNA, we carried out RPA
pushing experiments for various lower force bounds (13.5
to 16.0 pN). The effective pushing force that moves RPA
along the ssDNA is the difference between the character-
istic hairpin unzipping force (17.8 pN for the applied con-
ditions) and the applied force. In agreement with friction
being responsible for the slowed down dsDNA rezipping,
the average hairpin closing rate was inversely proportional
to the pushing force (Figure 7C). A linear fit to the data
is used to obtain the friction coefficient ! for RPA sliding
along ssDNA according to Fpush = Funz − F = ! · v. Us-
ing the Einstein relation D= kBT/! , the friction coefficient
is converted into the diffusion coefficient D, for which we
obtain 960 ± 350nt2/s.
DISCUSSION
RPA tightly binds ssDNA. The results presented here
demonstrate that RPA binding to a DNA substrate that
mimics a replication fork is, however, highly dynamic. In
this case, the finely balanced competition between continu-
ous association and dissociation of RPA at the fork deter-
mines the degree of bound RPA. The details of the dynamic
model that emerges from our findings (illustrated in Figure
8) is discussed below.
RPA supports rapid transactions at DNA forks
RPA binds to ssDNA with a dissociation constant in the
low nM to high pM range (3) and dissociates with a rate
as low as 0.006 s−1 (hRPA in 5 mM Mg2+) in the absence
of free RPA in solution (25,42). The coating of ssDNA by
RPA is therefore a rapid process, while an established RPA
filament features an extremely slow turnover. In contrast,
as shown in this study, RPA can be very rapidly displaced
at a DNA replication fork with speeds of several hundred
bp per second corresponding to a removal of up to >10
RPA heterotrimers per second. Thus, RPA acts as a ver-
satile platform: it binds and protects ssDNA generated in
a number of DNA processing steps, such as DNA repair,
stalled replication and homologous recombination. Dur-
ing replication it supposedly also prevents rehybridization
of parental DNA strands as long as a replicative helicase
acts on the fork. In contrast, RPA rapidly dissociates upon
rezipping of DNA at a forked substrate. Despite the sta-
ble protection of ssDNA conferred by RPA, the observed
speeds (up to 300 bp/s on the fork and 500 bp/s on the flap
substrate) exceed the ssDNA translocation and dsDNA un-
winding rates ofmost helicases and translocases. Thus, RPA
cannot maintain such a stretch of DNA as single-stranded
and will be rapidly expelled once a helicase ceases its ac-
tivity. This also implies that DNA helicases which orient
themselves away from a DNA replication fork with respect
to their translocation direction (28,43,44) are not required
to strip off RPA but rather remove other proteins that also
tightly bind ssDNA such as Rad51. An exception may be
enzymes that revert stalled replication forks and that have
been shown to actively anneal RPA coated ssDNA in par-
ticular in case of negative supercoiling (45). In general, he-
lix refolding appears to be sufficient to return dsDNA to
its native RPA-unbound state, once DNA processing has
been completed and the processing machinery has dissoci-
ated from the DNA.
Microdomain dynamics govern the behavior of RPA
The association and dissociation of RPA at a forked sub-
strate was found to be strongly force dependent. Increasing
forces promoted RPA association while slowing down RPA
dissociation. The competition between both processes de-
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Figure 6. Binding site size of RPA. (A) Exemplary time trace yRPA as-
sociation (2 nM yRPA, 10 mM Mg2+) on the hairpin substrate showing
clearly resolved steps at a force of 12.0 pN. (B) Step size distribution for
yRPA (from multiple traces collected under the same conditions), calcu-
lated using a step finding algorithm. The step size of 21.8 bp occurs most
frequently in the data). (C) The step size distribution for hRPA association
data (collected at (5 nM hRPA, 10 mMMg2+, 12.0 pN) is similar, with the
most common size being 23.8 bp.
termined whether fork opening and closing was observed.
The force-dependent kinetics of these processes could be
described by a simple model using transition-state theory.
This provided the distances from the transition states !zon
and!zoff for association and dissociation, respectively, that
were on the order of only a few bp throughout the investi-
gated experimental conditions (Table 1). Compared to the
binding-site size of RPA these values are quite small. This
indicates that only a small terminal portion of RPA has
to wedge in at the fork in order to allow the binding of
the full RPA heterotrimer, which results in hairpin open-
ing over the entire heterotrimer length. Similarly, for dis-
sociation only a small terminal portion of RPA has to be
lifted from the ssDNA due to helix refolding over one to
two bp in order to destabilize the binding of RPA suffi-
ciently and to shear it off. Note the transition state dis-
tances are consistently slightly lower for dissociation than
for association. The mode of RPA engagement and lift off
at the DNA fork is analogous to the widely used strand
displacement reactions in DNA nanotechnology, where a
few nucleotide long toehold provides a sufficient nucleation
point for hybridization to a complementary target and dis-
placement of an initially bound strand (35). Structural in-
formation of RPA shows that the heterotrimer comprises
multiple DBDs that are flexibly linked together (46,47) and
interact with the DNA in a defined orientation (48). The
toehold estimates we obtain here for RPA binding com-
pare well with the length of ssDNA that interacts with a
single DBD, crystallographically determined to be 3 nt for
DBDs A and B of hRPA (49). This suggests that associ-
ation of a single DBD is sufficient for the observed DNA
opening by RPA. Previously, such a microdomain associa-
tion has already been proposed, in order to explain some
of the binding properties of RPA (12,24,25). For example,
the dissociation of RPA bound to ssDNA was found to be
accelerated in the presence of unbound RPA in solution
and it was proposed that competing RPA from solution can
shear off bound molecules by initial association through
a microdomain (25). Here, we directly demonstrated that
RPA canmelt apart and wedge into dsDNA, or once bound
can be sheared off by a rezipping fork and that these pro-
cesses use microdomain engagement over a length of ∼1
DBD. Given that the loss (23) or inhibition (50) of DBD-
F located in the N-terminal region of the large subunit of
RPA results in specific inhibition of helix-destabilization,
we hypthesize that DBD-F is the likely candidate domain
for toehold binding.
DNA melting by RPA occurs without active dsDNA destabi-
lization
When applying sufficient force, RPA is capable of opening
a DNA fork. Similar to the unwinding reaction of a heli-
case, this could be either passive or active (51). For pas-
sive openingRPAwould only interact with ssDNAand trap
spontaneous helix openings (fraying of DNA duplex ends)
to accomplish microdomain association. For an active un-
winding RPA would also interact with the dsDNA at the
fork and cause helix destabilization. The unwinding rate of
aDNAhairpin under tension by a passive helicase with step
size n has been previously derived in a simplified form as
(52):
v = vmax exp
(
!GnF −!Gnbp
kBT
)
, (2)
where vmax is the maximum stepping rate of the helicase,
!Gnbp is the average base-pairing energy over n bp in ab-
sence of force and !GF the free energy change due to
the work that is done when opening n bp in presence of
force.When neglecting the entropic contribution for ssDNA
stretching (52),!GF = cF · F · zn and!Gbp = cunz · Funz · zn.
The latter equation uses the fact that at the hairpin unzip-
ping force the applied work exactly compensates the base-
pairing energy. Inserting these two equations into Equation
2, provides an expression that is mathematically similar to
the rate of force-dependent DNA opening due to RPA as-
sociation (left term in Eqn. 1). For a passive helicase, the
velocity approaches vmax only close to the hairpin unzip-
ping force at which the applied tension keeps the fraying
bp at the fork practically fully open, such that the forward
stepping is no longer hindered by duplex formation. For
an active helicase vmax is already reached at considerably
lower forces (52). Given the similarities between Equations
1 and 2, we would thus expect a similar distinction to be
valid also for active versus passive DNA opening by RPA.
As shown above the RPA induced DNA opening velocity
is monotonically increasing even when approaching Funz.
Furthermore, the velocity for hRPA amounts to only 2–6
bp s-1 nM-1 at Funz which is comparable to previously deter-
mined association rates of RPA with ssDNA of 2 s-1 nM-1
(53). Thus, the characteristics of the force-dependent DNA
opening by RPA support a passive model rather than an ac-
tive helix destabilization in agreement with previous reports
(23). A passive model for DNA duplex opening by RPA is
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Figure 7. Sliding ofRPAalong ssDNAupon dsDNArezipping. (A) Repet-
itive opening and closing the hairpin by alternating the applied force be-
tween 22.5 and 15.5 pN (as indicated in red) at a low hRPA concentration
of 150 pM (in 1 mM Mg2+ buffer). For the majority of the unzipping cy-
cles (gray background) the closing of the hairpin is unperturbed. Approx-
imately once in 10 cycles, a continuous slower closing is however observed
(pale yellow background) that is attributed to RPA sliding. (B) Cartoon il-
lustrating the observed behavior according to the background colors used
in A. In case of sliding events, a single hRPA heterotrimer is thought to
bind to the exposed ssDNA after hairpin opening. When the force is re-
duced, the closing hairpin pushes the hRPA along the ssDNA. (C) Mean
sliding velocity (black squares, error bars indicate standard errors) as a
function of the pushing force applied by the hairpin (difference between
characteristic unzipping force and the applied force). A linear fit describes
the observed trend well (R2 = 0.86), with the intersection of the velocity
axis at −18.23 nt/s for zero force. Furthermore, the slope of this fit can be
used to calculate a friction coefficient, as the velocity is expected to vary
with the force as given by F = ! · v, for which we find a value of ! = 0.005
± 0.0009 pN·nt−1 ·s.
also supported by the observed salt dependence of this re-
action for yRPA. In presence of 1 to 10 mMMg2+ no con-
siderable changes to the kinetics were found (Figure 5A).
This correlates with the determined unzipping forces of the
DNAhairpin that varied only slightly between 1 and 10mM
Mg2+ (Table 1). However, when carrying out experiments
in absence of Mg2+ the DNA opening kinetics shifted by
∼3 pN toward lower forces, though the overall shape of the
curve remained similar (Supplementary Figure S6). Again
the magnitude of the shift correlates with the measured un-
zipping force of the hairpin, which was found to be 3.5 pN
lower at these ionic conditions. A reduced base-pairing en-
ergy thus effects mechanical unzipping and RPA mediated
dsDNA opening kinetics to the same measure, lending fur-
ther support for the passive model.
Fine-tuned RPA binding energetics
The above discussion established a passive mechanism for
dsDNA opening by RPA. Since this process already occurs
at forces below Funz, it follows that it is driven exclusively by
the free energy gain of the RPA–ssDNA association to both
strands at the fork. At equilibrium, when the rates of RPA
association and dissociation balance out (yielding a net rate
of zero), the base-pairing energy (over a single step of DNA
opening of∼23 bp) equals the work done when opening the
hairpin under the external force plus the free energy change
associated with RPA binding:
!G23 bpbp = !G23 bpFequi + 2 ·!Gbind
Using the above expressions for!Gbp and!GF one obtains:
!Gbind = (cunzFunz − cequiFequi)(23 bp)/2
From the values in Table 1, one arrives at an average value
of !Gbind ∼40 ± 9 kJ/mol for both yRPA and hRPA
across all Mg2+ conditions. Using the equilibrium constant
of 1010 M−1 (3), one arrives at a value of∼57 kJ/mol which
compares well to the value we obtain from our measure-
ments. In a simplified view RPA binding contributes with
about one-third of the base-pairing energy to the duplex
opening, since the equilibrium force is about one third lower
than the unzipping force. Remarkably this is similar for
yRPA and hRPA across the range of ionic conditions in-
vestigated. In that respect RPA binding appears to be fine-
tuned. The binding free energy is strong enough for stable
binding but sufficiently weak to avoid DNA melting. This
tunable balance is retained in 50 mMKCl between 0–1 mM
Mg2+ but not observed at higher KCl concentrations (Sup-
plementary Figure S7). We think that melting is meaningful
within the intracellular context but probably happens on a
much smaller scale.Moreover, crowding effects can shift the
salt requirements for RPA-induced melting.
The obtained energetic contribution of RPA binding to
DNA opening appears to be geometry independent, since
also for the experiments on the DNA duplex substrate (Fig-
ure 3) the equilibrium force of 43 pN is one-third lower
than the overstretching force during which DNA melts.
Most likely the same contribution would be obtained when
evaluating RPA induced melting of supercoiled DNA (24).
However, in this case interpretation of the data may be
complicated by the fact that trapping of transient denat-
uration bubbles may occur on multiple sites all over the
DNA, as suggested by dsDNA overstretching experiments
(54,55). Overall the observed force/twist-dependent DNA
melting by RPA may be an important regulator in particu-
lar circumstances where DNA experiences high tension and
torque. This is the case for instance during the formation of
anaphase bridges in the S-phase of replication, where the
affinity of the Plk1-interacting checkpoint helicase (PICH)
for dsDNA greatly increases under tension causing a stabi-
lization of the dsDNA (56).
Regulation of RPA binding by Mg2+ ions
The magnesium concentration dependence of the dissocia-
tion rate we observed is specific to hRPA, yRPA did not ex-
hibit this behavior. The ionic strength in general andmagne-
sium in particular are of vital importance for DNA–protein
interactions. While the DNA duplex is stabilized by charge
screening, hindering the association of RPA, the mutual
approach of negatively charged RPA and the DNA is as-
sisted. This may account for minute variations in the appar-
ent association rates. However, the much more significant
influence on the hRPA dissociation rates seems to involve a
highly specific effect of magnesium on the binding of hRPA
to DNA. It is conceivable that yRPA may feature an evolu-
tionarily conserved salt independence, in order to allow for
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Figure 8. Dynamics of RPA on DNA fork. Initially, Association com-
mences from a RPA unbound DNA fork. Helix breathing exposes small
stretches of ssDNA to which RPA attaches via Toehold binding. Further
binding occurs in the same manner rendering the ssDNA arms of the fork
RPA bound. Individual bound RPA heterotrimers can slide along the ss-
DNAbyDiffusion.Dissociation ofRPA is triggeredwhenDNAHelix rehy-
bridization causes Toehold dissociation ultimately leading to Complex dis-
sociation. Further dissociation ultimately reverts the DNA fork to theRPA
unbound state. Both competing processes take place continuously, with the
balance being controlled by the concentration of RPA, the applied force
and (*in the case of hRPA) the Mg2+ concentration. Higher force or RPA
concentration favors association, while (for hRPA) more Mg2+ shifts the
balance toward dissociation.
variable magnesium concentrations in the cell. Yeast cells
are expected to have greater variability of their intracellu-
lar ion composition due to the diversity of environments in
which they grow. Indeed intracellular magnesium concen-
trations strongly depend on the magnesium concentration
outside of the cell (57). Alternatively, hRPA binding could
be regulated in a cell cycle dependent manner by controlling
the intra-nuclear magnesium levels. Moderate magnesium
concentrations are essential for the activity of a whole range
of DNA repair proteins (58) and the distribution of intra-
cellular magnesium is both variable (57,59,60) and tightly
regulated throughout the cell cycle progression (58).
Pushing of RPA along ssDNA
Despite the strong binding reported for each of the DBD
subdomains, with Kd values in the !M range (61), diffu-
sion of hRPA on ssDNA as been recently reported (26). We
further substantiated this observation by testing whether
single hRPA heterotrimers can slide along ssDNA when
pushed by a closing hairpin. Sliding was readily observed
and the obtained friction coefficient allowed to calculate a
diffusion coefficient of D = 960 ± 350 nt2/s on ssDNA.
This matches the previously reported value of D = 2800
± 200 nt2/s (26), considering the high salt concentration
of 0.5 M NaCl used in that study. Diffusion of RPA along
ssDNA allows bound RPA molecules to rearrange them-
selves on the ssDNA, e.g. to ensure a dense coverage but
also in order to free up access to other ssDNA binding
proteins. It may, for example, facilitate the exchange be-
tween bound and free RPA molecules (25) and allow the
recruitment of other DNA repair proteins. Rad52 for in-
stance binds RPA–ssDNA and stimulates the extension of
Rad51 filaments on the ssDNA (62–64) which is an impor-
tant precursor to later stages of homologous recombina-
tion. Additionally, RPA bound to ssDNA directly interacts
withATRIP, which contributes to the activation of theATR
checkpoint kinase as a response to ssDNAarising frompro-
cessing of DNA double-strand breaks and replication in-
terference (13). In vitro reconstitution experiments revealed
that the ATR activation is strongly dependent on the length
of ssDNA, suggesting a possible cooperative mechanism
of RPA–ssDNA in ATRIP mediated ATR activation (14).
Therefore, the sliding of RPA along ssDNA might allow
the formation of RPA nucleoprotein filaments that is op-
timally capable of interaction with ATRIP or proteins that
might be recruited through a similar mechanism. It was re-
cently also shown that ATR activation further depends on
the binding of MutS" to DNA hairpin loops that persist in
RPA-covered ssDNA (65). In order for the formation and
persistence of these hairpin regions the ability of rezipping
DNA hairpins to cause RPA to slide may also be a func-
tional requirement. Additionally, the sliding capability of
RPA on ssDNA suggests that molecular motors such as he-
licases may also be able to push along RPA bound to the
ssDNA along which they track.
CONCLUSION
Our results contribute to the emerging view that RPA fil-
aments are highly ‘vivid’ cellular structures. The binding
affinity of RPA to ssDNA appears to be carefully adjusted,
such that ssDNA intermediates arising during DNA pro-
cessing are stably protected, yet dsDNA is left unchanged.
When necessary, RPA can nevertheless be readily dislodged
or pushed along permitting access to other enzymes. Once
these molecular machines complete their task, rapid re-
moval of RPA at a fork is facilitated by the rehybridization
of the DNA helix, recovering the fully processed dsDNA.
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Unzipping curve of the DNA hairpin substrate 
 
 
Figure S1: The DNA hairpin substrate can be mechanically unzipped  
When the force applied to the DNA hairpin substrate is monotonically increased by lowering the 
magnets, the DNA extends in a series of sharp transitions amounting to 475 nm over the course of 
several seconds. The force at the final transition emanating from the intermediate state in which 
the hairpin is almost half open is defined is as the unzipping force, which is 18.2 pN in this case.  
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Conversion from DNA extension to ‘basepairs-opened’ 
To convert DNA extensions at a given force into the corresponding number of opened base-pairs, 
a conversion factor was calculated for yRPA and hRPA on each construct. Force extension curves 
were measured for bare and RPA covered constructs. In the latter case the rehybridization was 
prevented conveniently by using buffer containing < 3 mM Mg2+ (see Main Text) for hRPA, or by 
annealing a short oligonucleotide. The conversion factor was then calculated by taking the 
difference of Freely-Jointed-Chain (FJC) fits to the force extension curves and normalization to 
one base-pair. 
 
Figure S2: nm-to-bp conversion for the DNA hairpin obtained from force extension curves 
The conversion estimates obtained from fitting force extension curves with FJC model for (a) 
yRPA and (b) hRPA are shown (red lines) together with individual apparent conversions observed 
in the association/dissociation data. The latter were obtained from the length difference between 
bare dsDNA and fully RPA coated ssDNA (or vice versa) for a given force. 
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dsDNA Melting by hRPA  
 
Figure S3:  DNA melting capacity of human and yeast RPA  
(a) yRPA does not melt dsDNA. Lambda/HindIII DNA substrate (lane 1) was incubated with 
various concentrations of yRPA (lanes 2-7, 50-300 % of saturation as indicated) in buffer 
containing 2 mM magnesium acetate for 30 minutes at 30 °C and subsequently analyzed on a 1 % 
agarose gel. Throughout the range of yRPA concentrations tested, no melting occurred (cf. heat 
denatured substrate in lane 8). The lack of dsDNA melting by yRPA was not due to the lower 
reaction temperature of experiments with yRPA (30 °C). When yeast RPA was incubated at 37 °C 
at 300% saturation (lane 9, *) again no DNA melting was observed. (b) Experiment as in panel a, 
but with various concentrations of hRPA (as indicated) incubated for 30 minutes at 37 °C. In 
contrast to yRPA, hRPA melts dsDNA once its concentration reaches a level sufficient for dsDNA 
saturation (lanes 3-7). (c) Quantitation for the RPA concentration dependent dsDNA melting 
shown in panels b and c. The 2.3 kb long dsDNA (open symbols) becomes melted to increasing 
extent by higher concentrations of hRPA (black), but not by yRPA (red). However, the 9.4 kb long 
dsDNA (filled symbols), is not melted significantly. Error bars, SEM, n=2. 
 
 
Figure S4: Quantitation of magnesium dependent dsDNA melting by RPA 
Quantitation of dsDNA melting by yeast or human RPA and its dependence on the magnesium 
concentration (see Figure 4 of the Main Text). hRPA (black) melts both the 2.3 kb and 9.4 kb 
dsDNA (open and filled symbols, respectively) for magnesium concentrations below 3 mM, 
whereas yRPA (red) does not melt dsDNA throughout the observed range of conditions. Error bars, 
SEM, n=2. 
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Concentration dependent association of yRPA on the DNA hairpin  
 
Figure S5: Concentration dependent association of yRPA on the DNA hairpin substrate 
(a) Example time-traces of association at a force of 12.7 pN are shown. The rate of association is 
increased from 0.4 bp/s at 5 nM RPA (red curve), to 16.2 bp/s at 50 nM (blue curve). (b) Observed 
association rates (open circles) vary linearly with the concentration of RPA as indicated by the 
linear fit (red line). Points shown correspond to mean values of triplicate measurements with error 
bars representing one standard deviation. 
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yRPA association/dissociation kinetics in absence of Mg2+  
 
Figure S6: Salt-free association/dissociation kinetics of yRPA/ 
The measurement of yRPA binding kinetics were repeated in the absence of salt (black), for which 
we found that the entire curve is shifted towards lower forces (cf. the 1 mM Mg2+ curve in grey) 
while its shape is preserved. The shift is roughly consistent with the difference of 3.5 pN which we 
observe between the unzipping forces under these buffer conditions.                             
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Influence of  monovalent salt on dsDNA melting by hRPA 
 
a 
 
b 
 
Figure S7:  Effect of KCl on the DNA melting capacity of human RPA  
(a) In presence of 50 mM KCl, hRPA melts dsDNA at low magnesium concentrations. 
Lambda/HindIII DNA substrate (lane 6) was incubated in 50 mM KCl buffer supplemented with 
of 0-4 mM MgCl2 (lanes 2-5) for 30 minutes at 37 °C and subsequently analyzed on a 1 % agarose 
gel. Compared to conditions in which no monovalent salt is added, the range in which melting is 
observed is shifted down to 0-1 mM (lane 1 & 2, cf. heat denatured substrate in lane 1). (b) At 
higher concentrations of KCl the melting of hRPA is inhibited. The substrate (lane 6) was incubated 
in 100 mM KCl, in this case no melting was observed across the range of magnesium 
concentrations tested (0-4 mM MgCl2, lanes 2-5, cf. heat denatured substrate in lane 1).  
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Introduction
The accurate replication of our genome is an essential require-
ment for the high-fidelity transmission of genetic information 
to daughter cells. DNA replication forks are constantly chal-
lenged and arrested by DNA lesions, induced by endogenous 
and exogenous agents, and by a diverse range of intrinsic repli-
cation fork obstacles, such as transcribing RNA polymerases, 
unusual DNA structures or tightly bound protein–DNA com-
plexes (Carr and Lambert, 2013). An emerging model of how 
stalled or damaged forks are processed is that replication forks 
can reverse to aid repair of the damage (Atkinson and McGlynn, 
2009; Ray Chaudhuri et al., 2012; Berti et al., 2013). This model 
implies significant remodeling of replication fork structures into 
four-way junctions and the molecular determinants required for 
reversed fork processing and restart are just beginning to be 
elucidated. The first evidence that supports the physiological re-
levance of this DNA transaction during replication stress in 
human cells arose from studies with DNA topoisomerase I 
(TOP1) inhibitors (Ray Chaudhuri et al., 2012). Additional 
studies established that the human RECQ1 helicase promotes 
the restart of replication forks that have reversed upon TOP1 
inhibition by virtue of its ATPase and branch migration activi-
ties (Berti et al., 2013). These observations were recently ex-
tended to show that the RECQ1 mechanism of reversed fork 
restart is a more general response to a wide variety of replica-
tion challenges (Zellweger et al., 2015). Nonetheless, new lines 
of evidence point to alternative mechanisms and factors that 
might mediate either formation or processing of reversed repli-
cation forks (Bétous et al., 2012; Gari et al., 2008). These puta-
tive mechanisms likely include nucleases that are capable of 
processing stalled replication intermediates upon genotoxic 
stress (Cotta-Ramusino et al., 2005; Schlacher et al., 2011; 
Hu et al., 2012; Ying et al., 2012).
Here, we investigate the contribution of the human DNA2 
nuclease/helicase in reversed fork processing. DNA2 is a highly 
conserved nuclease/helicase initially identified in Saccharomyces 
cerevisiae screening for mutants deficient in DNA replication 
(Kuo et al., 1983; Budd and Campbell, 1995). Yeast Dna2 plays 
Accurate processing of stalled or damaged DNA replication forks is paramount to genomic integ-rity and recent work points to replication fork 
reversal and restart as a central mechanism to ensuring 
high-fidelity DNA replication. Here, we identify a novel 
DNA2- and WRN-dependent mechanism of reversed rep-
lication fork processing and restart after prolonged geno-
toxic stress. The human DNA2 nuclease and WRN ATPase 
activities functionally interact to degrade reversed replica-
tion forks with a 5-to-3 polarity and promote replication 
restart, thus preventing aberrant processing of unresolved 
replication intermediates. Unexpectedly, EXO1, MRE11, 
and CtIP are not involved in the same mechanism of 
reversed fork processing, whereas human RECQ1 limits 
DNA2 activity by preventing extensive nascent strand 
degradation. RAD51 depletion antagonizes this mecha-
nism, presumably by preventing reversed fork formation. 
These studies define a new mechanism for maintaining 
genome integrity tightly controlled by specific nucleolytic 
activities and central homologous recombination factors.
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single-molecule DNA fiber replication assays. We pulse- 
labeled human osteosarcoma (U-2 OS) cells with the thymidine 
analogue CldU for 20 min, followed by a 60-min exposure to a 
selected genotoxic agent during the CldU labeling period, and 
by labeling with the second thymidine analogue, IdU, for an ad-
ditional 40 min after removal of the genotoxic drug. We found 
that DNA2 plays an important role in restarting replication 
forks after treatment with the ribonucleotide reductase inhibitor 
hydroxyurea (HU), the topoisomerase I inhibitor camptothecin 
(CPT), and the interstrand cross-linking agent mitomycin C 
(MMC) (Fig. 1 A). In addition, DNA2 depletion increased the 
percentage of origin firing, but not of fork termination events 
(Fig. S1 A). Genetic knockdown–rescue experiments confirmed 
that complementation in DNA2-depleted U-2 OS cells with 
siRNA-resistant WT DNA2 abrogated the effect of DNA2 de-
pletion on replication fork restart upon HU treatment. More-
over, expression of the nuclease-deficient DNA2 mutant D294A 
in DNA2-depleted cells revealed that the nuclease activity 
of DNA2 was essential for its role in replication fork restart 
(Fig. 1 B and Fig. S1 B).
We next measured whether DNA2 uses its nuclease activ-
ity to process stalled replication intermediates by monitoring 
the integrity of the newly synthesized DNA after HU treatment. 
To this purpose, we changed the DNA labeling scheme. We first 
pulsed U-2 OS cells with IdU for 45 min, and then varied the 
exposure time to HU from 0 to 8 h. The mean length of the IdU 
tracts progressively decreased during HU treatment from 18.2 µm 
(0 h) to 12.0 µm (8 h; Fig. 1 C). However, shRNA-mediated 
DNA2 depletion largely prevented IdU tract shortening, con-
firming that DNA2 is responsible for the observed nascent 
strand degradation (Fig. 1 D). Double-labeling experiments 
confirmed that the observed nascent tract shortening is indeed 
caused by the DNA2-dependent processing of ongoing replica-
tion forks and that this degradation is important to mediate ef-
ficient replication fork restart upon prolonged HU treatment 
(Fig. 1 E). Clonogenic analysis of U-2 OS cells treated with the 
same HU concentration used for the DNA fiber experiments 
showed a significantly reduced cell survival upon DNA2 deple-
tion, indicating that the DNA2-dependent processing of stalled 
replication intermediates is critical for recovery from replica-
tion fork blockage (Fig. 2 A). The results obtained with the 
shRNA DNA2-depleted U-2 OS cells were validated using a 
new conditional knockout human colorectal carcinoma cell line 
(HCT116) where addition of tamoxifen to the culture medium 
led to DNA2-null cells. Analysis of the mean tract lengths con-
firmed that DNA2 knockout in HCT116 cells abrogates the 
prominent degradation observed upon HU treatment (Fig. 2 B). 
Collectively, these results indicate that human DNA2 degrades 
nascent strands at stalled replication forks to facilitate fork re-
start and promote viability after genotoxic stress induction.
RECQ1 regulates the fork processing 
activity of DNA2
On the basis of the recent discovery that RECQ1 is required to 
restart replication forks that have reversed upon genotoxic stress 
induction (Berti et al., 2013), we investigated whether RECQ1 
regulates the fork processing activity of DNA2. Nascent IdU 
an essential role in Okazaki fragment maturation during lagging 
strand DNA replication (Budd and Campbell, 1997; Bae et al., 
2001; Ayyagari et al., 2003). However, increasing evidence sug-
gests that DNA2 has important—albeit yet undefined—roles in 
DNA replication stress response and DNA repair, which go be-
yond its postulated role in Okazaki fragment processing (Duxin 
et al., 2012; Karanja et al., 2012; Peng et al., 2012). The notion 
that DNA2 is important for DNA replication is strengthened by 
the observation that DNA2 forms a complex with various repli-
cation core components, including the replisome protein And-1 
(Wawrousek et al., 2010; Duxin et al., 2012). Moreover, human 
DNA2 seems to play a partially redundant role with human exo-
nuclease I (EXO1) in replication-coupled repair (Karanja et al., 
2012), whereas a recent study in S. pombe suggested that the 
nuclease activity of DNA2 is required to prevent stalled forks 
from reversing upon HU treatment (Hu et al., 2012).
DNA2 also has an independent function in dsDNA break re-
pair. Two distinct pathways act redundantly to mediate processive 
DSB resection downstream from the MRE11-RAD50-NBS1 
(MRN) and CtIP factors in eukaryotic cells: one requires DNA2 
and the other EXO1 (Gravel et al., 2008; Mimitou and Symington, 
2008; Zhu et al., 2008; Nicolette et al., 2010). Specifically, DNA2 
and EXO1 resect the 5 ends of double-strand DNA breaks (DSBs) 
to generate 3 single-stranded overhangs, which are essential to 
initiate homologous recombination. In yeast, DNA2-dependent 
dsDNA-end resection reaction requires the Sgs1 helicase to un-
wind the DNA from the break (Zhu et al., 2008; Cejka et al., 2010; 
Niu et al., 2010). This mechanism appears to be largely conserved 
in mammalian cells where DNA2 cooperates with the human BLM 
helicase to resect dsDNA ends in vitro (Nimonkar et al., 2011). 
However, mammalian cells possess five human RecQ homologues 
(RECQ1, RECQ4, RECQ5, BLM, and WRN) and WRN can also 
assist DNA2-dependent end resection, suggesting that BLM might 
not be the sole RecQ homologue required for this process (Liao 
et al., 2008; Sturzenegger et al., 2014). The ability of DNA2 and 
EXO1 to process dsDNA ends might also be relevant in the con-
text of DNA replication to prevent the accumulation of replica-
tion-associated DSBs by promoting homologous recombination 
(HR) repair (Peng et al., 2012). Alternatively, these nucleases 
might be involved in the recovery of replication fork blockage 
by processing specific stalled replication fork structures.
This work uncovers a new DNA2- and WRN-dependent 
mechanism that mammalian cells use to process replication 
forks that have reversed as a result of replication inhibition. Im-
portantly, it also shows that this mechanism is tightly regulated 
by human RECQ1 and the HR factor RAD51. Our observations 
shed light on a novel pathway for the suppression of chromo-
somal instability in mammalian cells and provide important 
new insight into the mechanisms of replication stress response 
associated with chemotherapeutic drug damage.
Results
DNA2 is required for stalled fork 
processing and restart
To begin elucidating the role of human DNA2 during replication 
stress, we monitored replication perturbation by genome-wide 
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Figure 1. DNA2 is required for replication fork restart and stalled fork processing upon genotoxic stress. (A) Schematic of DNA fiber tract analysis. 
U-2 OS cells were transfected with control siRNA or DNA2 siRNA before CldU or IdU labeling. Red tracts, CldU; curved red tracts, CldU with genotoxic agents 
(HU or CPT or MMC); green tracts, IdU. (bottom) Representative DNA fiber image. (right) quantification of red-green contiguous tracts (restarting forks). 
Mean shown, n = 3. Error bars, standard error. ns, not significant; *, P < 0.05; **, P < 0.01 (paired t test). (B) Quantification of restarting forks in DNA2-
depleted cells expressing DNA-WT or DNA2-D294A. ns, not significant; *, P < 0.05 (paired Student’s t test). (C, top) Representative DNA fiber image. 
(bottom) Representative IdU tract length distributions in Luc-depleted cells during different exposure time to HU (out of 3 repeats; n ≥ 300 tracts scored 
for each dataset). Mean tract lengths are indicated in parentheses. (D) Top, DNA2 expression after shRNA knockdown. Bottom, representative IdU tracts 
in DNA2-depleted U-2 OS cells in the presence or absence of HU (out of 2 repeats; n ≥ 700 scored for each dataset). (E, left) Representative DNA fiber 
images. (middle) Quantification of red-green contiguous tracts (restarting forks) after 8 h of HU. Mean shown, n = 3. Error bars, standard error. **, P < 
0.01 (paired Student’s t test). (right) Statistical analysis of CldU tracts detected within contiguous red-green tracts. Whiskers the 10th and 90th percentiles. 
****, P < 0.0001 (Mann-Whitney test).
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Genetic knockdown–rescue experiments confirmed that 
complementation in RECQ1-depleted U-2 OS cells with shRNA-
resistant WT RECQ1 abrogates the effect of RECQ1 depletion 
on replication fork processing upon HU treatment (Fig. 3 F). 
Interestingly, expression of the ATPase-deficient RECQ1 mutant 
K119R in RECQ1-depleted cells also abrogated the effect of 
RECQ1 depletion indicating that the ATPase activity of RECQ1 
was not required for its role in protecting stalled forks from 
DNA2-dependent degradation (Fig. 3 F). These results point to 
an additional role of RECQ1 in protecting replication forks 
from extensive DNA2-dependent degradation, which is inde-
pendent of RECQ1 ATPase activity.
tracts were substantially shorter in RECQ1-depleted cells com-
pared with control when replication forks were stalled with HU 
(after 8 h of HU treatment, the mean tract lengths were 7.9 and 
12.0 µm, respectively; P < 0.0001; Fig. 3, A and B). In agree-
ment with results from luciferase-depleted cells, DNA2 was 
also responsible for the nascent strand degradation phenotype 
observed in RECQ1-deficient U-2 OS cells (Fig. 3 C). Analo-
gous results were obtained using the conditional DNA2 knock-
out HCT116 cell line (Fig. 2 C). In addition, we confirmed that 
the DNA2-dependent nascent strand degradation observed in 
the absence of RECQ1 is not limited to a specific replication in-
hibitor by replacing HU with CPT or MMC (Fig. 3, D and E).
Figure 2. DNA2 processes stalled replication forks. (A, top) DNA2 expression after siRNA knockdown. (bottom) Colony-forming assays in control and 
DNA2-depleted U-2 OS cells treated with 4 mM HU for the indicated time. (B) Representative IdU tracts in DNA2 conditional knockout HCT116 cells (out 
of two repeats). Tamoxifen was added to generate conditional knockout cells (see Materials and methods). (C, left) Expression of DNA2 and RECQ1 in 
tamoxifen-treated HCT116 cells. Right, representative IdU tracts in DNA2 conditional knockout HCT116 cells depleted for Luc or RECQ1 (out of three 
repeats). n ≥ 300 tracts scored for each dataset shown in B and C.
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Figure 3. RECQ1 regulates the DNA2-dependent degradation of stalled forks. (A) Representative IdU tracts in RECQ1-depleted U-2 OS cells during different 
exposure time to HU (out of 2 repeats; n ≥ 350 tracts scored for each dataset). (B) Bar graph represents the mean values of each time point from Figs. 1 C and 2 A. 
(top) RECQ1 expression after shRNA knockdown. (C, D, and E) Representative IdU tracts in RECQ1-, DNA2-, or RECQ1/DNA2-codepleted U-2 OS cells in the 
presence of HU (C), CPT (D), and MMC (E; out of 2 repeats; n ≥ 300 tracts scored for each dataset).(top) RECQ1 and DNA2 expression after shRNA or siRNA 
knockdown. (F) Representative IdU tracts in RECQ1-depleted U-2 OS cells complemented with shRNA-resistant WT RECQ1 (WT) or ATPase-deficient (K119R) 
RECQ1 (out of 2 repeats; n ≥ 325 tracts scored for each dataset). (top) Expression of Flag-tagged RECQ1-WT and RECQ1-K119R in RECQ1-depleted cells.
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part of the WRN:DNA2 complex. Collectively, these results 
suggest that DNA2 cooperates with WRN to promote nascent 
strand processing and fork restart after HU treatment.
The nuclease activity of DNA2  
and the ATPase activity of WRN are 
essential to process stalled replication forks
DNA2 is characterized by an N-terminal nuclease domain and 
by a C-terminal helicase domain, but the function of its helicase 
activity is still debated (Masuda-Sasa et al., 2006). To assess the 
roles of these two activities in stalled fork processing, we per-
formed genetic knockdown-rescue experiments where we de-
pleted DNA2 and then attempted to rescue fork processing by 
expressing a Flag-tagged siRNA resistant WT DNA2 control, 
nuclease-deficient DNA2-D294A, or ATPase-deficient DNA2-
K671E. All the experiments were performed in RECQ1-depleted 
cells, where the effect of DNA2 is more apparent. DNA fiber 
analysis showed that complementation with nuclease-deficient 
DNA2 prevents fork processing, whereas complementation 
with WT or ATPase-deficient DNA2 leads to the same fork pro-
cessing phenotype observed in DNA2-proficient cells (Fig. 5 D 
and Fig. S2 C). Therefore, the nuclease, but not the ATPase ac-
tivity of DNA2, is necessary for fork processing.
Next, we used a Werner Syndrome (WS) fibroblast cell 
line (AG11395) expressing missense mutant forms of WRN, 
which inactivate either the exonuclease (WRN-E84A) or the 
ATPase (K577M) activity of WRN (Pirzio et al., 2008). The 
ATPase, but not the nuclease activity of WRN, was important 
for fork processing (Fig. 5 E and Fig. S2 D). These findings 
were validated by genetic knockdown-rescue experiments where 
we complemented WRN-depleted U-2 OS cells either with 
an shRNA resistant WT WRN control or the ATPase-deficient 
WRN-K577M mutant and found that complementation with 
the ATPase-deficient mutant prevented fork processing (Fig. S2, 
E and F). Collectively, these results show that human DNA2 
needs the support of the ATPase activity of WRN to promote 
degradation of the nascent DNA strands.
DNA2 processes reversed replication forks
To gain insight into the actual replication structures processed 
by DNA2, we inspected the fine architecture of the replication 
intermediates using a combination of in vivo psoralen cross-
linking and EM (Neelsen et al., 2014). Our analysis showed 
a substantial fraction of reversed replication forks (Y24% of 
molecules analyzed) in control U-2 OS cells treated with 4 mM 
HU. RECQ1-depletion, and to an even greater extent DNA2-
depletion, resulted in a higher frequency of fork reversal events 
(Y30 and 40%, respectively) compared with HU-treated cells. 
Co-depletion of RECQ1 and DNA2 further increased the fre-
quency of reversed forks (Y50%), suggesting that RECQ1 and 
DNA2 are involved into two distinct mechanisms of reversed 
fork processing. Interestingly, RECQ1 and/or DNA2 depletion 
also led to a significant amount of fork reversal events in unper-
turbed U-2 OS cells (Fig. 6, A and B). WRN-depletion pheno-
copied DNA2-depletion in terms of reversed fork accumulation, 
both the presence and in the absence of HU. Moreover, DNA2/
DNA2 function in stalled fork processing  
is distinct from EXO1, Mre11, and CtIP
Next, we tested whether other nucleases share a function similar 
to DNA2 in stalled fork processing. To address this point, we 
depleted Mre11, EXO1, and CtIP in U-2 OS cells with siRNA-
mediated technologies. We found that none of these nucleases 
share the same phenotype of DNA2 in RECQ1-proficient cells 
(Fig. 4 A). Furthermore, depletion of these nucleases had only a 
marginal effect on the rescue of the prominent nascent strand 
degradation phenotype observed in the absence of RECQ1, indi-
cating that DNA2 has a unique function in reversed fork pro-
cessing that is not shared by these human nucleases (Fig. 4, B–D). 
MUS81 is another structure-specific nuclease that plays a critical 
role in replication fork rescue by converting stalled replication 
forks into DNA DSBs that can be processed by Homology Di-
rected Repair (HDR) (Hanada et al., 2007; Franchitto et al., 
2008). This raised the possibility that the DNA2-dependent 
degradation originated from the processing of MUS81-dependent 
DSBs. However, MUS81 depletion did not prevent nascent 
strand degradation, indicating that DNA2 is not processing 
stalled replication intermediates that are cleaved by MUS81 
(Fig. 4 E).
DNA2 and WRN act together to process 
stalled replication forks
DNA2-dependent dsDNA-end resection needs the support of 
a RecQ helicase to unwind the DNA from the break (Cejka 
et al., 2010; Niu et al., 2010; Nimonkar et al., 2011). To deter-
mine the identity of the helicase that acts in conjunction with 
DNA2 in stalled fork processing, we measured the extent of na-
scent strand degradation in BLM-, WRN-, and RECQ4-depleted 
U-2 OS cells. Our DNA fiber analysis showed that WRN deple-
tion mimicked the effect of DNA2-depletion, completely abro-
gating the prominent nascent strand degradation phenotype 
observed in RECQ1-depleted U-2 OS cells (Fig. 5 A). The same 
results were confirmed using WRN and DNA2 codepleted cells, 
suggesting that DNA2 and WRN are epistatic in nucleolytic 
processing of stalled forks (Fig. S1 C). The partial nascent 
strand degradation observed in RECQ1-proficient U-2 OS cells 
was also abrogated by WRN depletion (Fig. S1 D). Conversely, 
BLM depletion had only a marginal effect on the nascent strand 
degradation phenotype observed in RECQ1-depleted cells, 
whereas RECQ4 depletion had no effect (Fig. S2, A and B). Thus, 
the WRN helicase plays a prominent role in assisting DNA2-
dependent degradation of stalled replication forks.
We next compared the percentage of restarting replication 
forks in DNA2-depleted, WRN-depleted, and DNA2/WRN-
codepleted cells. WRN depletion leads to a decrease in restart-
ing forks (69 to 50%; P = 0.0068). These results are almost 
identical to those obtained with the DNA2-depleted or DNA2/
WRN-codepleted cells, implying that WRN and DNA2 are 
epistatic also in the restart process (Fig. 5 B). The notion that 
DNA2 and WRN functionally interact to process stalled repli-
cation intermediates is further supported by our observation that 
the two proteins form a complex both in the presence and ab-
sence of replication stress (Fig. 5 C). Of note, RECQ1 is not 
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Figure 4. EXO1, MRE11, CtIP, and MUS81 depletion does not affect stalled fork processing. (A) Statistical analysis of IdU tracts from U-2 OS cells depleted 
for the indicated proteins in the presence of 4 mM HU. (B) Representative IdU tracts in control, RECQ1-, MRE11-, or RECQ1/MRE11-codepleted U-2 
OS cells (out of 2 repeats). (top) Expression of RECQ1 and MRE11 after siRNA knockdown. (C) Representative IdU tracts in control, RECQ1-, EXO1-, or 
RECQ1/EXO1-codepleted U-2 OS cells (out of 2 repeats). (top) Expression of RECQ1 and EXO1 after siRNA knockdown. (D) Representative IdU tracts in 
control, RECQ1-, CtIP-, or RECQ1/CtIP-codepleted U-2 OS cells (out of 2 repeats). (top) Expression of RECQ1 and CtIP after siRNA knockdown. 
(E) Representative IdU tracts in Luc-, RECQ1-, MUS81-, or RECQ1/MUS81-codepleted U-2 OS cells in the presence of HU (out of 2 repeats). (left) Expres-
sion of RECQ1 and MUS81 after shRNA knockdown. n ≥ 300 tracts scored for each dataset shown in A–E.
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Figure 5. DNA2 and WRN are epistatic in stalled fork processing and replication restart. (A) Representative IdU tracts in RECQ1-, WRN-, or RECQ1/
WRN-codepleted U-2 OS cells (out of 2 repeats; n ≥ 300 tracts scored for each dataset). (top) RECQ1 and WRN expression after shRNA knockdown. 
(B) Quantification of restarting forks in DNA2-, WRN-, or DNA2/WRN-codepleted cells. Mean shown, n = 3. Error bars, standard error. *, P < 0.05; 
**, P < 0.01 (paired t test). (top) Expression of WRN and DNA2 after shRNA knockdown. (C) Co-IP experiments in HEK293T cells transfected with empty vec-
tors, Flag-DNA2, or Strep-HA-WRN. Cells were treated with 4 mM HU (3 h) where indicated. Whole-cell extracts were analyzed before (input) and after IP. 
(D) Statistical analysis of IdU tracts from RECQ1/DNA2-codepleted U-2 OS cells complemented with WT, ATPase-deficient (K671E), or nuclease-deficient 
(D294A) DNA2, when indicated. (E) Statistical analysis of IdU tracts from RECQ1-depleted WS cells complemented with WT, ATPase-deficient (K577M), 
or nuclease-deficient (E84A) WRN. Whiskers in D and E indicate the 10th and 90th percentiles. ns, not significant; ****, P < 0.0001 (Mann-Whitney 
test). n ≥ 300 tracts scored for each dataset shown in D and E.
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Figure 6. DNA2 resects reversed replication 
forks. (A) Electron micrograph of a partially 
single-stranded (left) and entirely double-
stranded (right) reversed fork observed on 
genomic DNA upon HU-treatment. The black 
arrow points to the ssDNA region on the re-
versed arm. Inset, magnified four-way junction 
at the reversed replication fork. D, Daughter 
strand; P, Parental strand; R, Reversed arm. 
(B) Frequency of fork reversal and ssDNA 
composition of the reversed arms in RECQ1- 
or DNA2-depleted U-2 OS cells treated with 
HU (left) or in unperturbed conditions (right). 
The percentage values are indicated on the 
top of the bar. “# RI” indicates the number of 
analyzed replication intermediates. Data in B 
are reproduced with very similar results in at 
least one independent experiment.
WRN-codepletion did not cause a further increase in reversed 
fork frequency, thus supporting our conclusion that DNA2 and 
WRN work together in reversed fork processing (Fig. S3 A).
Next, we evaluated the single-strand composition of the 
regressed arms. To measure ssDNA, we carefully inspected 
the frequency and length of ssDNA regions on the regressed 
arms by detecting local difference in filament thickness. 
DNA2 depletion led to a higher frequency of reversed forks 
with a dsDNA arm—and a corresponding decrease of partially 
or entirely single-stranded reversed forks—in both RECQ1-
proficient and deficient cells (Fig. 6). Thus, DNA2-mediated 
resection is directed to completely or partially digest one 
strand of the reversed arm leading to reversed forks that are 
either entirely single stranded or have a protruding ssDNA 
tail. However, prolonged stalling by HU was associated with 
accumulation of postreplicative ssDNA gaps on replicated 
duplexes, which was maximal in RECQ1-depleted cells and 
suppressed by DNA2 depletion (Fig. S3, B and C). Conse-
quently, ssDNA gaps may reflect additional activity of the 
same nucleolytic apparatus along the postreplicated duplexes 
or restart of partially resected reversed forks.
As an alternative readout for DNA2-dependent resection, 
we examined the phosphorylation status of RPA and the check-
point kinase Chk1 (Zeman and Cimprich, 2014). DNA2 deple-
tion caused a reduction in RPA and Chk1 phosphorylation in both 
RECQ1-proficient and RECQ1-deficient U-2 OS cells, suggest-
ing that the DNA2-dependent resection of nascent strands might 
also contribute to checkpoint activation (Fig. S3 D).
RAD51 promotes DNA2-dependent 
degradation of reversed replication forks
The central recombinase factor RAD51 is directly implicated in 
reversed fork formation upon genotoxic stress (Zellweger et al., 
2015). Thus, we investigated whether RAD51 depletion may 
affect the reversed fork processing activity of DNA2. We found 
that RAD51 knockdown largely prevents DNA2 nucleolytic 
processing both in RECQ1 proficient and RECQ1-deficient 
cells (Fig. 7 A). Genetic knockdown–rescue experiments 
confirmed that expression of exogenous RAD51 in RAD51- 
depleted U-2 OS cells restored the fork processing phenotype 
(Fig. 7 B). These results indicate that DNA2-dependent nucleolytic 
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Figure 7. RAD51 promotes DNA2-depedent 
degradation of reversed replication forks.  
(A) Representative IdU tracts in RECQ1-, RAD51-, 
or RECQ1/RAD51-codepleted U-2 OS cells 
(out of 2 repeats). Above, RECQ1 and RAD51 
expression after siRNA knockdown RAD51-
WT are U-2 OS cells stably expressing siRNA 
resistant exogenous RAD51. (B) Representa-
tive IdU tracts in U-2 OS cells expressing exog-
enous RAD51 (out of 2 repeats). n ≥ 300 tracts 
scored for each dataset shown in A and B.
processing is specifically targeted to reversed fork structures 
because it is not detected in a genetic background that prevents 
reversed fork formation—i.e., RAD51 knockdown.
DNA2 preferentially degrades reversed 
fork structures with a 5-to-3 polarity
The notion that DNA2 end resection has a preferential polarity 
in vivo is consistent with biochemical studies showing that even 
though DNA2 has the intrinsic capacity to degrade both 5- and 
3-terminated ssDNA, RPA enforces a primarily 5-to-3 end-
resection bias (Cejka et al., 2010; Niu et al., 2010; Nimonkar et al., 
2011). Thus, we set up new biochemical assays to test whether 
human DNA2 prefers four-way junction substrates—i.e., re-
versed replication forks—versus linear DNA duplexes and 
whether it degrades these substrates with a 5-to-3 polarity in 
the presence of RPA (Fig. 8, A and B). The sequences of the 
four arms of the four-way junction substrates are mutually 
heterologous to prevent four-way junction branch migration. 
DNA2-degraded four-way junction substrates more efficiently 
than linear dsDNA duplexes, with 20 nM DNA2 required to de-
grade Y60% of the four-way junction substrates versus only 
Y30% of the linear duplex (Fig. 8 C). Importantly, supplement-
ing the reaction with RPA greatly stimulated the degradation 
activity of human DNA2 (Fig. 8 D and Fig. S4 A). Additional 
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Figure 8. Human DNA2 preferentially degrades branched 
DNA in a 5-3 direction in reactions stimulated by WRN. 
(A) Degradation of a four-way junction by human DNA2 
(hDNA2) in the presence of hRPA (native 6% polyacryl-
amide gel) (B) Experiment as in A, but with dsDNA. 
(C) Quantitation of data from A and B. Averages shown ± 
SEM; n = 2. (D) DNA degradation is stimulated by 
hRPA. The data points from +hRPA condition are the 
same as in C. Averages shown ± SEM; n = 2. (E) Quan-
titation of degradation of a 3 or 5 ssDNA-tailed three-
way junction by hDNA2. The reactions were performed in 
3 mM magnesium acetate and 22.3 nM hRPA. Averages 
shown ± SEM; n = 2. (F) Kinetics of degradation of a four-
way junction by hDNA2 (9 nM) in the presence of hRPA 
(denaturing 20% polyacrylamide gel). The substrate was 
labeled at the 5 end (*). D294A, nuclease-dead variant 
of hDNA2. (G) Experiment as in F, but using a four-way 
junction labeled at the 3 end. (H) Quantitation of DNA 
cleavage near (less than 15 nt) a 5 or 3 DNA end from 
experiments of F and G. Averages shown ± SEM; n = 2. 
(I) WRN and hDNA2 degrade four-way junction DNA in a 
synergistic manner. Reactions with indicated hDNA2 
and/or WRN concentrations and 65 nM hRPA were ana-
lyzed on a 6% native polyacrylamide gel. Heat, partially 
heated DNA substrate indicating the positions of DNA 
unwinding intermediates. (J) Quantitation of four-way junc-
tion and dsDNA degradation by human EXO1 (hEXO1). 
Averages shown ± SEM; n = 2.
experiments using either 5-end or 3-end 32P-labeled four-way 
junctions confirmed that human DNA2 had a strong 5-to-3 
bias in end resection in the presence of RPA (Fig. 8, E–H; and 
Fig. S4, B and C). Catalytically dead DNA2 D294A had no 
capacity to degrade DNA, showing that the nuclease activity 
is inherent to WT DNA2 (Fig. 8 F). The same results were 
recapitulated using purified yeast DNA2 (Fig. S5, A–F). Inter-
estingly, addition of the ATPase-deficient RECQ1 mutant 
(RECQ1-K119R) to the reaction mix significantly inhibited 
the four-way junction degradation activity of human DNA2 
(Fig. S4, D and E). These results suggest that the binding of 
RECQ1 to stalled replication forks limits the fork processing 
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DNA2 function during DNA replication is vital for main-
tenance of genome stability (this study; Duxin et al., 2012; 
Karanja et al., 2012). These findings indicate that the controlled 
DNA2-dependent degradation of reversed replication forks is a 
physiologically relevant mechanism to provide resistance to 
prolonged genotoxic treatments. This mechanism is distinct 
from the pathological MRE11-dependent degradation of stalled 
replication intermediates detected in the absence of crucial 
Fanconi Anemia (FA)/HR factors (Schlacher et al., 2011, 2012; 
Hashimoto et al., 2012; Ying et al., 2012).
We find that depletion of the central recombinase factor 
RAD51 prevents nascent strand degradation. This finding, coupled 
with the recent observation that RAD51 is directly implicated in 
reversed fork formation (Zellweger et al., 2015), reinforce our con-
clusion that the DNA2-dependent pathway starts from the reversed 
arm of stalled replication forks and acts downstream of the 
RAD51-mediated replication fork reversal. Given that RAD51 is 
required for reversed fork formation (Zellweger et al., 2015), we 
speculate that the MRE11-dependent pathway is only uncovered in 
the absence of fork reversal—i.e., via a perturbation in RAD51 
function—and likely attacks unprotected and nonreversed forks 
upon prolonged stalling. A crucial challenge for future studies will 
be to investigate why we do not observe a contribution of the 
MRE11 pathway in nascent strand degradation upon RAD51 
depletion. It is tempting to speculate that RAD51 depletion might 
interfere with MRE11-dependent fork processing, in addition to 
preventing fork reversal. Conversely, perturbation of RAD51 
function—e.g., via BRCA2 depletion (Schlacher et al., 2011)—
might be sufficient to prevent fork reversal—hence DNA2- 
dependent degradation—but still allow residual RAD51 loading 
to promote MRE11-dependent degradation.
Our DNA fiber analysis suggests that DNA2 degrades 
stalled replication intermediates beyond the maximum length 
of the reversed arms measured by EM (up to several kilobases). 
A possible interpretation of these results is that after the initial 
DNA2/WRN-mediated regressed arm degradation is complete, 
other nucleolytic activities or DNA2 itself may codegrade both 
sides of the replication fork, thus leading to extensive degra-
dation events detectable by DNA fibers. In this scenario, our 
EM images likely represent snapshots of the “slow steps” of 
this reaction—i.e., the DNA2/WRN-mediated degradation of 
the regressed arms—resulting in the drastic increase in reversed 
fork frequency observed in the absence of DNA2. Once the 
regressed arm has been resolved, the nucleolytic degradation 
might quickly proceed to degrade nascent strands behind the 
junction—as suggested by the DNA2-dependent increase in 
ssDNA gaps behind the observed forks—finally leading to re-
annealing of the parental strands and backtracking of the fork 
(Fig. S3 E). A new reversal event may occur when this extensive 
degradation leads to asymmetric ssDNA accumulation at the fork 
(Zellweger et al., 2015), resetting the backtracked fork to the slow 
step of the process. However, fork backtracking is only one possi-
ble model to explain the extensive degradation detected by DNA 
fibers and further work would be required to uncover additional 
nucleolytic activities that might be involved in this process.
Biochemical studies suggested that Schizosaccharomyces 
pombe Dna2 cleaves the leading and lagging reversed strands of 
activity of DNA2, as inferred by our cellular studies. However, 
we cannot rule out the possibility that the inhibitory effect ob-
served in the biochemical assays is simply associated with com-
petition for substrate recognition between the two proteins. In 
agreement with our in vivo data, we show that WRN promoted 
the degradative capacity of DNA2 on nicked, gapped, or four-
way junction substrates (Fig. 8 I and Fig. S4, F and G); similar 
behavior was observed when yeast Dna2 was coupled with the 
Sgs1 helicase (Fig. S5, G and H). DNA was degraded by WRN 
and DNA2 in a remarkably synergistic manner: 5 nM concen-
tration of either WRN or DNA2 alone led only to a minor DNA 
unwinding/degradation (Fig. 8 I, lanes 2 and 8). When com-
bined, both enzymes completely degraded the four-way junc-
tion DNA (Fig. 8 I, lane 5). In contrast, no such synergy was 
observed when human DNA2 was combined with the noncog-
nate yeast meiotic Mer3 helicase (Fig. S4 H), suggesting that 
the species-specific interaction between DNA2 and WRN re-
sults in a vigorous DNA degradation. Similarly, WT RECQ1 
did not promote DNA degradation by DNA2 (Fig. S4 I).
On the basis of our results that DNA2 does not share the 
same function of EXO1 in reversed fork processing, we decided to 
compare the end-resection activities of human DNA2 and human 
EXO1 using the four-way junction substrates. EXO1—unlike 
DNA2—degraded both four-way junction substrates and linear 
duplexes with equal efficiency (Fig. 8 J and Fig. S4, J and K). The 
use of yeast variants of Dna2 and Exo1 yielded analogous results 
(Fig. S5, I–K). Collectively, these studies further implicate DNA2, 
and its nuclease activity, in reversed replication fork degradation—
that is specifically stimulated by WRN—and point to an important 
difference in substrate preference between DNA2 and EXO1. 
Moreover, the polarity of reversed fork degradation by DNA2 
measured in the presence of RPA displays the same bias antici-
pated from the EM analysis of the replication intermediates.
Discussion
The present work uncovers a new mechanism for reversed fork 
processing and restart that requires the coordinated activities of 
the human DNA2 nuclease and WRN helicase (Fig. 9). The 
DNA2-dependent end resection leads to partially single-stranded 
reversed forks and is required for efficient replication fork re-
start under conditions of persistent replication blockage. WRN 
interacts with DNA2 and its ATPase activity is needed for 
DNA2-dependent degradation, presumably to transiently open 
the dsDNA arm of the reversed replication forks.
To date, we have identified two mechanisms of reversed 
replication fork resolution, one dependent on RECQ1 ATPase 
and branch migration activity (Berti et al., 2013) and the other on 
DNA2 nuclease and WRN ATPase activity. Moreover, the DNA2/
WRN mechanism is tightly regulated by an ATPase-independent 
function of RECQ1 that might limit DNA2 activity by binding to 
reversed forks. Of note, our EM experiments show that reversed 
replication forks accumulate in RECQ1- and DNA2-depleted 
cells also in unperturbed conditions suggesting that fork reversal 
is remarkably frequent when DNA replication faces intrinsic rep-
lication fork obstacles, and that RECQ1 and DNA2 have a con-
served role in restarting reversed forks in unperturbed S-phase.
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depletion is consistent with observations that the deregulation 
of checkpoint activity leads to a large increase in the number of 
newly initiated origins (Couch et al., 2013). However, the extent 
of ATR activation does not necessarily reflect the amount of 
ssDNA detected at replication forks, whether at the junction, at 
ssDNA gaps, or at regressed arms (Zellweger et al., 2015). In 
light of these findings, we rather suggest that DNA2-dependent 
ATR activation may reflect DNA2 recruitment to the stalled 
forks per se, or subtle changes of fork architecture that are asso-
ciated with its recruitment but possibly escape our EM analysis. 
This interpretation is supported by the recent discovery that 
yeast Dna2 has a direct role in Mec1 activation (the ortholog of 
human ATR), independent from its nuclease or helicase activity 
(Kumar and Burgers, 2013). Of note, the increased origin firing 
frequency observed upon DNA2 depletion is not associated to a 
parallel increase in the frequency of termination events (Fig. S1 A) 
possibly because the defects in replication fork restart associated 
a model replication fork with similar efficiency in the absence of 
replication protein A (Hu et al., 2012). However, it is likely that 
only the 5-to-3 directionality is important in vivo, because RPA 
is known to stimulate the 5-to-3 and inhibit the 3-to-5 nuclease 
activity of yeast DNA2 (Cejka et al., 2010; Niu et al., 2010). In 
agreement with this conclusion, our biochemical data show that 
DNA2-dependent end resection proceeds with a 5 to 3 polarity 
in the presence of RPA. Moreover, our EM experiments clearly 
show that DNA2 depletion affects the frequency of reversed forks 
that are either entirely or partially single-stranded supporting the 
notion that DNA2-dependent degradation of reversed forks oc-
curs with a preferential polarity in vivo.
The resection activity of human DNA2 was postulated to 
activate the ATR/Chk1 checkpoint under conditions of replica-
tion stress (Karanja et al., 2012). Indeed, we find that DNA2 de-
pletion prevents ATR checkpoint activation after HU treatment. 
Moreover, the increased origin firing observed upon DNA2 
Figure 9. Schematic model for the combined 
roles of DNA2 and WRN in reversed fork pro-
cessing. DNA2 and WRN functionally interact 
to process reversed forks. DNA2 degrades 
reversed forks with a 5-to-3 polarity. WRN 
ATPase activity assists DNA2 degradation pos-
sibly by promoting the opening of the reversed 
arm of the fork. RECQ1 limits DNA2 activity 
by an ATPase-independent function. Branch 
migration factors specifically recognize the 
partially resected reversed forks to promote 
fork restart. Alternatively, the newly formed 3  
overhang of the reversed fork invades the 
duplex ahead of the fork, resulting in Holliday 
junction structures that can be resolved by spe-
cific resolvases or dissolvases to promote fork 
restart. Gray box, RECQ1 can independently 
restart reversed forks by virtue of its ATPase 
and branch migration activity.
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specific genetic backgrounds. For example, MRE11 degrades 
stalled replication intermediates only in a BRCA2-deficent back-
ground, as already discussed (Schlacher et al., 2011). Moreover, 
the cleavage of unresolved replicative intermediates by the 
structure-specific MUS81 endonuclease is a late response to 
replicative stress, which becomes activated only when other 
attempts to overcome stalled replication have been exhausted 
(Hanada et al., 2007; Franchitto et al., 2008). Thus, MUS81 
might still resolve reversed replication forks as a back-up sys-
tem to unlink sister chromatids and facilitate mitotic segregation 
in the absence of DNA2 or WRN.
Collectively, these studies highlight a new important 
mechanism for the recovery from replication blockage. This 
mechanism relies on the DNA2-dependent processing of re-
versed forks—leading to ssDNA stretches on the regressed 
arms—which appear to promote efficient fork restart. A possi-
ble explanation for the need of partially single-stranded DNA 
structures to promote fork restart is that they represent a key in-
termediate to activate an HDR-like mechanism of reversed fork 
restart, as recently proposed in S. pombe (Carr and Lambert, 
2013). In particular, the newly formed 3 overhang of the re-
versed fork might invade the duplex ahead of the fork resulting 
in Holliday junction structures that can be resolved by specific 
resolvases or dissolved by the combined action of the BLM 
helicase (Sgs1 in yeast) and the type I topoisomerase TOP3 
(Fig. 9). Alternatively, resumption of DNA replication might be 
obtained by reverse branch migration, where the partially re-
sected reversed fork structures might be specifically recognized 
by a motor protein—e.g., SMARCAL1 (Béous et al., 2013) or a 
human RecQ helicase—to promote the branch migration-assisted 
reestablishment of a functional replication fork.
Materials and methods
Cell lines, culture conditions, and reagents
U-2 OS, HEK 293, and Werner Syndrome fibroblast (AG11395) cells were 
grown in DMEM supplemented with 10% FBS at 37°C in 5% CO2. HCT116 
cells were grown in McCoy’s 5A medium supplemented with 10% FBS. 
CldU, IdU, BrdU, hydroxyurea, mitomycin C, camptothecin, tamoxifen, pu-
romycin, and hygromycin were obtained from Sigma-Aldrich.
DNA2 conditional knockout HCT116 cells
To examine the response of cells to the complete absence of DNA2, we used 
a DNA2 conditional knockout cell line where exon 2 of the DNA2 gene is 
deleted (Karanja et al., 2014). The colorectal carcinoma HCT116 cell line 
carries 3 copies of DNA2 due to a duplication on chromosome 10. Two 
chromosomal copies were disrupted using rAAV-mediated gene targeting 
technology and exon 2 of the third allele was replaced with a conditional 
exon where the exon was flanked by loxP sites (DNA2flox//). To create 
a conditional cell line these cells were stably transduced with a tamoxifen 
(4-OHT)-inducible Cre recombinase. Thus, the cell line is viable and can be 
propagated. The addition of tamoxifen to the culture media leads to excision 
of the endogenous DNA2 and the generation of a true DNA2-null cell. Com-
plete loss of DNA2 occurs after 72 h of tamoxifen treatment. However, the 
DNA fiber experiments were performed after 40 h of tamoxifen treatment to 
have enough S-phase cells for DNA labeling.
Antibodies
Anti-DNA2 rabbit polyclonal (ab96488; 1:1,000), anti-MUS81 mouse 
monoclonal (ab14387; 1:1,000), and anti-CldU/BrdU rat monoclonal 
(ab6326; 1:6) antibodies (all from Abcam); anti-CtIP rabbit polyclonal 
(A300-488A; 1:1,000), anti-EXO1 rabbit polyclonal (A302-639A; 
1:1,000), anti-pRPA32 (S4/S8) rabbit polyclonal (A300-245A; 1:1,000), 
and anti-pRPA32 (S33) rabbit polyclonal (300-246A; 1:2,000; all from 
with DNA2 depletion limit the number of termination events 
even under conditions of increased origin firing.
WRN plays an important—albeit mechanistically ill- 
defined—role in the recovery from replication blockage, and 
mutations in the WRN gene are linked to the cancer predisposi-
tion disorder Werner Syndrome (Sidorova et al., 2008; Murfuni 
et al., 2012). Our studies infer that the high genomic instability 
of WRN-deficient cells may result from aberrant processing of 
reversed replication intermediates. In particular, given the con-
solidated role of WRN at difficult-to-replicate regions—e.g., 
telomeres and fragile sites (Crabbe et al., 2004; Murfuni et al., 
2012)—we speculate that WRN, in conjunction with DNA2, is 
required to process reversed forks arising spontaneously at 
these genomic loci. Biochemical studies pointed to a putative 
role of WRN in fork reversal and/or restart by showing that 
WRN efficiently promotes both the formation and restoration 
of oligonucleotide-based reversed fork substrates (Machwe 
et al., 2011). We show that WRN ATPase activity is needed for 
the DNA2-dependent degradation of reversed replication forks. 
Our interpretation for the role of WRN ATPase activity is that 
it facilitates DNA2-dependent degradation of the reversed forks 
by transiently opening the dsDNA arm of the reversed fork. 
This mechanism is reminiscent to the DNA2-dependent mecha-
nism of DSB resection where the yeast Sgs1 helicase is required 
to transiently open the DNA duplex to generate a 5 ssDNA tail 
that is in turn degraded by DNA2 (Zhu et al., 2008; Cejka et al., 
2010; Niu et al., 2010). We suggest that WRN is the functional 
homologue of Sgs1 in mammalian cells, at least in the context 
of DNA2-dependent reversed replication fork processing. How-
ever, BLM was also shown to interact and cooperate with DNA2 
to resect dsDNA ends in vitro opening the possibility that other 
human RecQ helicases might substitute for WRN, depending 
on the nature of the DNA lesion being processed or the particu-
lar cellular context (Nimonkar et al., 2011; Sturzenegger et al., 
2014). This mechanism seems to be well-conserved throughout 
evolution because it is highly reminiscent of the stalled fork 
processing pathway described in E. coli where the RecJ nucle-
ase cooperates with bacterial RecQ to process blocked replication 
intermediates (Courcelle et al., 2003). In addition, the prokary-
otic RecBCD helicase-nuclease plays an important role in re-
secting replication forks after reversal (Seigneur et al., 1998) 
and DNA2 is of the same family of nucleases as RecB. Whether 
the DNA2/WRN-mediated resection activity can degrade addi-
tional stalled replication intermediates other than reversed forks 
is worth future investigation.
EXO1, MRE11, and CtIP play central roles in DNA repair 
and are also implicated in the recovery from replication fork 
blockage (Cotta-Ramusino et al., 2005; Schlacher et al., 2011; 
Yeo et al., 2014). None of these nucleases, however, partici-
pates in the DNA2-dependent processing of reversed replica-
tion forks pointing to a specific role of DNA2 that, unlike 
its function in DSB resection, is not shared by other nucleases. 
A possible interpretation of these results is that the reversed 
forks are characterized by a particular structure of the terminal 
end that does not require the trimming activity of other nucle-
ases to promote DNA2-dependent resection. However, some of 
these nucleases might still be able to access stalled forks under 
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were kind gifts from Dr. Pietro Pichierri (Insituto Superiore di Sanità, Rome, 
Italy). All transfections were done with Lipofectamine 2000 (Life technolo-
gies Catalog no: 11668027). An shRNA targeting luciferase (5-ACGCT-
GAGTACTTCGAAATGT-3) was used for control shRNA experiments. The 
silencer select negative control (Life technologies, Catalog no. 4390843) or 
an siRNA targeting luciferase (5-CGUACGCGGAAUACUUCGA-3) were 
used for control siRNA experiments, as indicated. Lentiviral mediated shRNA 
depletions were achieved using the following sequences cloned into the 
pLKO.1 lentiviral shRNA expression vector: BLM (5-CGAAGGAAGTTGTAT-
GCACTA-3), WRN (5-GCTGGCAATTACCAGAACAAT-3), and MUS81 
(5-CACGCGCTTCGTATTTCAGAA-3). The procedure for lentiviral genera-
tion and transduction has been described (Berti et al., 2013). Transduced U-2 
OS cells were selected with 6 µg/ml puromycin. siRNA-mediated depletions 
were achieved using the following siRNAs from Invitrogen: DNA2 (5-AUA-
GCCAGUAGUAUUCGAU-3), CtIP (5-CGAAUCUUAGAUGCACAAA-3), 
EXO1 (Invitrogen-HSS113557), and RAD51 (Invitrogen-1299001). In brief, 
siRNAs were transfected using Lipofectamine RNAiMAX (Life Technologies) 
following the manufacturer’s protocol. MRE11 (5-GAAAGGCUCUAUC-
GAAUGU-3) and RECQ4 (SMART pool) siRNAs were from Dharmacon 
and were transfected as previously described (Thangavel et al., 2010).
Microfluidic-assisted DNA fiber stretching
For DNA replication fork restart analysis, asynchronous cells were pulse-
labeled with 50 µM CldU for 20–30 min. 2 mM HU, 300 nM MMC, or 
150 nM CPT was added to the CldU containing media and incubated for the 
indicated times. Cells were washed three times with medium and released 
with 50 µM IdU for 40 min. For nascent strand degradation analysis, asyn-
chronous cells were pulse-labeled with 50 µM IdU for 45 min, washed 
three times with medium, incubated with 4 mM HU, 100 nM CPT, 200 nM 
MMC, or medium for times indicated. The pulse-labeled cells were trypsin 
collected and lysed in agarose plugs to prevent any mechanical breakage 
of replication tracts. Microfluidic platform for stretching the high-molecular 
weight DNA, coverslips, immunostaining and image acquisition of replica-
tion tracts were performed as described (Sidorova et al., 2009; Berti et al., 
2013). In brief, polydimethylsiloxane (PDMS) stamps with microchannels 
were Oxygen plasma treated and reversibly sealed to the silanized cover-
slips. High-molecular weight DNA was loaded and stretched by capillary 
force into the microchannels. PDMS stamps were peeled-off and coverslips 
were left drying overnight. For immunostaining, DNA-stretched coverslips 
were denatured (2.5N HCL for 45 min), neutralized (0.1 M sodium borate 
and 3 washes with PBS), blocked (5% BSA and 0.5% Tween 20 in PBS for 
30 min), incubated with primary antibodies (Anti-IdU/BrdU or both anti-
IdU/BrdU and anti-CldU/BrdU for 30 min), washed (1% BSA and 0.1% 
Tween 20 in PBS, 3 times 5 min each) and incubated with secondary anti-
bodies (anti–mouse Alexa Fluor 488-conjugated, or both anti–mouse Alexa 
Fluor 488–conjugated and anti–rat Alexa Fluor 594–conjugated for 1 h). 
Washed slides were mounted in prolong gold anti-fade reagent (Life Tech-
nologies) and images were sequentially acquired (for double-label) with 
LAS AF software using TCS SP5 confocal microscope (Leica). A 63×/1.4 
oil immersion objective was used. Images were captured at room tempera-
ture. n ≥ 300 fiber tracts scored for each dataset. The DNA tract lengths 
were measured using ImageJ and the pixel length values were converted 
into micrometers using the scale bars created by the microscope. Statistical 
analysis was done using GraphPad Prism.
Clonogenic survival assay
Colony-forming assays were performed as previously described (Franken 
et al., 2006). In brief, 1,000 cells were plated per well and treated on the 
next day with 4 mM HU for 3, 6, and 8 h or 100 nM CPT for 6 h. Colonies 
were fixed, stained, and quantified 10 d after release from genotoxic stress. 
The plating efficiency and survival fraction were calculated as previously 
described (Franken et al., 2006). In brief, colonies were counted using an 
inverted stereomicroscope and the plating efficiency was calculated using 
the following formula: Plating Efficiency (PE) = (no. of colonies formed/no. of 
cells seeded) × 100%. From the plating efficiency, the surviving fraction (SF) 
was calculated as: SF = (no. of colonies formed after treatment/no. of cells 
seeded) × PE. The experiments were performed in triplicate and the statistical 
analysis was performed using GraphPad Prism.
Western blotting
Cells were washed with PBS and lysed either in standard RIPA buffer (PBS, 
1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 10 µg/ml aprotinin, 
10 µg/ml PMSF, 1 mM Na3VO4, and 1 mM NaF) or MCL buffer (50 mM 
Tris, pH 8.0, 5 mM EDTA, 0.5% NP-40, 100 mM NaCl, 2 mM DTT, and 
freshly added protease and phosphatase inhibitors from Roche (1 tablet/10 ml 
of buffer). Cell lysates were resolved by SDS-PAGE and transferred to 
Bethyl); anti-WRN rabbit polyclonal (NB100-471; 1:1,000); and anti-
MRE11 rabbit polyclonal (NB100-142; 1:2,000; Novus); anti-RAD51 (H-92) 
rabbit polyclonal (sc-8349; 1:1,000) and anti-RECQ1 rabbit polyclonal 
(sc-25547; 1:2,000) from Santa Cruz; anti-rat Alexa (594-A11007; 
1:1,000); and anti–mouse Alexa Flour (488-A11001; 1:1,000; Invitro-
gen); anti-rabbit (31460; 1:10,000; Thermo Fisher Scientific); anti-tubulin 
mouse monoclonal (T5168; 1:5,000; Sigma-Aldrich); anti-IdU/BrdU 
mouse monoclonal (347580; 1:6) from BD; anti-Chk1 mouse monoclonal 
(sc-8408; 1:1,000; Santa Cruz Biotechnology, Inc.); anti-p-Chk1 (S345) 
rabbit monoclonal (2348; 1:1,000; Cell Signaling Technology); anti-RPA32 
mouse monoclonal (NA19L; 1:1,000) from EMD Millipore; anti-RECQ1 
rabbit polyclonal, raised against residues 634–649 of human RECQ1, is 
custom made (Mendoza-Maldonado et al., 2011); anti-BLM rabbit poly-
clonal, raised against residues 1–449 of human BLM (Wu and Hickson, 
2003), was a gift from I. Hickson (University of Copenhagen, Copenha-
gen, Denmark); and anti-RECQ4 rabbit polyclonal, raised against residues 
60–111 of human RECQ4 (Yin et al., 2004), was a gift from W. Wang 
(National Institute on Aging, Baltimore, MD).
Recombinant proteins
Yeast Dna2 was expressed in yeast WDH668 strain from pGAL:DNA2 
vector (Budd et al., 2000) and purified as previously described (Levikova 
et al., 2013). In brief, the cells were lysed and Dna2 was purified by 
affinity chromatography on Ni-NTA agarose (QIAGEN) and anti-Flag M2 
affinity gel (Sigma-Aldrich). Yeast RPA was expressed in yeast BJ5464 
strain containing three plasmids coding for Rfa1, Rfa2, and Rfa3 and 
purified as previously described (Kantake et al., 2003). In brief, the cells 
were lysed and yeast RPA was purified by affinity on ssDNA cellulose 
column (USB corporation) and by ion exchange chromatography using 
HiTrap Q column (GE Healthcare). Human DNA2 was expressed in Sf9 
cells from a pFastBac:hDNA2 vector (polyhedrin promoter) provided by 
J. Campbell (Masuda-Sasa et al., 2006). The soluble extracts were obtained 
by salt extraction as previously described for Sgs1 (Cejka and Kowalc-
zykowski, 2010). The subsequent purification of hDNA2 was performed 
as previously described for yeast Dna2 (Levikova et al., 2013) by affinity 
chromatography using Ni-NTA agarose (QIAGEN) and Anti-Flag M2 
affinity gel (Sigma-Aldrich). Human RPA was expressed from p11d-tRPA 
vector (Henricksen et al., 1994) in BL21 E. coli cells and purified as 
described (Henricksen et al., 1994). In brief, hRPA was first bound to 
HiTrap Blue column (GE healthcare) and then to HiTrap Q column. The 
sequence coding for yeast Mer3 helicase was amplified from yeast genomic 
DNA (SK1 strain) using primers Mer3FO (5-GCGCGCGGGCCCATGAAAA-
CAAAGTTTGATCGCCTCGGTACAGGAAAAAGAAGTAGACCCTCTC-
CAAATAATATTGACTTTAACGACCAG-3) and Mer3RE (5-CGCGCGCTC-
GAGTTCAAACTCTATATCGGAAC-3). The PCR product was digested 
with ApaI and XhoI restriction endonucleases (both from New England 
Biolabs) and cloned into corresponding sites in pFB-MBP-Sgs1-his after the 
polyhedrin promoter, creating pFB-MBP-Mer3-his vector. Mer3 was then 
expressed in Sf9 cells and purified using affinity chromatography as 
previously described for Sgs1 (Cejka and Kowalczykowski, 2010). In 
brief, MBP-tagged Mer3 was first bound to amylose resin (New England 
Biolabs), eluted and digested with PreScission protease to cleave the MBP 
tag. Mer3 was further purified by affinity on Ni-NTA agarose (QIAGEN) 
exploiting the 10x His-tag at its C-terminus. Sequence information is available 
on request.
Genetic knock-down-rescue experiments
RECQ1, DNA2, and RAD51 genetic knockdown-rescue experiments were 
performed using the procedure described (Berti et al., 2013; Yata et al., 
2012). In brief, RECQ1 is depleted using the pLKO.1-puro-shRECQ1 (5-GAG-
CTTATGTTACCAGTTA-3) construct and rescue experiments are performed 
using the shRNA resistant pIRES-RECQ1-WT or K119R (ATPase dead) con-
structs as described (Berti et al., 2013). DNA2 is depleted using an siRNA 
targeting the 3UTR of DNA2 (5-CAGUAUCUCCUCUAGCUAG-3). At 
least one isoform of DNA2 is not targeted by this sequence. DNA2 rescue 
experiments are performed using the pBabe-hygro-3xFLAG-DNA2 WT, 
D294A (Nuclease dead), or K671E (helicase dead) constructs. RAD51 
is depleted using siRNAs targeting the 3UTR (5-GACUGCCAGGAU-
AAAGCUU-3 and 5-GUGCUGCAGCCUAAUGAGA-3) in U-2 OS stable 
cell lines expressing WT RAD51 as described (Yata et al., 2012). WRN 
depletions were achieved using pRS-puro-shWRN (5-AGGCAGGTGTAG-
GAATTGAAGGAGATCAG-3; sequence ID: TI333414) and exogenous 
expression is done with the shRNA resistant Flag-pCMVTag2B-WRN WT 
or K577M (helicase dead) constructs. Constructs for WRN depletion and 
overexpression of WT WRN and ATPase-deficient WRN (WRN-K577M) 
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pyruvate kinase, 1 nM DNA substrate (molecules), and recombinant pro-
teins, as indicated. The reactions were assembled on ice and incubated 
for 30 min at 30°C for yeast proteins and at 37°C for human proteins. Un-
less indicated otherwise, RPA was present in the reactions at saturating 
concentrations corresponding to a threefold excess over DNA, assuming 
all DNA was single-stranded and a DNA-binding site size of 25 nt for 
hRPA and of 20 nt for yRPA. The reactions were terminated by adding 5 µl 
Stop buffer (150 mM EDTA, 2% SDS, 30% glycerol, and 0.01% bromo-
phenol blue), incubated for 30 min at room temperature and separated on 
polyacrylamide gels in TBE buffer under native conditions. Alternatively, 
for denaturing conditions, the reaction were terminated by adding 15 µl 
Formamide stop buffer (95% (vol/vol) formamide, 20 mM EDTA, 0.01% 
bromophenol blue), denatured by heating at 95°C for 5 min and sepa-
rated on 20% denaturing polyacrylamide gels in TBE buffer. Gels were 
fixed, dried, exposed to a storage phosphor screen, and analyzed on 
Typhoon phosphor imager (GE Healthcare).
Online supplemental material
Fig. S1 shows quantification of stalled forks, new origins, and termination 
events in DNA2-depleted cells upon genotoxic stress induction, as well as 
the statistical analysis of IdU tracts from RECQ1-, DNA2-, WRN-, RECQ1/
DNA2-, RECQ1/WRN-, WRN/DNA2-, and RECQ1/WRN/DNA2-depleted 
U-2 OS cells. Fig. S2 shows the IdU tract length distribution in BLM- and 
RECQ4-depleted cells, respectively, as well as statistical analysis of IdU 
tracts from RECQ1/WRN-codepleted cells complemented with WT WRN 
or with ATPase-deficient WRN. Fig. S3 shows additional EM analysis, as 
well as the Western blot analysis of ATR-checkpoint activation in RECQ1- 
and/or DNA2-depleted U-2 OS cells. Fig. S4 shows additional biochemi-
cal analysis of substrate specificity of human DNA2 and human EXO1. 
TFig. S5 shows biochemical assays of substrate specificity of yeast Dna2 
and yeast Exo1. Online supplemental material is available at http://www 
.jcb.org/cgi/content/full/jcb.201406100/DC1.
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PVDF membrane (GE Healthcare). Incubation with antibodies was per-
formed overnight at 4°C. Proteins were visualized using ECL (Thermo 
Fisher Scientific) according to the manufacturer’s instructions.
Co-immunoprecipitation experiments
HEK293T cells were transfected with empty vectors, FLAG-DNA2, and Strep-
HA-WRN by calcium phosphate. 48 h after transfection, cells were treated 
with 4 mM HU for 3 h, lysed in benzonase lysis buffer (50 mM Tris-HCl, 
pH 7.5, 75 mM KCl, 2 mM MgCl2, 20 mM NaF, 10 mM B-glycerophosphate, 
0.2 mM Na3VO4, and 0.2% Triton X-100) supplemented with protease in-
hibitors (EDTA-free tablet; Sigma-Aldrich) by passing 10 times through a 
26-G syringe needle and incubated 1 h at 4°C with 2 U/µl Benzonase 
(Sigma-Aldrich) to digest genomic DNA. KCl and EDTA concentrations were 
adjusted to 120 and 3 mM, respectively, and lysates were centrifuged at 
14,000 rpm for 30 min. Immunoprecipitations of clarified lysates were per-
formed with FLAG M2 or HA affinity agarose resin (Sigma-Aldrich) overnight 
at 4°C. Beads were washed 5 times with wash buffer (50 mM Tris-HCl, 
pH 7.5, 150 mM KCl, 3 mM EDTA, 2 mM MgCl2, 20 mM NaF, 10 mM 
B-glycerophosphate, 0.2 mM Na3VO4, and 0.2% Triton X-100) and bound 
proteins were eluted by boiling in SDS-PAGE sample buffer.
EM analysis of genomic DNA in mammalian cells
EM analysis of replication intermediates has been described in detail (Ray 
Chaudhuri et al., 2012; Neelsen et al., 2014), including a description of the 
important parameters to consider specifically for the identification and the 
scoring of reversed forks (Neelsen et al., 2014). In brief, 5–10 × 106 U-2 
OS cells were harvested and genomic DNA was cross-linked by two rounds 
of incubation in 10 µg/ml 4,5,8-trimethylpsoralen (Sigma-Aldrich) and 
3 min of irradiation with 366 nm UV light on a precooled metal block. Cells 
were lysed and genomic DNA was isolated from the nuclei by proteinase K 
(Roche) digestion and phenol-chloroform extraction. DNA was purified by 
isopropanol precipitation, digested with PvuII HF in the proper buffer for 3–5 h 
at 37°C, and replication intermediates were enriched on a benzoylated 
naphthoylated DEAE–cellulose (Sigma-Aldrich) column. EM samples were 
prepared by spreading the DNA on carbon-coated grids in the presence of 
benzyl-dimethyl-alkylammonium chloride and visualized by platinum rotary 
shadowing. Images were acquired on a transmission electron microscope 
(JOEL 1200 EX) with side-mounted camera (AMTXR41 supported by AMT 
software v601) and analyzed with ImageJ (National Institutes of Health).
Preparation of oligonucleotide-based DNA substrates
DNA oligonucleotides were purchased from Microsynth and 32P-labeled 
either at the 5 terminus with [G-32P] ATP and T4 polynucleotide kinase (New 
England Biolabs), or at the 3 end with [A-32P] cordycepin-5-triphosphate 
and terminal transferase (New England Biolabs) according to manufacturer’s 
instructions. Unincorporated nucleotides were removed using MicroSpin 
G25 columns (GE Healthcare). The substrates were prepared by heating the 
respective oligonucleotides at 95°C and gradually cooling to room temperature. 
The following oligonucleotides were used for the preparation of the four- 
way junction (X12-3 TOP L, HJ 1, HJ 2, and HJ 3), three-way junction with 
3 tail (X12-3 TOP L, HJ 1, HJ 2Sb, and HJ 3), three-way junction with 5 ssDNA 
tail (X12-3 TOP L, HJ 1S, HJ 2, and HJ 3), nicked four-way junction (X12-3 
TOP L, HJ 1, HJ 2Sa, HJ 2Sb, and HJ 3), replication fork (X12-3 TOP L, HJ 
1S, HJ 2Sb, and HJ 3), and dsDNA (X12-3 TOP L and Bottom LC), respec-
tively. The sequences of the oligonucleotides were: X12-3 TOP L (93 nt), 
5-GACGTCATAGACGATTACATTGCTAGGACATGCTGTCTAGAGACTATC-
GCGACTTACGTTCCATCGCTAGGTTATTTTTTTTTTTTTTTTTTT-3 X12-3 HJ 1 
(93 nt), 5-AAAAAAAAAAAAAAAAAAATAACCTAGCGATGGAACGTA-
AGTCGCGATGGGCTTAACTAGGATGCTACTGGCCCCGAATCAACCGT-
ACTTGGG-3 X12-3 HJ 1S (48 nt), 5-AAAAAAAAAAAAAAAAAAAT-
AACCTAGCGATGGAACGTAAGTCGCGAT-3 X12-3 HJ 2 (93 nt), 
5-CCCAAGTACGGTTGATTCGGGGCCAGTAGCATCCTAGTT AAGCCCA-
TTACGATTCGTTACCCATTCACTGTCAGAAGGCACCAGATAGATCTC-3 
X12-3 HJ 2Sa (45 nt), 5-CCCAAGTACGGTTGATTCGGGGCCAGTAGCA-
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AATAGTCTCTAGACAGCATGTCCTAGCAATGTAATCGTCTATGACGTC-3 
X12-3 BOTTOM LC, 5-AAAAAAAAAAAAAAAAAAATAACCTAGCGAT-
GGAACGTAAGTCGCGATAGTCTCTAGACAGCATGTCCTAGCAATGTA-
ATCGTCTATGACGTC-3.
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 Figure S1.  DNA2 and WRN function in stalled fork processing. (A, left) Schematic of DNA fi ber tract analysis. (right) Quantifi cation of red tracts (stalled 
forks), green tracts (new origins), and contiguous red–green–red tracts (termination events). Proper quantifi cation of stalled forks is complicated by the fact 
that termination events might also lead to red tracts if termination occurs before the addition of the second label. Mean shown,  n = 3. Error bars, standard 
error. ns, not signifi cant; *, P < 0.05; **, P < 0.01; ***, P < 0.001 (paired Student’s  t test). (B, left) Expression of Flag-tagged WT (DNA2-WT) or nuclease-
dead (DNA2-D294A) DNA2 in DNA2-depleted U-2 OS cells. (right) Quantifi cation of stalled forks in DNA2-depleted cells expressing DNA-WT or DNA2-
D294A. Mean shown,  n = 3. Error bars, standard error. ns, not signifi cant; *, P < 0.05 (paired  t test). (C, top) Expression of RECQ1, WRN, DNA2, and 
tubulin in U-2 OS cells transfected with the indicated shRNA or siRNA. (middle) Statistical analysis of IdU tracts from U-2 OS cells depleted for the indicated 
proteins in the presence of 4 mM HU. (bottom) Statistical analysis of IdU tracts from U-2 OS cells depleted for the indicated proteins in the absence of drug 
treatment. Whiskers indicate the 10th and 90th percentiles. ns, not signifi cant (Mann-Whitney test).  n ≥ 300 scored for each dataset. (D, top) Expression 
of WRN after WRN knockdown and representative fi ber tract images in Luc- and WRN-depleted U-2 OS cells. Bar, 15 µm. Representative IdU tracts in 
WRN-depleted U-2 OS cells in the presence or absence of HU (out of 2 repeats;  n ≥ 700 scored for each dataset). 
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 Figure S2.  BLM or RECQ4 depletion does not have a signifi cant effect on stalled fork processing. (A) Representative IdU tracts in Luc-, RECQ1-, BLM-, or 
RECQ1/BLM-codepleted U-2 OS cells in the presence of HU (out of 2 repeats;  n ≥ 300 scored for each dataset). (top) Expression of RECQ1, BLM and tubu-
lin in U-2 OS cells transfected with indicated shRNA. (B) Representative IdU tracts in control, RECQ1-, RECQ4-, or RECQ1/RECQ4-codepleted U-2 OS cells 
in the presence of HU (out of 2 repeats;  n ≥ 350 scored for each dataset). (top) Expression of RECQ1, RECQ4 and tubulin in U-2 OS cells transfected with 
indicated shRNA. (C) Expression of RECQ1, DNA2-WT, DNA2-K671E, and DNA2-D294A in U-2 OS cells transfected with the indicated shRNA or siRNA. 
(D) Expression of RECQ1, WRN-WT, WRN-K577M, and WRN-E84A in WS cells. (E) Statistical analysis of IdU tracts from RECQ1-, WRN-, or RECQ1/
WRN-codepleted U-2 OS cells. The RECQ1/WRN-codepleted cells were complemented with WT or ATPase-defi cient (K577M) WRN, where indicated. 
Whiskers indicate the 10th and 90th percentiles. ns, not signifi cant; ****, P < 0.0001 (Mann-Whitney test). (F) Expression of RECQ1, WRN-WT, and 
WRN-K577M in U-2 OS cells transfected with the indicated shRNA. 
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 Figure S3.  DNA2 promotes ssDNA gap accumulation on replicated duplexes and the ATR-mediated checkpoint activation. (A) Frequency of fork reversal 
and ssDNA composition of the reversed arms in WRN- and/or DNA2-depleted U-2 OS cells in the presence and absence of HU. The percentage values 
are indicated on the top of the bar. “# RI” indicates the number of analyzed replication intermediates. (B) Representative electron micrographs of replication 
forks displaying ssDNA gaps on the replicated duplexes or at the replication fork junction observed on genomic DNA in shRECQ1 U-2 OS cells upon HU-
treatment. The black arrows point to ssDNA gaps. D, Daughter strand; P, Parental strand. (C) Statistical distribution of ssDNA gaps on newly replicated du-
plexes in RECQ1- and/or DNA2-depleted U-2 OS cells treated with HU (top) or in unperturbed conditions (bottom). “# RI” is the number of analyzed 
replication intermediates. (D) Western blot analysis of ATR-checkpoint activation (pChk1 and pRPA) in RECQ1- and/or DNA2-depleted U-2 OS cells with 
or without HU treatment. Total Chk1 and RPA level are displayed and used as loading control. (E) Schematic of the different structures detected by EM and 
DNA fi bers. EM is a static method, which enriches for snapshots of the “slow steps” of a reaction (i.e., partially resected reversed forks). After fork restart, 
the nucleolytic degradation quickly proceeds to degrade nascent strands behind the junction. Reannealing of the parental strands leads to “backtracking” 
of the fork. A new reversal event arises as a consequence of asymmetric degradation, and thus ssDNA accumulation in proximity to the fork. Backtracking 
is easily detected by DNA fi ber, but not by EM because a reversed fork formed after degradation and backtracking is indistinguishable from the original re-
versed fork present before initial degradation. 
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 Figure S4.  Human DNA2 but not EXO1 preferentially degrades branched DNA. (A) Degradation of a four-way junction by hDNA2 without human RPA 
(hRPA). Reaction products were separated on a native polyacrylamide gel (6%); *, position of the  32 P label. (B) Degradation of a three-way junction with 
a 5 ! ssDNA tail by hDNA2 in the presence of hRPA (22.3 nM). Reaction products were separated on a native polyacrylamide gel (6%); *, position of the 
 32 P label. (C) Same experiment as in B, but with a junction containing a 3 ! ssDNA tail. (D) RECQ1 K119R (ATPase-dead) inhibits four-way junction degrada-
tion by hDNA2. Increasing concentrations of RECQ1 (K119R) were preincubated with the substrate, and then hDNA2 (20 nM) was added to the reaction 
mixture. All reactions contained hRPA (65 nM). Reaction products were separated on a native polyacrylamide gel (6%); *, position of the  32 P label. 
(E) Quantitation of data from D. Averages shown ± SEM,  n = 2. (F) Synergistic action of hDNA2 and WRN on a nicked plasmid based DNA substrate. 
The reactions contained 614 nM hRPA and were incubated at 37°C for 60 min. Products were separated on a 1% agarose gel and stained with GelRed. 
WRN helicase promotes degradation of nicked DNA by hDNA2. (G) Same experiment as in F, but with a gapped DNA substrate. (H) Degradation of a 
four-way junction by hDNA2 and  S. cerevisiae Mer3. hDNA2 only degrades ssDNA unwound by Mer3, no synergy in DNA degradation was observed. 
All reactions contained hRPA, and were analyzed on a native polyacrylamide gel (6%). (I) Degradation of four-way junction by hDNA2 is not stimulated 
by WT hRECQ1. All reactions contained hRPA (65 nM). Reaction products were separated on a native polyacrylamide gel (6%). (J) Degradation of a four-
way junction by hEXO1. Reaction products were separated on a native polyacrylamide gel (6%); *, position of the  32 P label. (K) Same experiment as in J, 
but with dsDNA. 
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 Figure S5.  Yeast Dna2 but not Exo1 preferentially degrades branched DNA. (A) Degradation of a four-way junction by yDna2 in presence (left) or absence (right) 
of yeast RPA (yRPA). Reactions were separated on a native polyacrylamide gel (6%), *, position of the  32 P label. (B) Experiment as in A, but with dsDNA and yRPA. 
(C) Yeast Dna2 preferentially degrades four-way junctions in the presence of yRPA. Quantitation of data from A and B. Averages shown ± SEM;  n = 2. (D) yRPA 
promotes DNA degradation by yDna2. Quantitation of data from A. The data points representing the degradation of a four-way junction in the presence of yRPA 
are identical to those from C. Mean shown ± SEM,  n = 2. (E) Yeast Dna2 preferentially degrades branched structures over dsDNA. Quantitation of degradation 
of various DNA substrates as indicated (cartoons on the right) by yDna2 WT in presence of yRPA. Averages shown ± SEM;  n = 2. (F) Denaturing 20% polyacryl-
amide gel showing that nuclease-dead yDna2 E675A variant does not degrade the four-way junction substrate. (G) Synergistic action of yDna2 and Sgs1 helicase 
on a nicked dsDNA plasmid based substrates. The reactions contained 770 nM yRPA and were incubated at 30°C for 60 min before being separated on a 1% 
agarose gel containing GelRed. (H) Experiment as in G, but with gapped DNA substrate. (I) Degradation of a four-way junction by yExo1 in the presence (right) 
or absence (left) of yRPA. (J) Same experiment as in I, but with dsDNA. (K) Quantitation of data from I and J. Averages shown ± SEM,  n = 2. 
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Background: DNA end resection is a critical step in the homology-directed repair of DNA double strand breaks (DSBs).
Results: Human WRN helicase stimulates the DNA2-catalyzed resection of DNA ends and acts in concert with DNA2 to
promote DSB repair by single strand annealing.
Conclusion: DNA2 cooperates with WRN or BLM to mediate the resection of DSBs in mammalian cells.
Significance:Defects in DNA end resectionmight, in part, account for the genomic instability phenotype ofWerner syndrome.
The 5!-3! resection of DNA ends is a prerequisite for the
repair of DNAdouble strand breaks by homologous recombina-
tion, microhomology-mediated end joining, and single strand
annealing. Recent studies in yeast have shown that, following
initial DNA end processing by the Mre11-Rad50-Xrs2 complex
and Sae2, the extension of resection tracts is mediated either by
exonuclease 1 or by combined activities of theRecQ familyDNA
helicase Sgs1 and the helicase/endonuclease Dna2. Although
human DNA2 has been shown to cooperate with the BLM heli-
case to catalyze the resectionofDNAends, it remains amatter of
debate whether another human RecQ helicase, WRN, can sub-
stitute for BLM in DNA2-catalyzed resection. Here we present
evidence that WRN and BLM act epistatically with DNA2 to
promote the long-range resectionof double strandbreak ends in
human cells. Our biochemical experiments show thatWRN and
DNA2 interact physically and coordinate their enzymatic activ-
ities to mediate 5!-3! DNA end resection in a reaction depen-
dent on RPA. In addition, we present in vitro and in vivo data
suggesting that BLMpromotesDNA end resection as part of the
BLM-TOPOIII!-RMI1-RMI2 complex.Our studyprovidesnew
mechanistic insights into the process of DNA end resection in
mammalian cells.
DNA double strand breaks (DSBs)4 are a very dangerous
formofDNAdamage because they can cause cell death or chro-
mosomal rearrangements, a hallmark of cancer (1). DSBs can
occur accidentally during normal cellular metabolism or upon
exposure of cells to exogenous agents such as ionizing radiation
and radiomimetic drugs (2). There are also programmed DSBs
that drive recombination events essential for physiological pro-
cesses, such as meiosis and lymphocyte development (3, 4). In
eukaryotic cells, DSBs are repaired by one of two major path-
ways: non-homologous end joining (NHEJ) and homologous
recombination (HR). NHEJ involves religation of the broken
DNA ends and is frequently associated with a short deletion or
insertion of DNA at the break site (5). In contrast, HR restores
the DNA integrity accurately because it uses sister chromatids
or homologous chromosomes as a template for repair (6, 7). HR
is initiated by resection of the broken DNA ends to generate 3!
single-stranded (ss) DNA tails that are utilized by the RAD51
recombinase for a homology search on the donor DNA mole-
cule (6, 7). Genetic and biochemical studies in budding yeast
have shown that broken DNA ends are resected in a two-step
process (8–10). DNA end resection in yeast is initiated by the
Mre11-Rad50-Xrs2 complex in conjunction with Sae2 (8, 9,
11). These proteinsmay initiate resection of the 5! strand of the
brokenDNA to remove a stretch of about 100–200 nucleotides
from the DNA end (8, 9, 11). The Mre11-Rad50-Xrs2 complex
also recruits the components of the long-range resection path-
ways Exo1 or Dna2-Sgs1 (8–10, 12, 13). Exo1 is a dsDNA-de-
pendent 5!-3! exonuclease that preferentially degrades DNA
substrates with a 3! ssDNA tail in a reaction stimulated by the
ssDNA-binding protein RPA (13). Dna2 is a ssDNA-specific
nuclease and aDNAhelicase that functions in conjunctionwith
the RecQ family DNA helicase Sgs1 and RPA to catalyze long-
range DNA end resection (10, 14). In this reaction, RPA stimu-
lates DNA unwinding by Sgs1 and promotes degradation of the
5!-terminated strand by Dna2 while protecting the growing 3!
ssDNA tail (10). DNAend resection is also the initial step in two
other DSB repair pathways, single strand annealing (SSA) and
microhomology-mediated end joining (8, 15).
The molecular machinery of DNA end resection appears to
be largely conserved between yeast andman (15–19). However,
it remains a matter of debate which DNA helicase mediates
DNA2-catalyzed resection in mammalian cells. Mammals pos-
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sess five RecQ homologues: RECQ1, BLM, WRN, RECQ4, and
RECQ5 (20). Biochemical studies have shown that human
DNA2 can act in conjunction with the BLM helicase and RPA
to mediate 5!-3! resection of DNA ends in vitro (17). In agree-
ment with these findings, it has been observed that cells
depleted of both BLM and EXO1 show a reduction in the for-
mation of RPA foci in response to DSBs and are defective in
DSB repair by HR (16, 19). However, studies usingXenopus egg
extracts and purified proteins have shown that Dna2 mediates
DNA end resection together with WRN rather than BLM (21–
23). This discrepancy prompted us to investigate the role of
WRN in DNA end resection in human cells. Here we demon-
strate that WRN helicase is capable of acting in concert with
DNA2 and RPA to resect 5!-recessed DNA ends in vitro with a
catalytic efficiency even higher than that of BLM. Moreover,
our results show that human cells may employ either BLM or
WRN to assist DNA2 in long-rangeDNAend resection. Finally,
we present data suggesting that BLMacts inDNAend resection
as part of the BLM-TOPOIII!-RMI1-RMI2 (BTRR) complex.
EXPERIMENTAL PROCEDURES
Antibodies and siRNA—Primary antibodies used for immu-
noblotting were as follows: mouse monoclonal anti-WRN (BD
Biosciences, catalog no. 611169), rabbit polyclonal anti-DNA2
(Abcam, catalog no. ab96488), rabbit polyclonal anti-BLM
(Abcam, catalog no. ab476), rabbit polyclonal anti-TFIIH
(Santa Cruz Biotechnology, catalog no. sc293), mouse mono-
clonal anti-FLAG (Sigma, catalog no. F1804), and rabbit poly-
clonal anti-RMI1 (Proteintech, catalog no. 14630-1-AP).
Anti-FLAG M2 magnetic beads (Sigma) were used for immu-
noprecipitation. Primary antibodies used for immunofluores-
cence staining were as follows: mouse monoclonal anti-RPA2
(Abcam, catalog no. ab2175) and rabbit monoclonal anti-"-
H2AX (Cell Signaling Technology, catalog no. 9718S). Rabbit
polyclonal anti-WRN antibody used for immunoprecipitation
has been described previously (24).
All siRNA oligoduplexes used in this study were purchased
from Microsynth. The sequences of the sense strands of these
duplexes were as follows: siLuc, 5!-CGUACGCGGAAUAC-
UUCGAdTdT-3!; siWRN, 5!-UAGAGGGAAACUUGGCAA-
AdTdT-3!; siBLM, 5!-CCGAAUCUCAAUGUACAUAGAd-
TdT-3!; siDNA2, 5!-UACCGCUUAAAUCUAAGUCAAdTdT-
3!; siEXO1, 5!-CAGCCAUUCUUACUACGCUAAdTdT-3!;
siMRE11, 5!-GAGCAUAACUCCAUAAGUAdTdT-3! (25);
siCtIP, 5!-UCCACAACAUAAUCCUAAUdTdT-3! (26); and
siRMI1, 5!-AGCCUUCACGAAUGUUGAUdTdT-3! (27).
Plasmid Constructions—The human DNA2 (hDNA2) ORF
was amplified by PCRwithout the initiation and stop codons to
generate a fragment including ggatcc-hDNA2-ctcgag. After
digestion with BamHI and XhoI, the hDNA2 fragment was
cloned into pFLAG-CMV2 (Sigma) digested with BglII/SalI
(pFLAG-CMV2-hDNA2). The humanWRN(hWRN)ORFwas
inserted into pcDNA3.1/Hygro(") (Invitrogen) via the NheI
and DraI sites (pcDNA3.1-hWRN). The siRNA-resistant form
of this construct was generated by changing four nucleotides in
the siWRN-targeting region (T270C, A273G, G276C, and
A279G) using the QuikChange site-directed mutagenesis kit
(Stratagene).
Protein Purifications—Wild-type andmutant forms ofWRN,
BLM, EXO1, and RPAwere produced and purified as described
previously (28–31). The TOPOIII!-RMI1-RMI2 (TRR) com-
plex was a gift from Drs. Kata Sarlos and Ian Hickson (Univer-
sity of Copenhagen, Denmark). DNA2was produced as a fusion
with aHis6 tag (N terminus) and a FLAG tag (C terminus) in Sf9
cells using theBac-to-Bac baculovirus expression system (Invit-
rogen). The transfer vector for bacmid preparation was a gift
from Dr. Judith L. Campbell (32). The transfer vectors for
nuclease-deficient (D227A) and helicase-deficient (K654R)
mutants of DNA2 were generated using the QuikChange site-
directed mutagenesis kit (Stratagene). Sf9 cells expressing
DNA2 fusion proteins were harvested 52 h after infection (typ-
ically a 800-ml culture) and washed with PBS. All subsequent
steps were carried out at 4 °C. Pelleted cells were resuspended
in lysis buffer (25 mM Tris-HCl (pH 7.5), 2 mM #-mercaptoeth-
anol, 1# complete EDTA-free protease inhibitor (Roche), 1mM
phenylmethylsulfonyl fluoride, 30 $g/ml leupeptin, and 15 mM
imidazole) and incubated for 20min under continuous stirring.
Subsequently, glycerol and 5 M NaCl were added slowly to final
concentrations of 15% (v/v) and 300 mM, respectively, while
mixing the sample. The cell suspension was then incubated for
an additional 30 min under continuous stirring. The cell lysate
was centrifuged at 55,000 # g for 30 min to obtain soluble
extract, which was then incubated with 5 ml of nickel-nitrilo-
triacetic acid-agarose beads (Qiagen) for 1 h batchwise. The
resin was washed extensively with lysis buffer containing 10%
(v/v) glycerol and 1 M NaCl. The protein was eluted with lysis
buffer supplementedwith 10% (v/v) glycerol, 100mMNaCl, and
250 mM imidazole. Fractions containing detectable amounts of
protein, as measured by Bradford assay, were pooled, diluted
1:1 with TBS buffer (50 mM Tris-HCl (pH 7.5) and 150 mM
NaCl) and incubated batchwise with 1 ml of anti-FLAG M2
affinity resin (Sigma) for 30min. The resin was then transferred
to a gravity flow column and washed with TBS-PI buffer (TBS
buffer containing 1 mM #-mercaptoethanol and 5 $g/ml leu-
peptin). Elution of the protein was achieved by adding TBS-PI
buffer supplemented with 200 $g/ml 3# FLAG peptide
(Sigma). Fractions containing DNA2 were pooled, diluted with
0.5 volumes of water and 1 volume of AQ buffer (25 mM Tris-
HCl (pH 7.5), 100 mM NaCl, 10% (v/v) glycerol, and 5 mM
#-mercaptoethanol) and loaded onto a 1-ml HiTrap Q column
(GE Healthcare) pre-equilibrated with AQ buffer. The column
was washedwith AQbuffer andDNA2was eluted byAQbuffer
supplemented with 600 mM NaCl. Fractions containing DNA2
were identified by SDS-PAGE, pooled, and stored at "80 °C.
The activity of purified recombinant DNA2 proteins was tested
using a Y structure oligonucleotide duplexwith single-stranded
arms (10). In agreementwith previous reports, wild-typeDNA2
was found to be capable of degrading both ssDNA arms of this
structure (data not shown) (10, 17). In the presence of RPA, the
cleavage of the 3! ssDNA arm by DNA2 was inhibited, and
DNA2 degraded preferentially the 5! ssDNA arm (data not
shown) (10, 17). TheDNA2-D227Amutant did not contain any
nuclease activity, which indicated that the nuclease activity of
our wild-type DNA2 preparation was inherent to DNA2 (data
not shown).
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Nuclease andHelicase Assays—To test the activity of purified
DNA2, we used a 31-bp forked duplex with 19-nt ssDNA arms,
as described previously (10). The helicase activity of WRN and
BLM was tested using a 29-bp forked duplex generated by
annealing of the following oligonucleotides: f-9 (5!-ACTAT-
CATTC AGTCATGTAA CCTAGTCAAT CTGCGAGCTC
GAATTCACTG GAGTGACCT-3!) and f-10 (5!-GAGGT-
CACTC CAGTGAATTC GAGCTCGCAG TCAATGTCGA
CATACCTAGT ACTTTACTCC-3!). Both DNA substrates
were radiolabeled at the end of the 5! ssDNA arm.
Nuclease and helicase assays were performed in buffer con-
taining 25mMTris acetate (pH 7.5), 2mMmagnesium acetate, 1
mM dithiothreitol, 0.1 mg/ml BSA, 10.7 mM phosphocreatine,
and 0.02mg/ml creatine phosphokinase. Reactions (15!l) con-
tained 1nM 32P-labeled forkedDNAsubstrate and the indicated
concentrations of DNA2 orWRN/BLM.Where indicated, RPA
was present at a concentration of 6 nM. Reactions were assem-
bled on ice and started by addition of ATP to a concentration of
1 mM. Reactions were incubated for 30 min at 37 °C. Termina-
tion of the reactions was achieved by adding 1/3 volume of stop
solution (150 mM EDTA, 2% (w/v) SDS, 30% (v/v) glycerol, and
0.1% (w/v) bromphenol blue) and 1/15 volume of Proteinase K
(10 mg/ml), followed by incubation at 37 °C for 15 min. The
reaction products were separated by electrophoresis in a 10%
Tris borate-EDTA polyacrylamide gel. Gels were dried on
WhatmanMM3paper and analyzed by phosphorimaging using
a Typhoon 9400 scanner (GE Healthcare). Images were quan-
tified using ImageQuantTL software.
Construction of DNA Substrates for Resection Assays—The
DNA substrates used in resection assays were derived from the
plasmid pUC19 (2686 bp). The self-complementary oligonu-
cleotide, 5!-AGCT GCTGAGG GCTGAGG GCTGAGG
GCTGAGG AGGCCT CCTCAGC CCTCAGC CCTCAGC
CCTCAGC-3!, was annealed to form a duplex that was cloned
into the HindIII site of pUC19. This destroyed the HindIII site
and inserted a single recognition sequence for StuI (AGGCCT)
flanked on each side by four recognition sequences for the nick-
ase Nt.BbvCI (CC*TCAGC; the cleavage position is indicated
by the asterisk) that are oriented as an inverted repeat with
respect to the StuI site. The resulting pOH-S plasmid allowed
us to prepare a linear DNA substrate with 3! overhangs of 26
nucleotides (nt) in length. A blunt-ended substrate was gener-
ated by digestion of pOH-S with StuI (New England Biolabs),
followed by DNA purification using a Macherey Nagel Nucle-
oSpin! gel and PCR cleanup kit. The substrate with 26-nt 3!
overhangs was generated as follows. After digestion of pOH-S
with StuI and its heat inactivation, Nt.BbvCI (New England
Biolabs) was added, and the reaction was incubated further for
2 h at 37 °C. Subsequently, the reaction mixture was diluted six
times with water and incubated at 85 °C for 15 min. DNA puri-
ficationwas performed as described above. DNAconcentration
was determined using a NanoDrop ND-1000 spectrophotome-
ter (Witec AG).
DNA End Resection Assays—DNA end resection reactions
were carried out in a buffer containing 25 mM Tris acetate (pH
7.5), 2 mM magnesium acetate, 1 mM dithiothreitol, 0.1 mg/ml
BSA, 10.7 mM phosphocreatine, 0.02 mg/ml creatine phospho-
kinase, and 1 mM ATP. Reactions contained 2 nM DNA sub-
strate (molecules), 8 nMDNA2, 350 nMRPA (100%DNA strand
coverage, assuming all DNA was single-stranded), and various
concentrations of WRN or BLM as indicated. EXO1 was pres-
ent at a concentration of 20 nM. The reactions were assembled
on ice and initiated by the addition of ATP. Reaction mixtures
(15!l) were incubated at 37 °C for 60min in the case of protein
titration experiments. In time course experiments, 15-!l reac-
tion aliquots were withdrawn at defined time points as indi-
cated. Reactions were terminated as described for the helicase
assays. The samples were subjected to electrophoresis in a 1%
agarose gel run in 1" TAE buffer. Gels were post-stained with
SYBR Gold (Invitrogen) and analyzed using MultiImage Light
Cabinet (Alpha Innotech). To monitor resection by hybridiza-
tion of radiolabeled oligonucleotide probes, terminated reac-
tions (21!l) were divided equally into two tubes. 5! end-labeled
oligonucleotide probes were then added to a final concentra-
tion of 5 nM. This mixture was heated in an oven to 75 °C for 5
min and then slowly cooled down to room temperature over
2.5 h. Reaction products were separated by electrophoresis in a
1% agarose gel. Gels were dried on DE81 anion exchange paper
(Whatman) and subjected to phosphorimaging analysis using a
Typhoon 9400 scanner (GE Healthcare). Images were quanti-
fied using ImageQuantTL software. The relative concentration
of the resection products generated in WRN-DNA2 or BLM-
DNA2 reactions was calculated as a percentage of the product
generated in a reaction containing 20 nM EXO1 at the 2-min
time point, which led to 100% resection within the region
probed with radiolabeled oligonucleotides. Usually, the EXO1
reaction was loaded on each gel in triplicates. The following
oligonucleotides were used for the preparation of the hybrid-
ization probes: oligo#224, 5!-GGCCGTCGTTTTACAA-
CGTCGT-3! (it anneals to the 3!-terminated strand; annea-
ling position, 112–133 nt upstream of the StuI cleavage site; the
complementary sequence is underlined); oligo#227, 5!-GGCA-
TAGTTAAGCCAGCCCCGA-3! (it anneals to the 3!-termin-
ated strand; annealing position, 353–374 nt upstream of the
StuI cleavage site); and oligo#237, 5!-GGTCGGGGCTGGCT-
TAACTATG-3! (it anneals to the 5!-terminated strand; anne-
aling position, 122–133 nt upstream of the StuI cleavage site).
Oligonucleotides were 5! end-labeled using ["-32P]ATP andT4
polynucleotide kinase (New England Biolabs). The two non-
complementary dG residues at the 5! end of the oligonucleot-
ides were added to ensure equal labeling efficiency.
Cell Culture and Transfection—U2OS and HEK293 cells
were grown in DMEM (Sigma) supplemented with 10% fetal
calf serum (Invitrogen) and streptomycin/penicillin (100 units/
ml). Plasmid DNA was transfected using standard linear poly-
ethyleneiminemethod. Lipofectamine RNAiMAX (Invitrogen)
was used for siRNA transfection. To generate HEK293 clones
stably expressing FLAG-DNA2, cells were cotransfected with
pFLAG-CMV2-hDNA2 and pBABE-puro (Addgene) and sub-
jected to puromycin 1 (!g/ml) selection. Puromycin-resistant
clones were tested for expression of FLAG-DNA2 by Western
blotting.
Immunoprecipitation—HEK293 cells were transfected with
the pcDNA3.1-hWRN and/or pFLAG-CMV2-hDNA2 vectors.
Cells were harvested to lysis buffer (50 mM Tris-HCl (pH 8.0),
120 mM NaCl, 20 mM NaF, 15 mM sodium pyrophosphate, and
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0.5% (v/v) Nonidet P-40) supplemented before use with prote-
ase (Complete EDTA-free, Roche) and phosphatase (PhosS-
TOP, Roche) inhibitors, 2 mMMgCl2 and benzonase (50 units/
ml). Cells were sonicated briefly, and lysates were clarified by
centrifugation at 16,000 ! g for 30 min. Cell extracts (1 mg of
protein) were subjected to immunoprecipitation using anti-
FLAG M2 magnetic beads (10 !l) or Protein A/G Plus
UltraLink Resin (10 !l, Thermo Scientific) coated with rabbit
polyclonal anti-WRN antibody (10 !g), which was carried out
overnight at 4 °C. Immunoprecipitates were washed four times
with lysis buffer. Bound proteins were eluted by Laemmli sam-
ple buffer and analyzed by SDS-PAGE and Western blotting.
To test the interaction between purifiedWRN and DNA2 pro-
teins, 500 ng of each protein was mixed in 200 !l of NET-N100
buffer (10 mM Tris-HCl (pH 8.0), 1 mM EDTA, 100 mM NaCl,
and 0.5% (v/v) Nonidet P-40) and incubated at 4 °C for 4 h. As a
control, DNA2was incubated in the absence ofWRN. The pro-
tein mixtures were subsequently subjected to immunoprecipi-
tation using anti-WRN antibody (4 !g), which was carried out
at 4 °C for 2 h. Immunoprecipitates were washed four times
with NET-N100 buffer. Bound proteins were eluted by Laem-
mli sample buffer and analyzed by SDS-PAGE and Western
blotting.
GST Pulldown Assay—GST-tagged fragments of WRN were
produced in the Escherichia coli BL21-CodonPlus(DE3)-RIL
strain (Stratagene) and bound to GSH Sepharose 4B (GE
Healthcare) as described previously (24). As a control, beads
were coated with GST protein only. The beads were incubated
with 500 ng of purified His6-DNA2-FLAG protein in 400 !l of
NET-N100 buffer at 4 °C for 2 h. After extensive washing with
NET-N100 buffer, proteins bound to the beads were analyzed
byWestern blotting. Blots were first stained in Ponceau S solu-
tion (0.1% (w/v) Ponceau S and 5% (v/v) acetic acid) to visualize
WRN fragments and subsequently probed with anti-FLAG
antibody.
Reverse Transcription and Quantitative Real-time PCR—
Total RNA was isolated from cells using the RNeasy mini kit
(Qiagen). 200 ng of RNA was used for cDNA synthesis using a
high-capacity cDNA reverse transcription kit (Applied Biosys-
tems). The target gene expression level was determined by
quantitative real-time PCR that was performed on a ABI Prism
7300 (Applied Biosystems) using SYBR Select Master Mix
(Applied Biosystems). The following primer pairs were used
to determine EXO1 mRNA levels: 5"-ACCTCTAAGG
AACAAGGTTC-3" (forward) and 5"-AGGAGGAAGCTTTTC-
AGAATC-3" (reverse). The housekeeping gene RPLPO, used as
a control, was amplified with the following primers: 5"-CCAG-
TCTGGA GAAACTGCTG-3" (forward) and 5"-CAGCAG-
CTGGCACCTTATTGG-3" (reverse). The Pfaffl equation was
used for normalization and calculation of relative EXO1 ex-
pression levels in comparison with the control gene (33).
SA-GFP Reporter Assay—SA-GFP reporter assays were per-
formed as described previously (34, 35). HEK293/SA-GFP cells
were seeded in poly-L-lysine-coated 6-well plates at a density of
0.5 million cells/well. U2OS/SA-GFP cells were seeded in
6-well plates at a density of 0.25 million cells/well. The next
day, cells were transfected with appropriate siRNA (40 nM)
using Lipofectamine RNAiMAX (Invitrogen). After 24 h,
siRNA-transfected cells were transferred into a 12-well plate,
with 200,000 cells/well for HEK293/SA-GFP and 100,000 cells/
well for U2OS/SA-GFP. 44 h after siRNA transfection, cells
were transfected with 0.6 !g of the I-SceI expression vector
pCBASce (36) using linear polyethyleneimine and, 6 h later,
with appropriate siRNA (20 nM) using the standard calcium
phosphate method. 52 h after I-SceI transfection, cells were
harvested and subjected to flow cytometry analysis using LSRII
(BD Biosciences) and FlowJo software to determine the per-
centage of GFP-positive cells. The mean values obtained with
control siRNA (siLuc) samples were 0.9% for HEK293/SA-GFP
cells and 2.0% for U2OS/SA-GFP cells. To test the effect of
ectopic expression of WRN on SSA repair efficiency of WRN-
depleted HEK293/SA-GFP cells, the mutant form of the
pcDNA3.1-hWRN construct harboring silent mutations in the
siWRN-targeting region (0.6 !g) was cotransfected with
pCBASce (0.6 !g). The plasmid pcDNA3.1 was used as a con-
trol vector in these experiments. Cells were subjected to flow
cytometry analysis at 52 h after plasmid transfection.
Immunofluorescence Assays—U2OS cells transfected with
the indicated siRNAs were cultured on glass coverslips. 48 h
after siRNA transfection, cells were treated with 1 !M camp-
tothecin (CPT) for 1 h. After pre-extraction for 5 min on ice in
25 mM HEPES (pH 7.4) buffer containing 0.5% (v/v) Triton
X-100, 50 mM NaCl, 1 mM EDTA, 3 mM MgCl2 and 0.3 M
sucrose, cells were fixed with 4% (v/v) formaldehyde for 15min
at room temperature. Subsequently, cells were permeabilized
by soaking in 0.2% (v/v) Triton X-100 for 5 min at room tem-
perature.After blocking inPBS containing 10mg/mlBSA for 30
min at room temperature, fixed cells were incubated for 2 h at
room temperature with the indicated primary antibodies. The
slides were washed with PBS and incubated for 1 h at room
temperature with secondary antibodies diluted in blocking
solution (Alexa Fluor 568-conjugated goat anti-rabbit IgG and
Alexa Fluor 488-conjugated goat anti-mouse IgG (Invitrogen)).
After washing with PBS, coverslips were mounted using
Vectashield containing DAPI (Vector Laboratories). Auto-
mated image acquisition was performed using an Olympus
IX70 microscope equipped with the ScanˆR imaging platform.
A!40/1.3 numerical aperture objective was used. 10 z stacks at
a spacing of 0.3 !m were taken, and 100 images were acquired
for each sample. Analysis was performed using ScanˆR analysis
software. Nuclei were identified on the basis of theDAPI signal,
and RPA foci were identified on the basis of edge-based subob-
ject counts. At least 1000 cellswere analyzed for each condition.
RESULTS
DNA2 CanMediate DNA End Resection in Conjunction with
WRNHelicase—To test whether the humanWRN helicase can
mediate resection of broken DNA ends in concert with DNA2,
we purified these proteins to homogeneity and analyzed their
activities in vitro (Fig. 1A). WRN and BLM unwind DNA in the
3"-5" direction and require a 3" ssDNA tail for loading onto the
DNA substrate (37, 38). Therefore, we generated a derivative of
the pUC19 plasmid inwhich a StuI site was flanked on each side
by four recognition sites for the nicking endonuclease Nt.
BbvCI. Cleavage of this pUC19 derivative with StuI andNt.BbvCI
resulted in a 2.7-kb-long linear DNA molecule ending with 3"
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overhangs of 26 nt in length, whereas its cleavage by StuI alone
gave rise to a linear DNAmolecule with blunt ends. Processing
of the DNA substrates was monitored by agarose gel electro-
phoresis followed by SYBR gold staining (Fig. 1B). In addition,
32P-labeled synthetic oligonucleotides complementary to the
3!-terminated strand were used as hybridization probes to
detect ssDNA generated by resection at specific positions (Fig.
1B) (10). We found that WRN, together with DNA2 and RPA,
could catalyze efficient 5! end resection on the 3!-tailed sub-
strate but not the blunt-ended substrate (Fig. 1C). As expected,
no reaction products were detected with an oligonucleotide
probe complementary to the 5!-terminated strand, indicating
that the observed DNA resection activity is limited to the 5!
strand (Fig. 1D). Of note, the end product of the resection reac-
tion on the 3!-tailedDNA substrate appeared as a discrete band
onSYBRgold-stained gel thatwas clearly shiftedwith respect to
the unprocessed dsDNA substrate, indicating extensive resec-
tion (Fig. 1C, top panel, compare lanes 2 and 7). In contrast, no
gradual shift in the electrophoretic mobility of the resection
product was apparent after annealing of the radioactive probes.
This ismost likely due to the fact thatDNA2nuclease generates
short oligonucleotides that can reanneal to the resected DNA
along with the radioactive probe, leading to a DNA molecule
with an electrophoretic mobility similar to that of the DNA
substrate. Together, these results clearly demonstrate that
DNA2, in conjunction withWRN and RPA, can catalyze exten-
sive 5! end resection, providing that the DNA substrate con-
tains a 3! ssDNA overhang.
To further characterize the DNA end resection reaction
mediated by WRN-DNA2, reactions with the 3!-tailed sub-
strate were carried out at various WRN concentrations,
whereas DNA2 was kept at a concentration of 8 nM. We
observed that the amount of resection product increased grad-
ually with WRN concentration, reaching a plateau at about 10
nM (Fig. 1E, lanes 2–7, and Fig. 1F). Quantitative analysis of gel
images revealed that about 35% of the DNA substrate was
resected to the position of 133 nt from the 3! end and that about
15% of the DNA substrate was resected to the position of 374 nt
FIGURE 1.DNAend resection byDNA2 andWRN. A, SDS-PAGE analysis of purifiedWRN (0.7!g) andDNA2 (0.4!g) proteins. Gel was stainedwith Coomassie
Brilliant Blue R-250. Themolecular weights of protein standards are indicated on the left. B, schematic of the DNA end resection assay. The resection products
were either left untreated or hybridizedwith synthetic 32P-labeled oligonucleotides complementary to the 3!-terminated strand. DNA specieswere separated
by electrophoresis in a 1% agarose gel and visualized by SYBR gold staining and phosphorimaging, respectively. Probes complementary to the regions
spanning nt positions 112–133 and 353–374 (relative to the 3! end) were used in this study. Only a part of the DNA substrate is shown. C, time course of
resection of 3!-tailed (26 nt) and blunt-ended DNA substrates by DNA2 andWRN. Reactions were carried out at 37 °C and contained 2 nMDNA, 350 nM RPA, 10
nMWRN, and 8nMDNA2. Reaction products at the indicated timepointswere analyzed as outlined in B. The 112- to 133-nt probewas used in this analysis. Lane
1, heat-denatured substrate; lane 14, 3!-tailed substrate incubated with 20 nM EXO1 and 350 nM RPA for 2 min (R1); lane 15, blunt-ended substrate incubated
with 20 nM EXO1 and 350 nM RPA for 2 min (R2). D, directionality of DNA end resection by WRN-DNA2. Reactions were carried out at 37 °C for 60 min and
contained 2 nM 3!-tailedDNA substrate, 350 nM RPA, 8 nMDNA2, and 10 nMWRN. Resection productswere annealedwith radiolabeled oligonucleotide probes
complementary to either 3!-terminated (position 353–374 nt relative to the 3! end) or 5!-terminated (position 353–374 nt relative to 3! end) strand and
analyzed as in C. E, 5! end resection of 3!-tailedDNA substrate byWRN-DNA2 is dependent onWRN concentration and the presence of ATP and RPA. Reactions
were carried out at 37 °C for 60 min and contained, as indicated, 2 nM DNA, 350 nM RPA, 1 mM ATP, 8 nM DNA2, and different WRN concentrations. Resection
productsweredetectedusing the112–133-nt probe. F, dependenceofWRN-DNA2-catalyzed resectionof 3!-tailed substrate onWRNconcentration. Resection
at the positions of 112–133 nt and 353–374 nt from the 3! end of the DNA substrate wasmonitored. Reactions were carried out as in E. Relative concentration
of the resection product generated by WRN-DNA2 at each WRN concentration was calculated as a percentage of the product generated by 20 nM EXO1 after
2 min. Data are mean" S.D. (n# 3).
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within 1 h of incubation (Fig. 1F). Interestingly, a small amount
of resected product (1–2%) could also be detected in the
absence of WRN, suggesting that DNA2 itself could slowly
resect dsDNA ends, likely following RPA-mediated stabiliza-
tion of ssDNA ends generated by thermal fraying (Fig. 1E, lane
2). In the absence of DNA2, WRN was only capable of DNA
unwinding, as evident from the appearance of a fast-migrating
band (Fig. 1E, lane 8). The resection process catalyzed byWRN
and DNA2 was found to be dependent on the presence of ATP
and RPA, as expected for a helicase-driven reaction (Fig. 1E,
compare lanes 9–12).
WRN acts not only as a 3!-5! DNA helicase, but it also pos-
sesses a dsDNA-dependent 3!-5! exonuclease activity residing
in a separate domain located in the N-terminal portion of the
protein (39, 40). DNA2 functions as a 5!-3! helicase and a
ssDNA-specific endonuclease (32, 41). To define the functions
of the enzymatic activities of WRN and DNA2 in DNA end
resection, we carried out a set of resection reactions with the
3!-tailed pUC19 substrate where either WRN or DNA2 were
substituted with catalytically inactive mutants. We found that
the helicase-deficient mutant of WRN (K567M) failed to stim-
ulate DNA resection by DNA2, whereas the nuclease-deficient
mutant of WRN (E84A) behaved similarly as the wild-type
WRN in this reaction (Fig. 2, lanes 2–4). Substitution of DNA2
with its nuclease-deficient mutant (D277A) completely abol-
ished resection and stimulated unwinding of the plasmid sub-
strate (Fig. 2, lane 6). In contrast, the helicase-deficient mutant
of DNA2 (K654E) could resect the DNA substrate to the same
degree as the wild-type protein (Fig. 2, compare lanes 3 and 7).
These results indicate that DNA end resection mediated by
DNA2, WRN, and RPA is dependent on the helicase activity of
WRN and the endonuclease activity of DNA2.
DNA2 and WRN Interact Physically—Yeast Dna2 has been
shown to interact physically with Sgs1 (10). Likewise, BLM
forms a complex with human DNA2 (17). Therefore, we inves-
tigated whether human DNA2 interacts physically with WRN.
To this end, HEK293 cells were transfected with plasmids
expressing WRN and FLAG-tagged DNA2, respectively, and
complex formation between these proteins was tested by
immunoprecipitation using beads conjugated with anti-FLAG
M2antibody.We found thatWRNcoimmunoprecipitatedwith
FLAG-DNA2, indicating that these proteins form a complex in
vivo (Fig. 3A, lane 3). This interactionwas specific because anti-
FLAG beads did not immunoprecipitate WRN from an extract
lacking FLAG-DNA2 (Fig. 3A, lane 1). To further investigate
complex formation between WRN and DNA2, we generated a
stable HEK293 cell line expressing FLAG-DNA2. By immuno-
precipitation using anti-FLAG M2 beads or anti-WRN anti-
body, we found that FLAG-DNA2 formed a complex with
endogenousWRN in these cells (Fig. 3, B and C). Western blot
analysis indicated that the level of FLAG-DNA2 in these cells
was only slightly higher than that of endogenous DNA2, sug-
gesting thatWRN andDNA2 form a complex under physiolog-
ical conditions (Fig. 3B, top panel). Interaction between FLAG-
DNA2 and endogenous BLM was also detected as expected
(Fig. 3B) (17). The cellular concentration of these protein com-
plexes was not altered when cells were subjected to treatment
withCPT,which causes breakage ofDNA replication forks (Fig.
3B, lanes 2–5) (42). This suggests that the interaction of DNA2
with WRN and BLM in the cell is not dependent on DNA
damage.
To test whether WRN and DNA2 interact directly, purified
proteins were mixed and incubated at 4 °C for 4 h. Complex
formation between WRN and DNA2 was tested by immuno-
precipitation using anti-WRN antibody. We found that DNA2
coimmunoprecipitated with WRN. DNA2 was not present in
the immunoprecipitated material whether WRN was omitted,
confirming a direct protein-protein interaction (Fig. 3D). To
map the interaction site ofDNA2onWRN,we tested binding of
purified His6-DNA2-FLAG protein to variousWRN fragments
covering the entireWRNpolypeptide (Fig. 3E). TheWRN frag-
ments were produced in E. coli as fusions with a GST tag and
isolated on GSH-Sepharose beads. Using a GST pulldown
assay, we found that DNA2 bound specifically to a WRN frag-
ment including the core helicase domain (helicase/Zn2"-bind-
ing domains) and the winged helix domain (Fig. 3F, compare
lanes 1 and 4) a binding site of a number of other proteins
shown to interact withWRN (43, 44). DNA2 was also bound to
a fragment containing only the helicase core or to the C-termi-
nal portion of WRN starting at the beginning of the winged
helix domain (Fig. 3F, compare lanes 1, 3, 4, and 5). In contrast,
DNA2 did not bind theN-terminal portion ofWRN containing
the exonuclease domain (Fig. 3F, lane 2). Collectively, these
results suggest that there are at least two DNA2-interaction
sites on WRN: one located in the central helicase domain and
the other in the C-terminal region of WRN.
WRN-DNA2 Resects DNA Ends More Efficiently Than
BLM-DNA2—Next, we set out to compareWRNandBLMwith
respect to their abilities to resect DNA ends in concert with
DNA2 and RPA in vitro. Using a Y structure oligonucleotide
duplex (29 bp)with single-stranded arms (30 nt each), we found
that our preparations ofWRNandBLMexhibited similar levels
of specific helicase activity (Fig. 4A). For resection reactions, we
used the 3!-tailed DNA substrate that was readily processed by
FIGURE 2. 5! end resection of 3!-tailed DNA substrate by WRN-DNA2
depends on the helicase activity of WRN and the nuclease activity of
DNA2. Reactions were carried out at 37 °C for 60 min and contained 2 nM
DNA, 350 nM RPA, 1mM ATP, 8 nM DNA2, and 10 nMWRN. Resection products
weredetectedusing the112–133ntprobe.WRNHD, helicase-deficientmutant
of WRN (K567M);WRNND, nuclease-deficient mutant of WRN (E84A); DNA2HD,
helicase-deficient mutant of DNA2 (K654R); DNA2ND, nuclease-deficient
mutant of DNA2 (D277A).
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WRN-DNA2 in the presence of RPA (Fig. 1C). The extent of
DNA resection at various reaction time points was monitored
by annealing of radiolabeled oligonucleotide probes. These
experiments clearly showed that WRN-DNA2 resected the
DNA substrate at a much higher rate compared with BLM-
DNA2 (Fig. 4,B andC). Notably,WRN-DNA2-catalyzed resec-
tion to the position of 374 nt away from the 3! end was faster
than BLM-DNA2-catalyzed resection to the position of 133 nt
(Fig. 4, B and C). We also compared the activities of WRN-
DNA2 and BLM-DNA2 on blunt-ended DNA substrate in the
presence of RPA.We found that this DNA substrate was largely
refractory not only to processing by WRN-DNA2 but also to
processing by BLM-DNA2 (Fig. 4D, compare lanes 4 and 5 to
lanes 10 and 11). Taken together, we show that WRN-DNA2
resects DNA ends more efficiently than BLM-DNA2 in vitro.
Dissection of Pathways Involved in DNA End Resection in
HumanCells—To assesswhetherWRN is involved inDNAend
resection in vivo, we investigated the effect of its depletion on
the efficiency of SSA-mediated repair of endonuclease-induced
DSBs in cells that were either proficient or deficient for EXO1
and DNA2, respectively. For this epistasis analysis, we initially
used the human embryonic kidney cell line HEK293 stably
transfectedwith the SA-GFP reporter cassette consisting of two
truncated GFP gene alleles (5!GFP and Sce3!GFP) that form a
direct sequence repeat (280 bp) separated by a region of about
2.4 kb (Fig. 5A) (34, 45). SSA-mediated recombination between
these homologous sequences triggered by a DSB generated in
the distal GFP allele by the I-SceI endonuclease results in the
formation of a functional GFP gene (Fig. 5A). This requires
extensive DNA end resection to expose the complementary
ssDNA regions for annealing. The proteins of interest were
depleted from HEK293/SA-GFP cells by RNA interference.
Cells were subsequently transfected with an I-SceI expression
vector to create a DSB in the reporter cassette, and the percent-
age of GFP positive cells arising upon SSA-mediated repair was
determined by flow cytometry 2 days after plasmid transfec-
tion. We found that cells depleted of either EXO1, WRN, or
DNA2 exhibited a marked reduction in the frequency of SSA
repair events (55, 65, and 75%, respectively) compared with
mock-depleted cells (Fig. 5,B andC). In contrast, knockdownof
FIGURE 3. Physical interaction between DNA2 andWRN in vitro and in vivo. A, coimmunoprecipitation of WRNwith DNA2 from human cells. HEK293 cells
were transfectedwith vectors expressing FLAG-DNA2 andWRN as indicated. Cell extractswere immunoprecipitated (IP) with anti-FLAG antibody as described
under “Experimental Procedures.” Blotswereprobedwith the indicated antibodies. 5%of inputmaterialwas loaded.B, effect ofDNAdamageon the formation
of DNA2-WRN and DNA2-BLM complexes in human cells. HEK293 cells stably transfected with the FLAG-DNA2 construct (HEK293-D) were treated with 1 !M
CPT. At the indicated time points, complex formation between FLAG-DNA2 and endogenousWRN and BLM, respectively, was tested by immunoprecipitation
using anti-FLAG antibody. C, coimmunoprecipitation of DNA2 with WRN from human cells. Extracts from HEK293-D cells were subjected to immunoprecipi-
tationwith anti-WRNantibody or control IgG. The immunoprecipitateswere tested for the presence of FLAG-DNA2 andWRNbyWestern blotting. As a control,
a WRN immunoprecipitate from HEK293 cells was also analyzed (lane 3). D, coimmunoprecipitation of DNA2 with WRN from a mixture of purified proteins.
DNA2 (500 ng) was incubated with or without WRN (500 ng) at 4 °C for 4 h. The mixtures were subjected to immunoprecipitation with anti-WRN antibody. E,
domain organization of WRN. Exo, exonuclease domain; Zn, zinc-binding domain;WH, winged-helix domain; HRDC, helicase and RNaseD C-terminal domain.
Black lines indicateWRN fragments used for mapping the DNA2-interaction site onWRN. F, GST pulldown assay. Glutathione beads coated with the indicated
GST-tagged fragments ofWRNwere incubatedwith purifiedHis6-DNA2-FLAGprotein at 4 °C for 2 h, and boundproteinswere analyzed byWestern blotting as
described under “Experimental Procedures.” 1% of input was loaded in B and C, whereas 10% of input was loaded in D and F.
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BLM was found to be associated with a significant increase in
SSA repair efficiency (140%) comparedwith control cells (Fig. 5,B
andC).Ofnote, theSSArepairdefectofWRN-depletedcells could
be rescued by ectopic expression of the siRNA-resistant form of
WRN, excluding an off-target effect of theWRN siRNA used in
this study (Fig. 5D). Combined depletion of EXO1 andWRNor
EXO1 and DNA2 further decreased the repair efficiency com-
pared with the respective single depletions, whereas codeple-
tion of DNA2 and WRN did not (Fig. 5, B and C). In addition,
combined depletion of EXO1 and BLM had nearly the same
effect on the SSA repair efficiency as EXO1 depletion (Fig. 5, B
and C). Therefore, these findings suggest that HEK293 cells
have at least two pathways for long-range resection of DSB
ends: one mediated by EXO1 and the other dependent upon
DNA2 and WRN.
To substantiate these findings, we performed a similar set of
experiments using U2OS/SA-GFP cells (35). This analysis indi-
cated that combined depletion of EXO1 and DNA2 almost
completely abolished (reduced by 91%) SSA-mediated DSB
repair in U2OS/SA-GFP cells, as did depletion of MRE11 (by
89%) or CtIP (by 82%), suggesting that long-range DNA end
resection in U2OS cells is largely dependent on EXO1 and
DNA2 (Fig. 5, E–G). However, in contrast to the results
obtained with HEK293/SA-GFP cells, we observed a significant
reduction in SSA repair efficiency not only after depletion of
WRN (by 57%) but also after depletion of BLM (by 59%) (Fig. 5,
E and F). Codepletion of BLM andWRN further decreased the
repair efficiency to a level comparable with that in DNA2-de-
pleted (by 73%) cells (Fig. 5, E and F). Moreover, combined
depletion of DNA2 with either BLM or WRN had nearly the
FIGURE 4. Comparison of DNA end resection activities of WRN-DNA2 and BLM-DNA2. A, comparison of helicase activities of WRN and BLM. Reactions
contained 1 nM 32P-labeled forked DNA duplex (inset) and different concentrations ofWRN or BLM. Reactions were incubated at 37 °C for 30min, and reaction
products were quantified as described under “Experimental Procedures.” Data are mean! S.D. (n" 3). B, time course of resection of 3#-tailed DNA substrate
catalyzed by WRN-DNA2 and BLM-DNA2, respectively. Reactions contained 2 nM DNA, 350 nM RPA, 8 nM DNA2, and 10 nM WRN/BLM. Reaction aliquots
withdrawn at the indicated time points were subjected to electrophoresis on a 1% agarose gel after hybridization of radiolabeled probes complementary to
3#-terminated strand at the indicatedpositions. RadiolabeledDNA specieswere visualizedbyphosphorimaging.C, quantification of the reactions in B. Relative
concentration of resectionproducts generated at each timepointwas calculated as a percentageof theproduct generatedby 20nMEXO1after 2min. Data are
mean! S.D. (n" 3).D, processing of 3#-tailed (26 nt) and blunt-ended DNA substrates in reactions with indicated composition. Reactions were carried out at
37 °C for 60min and contained 2nMDNA, 350 nMRPA, and,where indicated, 8 nMDNA2, 20 nMWRN, and 20nMBLM. Reaction productswere analyzed as in Fig.
1C. Lane 1, heat-denatured substrate; lane 14, 3#-tailed substrate incubated with 20 nM EXO1 for 2 min (R1); lane 15, blunt-ended substrate incubated with 20
nM EXO1 for 2 min (R2).
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same inhibitory effect on SSA repair as DNA2 depletion (Fig. 5,
E and F). On the contrary, codepletion of EXO1 with either
WRN or BLM caused a much higher reduction in repair effi-
ciency than depletion of DNA2 alone, and triple depletion of
EXO1, BLM, and WRN brought repair efficiency down to the
level measured in cells depleted of EXO1 and DNA2 (Fig. 5, E
and F). Collectively, these data suggest that, in U2OS cells, both
WRNandBLMassist DNA2 tomediate long-range resection of
broken DNA ends.
To bolster our conclusion that DNA2, WRN, and BLM have
an epistatic relationship in DSB end resection, we extended our
analysis to measurement of RPA focus formation in U2OS cells
treated with CPT. As expected, 1 h after addition of CPT, RPA
formed numerous foci in !-H2AX-positive cells, which were
dependent on the presence of CtIP (Fig. 6). Depletion of DNA2
resulted in a marked reduction in the number of RPA foci per
cell compared with mock-depleted cells (Fig. 6). Cells depleted
of BLM or WRN displayed a mild decrease in RPA focus fre-
quency comparedwithmock-depleted cells (Fig. 6). In contrast,
combined depletion of BLM and WRN caused approximately
the same reduction in RPA focus frequency as depletion of
DNA2 alone. Moreover, cells depleted of DNA2 and BLM or
DNA2 andWRN displayed an RPA foci frequency comparable
with that of DNA2-depleted cells (Fig. 6). These data further
support the conclusion that DNA2,WRN, and BLM operate in
the same DNA end resection pathway.
Role of the BLM-TOPOIII"-RMI1-RMI2 Complex in DNA
End Resection—In human cells, BLM exists in a complex with
TOPOIII", RMI1, and RMI2, which is known to catalyze dou-
ble Holliday junction dissolution during HR (46–49). Studies
in yeast have shown that Top3" and Rmi1 are also required for
DNA-end resection in vivo and stimulateDNAend resection by
FIGURE 5.WRN and BLM interact epistatically with DNA2 to promote DSB repair by SSA in human cells. A, schematic of the SA-GFP reporter cassette.
SSA-mediated repair of a DSB at the I-SceI-cutting site results in the formation of a functional GFP allele. B, efficiency of SSA-mediated repair of I-SceI-induced
DSB in HEK293/SA-GFP cells treated with the indicated siRNAs. Cells were transfected with the appropriate siRNAs (40 nM) 2 days prior to transfection of the
I-SceI-expressing plasmid. The percentage of GFP-positive cells in each sample was measured by flow cytometry 2 days after I-SceI plasmid transfection and
taken as ameasure of DSB repair efficiency. The plotted values represent the relative repair efficiency calculated as a percentage of repair efficiencymeasured
in cells transfected with control siRNA (siLuc, 100%). Data are mean! S.D. (n# 3). C, Western blot analysis of extracts from HEK293/SA-GFP cells transfected
with indicated siRNAs under the same conditions as for SA-GFP reporter assays. Blots were probed with the indicated antibodies. D, rescue of the SSA-repair
defect of WRN-depleted HEK293/SA-GFP cells by expression of the siRNA-resistant variant of WRN. An SA-GFP reporter assay was performed as in B. TheWRN
plasmid (WRN) or empty vector (EV) were cotransfectedwith the I-SceI plasmid. E, efficiency of SSA-mediated repair of I-SceI-inducedDSB inU2OS/SA-GFP cells
treated with the indicated siRNAs. Experiments were performed as in B. F, Western blot analysis of extracts from U2OS/SA-GFP cells transfected with the
indicated siRNAs. Blots were probed with the indicated antibodies. G, quantitative real-time PCR showing that EXO1 mRNA levels are down-regulated by
specific siRNA. Data are mean! S.D. (n" 3).
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Sgs1-Dna2 in vitro by promoting the helicase activity of Sgs1 (9,
10, 14). Our study revealed that BLM-DNA2 resects DNA ends
less efficiently than WRN-DNA2 in vitro, whereas in vivo, at
least in U2OS cells, BLM and WRN appeared to contribute
equally to promote DNA end resection (Fig. 5E). Therefore, we
investigated whether BLM requires TOPOIII!, RMI1, and
RMI2 (TRR) to efficiently support DNA end resection by
DNA2. To this end, we first investigated the effect of a purified
TRR complex on DNA end resection by BLM-DNA2 in vitro
(Fig. 7A). We found that TRR enhanced resection of the
3!-tailed pUC19 substrate by BLM-DNA2 (Fig. 7,B andC, lanes
3–6). On the contrary, the TRR complex had no effect on DNA
end resection by WRN-DNA2 (data not shown). Moreover, it
could not enhance DNA end resection by DNA2 in the absence
of BLM (Fig. 7, B and C, compare lanes 2 and 7).
Next we tested the effect of depletion of RMI1 on the effi-
ciency of SSA-mediated repair of I-SceI-induced DSBs in
U2OS/SA-GFP cells. We found that RMI1 depletion reduced
the repair efficiency to the level displayed by BLM- or DNA2-
depleted cells (Fig. 7, D and E). Importantly, codepletion of
RMI1 with BLM or DNA2 did not further reduce the repair
efficiency compared with single depletions of these proteins,
suggesting that RMI1, BLM, andDNA2act in the samepathway
(Fig. 7, D and E). Collectively, these results suggest that, in
human cells, BLM promotes long-range DNA end resection as
part of the BTRR complex.
DISCUSSION
Here we present evidence suggesting that humanDNA2 acts
in conjunctionwith eitherWRNor BLM tomediate long-range
resection of broken DNA ends in vivo. Moreover, we show that
WRN helicase can cooperate with DNA2 and RPA to catalyze
resection of DNA ends in vitro, generating long 3!-terminated
ssDNA tails. Our study also reveals that bothWRN-DNA2 and
BLM-DNA2 require a 3! ssDNA overhang to efficiently initiate
DNA end resection in vitro, which is in agreement with the
“two-step” resectionmodel in which the initial 5! end trimming
is carried out by the MRE11-RAD50-NBS1/Xrs2 complex in
conjunction with CtIP/Sae2 (8, 9, 11, 19). In addition, we pres-
ent evidence that BLM and DNA2 interact epistatically with
RMI1 to mediate DNA end resection in vivo. Moreover, we
show that the TRR complex stimulates DNA end resection by
BLM-DNA2 in vitro. These data suggest that, in cells, BLM
mediates DNA end resection as part of the BTRR complex.
Our discovery of the involvement ofWRN inDNAend resec-
tion is consistent with the findings that WRN interacts physi-
cally with the MRN complex and accumulates at sites of DSBs
in human cells (50, 51). Moreover, it has been demonstrated
that WRN depletion leads to a marked reduction in the fre-
quency of RPA and BrdU/ssDNA foci formed in response to
ionizing radiation, indicative of a resection defect (52). A simi-
lar phenotype has been observed in DNA2-depleted cells (18).
Although the previous studies did not address the relationship
between WRN and DNA2, they demonstrated that these
enzymes act synergistically with EXO1 to promote DNA end
resection in human cells (18, 52). A role for WRN as a critical
DNA end resection factor is also consistent with the cellular
phenotype of Werner syndrome, a severe premature aging dis-
order caused by inherited mutations in the WRN gene (53).
Cells derived from Werner syndrome patients are character-
ized by non-homologous chromosome exchanges, termed var-
iegated translocation mosaicism, and large chromosomal dele-
tions that may result from aberrant DSB repair by NHEJ as a
consequence of a defect inDNA end resection (54–56). Indeed,
it is becoming clear that NHEJ accounts formost chromosomal
translocations in humans (57). Moreover, a role for DNA end
resection as the critical determinant of DSB repair pathway
choice is well established (58). Accumulating evidence suggests
that defects in homology-directed repair pathways, which are
dependent onDNAend resection, result in overuse ofNHEJ for
repair, leading to accumulation of chromosomal rearrange-
ments (57). However, it should be noted that WRN is also
known to promote DSB repair by the classical Ku-dependent
NHEJ (C-NHEJ) pathway to suppress microhomology-medi-
ated end joining (59, 60). This alternative end joining pathway is
capable of producing chromosomal translocations, particularly
when Ku-dependent NHEJ is deficient (57). Moreover, WRN
has been shown to be involved in the resolution HR intermedi-
ates (61, 62). Therefore, it seems that the genomic instability in
Werner syndrome is a consequence of multiple defects in DNA
repair pathways.
Our finding that the TRR complex stimulates DNA end
resection by BLM-DNA2 in vitro is consistent with previous
reports showing that the association of BLM with TOPOIII!
and RMI1 enhances its DNA unwinding activity, which drives
the BLM-DNA2-catalyzed resection reaction (17, 63). Simi-
larly, RMI1 and RMI2 have been shown to enhance the effi-
ciency of the BLM-TOPOIII!-mediated double Holliday junc-
tion dissolution reaction (48, 49, 64). It has also been shown that
RMI1 forms a complex with RPA and that this interaction is
essential for the stimulatory effect of RPA on double Holliday
junction dissolution by the BTRR complex (65). Therefore, it is
possible that a physical interaction between RMI1 and RPA
FIGURE 6. DNA2, WRN, and BLM act in the same pathway of DSB end
resection. A, frequency of camptothecin-induced RPA foci in nuclei of U2OS
cells depleted of the indicated proteins. Cells were transfectedwith appropri-
ate siRNAs and, 48 h later, treated with 1"M camptothecin for 1 h. Cells were
then detergent-extracted and fixed with formaldehyde. RPA and #-H2AX (a
marker of DNA damage) were visualized by indirect immunofluorescence.
DAPI was used to stain nuclei. The average number of RPA foci per #-H2AX-
positive cell was determined for each sample using an Olympus ScanˆR
screening station. The data points are mean " S.D. (n # 3). B, Western blot
analysis of extracts from U2OS cells transfected with indicated siRNAs. Blots
were probed with the antibodies indicated on the right.
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loaded on the 3!-terminated DNA strand during DNA2-cata-
lyzed resection might enhance the DNA unwinding processiv-
ity of the BTRR complex and, hence, increase the efficiency of
the resection reaction. However, it should be noted that the
stimulatory effect of the TRR complex on DNA end resection
by BLM-DNA2 in vitro was rather modest under our experi-
mental conditions. On the contrary, RMI1 depletion in U2OS/
SA-GFP cells reduced the efficiency of SSA-mediated DSB
repair to levels displayed byBLM-orDNA2-deficient cells, sug-
gesting that BLM requires RMI1 to promote DNA end resec-
tion in vivo. Of note, it has been shown that silencing of RMI1 or
RMI2 expression by RNA interference destabilizes both BLM
andTOPOIII! (47, 49). Therefore, it is evident that, in addition
to being important for the functional attributes of the BTRR
complex, RMI1 and RMI2 are indispensable for the structural
integrity of its components in vivo.
Although BLM depletion compromised SSA-mediated DSB
repair in U2OS/SA-GFP cells, it had an opposite effect on SSA
in HEK293/SA-GFP cells. Similarly, the efficiency of SSA-me-
diatedDSB repair inHEK293/SA-GFP cells was elevated signif-
icantly upon depletion of RMI1 (data not shown). These find-
ings suggest that, inHEK293 cells, the BTRR complexmight act
as an SSA suppressor, most likely through unwinding of the
annealed intermediate formed following DNA end resection.
Strikingly, we found that BLM concentration in HEK293 cells
was much higher than in U2OS cells (data not shown). There-
fore, it appears that the BTRR complex exerts an inhibitory
effect on SSAwhen its concentration in the cell exceeds certain
threshold.
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3.	  DISCUSSION	  
	  
DNA2	  homologues	  have	  been	  found	   in	  every	  eukaryotic	  organism	  tested	  to	  date	   including	  
yeast	   and	   humans	   (71,	   189,	   190).	   Yeast	   Dna2	   was	   characterized	   as	   a	   tripartite	   protein	  
consisting	  of	  an	  N-­‐terminal	  regulatory	  domain	  followed	  by	  a	  RecB-­‐like	  nuclease	  domain	  (66)	  
and	   a	   C-­‐terminal	   superfamily	   I	   helicase	   domain	   (71).	   The	   human	   homologue	   hDNA2	   only	  
contains	   the	   nuclease-­‐	   and	   helicase-­‐domain,	   as	   the	   N-­‐terminal	   domain	   is	   only	   found	   in	  
lower	  eukaryotes	  (69,	  139,	  191).	  DNA2	  has	  essential	  functions	  in	  all	  organisms	  tested	  so	  far,	  
which	  are	  dependent	  on	  its	  nuclease	  activity	  (77,	  139,	  191).	  yDna2	  seems	  to	  function	  non-­‐
enzymatically	  via	  its	  N-­‐terminal	  domain	  only	  in	  the	  S-­‐phase	  checkpoint	  in	  yeast	  (140).	  Yeast	  
cells	   expressing	   helicase-­‐deficient	   yDna2	  were	   viable	   under	   some	   growth	   conditions,	   but	  
very	   sensitive	   to	   DNA	   damaging	   agents	   (71,	   100).	   The	   essential	   function	   of	   yDna2	   was	  
ascribed	  to	   its	  function	  in	  Okazaki	  fragment	  processing	  on	  its	  own	  or	   in	  concert	  with	  Fen1	  
(58,	  60,	  69,	  91,	  102,	  103).	  However,	   the	   role	  of	  hDNA2	   in	   the	  DNA	  metabolism	  of	  human	  
cells	   is	   still	   a	   matter	   of	   discussion.	   Depletion	   of	   hDNA2	   in	   human	   cells	   led	   to	   genomic	  
instability	   monitored	   by	   the	   presence	   of	   aneuploid	   cells,	   interchromatin	   bridges,	  
micronuclei	  or	  the	  accumulation	  of	  cells	  in	  late	  S/G2	  phase	  (75,	  133).	  Such	  findings	  indicate	  
that	   hDNA2	   is	   important	   for	   successfully	   finishing	   DNA	   replication.	   However,	   neither	   the	  
kinetics	   of	   DNA	   replication	   nor	   the	   processing	   of	   Okazaki	   fragments	   were	   altered	   upon	  
hDNA2	  depletion	  (75),	  indicating	  that	  hDNA2	  helps	  to	  finalize	  DNA	  replication	  in	  an	  Okazaki	  
fragment	  processing	  independent	  manner.	  Upon	  the	  depletion	  of	  endogenous	  hDNA2	  only	  
the	  ectopic	  expression	  of	  wild	   type	  hDNA2	  could	   restore	   the	  normal	  phenotype	  while	   the	  
expression	  of	  either	  nuclease-­‐	  or	  helicase-­‐deficient	  hDNA2	  led	  to	  impaired	  DNA	  metabolism	  
indicating	  that	  both	  nuclease	  and	  helicase	  activities	  of	  hDNA2	  are	  essential	  (75).	  
Furthermore,	   cells	   overexpressing	   nuclease-­‐deficient	   hDNA2	   showed	   a	   more	   severe	  
phenotype	   then	   cells	   overexpressing	   helicase-­‐deficient	   or	   nuclease-­‐helicase-­‐deficient	  
hDNA2	  (75).	  This	  suggests	  that	  the	  helicase	  activity	  of	  hDNA2	  is	  toxic	  on	  its	  own.	  However,	  
such	   findings	   stand	   in	   contrast	   to	   biochemical	   reports	   showing	   that	   recombinant	   hDNA2	  
possesses	  only	  very	  limited	  or	  no	  helicase	  activity	  (112,	  114).	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3.	  1	  Biochemical	  activities	  of	  human	  DNA2	  
	  
Since	  genetic	  and	  cell	  biological	  studies	  could	  not	  entirely	  explain	  hDNA2’s	  essential	  role	  in	  
DNA	   metabolism,	   we	   decided	   to	   study	   the	   enzyme	   using	   biochemical	   approaches.	   I	  
expressed	  and	  purified	  wild	  type	  hDNA2	  and	  its	  mutant	  variants	  using	  improved	  purification	  
strategies	  that	  already	  helped	  to	  increase	  the	  amount	  and	  activity	  of	  the	  yeast	  protein	  (67,	  
70,	   103).	  We	   could	   recapitulate	   the	   nuclease	   activity	   of	   hDNA2	   degrading	   exclusively	   5’-­‐
terminated	  ssDNA	  in	  the	  presence	  of	  hRPA,	  which	  was	  in	  agreement	  with	  preceding	  studies	  
(112,	   114).	   In	   addition,	   we	   were	   able	   to	   show	   that	   hDNA2	   possesses	   a	   vigorous	   and	  
processive	  DNA	  unwinding	  activity	  dependent	  on	  ATP	  and	  hRPA.	  The	  helicase	  activity	  was	  
masked	   by	   the	   enzyme’s	   nuclease	   activity,	   meaning	   it	   was	   only	   detectable	   when	   the	  
nuclease	  was	  abolished.	  This	  is	  very	  similar	  to	  what	  was	  observed	  for	  the	  yeast	  enzyme	  (70).	  
DNA	  unwinding	  was	  only	  observed	  with	  oligonucleotide-­‐based	  DNA	  substrates	  that	  harbor	  
5’	   ssDNA	   and	   with	   plasmid-­‐based	   dsDNA	   substrates	   in	   the	   presence	   of	   hRPA	   (186).	   In	   a	  
collaboration,	  we	  could	  show	  that	  hRPA	  has	  the	  potential	  to	  melt	  dsDNA	  in	  a	  concentration-­‐
dependent	  manner	  (188).	  Such	  limited	  melting	  at	  the	  dsDNA	  substrates’	  end	  could	  provide	  
hDNA2	  with	  the	  required	  5’	  ssDNA	  that	  is	  required	  for	  the	  enzyme	  to	  load	  onto	  a	  substrate	  
and	   needed	   to	   initiate	   dsDNA	   unwinding.	   The	   structure	   of	   mouse	   DNA2	   shows	   that	   the	  
nuclease	  is	  positioned	  ahead	  of	  the	  helicase	  (118).	  The	  ssDNA	  needs	  to	  pass	  a	  narrow	  tunnel	  
containing	  the	  nuclease	  to	  reach	  the	  helicase	  of	  hDNA2.	  However,	   if	   the	  DNA	  substrate	   is	  
cleaved	   before	   accessing	   the	   helicase	   domain,	   unwinding	   could	   be	   prevented.	   This	   could	  
explain	   our	   finding	   that	   the	   strong	   helicase	   of	   hDNA2	   is	   unleashed	   only	   upon	   the	  
inactivation	   of	   the	   nuclease	   (186).	   Our	   conclusion	   that	   hDNA2	   exhibits	   a	   strong	   DNA	  
helicase	   activity	   could	   explain	   the	   severe	   phenotype	   generated	   by	   the	   expression	   of	  
nuclease-­‐deficient	   hDNA2	   in	   human	   cells	   (75).	  Upon	   the	   inactivation	   of	   the	   nuclease,	   the	  
helicase	  of	  hDNA2	  could	   lose	   its	   internal	   regulation	  mechanism	  and	  start	  unwinding	   in	  an	  
uncontrolled	  way.	  
Having	   established	   that	   the	   yeast	   and	   human	   DNA2	   polypeptides	   possess	   two	   different	  
enzymatic	  functions	  (70,	  186),	  it	  is	  of	  interest	  if	  and	  how	  the	  enzyme	  is	  regulated.	  
Unpublished	   results	   from	   our	   group	   indicate	   that	   yeast	   Dna2	   levels	   vary	   in	   a	   cell	   cycle-­‐
dependent	   manner	   being	   lowest	   in	   the	   early	   S	   phase	   and	   highest	   in	   late	   S/G2	   phase.	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Furthermore,	  yDna2	  gets	  sumoylated	  in	  late	  S/G2	  phase.	  Treatment	  of	  the	  yeast	  cells	  with	  
methyl	  methanosulfate	  (MMS)	  or	  bleomycin	  reduced	  the	  overall	  sumoylation	   in	  vivo.	  Such	  
post-­‐translational	   modifications	   are	   very	   likely	   to	   regulate	   proteins’	   activities.	   In	   vitro	  
sumoylation	  of	   recombinant	   yDna2	  did	  not	   affect	   the	  helicase	   activity	  while	   the	  nuclease	  
was	   reduced	   (M.	   Levikova	   and	   P.	   Cejka,	   manuscript	   in	   preparation).	   However,	   these	  
sumoylation	  sites	  were	  located	  to	  the	  regulatory	  N-­‐terminal	  domain	  of	  yDna2	  that	  is	  lacking	  
in	  the	  human	  polypeptide.	  This	  raised	  the	  question	  if	  a	  protein	  interacting	  with	  hDNA2	  could	  
play	  a	  similar	  role	  as	  the	  N-­‐terminal	  domain	  in	  yeast	  does?	  We	  set	  out	  to	  identify	  possible	  
interaction	   partners	   of	   hDNA2	   via	   an	   interaction	   pull-­‐down	   and	   subsequent	   mass	  
spectrometry	  analysis.	  We	  identified	  several	  enzymes	  potentially	  modifying	  hDNA2,	  but	  did	  
not	  yet	  investigate	  them	  in	  further	  detail	  (C.	  Pinto	  and	  P.	  Cejka,	  unpublished	  data).	  
Another	  possibility	   is	   that	   the	  activities	  of	  hDNA2	  are	  regulated	  via	   the	  redox	  state	  of	   the	  
iron-­‐sulfur	   cluster	   located	   in	   the	   nuclease	   domain	   (78,	   104,	   192).	   So	   far,	   the	   iron-­‐sulfur	  
cluster	   is	   believed	   to	   have	   structural	   features,	   but	   additional	   functions	   are	   unknown	   and	  
need	  to	  be	  determined.	  	  
	  
3.2	  The	  role	  of	  human	  DNA2	  in	  DNA	  end	  resection	  
	  
DNA2	  enzymes	  were	  shown	  to	  interact	  with	  cognate	  RecQ	  helicases	  to	  resect	  the	  DNA	  ends	  
required	   for	   the	  repair	  of	  DSBs	  via	  homologous	  recombination	   (39,	  104).	  The	   initial	   short-­‐
range	  resection	  is	  mediated	  by	  the	  MRN	  (MRX	  in	  yeast)	  complex	  together	  with	  CtIP	  (Sae2	  in	  
yeast)	  in	  human	  cells	  (107,	  109).	  For	  the	  subsequent	  long-­‐range	  resection	  two	  pathways	  are	  
proposed:	  either	  via	  EXO1/Exo1	  or	  via	  a	  RecQ	  homologue	  (Sgs1	  in	  yeast,	  BLM	  in	  human)	  and	  
DNA2	  (67,	  110,	  111,	  113,	  115,	  193).	  The	  helicase	  activity	  of	  Sgs1/BLM	  and	  the	  nuclease	  but	  
not	  the	  helicase	  function	  of	  DNA2	  were	  essential	  for	  resection	  (67,	  113,	  115).	  Results	  from	  a	  
collaboration	   indicated	   that	   in	  human	   cells	   hDNA2	  does	  not	  only	   interact	  with	  BLM	   (115)	  
but	   also	   with	   WRN,	   another	   RecQ	   helicase	   family	   member	   found	   in	   human	   cells	   (116).	  
Having	  established	  that	  hDNA2	  possesses	  a	  strong	  and	  processive	  helicase	  activity	  (186)	  and	  
knowing	  that	  hDNA2	  physically	  and	  functionally	  interacts	  with	  WRN	  and	  BLM	  helicases	  (115,	  
116),	  we	  decided	   to	  characterize	   these	   interplays	   in	  more	  detail.	   In	  electrophoresis-­‐based	  
assays,	  we	  could	  show	  that	  hDNA2	  and	  WRN/BLM	  synergize	   in	   the	  degradation	  of	  dsDNA	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substrates	  mimicking	  the	  ends	  of	  DSBs.	  Such	  synergies	  were	  only	  observed	  with	  hDNA2	  and	  
WRN/BLM	  but	  not	  with	  any	  other	  human	  RecQ	  homologues	  or	  yeast	  Sgs1,	   indicating	   that	  
the	  interplay	  is	  very	  specific.	  As	  expected,	  such	  resection	  reactions	  were	  fully	  dependent	  on	  
the	  helicase	  of	  WRN/BLM	  and	  the	  nuclease	  of	  hDNA2.	  To	  our	  surprise,	  the	  helicase-­‐deficient	  
version	   of	   hDNA2	   was	   not	   as	   efficient	   in	   dsDNA	   degradation	   as	   the	   wild	   type	   protein	  
indicating	  a	  role	  for	  the	  helicase	  activity	  (186).	  Resection	  assays	  are	  challenging	  to	  interpret	  
since	   DNA	   unwinding	   and	   cleavage	   can	   occur	   at	   the	   same	   time.	   Using	   nuclease-­‐deficient	  
hDNA2	  and	   focusing	  on	  helicase	  assays,	  we	  could	   show	   that	  WRN/BLM	  can	   stimulate	   the	  
hDNA2	   helicase	   in	   a	   non-­‐enzymatic	   but	   structural	   way	   and	   vice	   versa,	   the	  WRN	   or	   BLM	  
helicase	   activity	   is	   enhanced	   by	   the	   hDNA2	   helicase	   in	   a	   structural	   way	   (186).	   Such	   a	  
stimulation	  of	  BLM	  was	  already	  described	  in	  the	  literature	  (115).	  
We	  showed	  that	  the	  active	  helicase	  domain	  of	  hDNA2	  accelerates	  the	  degradation	  of	  ssDNA	  
especially	   under	   physiological	   conditions	  where	   the	   ssDNA	   is	   covered	   by	   hRPA	   (187).	  We	  
believe	   that	   the	  motor	   activity	   of	   hDNA2	  more	   likely	   acts	   as	   a	   ssDNA	   translocase	   than	   a	  
dsDNA	  helicase	  in	  eukaryotic	  cells.	  Interestingly,	  the	  ssDNA	  degradation	  capacity	  of	  hDNA2	  
is	   further	   increased	   by	   the	   presence	   of	   (catalytically	   inactive)	   WRN	   and	   BLM	   (187).	   We	  
supplemented	   these	  biochemical	  data	  with	   in	   vivo	   experiments	   in	   yeast	   showing	   that	   the	  
motor	   function	   of	   yDna2	   helps	   to	   accelerate	   DNA	   resection	   in	   such	   a	   setup	   as	   well.	  
Previously,	  the	  DNA2’s	  motor	  seemed	  dispensable	  for	  end	  resection	  in	  vivo	  and	  in	  vitro	  (67,	  
111,	  115,	  116).	  However,	  we	  believe	   that	   in	   these	  studies	  overexpressing	  DNA2	   in	  vivo	  or	  
using	   saturating	   concentrations	   in	   vitro	   circumvented	   the	   requirement	   for	   DNA2’s	  motor	  
activity.	   Of	   note,	   the	   amount	   of	   DNA2	   in	   cells	   needs	   to	   be	   tightly	   regulated	   since	   the	  
overexpression	  of	  yDna2	  led	  to	  cell	  cycle	  arrest	  (194).	  This	  further	  strengthens	  the	  idea	  that	  
cells	   require	   a	   processive	   but	   well	   balanced	   resection	  machinery.	   Together	   these	   results	  
propose	   a	  mechanism	   for	   DNA	   end	   resection	  where	   hDNA2	   forms	   a	   complex	  with	   either	  
WRN	  or	  BLM.	  The	  RecQ	  homologues	  WRN	  and	  BLM	  function	  as	   leading	  helicases	  traveling	  
on	  one	  DNA	  strand	  in	  a	  3’-­‐5’	  direction	  to	  unwind	  dsDNA.	  The	  presence	  of	  hDNA2	  and	  its	  5’-­‐
3’	  motor	  activity	  helps	  to	  speed	  up	  the	  unwinding.	  Subsequently,	  hDNA2	  nuclease	  activity	  
degrades	  the	  generated	  5’	  terminated	  ssDNA	  using	  its	  own	  motor	  activity	  to	  accelerate	  the	  
process	  (186,	  187).	  
In	   prokaryotic	   organisms	   the	   resection	   machinery	   can	   consist	   of	   several	   subunits	   that	  
interact	  and	  enhance	  their	  resection	  capacity	  synergizing	  in	  DNA	  degradation.	  For	  example,	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in	  E.	  coli	  RecBCD	  forms	  a	  complex	  using	  the	  RecB	  3’-­‐5’	  and	  RecD	  5’-­‐3	  helicases	  to	  unwind	  
dsDNA	  and	  RecB	  5’-­‐3’	  and	  3’-­‐5’	  nuclease	  to	  cleave	  the	  ssDNA	  (195-­‐197).	  In	  Bacillus	  subtilis	  
the	   AddAB	   resection	  machinery	   consists	   of	   one	   helicase	   (AddA)	   and	   two	   nucleases	   (3’-­‐5’	  
from	  AddA	  and	  5’-­‐3’	  from	  AddB,	  (198,	  199)).	   Interestingly,	  the	  AddB	  nuclease	  seems	  to	  be	  
similar	  to	  DNA2	  nuclease	  since	  both	  proteins	  contain	  an	  iron-­‐sulfur	  cluster	  (79).	  
	  
3.3	  Human	  DNA2	  and	  DNA	  replication	  
	  
The	  remodeling	  of	  damaged	  or	  stalled	  replication	  fork	  into	  a	  four-­‐way	  junction-­‐like	  structure	  
(or	   “chicken	   foot”	   structure)	  was	   proposed	   to	   be	   a	  mechanism	   to	   protect	   the	   replication	  
fork	  from	  further	  damage	  and	  to	  be	  a	  first	  step	  in	  the	  repair	  and	  restart	  of	  perturbed	  forks	  
(119,	  200).	  
Human	  DNA2	  was	  proposed	  to	  have	  a	  function	  in	  the	  completion	  of	  DNA	  replication	  beyond	  
the	  Okazaki	  fragment	  processing	  observed	  in	  yeast	  (58,	  60,	  69,	  75,	  91,	  102)	  and	  that	  DNA2	  
interacts	  with	  the	  replisome	  via	  And-­‐1	  (75,	  76,	  201).	  In	  a	  collaboration,	  we	  could	  show	  that	  
human	  DNA2	  interacts	  with	  WRN	  but	  not	  BLM	  to	  degrade	  reversed	  replication	  forks	  using	  
its	  5’-­‐3’	  nuclease	  activity	  and	  hence	  help	  to	  restart	  and	  complete	  DNA	  replication	  (65).	  This	  
reversed	   fork	   processing	   activity	   of	   hDNA2/WRN	   was	   tightly	   regulated	   by	   RECQ1	   in	   an	  
ATPase-­‐independent	   manner,	   most	   likely	   by	   binding	   to	   the	   reversed	   forks	   preventing	  
hDNA2’s	  nuclease	  access	  (65).	  Since	  the	  DNA2-­‐dependent	  pathway	  in	  DNA	  end	  resection	  is	  
redundant	  with	  the	  EXO1	  pathway	  (39,	  104,	  113,	  193)	  and	  hDNA2	  does	  not	  or	  only	  to	  a	  very	  
limited	  extent	  contributes	  to	  the	  processing	  of	  Okazaki	  fragments	  (75),	  the	  resolving	  of	  such	  
aberrant	   structures	   occurring	   during	   DNA	   replication	   could	   point	   towards	   an	   essential	  
function	  of	  hDNA2.	  
	  
3.4	  Human	  DNA2	  and	  cancer	  
	  
hDNA2	   was	   shown	   to	   have	   a	   multifaceted	   role	   in	   the	   development	   of	   cancer	   (76,	   202).	  
Replication	  stress	  in	  precancerous	  lesions	  can	  lead	  to	  high	  loads	  of	  DNA	  damage,	  especially	  
DSBs	  that	  activate	  the	  DNA	  damage	  response	  (DDR).	  hDNA2	  has	  pivotal	  roles	  in	  DSB	  repair	  
as	  well	  as	   in	  DNA	  replication	  and	   is	   therefore	   important	   for	  maintaining	  genomic	   integrity	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(65,	  75,	  76,	  116,	  186,	  202).	  Estrogens,	  as	  the	  primary	  female	  sex	  hormones,	  can	  stimulate	  
cell	   proliferation	   and	   induce	   DNA	   damage,	   thus	   are	   tumorigenic.	   Estrogen-­‐dependent	  
cancers	  such	  as	  breast,	  uterine	  and	  ovarian	  cancers	  are	  among	  the	  most	  dangerous	  cancers	  
in	  women	  (203).	  Upon	  the	  treatment	  of	  MCF7	  breast	  cancer	  cells	  with	  estradiol	  (the	  primary	  
type	   of	   estrogen)	   the	   expression	   of	   hDNA2	   was	   shown	   to	   be	   elevated	   (202).	   Correct	  
function	   of	   hDNA2	   in	   the	   DNA	   repair	   pathways	   can	   prevent	   mutations	   and	   genomic	  
instability	  and	  can	  counteract	  cancer	  development.	  However,	  estrogen-­‐dependent	  cancers	  
were	   shown	   to	   express	   hDNA2	   mutated	   in	   its	   nuclease	   and	   helicase	   domain	   (202).	  
Therefore,	   the	   expression	   of	  mutant	   versions	   of	   hDNA2	   could	   lead	   to	   genomic	   instability	  
and	  cancer	  development.	  
Continuous	  DNA	  damage	  response	  may	  trigger	  senescence	  or	  apoptosis	  and	  hence	  prevent	  
the	  formation	  of	  malignant	   lesions	  (204-­‐207).	  Coping	  with	  increased	  replication-­‐associated	  
DSBs	  to	  maintain	  the	  hyperactive	  DNA	  replication	  status	  is	  required	  for	  precancerous	  lesion	  
to	  develop	  to	  cancer.	  Human	  DNA2	  was	  reported	  to	  be	  overexpressed	  in	  a	  broad	  range	  of	  
cancers	  helping	  to	  alleviate	  replication	  stress	  and	  the	  overexpression	  was	  observed	  already	  
at	  an	  early	  stage	  of	  transformation	  (76).	  In	  breast	  cancer	  patients	  the	  expression	  of	  hDNA2	  
positively	   correlated	  with	   the	   probability	   to	   develop	  metastasis	   and	  negatively	   correlated	  
with	   overall	   survival	   (76).	   Depletion	   of	   hDNA2	   in	   breast	   cancer	   cell	   lines	   decreased	   the	  
xenograft	  growth	  in	  mice	  and	  reduced	  the	  formation	  of	  lung	  metastasis	  indicating	  a	  tumor-­‐
promoting	   role	   for	   hDNA2	   (202).	  While	   a	   complete	   knockout	   of	   DNA2	   led	   to	   embryonic	  
lethality	  in	  mice,	  heterozygous	  DNA2+/−	  mice	  showed	  higher	  cancer	  susceptibility	  than	  wild	  
type	  mice	  (77).	  Together	  these	  data	  indicate	  that	  hDNA2	  helps	  to	  prevent	  the	  accumulation	  
of	  mutations,	  maintain	  genomic	  integrity	  and	  prevent	  cancer	  development	  in	  normal	  cells.	  
However,	  in	  (pre-­‐)cancerous	  cells	  higher	  hDNA2	  levels	  can	  help	  to	  overcome	  high	  replication	  
stress	  and	  to	  escape	  senescence	  therefore	  triggering	  cell	  survival	  and	  cancer	  development	  
(202).	  
hDNA2	   is	   linked	   to	   many	   functions	   in	   the	   DNA	   metabolism	   and	   is	   implicated	   in	   cancer	  
development	   as	   described	   above.	   Such	   findings	   implicate	   that	   the	   enzyme	   could	   be	   a	  
putative	   target	   in	   anti-­‐cancer	   therapy.	   In	   fact,	   targeting	   the	   DNA	   damage	   response	   is	   in	  
focus	   for	   novel	   cancer	   therapies	  with	   PARP1	   inhibition	   in	   BRCA2	   negative	   cancers	   as	   the	  
best	   example	   (208).	  One	   small	  molecule	   inhibitor	  was	   described	   to	   interfere	  with	   hDNA2	  
nuclease	  and	  helicase	  function	  inhibiting	  its	  DNA	  end	  resection,	  reversed	  fork	  restarting	  and	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stalled	   fork	   over-­‐resection	   activities	   (209).	   Furthermore,	   the	   DNA2	   inhibitor	   sensitized	  
cancer	   cells	   to	   CPT	   treatment	   and	   showed	   synthetic	   lethality	   together	   with	   a	   PARP1	  
inhibitor	   (209).	   We	   showed	   that	   inhibiting	   the	   nuclease	   activity	   of	   hDNA2	   unleashes	   its	  
strong	   helicase	   activity	   (186)	   that	   could	   explain	   the	   toxic	   effect	   of	   expressing	   nuclease-­‐
deficient	  hDNA2	  in	  human	  cells	  (75).	  Cells	  expressing	  nuclease-­‐deficient	  hDNA2	  die	  very	  fast	  
during	   the	   course	   of	   an	   experiment	  while	   cells	   expressing	   the	   nuclease/helicase-­‐deficient	  
double	   mutant	   were	   maintained	   at	   constant	   levels	   (75).	   This	   raises	   the	   possibility	   that	  
subsequent	   mutation	   and	   inactivation	   of	   the	   helicase	   activity	   may	   lead	   to	   resistance	   of	  
future	   hDNA2	   nuclease	   inhibitors.	   The	   biochemical	   analysis	   of	   hDNA2	   in	   isolation	   and	   in	  
interplay	  with	   the	  RECQ	  helicases	  WRN	  and	  BLM	  will	  help	   to	  understand	   the	   functions	  of	  
these	   enzymes	   in	   normal	   and	   pathological	   DNA	   metabolism.	   In	   addition,	   the	   assays	  
developed	   in	   this	   work	   will	   be	   useful	   to	   develop	   and	   validate	   putative	   cancer	   treatment	  
agents.	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4.	  PERSPECTIVES	  
	  
Human	  DNA2’s	  role	  in	  cancer	  development	  seems	  to	  be	  ambiguous.	  In	  normal	  cells	  hDNA2’s	  
functions	  help	  to	  avoid	  genome	  instability	  and	  aberrant	  activity	  of	  hDNA2	  can	  increase	  the	  
risk	  of	  mutations.	  At	  later	  stages,	  high	  expression	  of	  hDNA2	  helps	  cancer	  cells	  to	  overcome	  
high	  replication	  stress	  and	  therefore	  give	  them	  a	  growth	  advantage.	  Working	  with	  hDNA2	  in	  
vivo	   is	   difficult	   since	   the	   protein	   is	   essential	   and	   has	   multifaceted	   roles	   in	   the	   DNA	  
metabolism.	   We	   used	   a	   biochemical	   setup	   to	   study	   hDNA2’s	   functions	   in	   a	   defined	  
reconstituted	  system.	  
We	  characterized	  the	  interplay	  of	  hDNA2	  with	  RPA	  and	  the	  RECQ	  helicases	  BLM	  and	  WRN.	  
We	  could	  show	  the	  synergy	  of	  these	  protein	  complexes	  in	  the	  degradation	  of	  DSB	  ends	  and	  
reversed	  forks.	   In	   future	  studies,	   it	  would	  be	   interesting	  to	   investigate	  the	   interaction	  and	  
interplay	  of	  hDNA2	  and	  BLM/WRN	  in	  more	  detail,	  for	  example	  defining	  specific	  interaction	  
sites	  and	  generate	  interaction-­‐deficient	  mutants.	  These	  can	  be	  analyzed	  in	  biochemical	  and	  
cellular	  assays.	  Most	  likely	  further	  proteins	  such	  as	  the	  MRN	  complex	  and	  TopoIIIa/RMI1/2	  
support	  hDNA2-­‐BLM/WRN.	   Supplementing	  our	   reactions	  with	   these	   complexes	   could	   give	  
additional	  information	  towards	  the	  understanding	  of	  DNA	  resection	  and	  its	  regulation.	  
More	   detailed	   mechanistic	   insights	   would	   offer	   possibilities	   to	   impede	   with	   hDNA2’s	  
functions	   in	   cancer	   cells.	   This	   could	   be	   achieved	   by	   preventing	   complex	   formation	   or	   by	  
specific	  inhibition	  of	  enzymatic	  activities	  and	  such	  interferences	  could	  lead	  to	  a	  reduction	  of	  
cancer	  cells’	  capability	  to	  proliferate.	  At	  the	  moment,	  we	  are	  testing	  various	  small	  molecule	  
compounds	  that	  specifically	  interfere	  with	  either	  DNA2’s	  DNA	  binding,	  nuclease	  or	  helicase	  
activity.	  Targeting	  DNA	  repair	  pathways	  with	  small-­‐molecule	  inhibitors	  blocking	  the	  function	  
of	  proteins	  involved	  is	  a	  growing	  field	  in	  cancer	  therapy.	  hDNA2	  and	  its	  cognate	  partners	  are	  
very	  interesting	  candidates	  to	  be	  inhibited	  and	  in	  the	  future	  screening	  for	  and	  validation	  of	  
potential	  inhibitors	  will	  be	  essential.	  My	  work	  gives	  a	  solid	  base	  for	  such	  drug	  development	  
strategies.	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